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Chromatin structure and epigenetic mechanisms play an important role in initiating and 
maintaining the intricate patterns of gene expression required for embryonic development.  
One such mechanism, DNA methylation (5mC), involves the chemical modification of 
cytosine bases in DNA and is implicated in maintaining patterns of transcription.  However, 
many fundamental aspects of DNA methylation are not fully understood, including the 
mechanisms by which it influences transcriptional states.  Recent data suggest functional 
links between DNA methylation and a second epigenetic mechanism that has important roles 
in transcriptional repression, the polycomb group (PcG) repressor system.  Here, I suggest 
that an intact DNA methylation system is required for the repression of many PcG target 
genes by influencing the genomic targeting of the polycomb repressor 2 complex (PRC2) 
and its signature histone modification, H3K27me3 (K27me3).  I demonstrate differential 
genomic localisation of K27me3 at gene promoter regions in hypomethylated mouse 
embryonic fibroblast (MEF) cells deficient for the major maintenance DNA 
methyltransferase, Dnmt1.  Globally, Dnmt1-/- MEFs have a higher level of the K27me3 
mark than controls, as assessed by western blot and immunofluorescence.  I observe 
increased K27me3 at a relatively small number of gene promoters in Dnmt1-/- MEFs that 
often are associated with high levels of DNA methylation in wildtype MEFs, consistent with 
the notion that DNA methylation is capable of antagonising PRC2 binding at certain loci.  
Conversely, I show that a large number of developmentally important genes that are 
normally repressed and highly bound by K27me3, including classic polycomb targets, the 
Hox genes, display dramatically reduced association with K27me3 in Dnmt1-/- MEFs.  Many 
of these genes, but not all, show reciprocal increases in promoter H3K4me3 modification 
and are transcriptionally de-repressed in Dnmt1-/- MEFs.  I suggest that these genes are 
mostly associated with CpG-rich promoters with low levels of DNA methylation in wildtype 
cells, implying that their silencing is not dependent on the canonical role of DNA 
methylation.  Consistent with the findings of recently published work, I suggest a working 
model where PRC2 binding in wildtype cells is restricted by CpG methylation.  According to 
this model, the differential genomic location of K27me3 in hypomethylated Dnmt1-/- MEFs 
is explained by a redistribution of PRC2 to normally DNA methylated, unbound loci, 
resulting in a titration effect and coincident loss of K27me3 from normal targets.  It was also 
apparent that certain PRC2-target genes, including the developmentally important Hox gene 
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clusters, are strongly affected in Dnmt1-/- MEFs, displaying striking loss of K27me3.  As 
intergenic transcription has been implicated in relief from polycomb silencing and abundant 
intergenic transcription has been reported within Hox clusters, I measured RNA expression 
at Hox clusters and a small number of other PcG target genes in Dnmt1-/- MEFs using high-
density tiling arrays.  In Dnmt1-deficient MEFs, widespread increases in intergenic 
transcription were observed within Hox clusters.  In addition, mapping of the elongating-
polymerase-associated H3K36me3 histone modification showed widespread increases in this 
mark at intergenic and promoter regions in Dnmt1-/- MEFs.  Increased local intergenic RNA 
and H3K36me3 were found to correlate with K27me3 loss for this cohort of genes.  I suggest 
a working model where increased intergenic transcription and H3K36me3 in Dnmt1-/- MEFs 
leads to accelerated loss of K27me3 at certain loci, including Hox clusters.  Taken together 
with recently published data, this work suggests that a major role of DNA methylation is in 
shaping the PRC2/K27me3 landscape.  The potential implications of this putative role for 
DNA methylation are widespread, including our knowledge of how DNA methylation 
influences transcriptional regulation, and the consequence of rearranged DNA methylation 
patterns that are observed in many diseases including cancers. 
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Chapter 1 - Introduction 
  
1
A major challenge of molecular biology is to decipher the molecular organisation of 
eukaryotic genomes and to establish the role that it plays in coordinating gene expression.  In 
eukaryotes, nuclear DNA is complexed with small basic scaffold proteins and other protein 
components in a structure referred to as chromatin.  Chromatin organisation occurs at 
multiple levels within the nucleus and is dynamic allowing it to play a crucial role in the 
regulation of DNA-dependent processes such as transcription (reviewed in Li et al., 2007).  
Considerable effort has been applied to the study of chromatin organisation in recent years 
and while we are beginning to understand some of the processes involved, many 
fundamental questions remain unanswered.  Of particular interest are the mechanisms by 
which chromatin organisation contributes to the complex regulation of gene transcription 
necessary for multi-cellular life.  Mammalian development involves the specification and 
maintenance of over 200 cell types, via multiple developmental transitions, that originate 
from one original totipotent cell (Hochedlinger and Plath, 2009).  During development, 
transcriptional changes are initiated by the action of transcription factor networks.  Changes 
in chromatin structure occur in response to this process and can contribute to the 
maintenance of transcription states (Li et al., 2007).  The term 'epigenetics' is often used to 
describe processes involved in regulating genome activity that are independent of changes in 
DNA sequence (Bird, 2007).  However, the meaning of this term is often confounded, 
perhaps owing to both the ambiguity of this definition and the existence of multiple 
definitions.  The term 'epigenetic' was more precisely defined as a mechanism involving; 'the 
structural adaptation of chromosomal regions so as to register, signal or perpetuate altered 
activity states' (Bird, 2007), and this latter definition is assumed to be the definition of 
epigenetic mechanisms throughout this thesis.  Eukaryotic cells could be said to have a 
memory, imparted by epigenetic mechanisms, that contributes to their maintenance of gene 
transcription patterns through time and/or cell divisions.  A detailed comprehension of 
epigenetic mechanisms is therefore key to understanding how patterns of gene expression are 
maintained in normal development and how these processes malfunction in human disease.  
In this chapter I will begin by briefly discussing examples of how epigenetic mechanisms are 
involved in gene regulation, followed by a more detailed review of our knowledge of two 
such mechanisms, DNA methylation and the polycomb-group (PcG) repressor system, which 
are the subjects of this thesis.  
2
1.1.  Epigenetic regulation of transcription 
 
 
In humans, approximately two metres of DNA is packed into the nucleus (Alberts et al., 
2002).  It is believed that this level of compaction is achieved by multiple levels of 
chromatin organisation.  This organisation is currently better understood at the lower levels 
(i.e. the nucleosome) while the higher levels of chromatin organisation remain relatively 
obscure.  This thesis focuses on mechanisms that are thought to act mainly at the lower 
levels of chromatin organisation and therefore higher levels of organisation will only be 
touched upon.  The primary level of chromatin compaction is achieved by wrapping DNA 
around a protein scaffold formed, in most eukaryotes, by histone proteins.  This fundamental 
repeating unit of chromatin is the nucleosome, DNA associated with an octomer of histone 
proteins (Burlingame et al., 1985; Luger et al., 1997).  The core particle is the name given to 
146bp of DNA wrapped ~1.7 times around the histone octomer (Burlingame et al., 1985; 
Luger et al., 1997; van Holde and Zlatanova, 1999).  The histone octomer itself is composed 
of two molecules of each of the four types of histone protein.  In most eukaryotes, 
nucleosomes are generally composed of the core histones, H2A, H2B, H3 and H4 
(Burlingame et al., 1985; Luger et al., 1997).  The core histones each have a distinct C-
terminal, structured, globular domain and a flexible, unstructured N-terminal tail which 
protrudes from the nucleosome (Schroth et al., 1990; Luger et al., 1997).  In addition to the 
nucleosomal histones, linker histones form part of chromatin and are thought to influence its 
structure at a higher level.  Mammalian genomes encode many linker histone genes that code 
for proteins of the H1 and H5 histone families that are structurally distinct from nucleosomal 
histones (reviewed in McBryant et al., 2010).   
 Importantly, chromatin organisation is dynamic and variable across different regions 
of the genome and between cell types.  Many mechanisms have been proposed to influence 
gene expression through chromatin dynamics.  A very brief overview of some of the best 
studied mechanisms is given here.   
 Firstly, nucleosomes can be mobile on the DNA template meaning that nucleosome 
positioning can be variable (Pennings et al., 1991).  RNA polymerase activity is thought to 
be inhibited by packaging DNA into nucleosomes (Huang and Bonner, 1962; Allfrey et al., 
1963) and some DNA binding factors are thought to be inhibited by the positioning of a 
nucleosome over their recognition site (Almer et al., 1986; reviewed in Cairns, 2009), 
leading to the opinion that nucleosome positioning can influence transcription.  In support of 
this idea, gene promoters and enhancer regions often contain a nucleosome depleted region 
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that can be constitutive and mediated by DNA sequence elements or variable and dependent 
on nucleosome remodelling factors (Struhl, 1985; reviewed in Cairns, 2009).  Indeed, 
proteins that use ATP to reposition or eject nucleosomes, nucleosome remodelers, are often 
required to establish and maintain patterns of transcription (Whitehouse et al., 1999; Lorch et 
al., 1999; reviewed in Cairns, 2009).  Also, a characteristic pattern of nucleosome 
positioning exists downstream of transcription start sites that is established, at least in part, 
by active ATP-dependent mechanisms, not transcription itself, highlighting the importance 
of nucleosome positioning out with of promoter regions (Zhang et al., 2011a).   
 Secondly, variants of histone proteins can be incorporated into nucleosomes and 
affect chromatin structure by possessing different molecular properties from their core 
histone analogues.  All of the core histones, with the exception of H4, have known variants 
in mammals (reviewed in Banaszynski et al., 2010).  Variants can contain minor sequence 
differences, such as the variant of H3, H3.3, or significant structural differences, such as 
macroH2A (Pehrson and Fried, 1992; reviewed in Banaszynski et al., 2010).  Histone 
variants appear to play crucial roles in chromatin structure and transcriptional regulation.  
For example, the H2A variant, H2A.Z, is essential for mouse embryogenesis (Faast et al., 
2001).  H2A.Z is abundant in chromatin and was found to be present primarily at promoter 
regions in the yeast Saccharomyces cerevisiae (Zhang et al., 2005).  H2A.Z has many 
proposed functions including promoting gene activation by increasing access to DNA 
(Zhang et al., 2005) and, conversely, in heterochromatin formation (Rangasamy et al., 2003). 
 Thirdly, linker histones are thought to influence chromatin structure.  In vitro, it is 
well established that linker histones affect chromatin structure by promoting the conversion 
of a heterogeneous population of nucleosomal arrays into a 30nm fibre, an enigmatic higher 
order chromatin structure (Thoma et al., 1979).  This chromatin compaction appears to be 
achieved by the ability of linker histones to bind inter-nucleosomal DNA, termed linker 
DNA, at the nucleosomal DNA entry/exit sites (Buckle et al., 1992; Thomas et al., 1992; 
reviewed in McBryant et al., 2010).  The relative amount of linker histones in chromatin has 
been linked to transcriptional regulation as actively transcribed chromatin regions are 
thought to be depleted of linker histone relative to inactive regions (Woodcock et al., 2006; 
reviewed in McBryant et al., 2010).  However, the role of linker histones in gene expression 
remains unclear as embryonic stem cells with depleted histone H1 showed only a small 
number of gene expression changes despite dramatic changes in chromatin structure (Fan et 
al., 2005).  
 Fourthly, histones are subject to a wealth of post-translational modifications, most of 
which occur within the unstructured N-terminal tails, many of which are associated with 
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transcriptional states (Cao et al., 2002; reviewed in Kouzarides, 2007).  Currently, there are 
~100 different histone modifications identified, many of which are proposed to influence the 
presence of others, highlighting the complexity of this level of chromatin structure, 
sometimes referred to as the 'histone code' (Turner, 2000; Jenuwein and Allis, 2001; Tan et 
al., 2011).  Among the well studied histone modifications with respect to gene regulation are 
methylation and acetylation of lysine residues.  Modifications of histones are thought to 
influence chromatin structure in two ways; (1) by affecting nucleosome-nucleosome or 
nucleosome-DNA interactions directly, or, (2) by influencing the binding of proteins to 
chromatin (reviewed in Kouzarides, 2007).  Acetylation of lysines was predicted to cause 
local decompaction of chromatin by neutralising the basic charge of the lysine residue, hence 
affecting its interactions.  Indeed, acetylation of H4K16 inhibits both the formation of the 
30nm fibre and the binding of an ATP-dependent chromatin remodeler, ACF, in vitro, 
fulfilling both of the proposed functions of a histone modification (Shogren-Knaak et al., 
2006).  A conserved protein domain, the bromodomain, has been identified that binds to 
acetylated lysine and is present in many proteins with roles in transcriptional regulation  
(Tamkun et al., 1992).  In addition, mapping of histone acetylation has shown that it is 
generally a marker of active gene promoters (Kurdistani et al., 2004; reviewed in Choi and 
Howe, 2009) contributing to the idea that histone acetylation is tightly coupled with the 
process of transcription initiation.  Recently, histone acetylation at the lysine 27 (K27) of the 
histone H3 tail has been shown to be present at enhancer elements in mammals, particularly 
at 'active' enhancers, expanding our view of the roles of histone acetylation outside of 
annotated gene promoters (Creyghton et al., 2010; Rada-Iglesias et al., 2011).  It is 
interesting to speculate that histone acetylation at active enhancers serves a similar purpose 
as the proposed role at gene promoters, by allowing for a more open chromatin structure that 
is more compatible with protein-DNA interactions.  In contrast to lysine acetylation, lysine 
methylation has been associated with roles in both gene activation and repression depending 
on the particular lysine residue that is modified and the location of the modification relative 
to genes.  For example, di- and tri-methylation of lysine at position 9 of histone H3 
(H3K9me2 and H3K9me3) are associated with transcriptional repression when present at the 
promoter region of genes (reviewed in Kouzarides, 2007).  H3K9me3 is required for the 
formation of large nuclear heterochromatin compartments, such as pericentromeric 
heterochromatin (Schotta et al., 2004), and is also linked to the repression of genes in 
euchromatic regions of the genome (Tachibana et al., 2002).  Another well studied form of 
lysine methylation is H3K27me3 which is deposited by polycomb group proteins.  This 
modification will be discussed in detail in a later section of this chapter. 
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 In addition to post-translational modification of histone proteins, chromatin can be 
modified on DNA molecules, in the form of DNA methylation, and this can contribute to the 
regulation of transcription.  The following section summarises our knowledge of the DNA 
methylation system and its role in gene regulation. 
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1.2.  DNA methylation 
 
 
1.2.1.  The mark 
 
In mammals, the cytosine nucleotide of DNA can exist in at least three forms including (but 
not exclusive to) un-modified cytosine, methyl-cytosine and hydroxymethyl-cytosine, 
representing the only known modifications of DNA to date (reviewed in Bird, 2011).  
Methyl-cytosine (5mC) is formed by the addition of a methyl group to the 5' carbon of the 
pyrimidine ring of cytosine, a reaction catalysed by DNA methyltransferases (Fig. 1.1).  
Hydroxymethyl-cytosine (5hmC) is catalysed by the hydroxylation of methyl-cytosine by 
enzymes of the Tet (Ten Eleven Translocation) family (Fig. 1.1).   
 
 
Figure 1.1 - The three major forms of the cytosine base.  Cytosine can be converted to 
methyl-cytosine by DNA methyltransferases (DNMTs) with co-factor S-adenosyl methionine 
(SAM).  Methyl-cytosine can be hydroxylated to form hydroxymethyl-cytosine by Ten-
eleven-translocation (TET) family proteins in the presence of α-keto gluterate (αKG) and 
oxygen.  Other modified forms of cytosine have been identified but are present at very low 
levels where identified so far.   
 
 In animals, 5mC, herein referred to as DNA methylation, exists mainly where 
cytosine is adjacent to guanosine in a 5'-CG-3' context, although it has been reported in other 
sequence contexts (discussed in 1.2.4.7).  In vertebrates, it is estimated that 70-80% of 
cytosines in the CG context are methylated (5mC) with the exception of CpG islands, 
stretches of CpG- and GC-rich DNA, leading to an overall bimodal distribution of the mark 
(reviewed in Ndlovo et al., 2011).  Importantly, the methyl group of 5mC lies within the 
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major groove of B-form DNA and so does not change base pairing properties of the DNA 
template (see for example Ohki et al., 2001).   
 DNA methylation is proposed to play crucial roles in the regulation of transcription 
and the formation of epigenetic memory.  This, in addition to our knowledge of its 
distribution, mechanisms of action and dynamics are discussed in the following sections.        
 
1.2.2.  The mediators - DNA methyltransferases 
 
The enzymes responsible for catalysing methylation (5mC) of cytosine are DNA 
methyltransferases (DNMTs).  The reaction mechanism of the DNMTs requires a methyl 
donor, S-adenosyl methionine (SAM) and is thought to occur as follows (O'Gara et al., 1996; 
reviewed in Goll and Bestor, 2005).  A covalent bond is formed between a conserved 
cysteine residue of the methyltransferase and the C6 carbon of the cytosine ring and 
protonation of the N3 position results in a reactive intermediate which attacks the methyl 
group of SAM leading to methyl transfer to the C5 position of cytosine (Santi et al., 1983; 
Chen et al., 1991).  Subsequently, the enzyme is released through β elimination (O'Gara et 
al., 1996; reviewed in Goll and Bestor, 2005).  This reaction depends on six amino acid 
motifs, that are well conserved in all 5'-cytosine methyltransferases, that are involved in the 
processes described above (reviewed in Goll and Bestor, 2005).    
 Here I discuss our knowledge of the different families of DNMTs with a strong 
emphasis on the vertebrate proteins.  Unless otherwise stated, it should be assumed that I am 
referring to vertebrate proteins.    
 
1.2.2.1. Dnmt1 and maintenance methylation 
 
It is thought that DNA methylation patterns, with the exception of specific regions and in 
response to certain developmental signals, are relatively stable.  It was shown that 
methylation, in the form of a 5mCpG dinucleotide, is stably maintained in mouse cells across 
cell divisions (Stein et al., 1982).  This property of DNA methylation is fundamental for a 
role in epigenetic memory where patterns of transcription must be maintained.  This role is 
fulfilled by an exquisite mechanism for maintenance methylation dependent on the so called 
maintenance methyltransferase, Dnmt1, and a co-factor, Uhrf1.  During S-phase of the cell 
cycle, DNA is replicated in a semi-conservative manner producing two double-stranded 
DNA molecules, each composed of one of the parent strands and a nascent strand (Meselson 
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and Stahl, 1958).  This means that the DNA methylation pattern from the parent DNA is still 
present on the parent strand and is now paired with an unmethylated nascent strand.  We now 
know that the process of maintenance methylation copies the pattern of methylation from the 
parent strand to the nascent strand leading to propagation of DNA methylation patterns 
across cell divisions.  This process is achieved by the affinity of Dnmt1 for hemi-methylated 
DNA (Yoder et al., 1997) and the action of a maintenance methylation co-factor, Uhrf1.  
Uhrf1 (also known as Np95 and ICBP90) was shown to be required for normal levels of 
DNA methylation and to interact with the Dnmt1 protein.  Uhrf1 contains a methyl-CpG 
binding SRA (SET and RING associated) domain with a strong preference for hemi-
methylated CpG motifs leading to the idea that it may recruit Dnmt1 to hemi-methylated 
CpGs (Bostick et al., 2007; Sharif et al., 2007; Avvakumov et al., 2008).  In support of this 
model, Uhrf1 and Dnmt1 co-localise at replication foci during S-phase, Uhrf1 is required for 
full association of Dnmt1 with replication foci (Bostick et al., 2007; Sharif et al., 2007) and 
Uhrf1-/- mice show a similar embryonic lethality phenotype to Dnmt1-mutants (Sharif et al., 
2007).  The SRA domain of Uhrf1 binds to hemi-methylated DNA by a base flipping 
mechanism where the methylated base is rotated out into a protein binding pocket of Uhrf1.  
Subsequently, the unmethylated cytosine on the other strand is flipped out, suggesting that it 
may be presented in this way to Dnmt1 (Arita et al., 2008).  In addition to Uhrf1, Dnmt1 is 
targeted to replication foci by an interaction with PCNA (proliferating cell nuclear antigen) 
which modestly increases the fecundity of maintenance methylation by about two-fold 










Figure 1.2 - Model for maintenance methylation.  DNA methylation patterns are maintained 
across cell divisions by Dnmt1.  Dnmt1 is targeted to replication foci and hemi-methylated 
CpGs by interactions with PCNA and Uhrf1.  
 
The above model is proposed to account for the vast majority of maintenance methylation 
but it is likely that other factors are involved to complete the process.  For example, it has 
been suggested that Dnmt3 proteins may 'top up' methylation that is missed by an imperfect 
Dnmt1-based mechanism (Jones and Liang, 2009). 
 The structure of the Dnmt1 protein is bipartite, containing a C-terminal catalytic 
domain and an N-terminal regulatory domain separated by an unstructured linker (Goll and 
Bestor, 2005; Turek-Plewa and Jagodzinski, 2005)(Fig. 1.3).  The catalytic domain contains 
the conserved motifs characteristic of a 5'-cytosine methyltransferase.  The N-terminal 
portion has many conserved and functional domains.  At the N-terminus of the protein is a 
domain responsible for binding to DMAP (Dnmt1 associated protein 1), a protein implicated 
in transcriptional repression (Rountree et al., 2000).  DMAP1 is recruited to replication foci 
by Dnmt1 and this complex is joined by HDAC2 (histone deacetylase 2) late in S-phase 
(Rountree et al., 2000).  However, the functional significance of the Dnmt1-DMAP1 
interaction is unclear as mice that express only Dnmt1 that lacks the DMAP-interaction 
domain are phenotypically normal (Ding and Chaillet, 2002).  The N-terminal portion of the 
protein also contains a domain responsible for nuclear localisation and a replication foci 
targeting domain that is alone capable of targeting Dnmt1 to PCNA foci during S-phase 
(Leonhardt et al., 1992).  Interestingly, Dnmt1 forms foci at heterochromatin in G2 and M-
phases of the cell cycle and is continuously loaded onto chromatin during this time.  This 
localisation is dependent on a different domain than the targeting domain described above 
and is independent of heterochromatin components HP1 and H3K9me3 (Easwaran et al., 
2004).  The function of this localisation is currently unclear but it suggests that Dnmt1 may 
function outside of S-phase.  The two BAH (bromo adjacent homology) domains are of 
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unknown function but are present in other chromatin-associated proteins and have been 
suggested to be involved in protein-protein interactions (Goll and Bestor, 2005). 
     
 
Figure 1.3 - Domain structure of the mammalian DNA methyltransferase family proteins.  
NLS: nuclear localisation signal. BAH: bromo adjacent homology. CXXC and PWWP refer to 
amino acid motifs present in each domain. PHD: plant homeodomain. Adapted from Goll 
and Bestor (2005) and Turek-Plewa and Jagodzinski (2005).  
 
Dnmt1 contains a CXXC zinc finger domain, a domain also found in Cfp1 and Mll1 
proteins, that is associated with DNA binding.  The presence of this domain was intriguing 
as it is known to bind unmethylated CpG motifs in other proteins (Thomson et al., 2010).  
Recent structural data has shed light on the possible function of this domain in maintenance 
methylation where it was suggested to play an autoinhibitory role (Song et al,. 2011).  
Specifically, when bound to an unmethylated CpG, the CXXC domain places the CXXC-
BAH linker between the DNA and active site of the enzyme preventing de novo methylation.  
This idea is supported by an increased de novo methyltransferase activity of Dnmt1 either 
lacking, or with mutation in, the CXXC domain (Song et al,. 2011).  Further structural 
studies suggest that methylation by Dnmt1 is a multi-step and highly regulated process 
(Takeshita et al., 2011). These data begin to provide an explanation for how Dnmt1 
methyltransferase activity is regulated and how it is intrinsically inhibited for de novo 
methyltransferase activity, a potentially harmful property for a maintenance methylase.            
 Dnmt1 is widely expressed and particularly highly abundant in dividing cells (Goll 
and Bestor, 2005).  Functional studies of Dnmt1 and its orthologs have shown that they are 
essential for many biological processes in a variety of organisms including mouse, human, 
frog, fish, plant, invertebrate and fungal species (discussed in section 1.2.5.1).  Although 
most of the phenotypes of Dnmt1 mutation are commonly attributed to decreases in DNA 
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methylation, in most cases it cannot be formally excluded that DNA methylation 
independent roles of DNA methyltransferases contribute to the defects.  Indeed, roles for 
Dnmt1 outside of methylation have been proposed but it remains unclear how important they 
are as a catalytic Dnmt1 mutation produces the same ES cell differentiation and embryonic 
lethality phenotypes as null mutation (Damelin and Bestor, 2007; Takebayashi et al., 2007).  
However, it has emerged that the catalytic and non-catalytic roles of Dnmt1 are difficult to 
separate as proper localisation of Dnmt1 during S-phase requires pre-existing methylation 
(Takebayashi et al., 2007).  Suggestive evidence for methylation independent roles of Dnmt1 
exists.  Suggested interactors of Dnmt1 include histone methyltransferases, histone 
deacetylases, transcription factors, chromatin binding proteins, methyl-binding proteins and 
putative chromatin remodelers (discussed in section 1.2.6).  In Xenopus laevis, catalytically 
inactive human DNMT1 can rescue some of the defects associated with xDnmt1 depletion 
(Dunican et al., 2008).  DNMT1 is also suggested to modulate expression of E-cadherin in 
human cancer cells, an effect that is rescued by the presence of catalytically inactive protein 
(Espada et al., 2011).  Roles for Dnmt1 in genomic stability have also been proposed based 
on observed functions in the DNA damage response and apoptosis.  For example, Dnmt1 
interacts with repair proteins, is recruited to laser-induced DNA double strand breaks and is 
required for their timely repair (Ha et al., 2011).  Currently, a role for Dnmt1 out with of 
DNA methylation is considered atypical and further investigation in this area is needed. 
 The stability and activity of Dnmt1 must be tightly regulated to ensure its proper 
function.  In this regard, an interesting interplay between post-translational modifications of 
Dnmt1 and its interacting proteins has emerged (reviewed in Denis et al., 2011).  In addition 
to its direct role in maintenance methylation, Uhrf1 contains ubiquitin-ligase activity and 
may control the stability of Dnmt1 through ubiquitination leading to proteolysis (Qin et al., 
2011).  The two proteins are bridged by Usp1, a de-ubiquitinating enzyme, in a trimeric 
complex where the result is thought to be fine tuning of Dnmt1 protein levels (Qin et al., 
2011).  Usp7 has been shown to increase both the maintenance and de novo methylation 
activity of Dnmt1 in vitro suggesting that it may participate at multiple levels in Dnmt1 
regulation (Felle et al., 2011a).  In addition to ubiquitination, Dnmt1 may be regulated by 
lysine methylation and serine phosphorylation.  It is thought that lysine methylation by 
Set7/9 destabilises Dnmt1 protein and that a balance is struck with Lsd1 (lysine specific 
demethylase 1) to obtain appropriate Dnmt1 levels (Wang et al., 2009a).  Also a 
phosphorylation-methylation switch has been suggested to control Dnmt1 protein stability.  
Specifically, phosphorylation of Ser143 of Dnmt1 by AKT1 is mutually exclusive with 
methylation of the adjacent Set7/9 target Lys142 residue.  This means that Ser143 
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phosphorylated Dnmt1 is more stable.  Consistent with this idea, phosphorylation of Dnmt1 
peaks just before S-phase when abundant Dnmt1 protein is required for maintenance 
methylation (Esteve et al., 2010).  Heterozygous mutations in DNMT1 have been associated 
with hereditary sensory neuropathy with dementia and hearing loss, a dominant neuro-
degenerative disorder (Klein et al., 2011).  The mutations consisted of one to three amino 
acid substitutions which lead to misfolding, instability and reduced methyltransferase 
activity of the DNMT1 protein. 
                 
1.2.2.2.  Dnmt3 proteins and de novo methylation 
 
The establishment of DNA methylation on previously unmethylated cytosines, de novo 
methylation, is performed primarily by two homologous Dnmt3 proteins, Dnmt3a and 
Dnmt3b.  These proteins are similar to Dnmt1 in that they comprise an N-terminal domain 
implicated in protein-protein interactions and chromatin binding and a C-terminal catalytic 
domain (Fig. 1.3).  Their N-terminal portions contain PWWP domains, named after the 
amino acid motif that it contains, and a cysteine-rich PHD-like (plant homeodomain-like) 
domain.  Both are thought to be involved in chromatin binding and recognition of specific 
histone modifications (reviewed in Denis et al., 2011).  The PWWP domain of Dnmt3b is 
required for association of the protein with, and methylation of, pericentric heterochromatin 
implicating it in chromatin binding (Chen et al. 2004; Ge et al., 2004).  The PHD-like 
domain (sometimes referred to as the ADD domain - ATRX, Dnmt3 and Dnmt3L domain) is 
not absolutely required for this localisation but may facilitate it (Chen et al. 2004).   Both the 
PWWP and PHD-like domains of Dnmt3a are also implicated in targeting de novo 
methylation to chromatin containing certain histone modifications (discussed in section 
1.2.4.11).   
 Dnmt3 proteins are expressed in a range of adult tissues but are less abundant than 
Dnmt1 (Goll and Bestor, 2005).  Dnmt3b is expressed highly in ES cells, early development 
and in germ cells while its expression is very low in most somatic cells apart from thyroid 
and bone marrow (Xie et al., 1999).  Dnmt3a is thought to be expressed at low levels 
ubiquitously but is abundant in ES cells (Okano et al., 1998a; Xie et al., 1999; Chen et al., 
2002).  Functional studies of Dnmt3a and Dnmt3b suggest that they have non-overlapping 
functions in development.  Although null mutation of each gene in mouse is incompatible 
with viability, the phenotypes and stage of lethality differ considerably (Okano et al., 
1999a)(discussed further in 1.2.5.1).  This suggests that each enzyme has specific targets.  
Indeed, Dnmt3b is required for methylation of pericentric repeats which contributes to 
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chromosomal stability, and Dnmt3a cannot substitute for the absence of Dnmt3b in this 
respect (Okano et al., 1999a).  Conversely, Dnmt3a, but not Dnmt3b, is required for 
establishing most imprinting during male and female germ cell development (Kaneda et al., 
2004).   
 Early in vitro studies showed that Dnmt3 proteins have no preference for hemi-
methylated over unmethylated CpGs suggesting that they may perform as de novo 
methyltransferases (Okano et al., 1998a).  The activity of methyl transfer in vitro by Dnmt3s 
is low, consistent with the idea that other factors stimulate de novo methylation in vivo 
(Okano et al., 1998a).  Dnmt3a may also methylate cytosine outside of the CpG context, 
primarily at CpA and CpT dinucleotides, although its major target is CpG (Ramsahoye et al., 
2000)(discussed further in 1.2.4.7).  It has been suggested that Dnmt3 proteins have a DNA 
sequence preference based on the nucleotides flanking the central CpG dinucleotide as 
certain sequences were found to be preferentially methylated in vivo and in vitro (Handa and 
Jeltsch, 2005; Zhang et al., 2009; Wienholz et al., 2010).  It has been reported that Dnmt3b 
has a higher methyltransferase activity on nucleosomal DNA than Dnmt3a (Shen et al., 
2010).  Interestingly, this appears to be a mammal-specific adaption of Dnmt3b as non-
mammalian orthologous proteins do not show increased activity on nucleosomal DNA.  This 
variation may be crucial for proper methylation of relatively compact nucleosomal repetitive 
DNA in mammals, and has thus been linked to the rapid expansion of such sequences in 
mammalian genomes (Shen et al., 2010).  
 Dnmt3a and Dnmt3b proteins, in contrast to Dnmt1, are tightly associated with 
chromatin containing methylated DNA, a property that depends on the presence of an intact 
N-terminal region (Jeong et al., 2009).  In fact, it has been suggested that free Dnmt3 
proteins are subject to degradation, therefore methylated DNA-containing nucleosomes have 
a stabilising effect on these proteins (Sharma et al., 2011).  Dnmt3b preferentially associates 
with condensed, histone H1 containing chromatin in vivo but does not show a clear 
preference for chromatin enriched in any repression-associated histone marks such as 
H3K9me3 (Kashiwagi et al., 2010).  There is, however, a modest depletion of activation-
associated marks, H3K4me3 and H4K16ac, in Dnmt3b-bound chromatin.  This may be a 
cause or consequence of Dnmt3b binding as Dnmt3b associates with histone deacetylases 
(Kashiwagi et al., 2010).  
 Dnmt3 proteins are thought to interact with other Dnmt3 proteins, including non-
catalytic isoforms, to form homo- and heterodimers (reviewed in Cheng and Blumenthal, 
2008).  The dimerisation of Dnmt3 proteins is thought to influence various properties of the 
enzymes (van Emburgh et al., 2011).  Dnmt3L is a catalytically inactive DNMT-like protein 
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with roles in regulation of Dnmt3 proteins (discussed in 1.2.2.4).  Models of a tetrameric 
complex consisting of two Dnmt3a-Dnmt3L heterodimers bound to DNA suggest that they 
could methylate two CpGs separated by one helical turn (Jia et al., 2007; Cheng and 
Blumenthal, 2008).  In agreement with this model a periodicity of 9 bp has been observed in 
highly methylated regions of human chromosome 21 (Zhang et al., 2009) and of imprinted 
control regions (Jia et al., 2007).  Other suggested interactions of Dnmt3 proteins include 
Dnmt1 and chromatin modifying proteins such as HDACs and hSNF2H suggesting that, like 
Dnmt1, non-catalytic roles of Dnmt3 proteins may be important for their function (Kim et 
al., 2002; Geiman et al., 2004). 
 Mutations in human DNMT3 genes are associated with pathological conditions.  
Mutations in DNMT3B cause the rare autosomal recessive disorder ICF (immunodeficiency, 
centromere instability and facial abnormalities) syndrome, a disorder characterised by the 
three main symptoms from which it is named (Xu et al., 1999).  Two thirds of ICF patients 
have DNMT3B mutations (Jin et al., 2008).  A major contributor to these phenotypes is 
thought to be severe hypomethylation of pericentric repeats leading to chromosomal 
abnormalities, a problem that manifests itself most strongly in cells of the immune system 
(Xu et al., 1999; reviewed in Goll and Bestor, 2005).  It is not clear if hypomethylation of 
pericentric regions is the only contributor to the disorder as defects in regulation of 
developmental genes and disorganisation of chromosome territories have also been observed 
in patient cell lines (Matarazzo et al., 2007; Jin et al., 2008).  ICF-causing missense 
mutations throughout the protein have been identified, including the PWWP domain and 
many throughout the catalytic domain (Xu et al., 1999).  ICF mutations are thought to affect 
various biochemical properties of DNMT3B including SAM binding and utilisation, DNA 
binding, and homodimerisation (Moarefi and Chedin, 2011).  Recently, mutations in human 
DNMT3A have been found in patients with certain subtypes of leukemia.  In one study, 
22.1% of acute myeloid leukemia (AML) patients were found to carry a non-silent mutation 
in DNMT3A and presence of DNMT3A mutation correlated with poor prognosis (Fey et al., 
2010).  In another study, 20.5% of patients with acute monocytic leukemia (a subtype of 
AML, AML-M5) were found to carry DNMT3A mutations (Yan et al., 2011).  Lower levels 
of DNA methylation were observed at candidate regions in DNMT3A-mutants relative to 
controls correlating with increased transcription of certain Hox genes thought to be important 
in haematopoiesis (Yan et al., 2011).  However, the cause of leukemiagenesis in DNMT3A-
mutation carriers is currently unclear but the striking proportion of DNMT3A mutations 
found in these studies points towards a major contribution of DNMT3A to normal 
haematopoiesis. 
15
     
1.2.2.3.  Dnmt2 
 
A third family of DNMT enzymes exists, known as Dnmt2 proteins, and they have a 
controversial history in terms of their biological function.  Dnmt2 consists solely of a 
catalytic domain and contains all the motifs required for catalytic activity on cytosine, 
making it an exciting candidate for a DNA methyltransferase when it was originally cloned  
(Fig. 1.3)(Yoder and Bestor, 1998; Okano et al., 1998b).  In fact, Dnmt2 is the most widely 
conserved of the DNMT proteins with homologs in Drosophila melanogaster and 
Schizosaccharomyces pombe (Hermann et al., 2003).  However, it was noticed that Dnmt2 is 
more similar to a fission yeast methyltransferase than to Dnmt1, fission yeast having no 
DNA methylation (Yoder and Bestor, 1998).  Indeed, early functional studies suggested that 
Dnmt2 is not a major DNA methyltransferase as it was unable to methylate DNA in vitro 
and deletion of its catalytic domain in mammalian cells had no effect on methylation of 
newly integrated viral DNA (Okano et al., 1998b).  A few years later, weak residual cytosine 
methyltransferase activity of Dnmt2 was shown in vitro and Dnmt2 depletion during 
Drosophila development abolished detectable low-level DNA methylation (Hermann et al., 
2003; Kunert et al., 2003).  A breakthrough came when it was discovered that Dnmt2 is 
present in the cytoplasm and responsible for methylation of the tRNA for aspartic acid, a 
property that is now generally considered to be its major conserved function (Goll et al., 
2006).  Dnmt2 has since been shown to methylate other tRNAs, a process responsible for 
protecting them against stress-induced cleavage (Schaefer et al., 2010a).  In keeping with 
this idea, Dnmt2 depletion in zebrafish results in developmental defects but only its 
cytoplasmic localisation is required (Rai et al., 2007).  However, more recently, Dnmt2 
protein in Drosophila was shown to associate with the nuclear matrix and have access to 
DNA during mitosis (Schaefer et al., 2008).  In addition, evidence was presented that 
Drosophila Dnmt2 is required for transposon silencing and telomere integrity.  This report 
suggested that Dnmt2 methylates DNA of retrotransposons in early development and that 
this was essential for heterochromatinisation and silencing of a particular type of repeat 
(Phalke et al., 2009).  Another report supported this idea by suggesting that DNA 
methylation of transposons does indeed occur during Drosophila development via a 
mechanism that involves Dnmt2 recruitment by SETDB1 (Gou et al., 2010).  However, 
DNA methylation of Invader4 elements, the transposon class studied in Phalke et al, and the 
role of Dnmt2 in DNA methylation has been strongly questioned (Schaefer et al., 2010b).  
Here, the authors suggest that there is no convincing evidence for DNA methylation at these 
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elements in Drosophila and therefore the Dnmt2 protein, in regard to its putative function in 
DNA methylation, remains an enigma.                 
 
1.2.2.4.  Co-factors of the DNA methylation machinery 
 
In addition to catalytically active DNA methyltransferases, many protein co-factors are 
required to establish and maintain DNA methylation patterns.  Here I discuss a few of the 
best studied co-factors of DNA methylation, although more have been suggested.   
 One such protein is Dnmt3L, a mammal-specific DNMT-like protein that lacks any 
catalytic activity (Fig. 1.3)(Hata et al., 2002).  Dnmt3L resembles a portion of Dnmt3 
proteins and contains a PHD-like domain similar to that of Dnmt3 proteins (Fig. 1.3).  
Dnmt3L is expressed in germ cells and the early embryo at periods where widespread de 
novo methylation is taking place (Bourc'his et al., 2001).  The role of Dnmt3L appears to be 
in the regulation and targeting of Dnmt3 proteins for de novo methylation (Hata et al., 2002).  
Mice lacking Dnmt3l develop normally but males are infertile due to azoospermia (Bourc'his 
et al., 2001; Hata et al., 2002).  Female mice lacking Dnmt3L are fertile but their 
heterozygous offspring die in mid-gestation, even when transplanted into a surrogate uterus 
(Bourc'his et al., 2001; Hata et al., 2002).  This suggested that Dnmt3L may be required for 
establishing imprints, DNA methylation marks laid down in germ cells that will control 
parent of origin specific gene expression in the offspring.  Indeed, this appears to be the case 
as oocytes from Dnmt3l-/- mice show severely reduced methylation at imprint control regions 
and embryos from Dnmt3l-/- oocytes have biallelic expression of normally imprinted genes 
(Bourc'his et al., 2001).  Also, Dnmt3L was shown to be required for DNA methylation and 
silencing of different retrotransposon classes during spermatogenesis and Dnmt3l-/- testes 
undergo meiotic defects (Bourc'his et al., 2004).  Overall, the Dnmt3l-/- mice phenocopy 
conditional knock out of Dnmt3a in germ cells (Kandeda et al., 2004).  It is now thought that 
Dnmt3L is required to stimulate and target Dnmt3 enzymes during specific waves of de novo 
methylation during development.  In particular, it is believed that Dnmt3L targets de novo 
methyltransferases Dnmt3b and Dnmt3a2 to chromatin containing H3K4me0 (non-
methylated K4).  This is thought to be achieved through an interaction between the PHD-like 
domain of Dnmt3L and the N-terminal tail of histone H3, an interaction that is inhibited by 
K4me (Ooi et al., 2007).  In addition to targeting, Dnmt3L stimulates Dnmt3a activity by 
increasing its binding to SAM, the methyl donor (Chedin et al., 2002; Kareta et al., 2006).  
This activity may be caused by a Dnmt3L-mediated conformational change in the active site 
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of Dnmt3a and/or by the interaction surfaces formed which stabilise Dnmt3a-SAM 
interactions (reviewed in Cheng et al., 2008).  
 Another co-factor of the DNA methyltransferases is Lsh (sometimes called HELLS - 
helicase lymphoid-specific).  Lsh is a putative member of the Snf2 helicase family, a protein 
family frequently involved in nucleosome remodelling (Geiman et al., 1998; Dennis et al., 
2001).  Lsh is expressed at high levels in lymphoid cells but can be detected at low levels in 
many tissues (Geiman et al., 2001).  Lsh first became associated with DNA methylation 
when it was observed that Lsh-/- mice are hypomethylated at certain loci (Dennis et al., 2001; 
Sun et al., 2004).  Mice deficient in Lsh die perinatally or within weeks of birth, are runted 
compared to wildtype littermates and show premature aging phenotypes (Geiman et al., 
2001; Sun et al., 2004).  Hypomethylation in Lsh-/- mice was originally reported to occur at 
repetitive regions and some single copy loci (Dennis et al., 2001).  It was subsequently 
shown that repeats are a major target of Lsh as, in one study using expression microarrays, 
two thirds of upregulated transcripts in the absence of Lsh were suggested to originate from 
repetitive regions (Huang et al., 2004).  DNA methylation changes have been mapped in 
higher detail in the absence of Lsh which suggested that it is required to both promote and 
prevent DNA methylation of large chromosomal regions including many gene promoters 
(Myant et al., 2010; Tao et al., 2011a).  As Lsh contains Snf2 and helicase domains, 
frequently involved in chromatin remodelling, an attractive function for Lsh in DNA 
methylation is to move nucleosomes to facilitate access by DNA methyltransferases.  Indeed, 
nucleosome covered regions of DNA show lower levels of methylation than non-covered 
regions and are methylated at a lower efficiency by Dnmt3a in vitro (Felle et al., 2011b).  
However, to date, no catalytic activity of Lsh on nucleosome templates has been reported.  
Instead, it has been suggested that Lsh is required for de novo methylation by interaction 
with Dnmt3a and Dnmt3b (Zhu et al., 2006).  The precise function of Lsh in DNA 
methylation remains unknown but it may involve targeting of Dnmt3s to genomic regions as, 
for example, Lsh associates with intact heterochromatin at pericentric regions (Yan et al., 
2003a).  This model would be compatible with the large domains of DNA methylation that 
change in the absence of Lsh (Tao et al., 2011a).  Another possibility is that Lsh is required 
for maintaining or establishing a certain chromatin state that then secondarily influences 
DNA methylation levels.  This idea is consistent with the observation that levels of histone 
modifications are altered in the absence of Lsh (Yan et al., 2003b).  Although it appears to 
be an important co-factor, further research is required to firmly establish the role of Lsh in 
DNA methylation. 
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 G9a (otherwise known as Ehmt2 - euchromatic histone methyltransferase 2) has 
been implicated in DNA methylation.  G9a is a histone methyltransferase responsible for a 
large amount of H3K9me2/3 (particularly K9me2) in euchromatic regions of the genome and 
is essential for embryonic development in mice (Tachibana et al., 2002).  Studies of the 
pluripotency-associated Oct4 (Pou5f1) gene upon embryonic stem cell differentiation 
showed that G9a is required for accumulation of H3K9me2/3 and DNA methylation at the 
promoter region during the silencing of this gene (Feldman et al., 2006).  One role of G9a at 
this locus appears to be in recruiting Dnmt3 proteins, as catalytically inactive G9a could 
partially rescue the failure to acquire full levels of DNA methylation in G9a-/- ES cells 
(Epsztejn-Litman et al., 2008).  The role for G9a in targeting DNA methylation appears to be 
more widespread, acting at various repetitive elements and gene promoters (Dong et al., 
2008; Tachibana et al., 2008).  It was reported that ~150 promoter regions are DNA 
hypomethylated in G9a-/- ES cells, many of which overlap with those hypomethylated in the 
absence of Lsh, suggesting a possible cross-talk between the two proteins (Myant et al., 
2010).  Several other proteins have also been suggested to modulate DNA methylation 
patterns in mammals, such as the SWI/SNF containing ATRX protein (Gibbons et al., 2000).  
An understanding of the full complement of DNA methylation co-factors is necessary to 
fully understand this epigenetic mark.        
       
1.2.3.  5-Hydroxymethylation and other forms of modified cytosine 
 
Recently, methyl-cytosine (5mC) was joined, as a major modified form of cytosine in 
mammalian genomes, by hydroxymethyl-cytosine (5hmC).  Hydroxymethyl-cytosine 
consists of a hydroxymethyl group added to the 5' carbon of the pyrimidine ring of cytosine, 
the same position that is modified in methyl-cytosine (Fig. 1.1).  The 5hmC base was 
rediscovered recently where it was found to be relatively abundant (~40% as abundant as 
5mC as a neighbour of G) in Purkinje neurons of the brain (Kriaucionis and Heintz, 2009).  
The global abundance of 5hmC is variable between tissues and does not always correlate 
with global 5mC abundance (Li et al., 2011c; Ruzov et al., 2011; Nestor et al., 2011).  It was 
predicted that mammalian enzymes of the TET (ten eleven translocation) family could 
convert 5mC to 5hmC by oxidation and this was shown to be true for TET1 (Tahiliani et al., 
2009).  Subsequently, a flurry of papers have emerged detailing the distribution and function 
of 5hmC and the TET proteins.  A brief overview is given here followed by further 
discussion of 5hmC function and distribution in later sections. 
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 There are three proteins of the TET family in mammals, Tet1, Tet2 and Tet3, and all 
have been implicated in conversion of 5mC to 5hmC in mammalian cells (Ito et al., 2010).  
Tet1 was identified as being highly expressed in ES cells but its function here is unclear.  
Knockdown of Tet1 in mouse ES cells reduced 5hmC, altered gene expression and 
influenced differentiation of ES cells, promoting trophectoderm differentiation, suggesting a 
role for the mark in pluripotency and differentiation (Ito et al., 2010; Ficz et al., 2011; Koh 
et al., 2011; Williams et al., 2011; Xu et al., 2011b).  However, Tet1-/- ES cells show only 
subtle changes in gene expression and Tet1-/- mice are viable displaying only a modest 
reduction in birth weight, suggesting that Tet1 is not required for pluripotency in vivo 
(Dawlaty et al., 2011).  A differentiation skew towards trophectoderm was observed for 
Tet1-/- ES cells in vitro in this report, consistent with the earlier knockdown studies.  Only a 
modest reduction in 5hmC levels were observed in Tet1-/- ES cells suggesting that other 
enzymes contribute to the abundance of this modified base, and, that this modest reduction 
does not lead to major defects in embryogenesis (Dawlaty et al., 2011).  Tet2 is implicated in 
haematopoiesis and mutations in TET2 are common in certain types of blood cancer (Ko et 
al., 2010).  Mutation of Tet2 in mice results in differential maintenance and differentiation of 
hematopoietic stem cells (Ko et al., 2011; Li et al., 2011c; Quivoron et al., 2011).  
Phenotypes out with of the hematopoietic system have not been reported to date in mice 
lacking Tet2, suggesting that it is not required for general embryonic development.  Tet3 has 
been implicated in catalysing 5hmC of paternal DNA in the zygote but also appears to be 
expressed in many human somatic tissues suggesting a wider function (Wossidlo et al., 
2011; Gu et al., 2011; Nestor et al., 2011).  Expression of TET genes and hmC patterns are 
variable across human tissues and it is currently unclear what the contribution of each TET 
protein is (Nestor et al., 2011).  Mutation or depletion of multiple Tet proteins 
simultaneously will further shed light on the importance of this reaction and the 5hmC base 
in vivo. 
 It is currently not clear whether 5hmC is functional in its own right or is a non-
functional chemical intermediate of DNA metabolism as some lines of evidence link 5hmC 
to DNA demethylation (discussed in 1.2.4.9).  Studies investigating the difference in binding 
and activity of proteins on 5mC- and 5hmC-containing DNA have begun to shed light on this 
question.  Firstly, it has been shown that Dnmt1 maintenance methylation activity in vitro 
does not occur on hemi-methylated 5hmC templates (Valinluck and Sowers, 2007).  A recent 
report provides evidence suggesting that 5hmC is lost in a replication-dependent manner in 
mouse pre-implantation embryos, supporting a model of 5hmC-mediated passive 
demethylation (Inoue and Zhang, 2011).  However, the maintenance activity of Dnmt1 in 
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vivo is dependent on the co-factor Uhrf1, the SRA domain of which can bind both 5mCpG 
and 5hmCpG with equal efficiency in vitro (Frauer et al., 2011).  This means that 
speculation about 5hmC-mediated passive demethylation by prevention of maintenance 
methylation need to be suspended until further investigation is conducted.  Secondly, the 
binding of some methyl-CpG-binding proteins, for example MeCP2, does not occur on 
5hmC suggesting that this base may function to antagonise binding of certain methyl-CpG-
binding proteins to DNA (Frauer et al., 2011).  To date, no protein has been identified that 
binds specifically to 5hmC but no doubt this will be a subject of intense research in the near 
future.     
 Recently, two further forms of modified cytosine have been detected in mouse 
tissues, 5-Formylcytosine (5fC) and 5-Carboxylcytosine (5caC)(Ito et al., 2011; He et al., 
2011a).  These bases were detected at very low levels (<20 bases for every million cytosines) 
and may be intermediates produced by Tet enzymes in a putative process of demethylation 
(Ito et al., 2011).  The putative role of Tet enzymes and 5hmC in the removal of 5mC as well 
as the genomic distribution of 5hmC will be discussed in later sections (1.2.4.8 and 1.2.4.9).            
 
1.2.4.  The distribution of DNA methylation 
 
Understanding where the 5mC and 5hmC bases are located in the genome is key to 
understanding their function in development and disease.  The development of large-scale 
DNA methylation mapping technologies, often coupled with next generation sequencing 
technologies, has greatly increased our knowledge of the distribution and dynamics of 
modified cytosine bases in multiple organisms (for example, Illingworth et al., 2008).  This 
section aims to summarise that knowledge in the context of understanding the function of 
DNA methylation.  I will focus on DNA methylation patterns in mammals and will 
summarise insights into patterns in other organisms later in this section. 
 Following the observation that 5hmC can be relatively abundant in mammalian 
DNA, it was disturbing to learn that many of the techniques used to map 5mC cannot 
distinguish between this modified base and 5hmC.  These techniques include most where 
bisulfite treatment is used to distinguish 5mC and unmodified cytosine, the use of many 
restriction enzymes and also certain protein domains used for enriching methylated DNA 
(Nestor et al., 2010).  This means that a caveat must be added to all the data generated using 
these techniques that formally we cannot distinguish between these two forms of modified 
cytosine.   
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 A simplified representation of our current knowledge of the mammalian DNA 
methylome is shown in figure 1.4.  The pattern and dynamics of methylation at some of 
these regions will now be discussed in more detail.  
 
 
Figure 1.4 - The 5mCpG methylation landscape of mammalian genomes.  5mCpG 
methylation in vertebrate genomes is generally bimodal, with high methylation as the 
background level punctuated by low level DNA methylation at CpG islands.  CpG islands are 
often associated with the 5' region of genes and these rarely have high levels of DNA 
methylation with the exception of those on the inactive X chromosome in female cells.  A 
large proportion of CpG islands are not associated with annotated gene promoters (orphan 
CpG islands) and these are methylated more frequently and may represent putative 
promoters of unknown function (see 'intergenic orphan CGI') or alternative promoters of 
genes (see 'active gene').  Repeats and retrotransposons generally have high levels of DNA 
methylation and some contain an enrichment for CpG dinucleotides (as represented in the 
diagram).  Many inactive genes are associated with a CpG island at their 5' end and these, 
like active genes, are usually unmethylated and are repressed through other mechanisms 
(inactive gene - left).  A small proportion of promoter CpG islands have high levels of DNA 
methylation in a given cell type and this correlates with transcriptional repression (inactive 
gene - right).  Gene bodies are often methylated, with exons showing higher DNA 
methylation than introns, and this may positively correlate with transcriptional activity (see 
'active gene'). CGI: CpG island.  The proportions of each feature in this diagram are of 
course not representative of the genome as a whole.     
 
1.2.4.1.  CpG islands 
 
The vast majority of 5mC in mammals occurs at CpG dinucleotides (Lister et al., 2009).  
Therefore, to understand the distribution of DNA methylation we first need to understand the 
distribution of its substrate within the genome.  CpG dinucleotides are not distributed evenly 
throughout the mammalian genome.  Instead they are found clustered in short stretches of 
DNA called CpG islands (Cooper et al., 1983; Bird et al., 1985).  CpG islands are on 
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average ~1kb long and have a CpG-content and GC-content higher than the bulk genome.  
The commonly used sequence-based criteria for identifying a CpG island is at least 200bp of 
sequence with an observed/expected CpG content of greater than 0.6 and a GC content 
greater than 50%, although the stringency of this method can be adjusted by altering the 
criteria (Illingworth et al., 2009).  This method combined with repeat masking to discard 
repetitive sequences is used by the UCSC genome browser and yields about 28,000 islands 
in the human genome (Illingworth et al., 2009).  The CpG content of CpG islands (at 0.6 
observed/expected) is not enriched compared to what is expected by chance but instead is 
merely less depleted than the bulk genome.   
 The pattern of CpG methylation in the mammalian genome is generally bimodal, as 
CpGs in the bulk of the genome are usually methylated and CpGs in CpG islands are usually 
unmethylated (Fig. 1.4)(Weber et al., 2007; Meissner et al., 2008).  It was suggested that this 
pattern of methylation contributes to the depletion of the CpG dinucleotide that is observed 
in vertebrate genomes, as spontaneous deamination of methyl-cytosine to uracil, if not 
repaired by the mismatch repair machinery, will lead to its replacement by thymine (Bird et 
al., 1985; Weber et al., 2007).  It is now suggested that this process, along with multiple 
other forms of selection, has lead to the distribution of CpG dinucleotides in living 
vertebrates (Cohen et al., 2011).  In contrast to purely sequence based classification, CpG 
islands have also been identified more functionally, by mapping DNA binding by an 
unmodified cytosine binding protein (Illingworth et al., 2008; Illingworth et al., 2010).  For a 
CpG island to be identified in these studies it must have low levels of DNA methylation in at 
least one tissue studied, making the list of CpG islands identified non-comprehensive.  These 
studies reconciled the number of CpG islands in mouse and human DNA, as sequence based 
methods had predicted far fewer CpG islands in the mouse genome.  They showed that about 
half of CpG islands in mouse and human genomes are associated with the 5' end of annotated 
genes, and the other half were found in intra- or intergenic regions and were termed 'orphan' 
CpG islands.  About 70% of protein coding genes were associated with a CpG island and 
44% were associated with a CpG island at their 5' end.  Unmethylated CpG islands show 
many properties that make them suited for a function at a gene promoter including 
nucleosome instability, depleted H1 occupancy and histone marks associated with a more 
open chromatin configuration (Tazi and Bird, 1990; Thomson et al., 2010).  This has lead to 
the idea that CpG islands facilitate transcription by differentiating gene promoters from bulk 
chromatin.  Unmethylated CpG islands are also associated with the promoters of inactive 
genes, like tissue-specific developmental regulators, that need to be tightly regulated in time 
and space (Fig. 1.4).  These genes are targets for repression by the polycomb repressor 
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complexes which have been suggested to use CpG islands for their recruitment (discussed in 
section 1.3).  So, it appears that CpG islands are an integral part of a chromatin based switch 
for regulating gene expression.   
  Only a small proportion of CpG islands are highly methylated in normal tissues 
(around 10%)(Illingworth et al., 2008; Deaton et al., 2011).  In particular, promoter-
associated CpG islands are rarely methylated (<3% of them), but methylation, when present, 
does correlate with transcriptional silencing (Illingworth et al., 2008; Maunakea et al., 2010; 
Deaton et al., 2011).  Interestingly, orphan CpG islands are more often found to be 
methylated than promoter-associated CpG islands in normal tissues (intragenic CpG islands 
~26% are methylated, intergenic ~ 13% in any of the tissues studied)(Illingworth et al., 
2008; Illingworth et al., 2010; Maunakea et al., 2010).  The function of orphan CpG islands 
is unclear but many of them show evidence of promoter activity and therefore may be 
promoters for unannotated transcripts (Illingworth et al., 2010; Maunakea et al., 2010).  If 
the methylation status of CpG islands is important for maintaining a transcriptional memory, 
then one would expect to find differential patterns of methylation at CpG islands in different 
tissues.  In one study, only ~3% of promoter associated CpG islands showed differential 
methylation between blood, brain, muscle and spleen.  This compared to 6.6-10.1% of 
orphan CpG islands that show differential methylation (Illingworth et al., 2008).  Although 
the proportions are small, the differentially methylated CpG islands were enriched for 
locations near developmentally important genes such as Hox and Pax genes.  In another 
study looking at different cell lineages of the immune system, less than 0.5% of promoter 
associated CpG islands showed differential methylation compared to 0.6-2% of orphan 
islands (Deaton et al., 2011).  Again, many of the differentially methylated islands were 
located near genes of importance in the immune system.  In this study a larger number of 
differentially methylated regions was found between brain and immune cells suggesting that 
more distantly related tissues may have more differential methylation.  In addition, a larger 
number of differentially methylated regions were found outside of CpG islands.  The 
methylation status of CpG islands may not always be uniform as blocks of hypermethylated 
and hypomethylated regions have been observed within the same CpG island (Hodges et al. 
2009; Zhang et al., 2009).  Many of these blocks may correspond to underlying features such 
as exons but methylation heterogeneity within CpG islands will need to be explored in more 
detail.  
 The data from Illingworth et al., (2008; 2010) and Deaton et al., (2011) were 
generated using a CXXC domain from Mbd1 to bind unmethylated CpGs and a MBD 
(methyl-CpG binding domain) from the rat MeCP2 protein to bind methylated DNA (Nan et 
24
al., 1993; Cross et al., 1994; Illingworth et al., 2008).  It is currently unknown if this CXXC 
domain binds to 5hmC, although this seems unlikely based on structural studies of CXXC-
DNA interactions, which are thought to be sterically inhibited by the 5mC modification 
(Cierpicki et al., 2010).  The MBD domain of mammalian MeCP2 has been shown to not 
bind, or bind with greatly reduced efficiency, to 5hmC compared with 5mC (Frauer et al., 
2011).  This suggests that data collected using the MAP technique probably does not suffer 
from 5hmC contamination while for the CAP technique, it remains untested.    
 Together, these data suggest that the vast majority of CpG islands in the mammalian 
genome are not dynamically methylated and remain with low levels of DNA methylation in 
all tissues.  Methylation of a small number of CpG islands does change in a tissue-specific 
manner and these changes may be important in differentiation.  Interestingly, orphan CpG 
islands show higher variance in DNA methylation levels between tissues.  The methylation 
dynamics at CpG islands, particularly orphan islands, will have to be studied in more detail 
in order to elucidate their function.    
 
1.2.4.2.  CpG island 'shores' 
 
In an independent study, using a different experimental approach, tissue-specific methylation 
patterns were found to occur infrequently within CpG islands and gene promoters (Irizarry et 
al., 2009).  Instead, most variation in DNA methylation between tissues was observed at 
regions flanking CpG islands, termed 'CpG island shores'.  These regions also showed the 
most variation, in studies by the same group, between normal colon and colon cancer DNA 
and also between human induced pluripotent cells and their parental fibroblasts (Irizarry et 
al., 2009; Doi et al., 2009).  CpG island shores were defined as regions flanking a CpG 
island, within 2kb either side, and so have lower CpG content relative to their neighbouring 
CpG island (Irizarry et al., 2009).  The functional consequence of CpG shore methylation is 
unclear but methylation of CpG shores correlates with lower transcription of the nearby gene 
(Irizarry et al., 2009; Ji et al., 2010).  Study of candidate genes showed that differential 
methylation at CpG shores correlates with the use of alternative promoters in some cases, 
suggesting that this process may influence the regulation of transcription and promoter 
choice (Irizarry et al., 2009).  Further support for a functional consequence of CpG shore 
methylation comes from the observation that human CpG shore methylation patterns are 
often conserved in equivalent mouse tissues (Irizarry et al., 2009).   
 The same approach was applied to lineage committed and progenitor cells of the 
hematopoietic system in order to study the dynamics of DNA methylation during lineage 
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commitment (Ji et al., 2010).  Again, most differentially methylated regions were found in 
CpG shores and their methylation negatively correlated with the expression status of the 
nearby gene.  In addition, the methylation status of shores correlated better with 
transcriptional activity than the methylation status of islands (Ji et al., 2010).  These 
correlations, however, do not take into account the large number of genes associated with an 
unmethylated CpG island that are silenced by other mechanisms, such as polycomb repressor 
complexes.  In addition, the data on shores and transcription are so far only correlative.  It 
must also be considered that the technique used to generate this data, digestion of 5mC with 
restriction enzyme McrBC, also cuts at 5hmC.  This, together with the observation that 
5hmC may be present at promoter and gene body regions (discussed in 1.2.4.8), means that a 
caveat must be added to this data currently that the observed variation may be at least in part 
due to variation in the 5hmC base.  Nevertheless, further study of CpG island shores will 
illuminate their putative function in transcriptional regulation.    
 
1.2.4.3.  Gene promoters 
 
As CpG methylation is linked to transcriptional regulation many studies have focussed on 
gene promoters when mapping DNA methylation.  As a large proportion of genes in 
mammalian genomes are associated with a CpG island at their 5' end, much of the data 
discussed in the previous section on CpG islands is also relevant here.  Similarly to CpG 
islands, the majority of promoter regions have low level methylation (for example, ~10% of 
promoters in B cells are highly methylated) and the methylation (5mCpG) on average at 
promoters is lower than surrounding regions (Rauch et al., 2009; Borgel et al., 2010).  
Importantly, the methylation level in promoter regions and in first exon has been anti-
correlated with transcription in many studies (Eckhardt et al., 2006; Shen et al., 2007; Weber 
et al., 2007; Meissner et al., 2008; Rauch et al., 2009; Borgel et al., 2010; Brenet et al., 
2011).  These data have lead to the generally accepted view that high levels of DNA 
methylation in a CpG-rich promoter region can attenuate its activity.    
 The density of CpGs in a gene promoter has been shown to predict both its 
methylation status and its relationship with transcriptional status (Weber et al., 2007; 
Meissner et al., 2008).  Promoters can be divided into groups based on their CpG content.  
Weber et al. (2007) defined high-density CpG promoters (HCPs), intermediate-density CpG 
promoters (ICPs - sometimes known as 'weak CpG island promoters') and low-density CpG 
promoters (LCPs) based on sequence parameters.  By mapping DNA methylation in human 
somatic and germline cells, they found that LCPs were nearly always highly methylated, 
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regardless of their transcriptional activity (Weber et al., 2007).  Conversely, HCPs were 
nearly always unmethylated, but the rare event of high methylation of a HCP correlated with 
transcriptional repression.  These observations are in accordance with CpG island profiling 
that suggests that most CpG rich regions have very low levels of DNA methylation in all 
tissues.  Also, these data are in accordance with the suggestion that a specific density of 
CpGs is required to have a significant silencing effect when methylated.  ICPs were 
particularly interesting as they were more often found to be highly methylated and their 
promoter RNA polymerase II (polII) association was inversely correlated with DNA 
methylation status (Weber et al., 2007).  HCPs and ICPs were found to contain high levels of 
the histone mark H3K4me2 which is also inversely correlated with DNA methylation.  One 
explanation of these data is that something, potentially a histone mark such as H3K4me2, 
protects regions with high CpG density from DNA methylation, and ICP promoters are more 
often subject to DNA methylation due to their reduced CpG content.  ICPs have also been 
suggested to undergo hypermethylation more often than other promoter classes in cell 
culture suggesting that they are prone to de novo methylation (Meissner et al., 2008).  ICPs 
could therefore represent a balance between having enough CpGs so that, when methylated, 
they are capable of repressing transcription, and having not too high a CpG content that 
would be somehow refractory to methylation.  There are of course additional determinants of 
DNA methylation, as, for example, many CpG rich promoters of germline genes are found to 
be highly methylated in somatic cells (Weber et al., 2007).  This data (Weber et al., 2007) 
was generated using methyl-DNA immunoprecipitation (MeDIP) using an antibody that does 
not recognise 5hmC. 
 Profiling DNA methylation in combination with histone modifications at gene 
promoters has shown that the two types of chromatin mark are often highly correlated.  In 
fact, it has been suggested that histone modifications are a better predictor of DNA 
methylation status than DNA sequence (Meissner et al., 2008).  For example, the presence of 
H3K4me3 at HCPs is negatively correlated with DNA methylation status (Meissner et al., 
2008; Hawkins et al., 2010).   
 As with CpG islands, tissue specific patterns of DNA methylation at promoters have 
been investigated.  Between 12 human tissues, 17% of promoter regions were found to be 
differentially methylated (Eckhardt et al., 2006).  Many promoter regions were shown to be 
differentially methylated between pluripotent ES cells and somatic fibroblasts suggesting 
dynamic methylation during differentiation (Meissner et al., 2008).  Promoter DNA 
methylation has been mapped during early mouse development suggesting that many 
promoters (476 genes) are de novo methylated between the blastocyst stage and E9.5 (Borgel 
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et al., 2010).  A large proportion of these genes appear to be associated with ICP promoters 
and are expressed and have functions in the germline (Borgel et al., 2010).  This indicates 
that promoter methylation may be important for silencing germline gene expression 
programs in somatic cells (discussed in 1.2.5.5).    
 These studies indicate that promoter regions can be differentially methylated 
between tissues, a key property if they are to be involved in maintaining patterns of 
transcription.               
 
1.2.4.4.  Gene body methylation 
 
Unbiased methods for DNA methylation mapping have allowed attention to move away 
from a promoter-centric approach which had previously dominated.  One of the exciting new 
avenues of research that these studies have provided is gene body methylation.  As vertebrate 
methylomes belong to the class of 'globally methylated', it may be no surprise that gene 
bodies are also methylated (Fig. 1.4).  However, provocative evidence suggests that gene 
body methylation may represent a crucial function of DNA methylation that is relatively 
poorly understood.  Gene body methylation is evolutionarily ancient and many organisms 
that have a so called 'mosaic' methylome exhibit gene body methylation (discussed in 
1.2.4.10).  For example, in the model flowering plant, Arabidopsis thaliana, the vast 
majority of DNA methylation (5mC) occurs at gene bodies and transposon sequences 
(Zilberman et al., 2007).  Furthermore, methylation is more prominent near the centre of the 
gene body than the ends (Zilberman et al., 2007).  In mammals, many tissue-specific 
differentially methylated regions have been found in gene bodies, including intragenic CpG 
islands, suggesting a function in gene regulation (Eckhardt et al., 2006; Illingworth et al., 
2010; Maunakea et al., 2010).   
 The function of gene body methylation is currently unclear.  Many studies have 
found positive correlations between gene body methylation and transcription in mammals 
(Rauch et al., 2009; Ball et al., 2009; Laurent et al., 2010; Aran et al., 2011).  In addition, an 
elegant study of the active (Xa) and inactive (Xi) X chromosomes in female cells showed 
that the Xa, where many genes are expressed, contains methylation concentrated at gene 
bodies, whereas the Xi was depleted of methylation at gene bodies (Hellman and Chess, 
2007).  In one study, this correlation was observed only in highly proliferative tissues linking 
it to actively dividing cells (Aran et al., 2011).  These data suggest that gene body 
methylation may be somehow linked to transcription.  In contrast, the first single base 
resolution methylation map in mammals showed no correlation between gene body CpG 
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methylation and transcription in human ES cells, although a weak correlation was observed 
for fibroblast cells (Lister et al., 2009; Hawkins et al., 2010).  In Arabidopsis, genes that are 
moderately transcribed are the most methylated while both high and low expressed genes 
contain lower methylation (Zilberman et al., 2007).  In addition, reduction of methylation in 
Arabidopsis leads to upregulation of genes with gene body methylation (Zilberman et al., 
2007).  DNA methylation has also been suggested to inhibit transcriptional elongation in the 
filamentous fungi, Neurospora crassa (Rountree et al., 1997).  In mammals, certain histone 
marks associated with a more closed chromatin structure, such as H3K36me3 and 
H3K9me2/3, are associated with gene bodies of active genes (Barski et al., 2007).  In fact, 
H3K36me3 is considered a marker of actively elongating transcription units and a link 
between this modification and de novo DNA methylation has been established (discussed in 
1.2.4.11).  Therefore, it is feasible that DNA methylation could contribute to a more closed 
chromatin structure at gene bodies.  DNA methylation may be required specifically in 
dividing cells where a memory of chromatin state across cell divisions must be maintained, 
but not required in quiescent cells where chromatin states may be more stable.  But what is 
the function of a more closed chromatin conformation at gene bodies?  One of the functions 
could be to prevent spurious transcription initiation.  A speculation is that as the act of 
transcription ejects nucleosomes, leading to a more open chromatin conformation, this could 
promote new transcription initiation events producing cryptic transcripts.  This could explain 
why in Arabidopsis moderately expressed genes contain highest gene body methylation, as at 
highly transcribed genes the next polymerase runs through the gene without time for 
reassembly of chromatin into a more closed state.  Some evidence does exist for a role of 
DNA methylation in prevention of transcription initiation in gene bodies.  A tissue-
specifically methylated CpG island was shown to act as an alternative promoter at the 
Shank3 gene, in both mouse and human, the activity of which is negatively regulated by 
DNA methylation (Maunakea et al., 2010).  However, a general role for gene body 
methylation in prevention of spurious transcription initiation within transcription units has 
not been tested and remains speculation.          
 
1.2.4.5.  Enhancers 
 
Another finding of DNA methylation mapping studies is that enhancers may be differentially 
methylated, correlating with their activity.  The binding sites for certain pluripotency-
associated transcription factors in human ES cells were shown to be depleted of DNA 
methylation (Lister et al., 2009).  Some were found to be more depleted of methylation in ES 
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cells, where these factors are highly expressed, and less depleted in fibroblasts, where these 
factors are not expressed (Lister et al., 2009).  In addition, using a chromatin signature to 
differentiate active from inactive enhancers, it was shown that DNA methylation depletion 
was evident in fibroblasts at enhancers specifically active in these cells, although the same 
was not true for ES cell-specific enhancers (Lister et al., 2009).  This analysis was extended 
and many signatures of differential DNA methylation were found at cell-specific enhancers 
(Hawkins et al., 2010).  DNA methylation at enhancers has not been extensively studied and 
it is unclear from this data what the cause and effect relationships are between DNA 
methylation and enhancer activity.  For example, it is feasible that DNA methylation is 
capable of blocking the binding of a DNA binding protein directly or contributing to a 
chromatin state that is incompatible with binding therefore precluding the activity of an 
enhancer (see later section 1.2.6 on the molecular function of DNA methylation).  It is also 
feasible that enhancer binding proteins can prevent access to DNA by DNMTs and therefore 
lead to reduction in methylation at an active enhancer, or that a similar effect is achieved by 
a chromatin state that is refractory to DNA methylation.  More study is needed in this respect 
to establish a potential role for DNA methylation in enhancer activity.  Interestingly, a study 
on glucocorticoid receptor binding at enhancers showed that DNA methylation prevents 
binding and formation of a DNaseI hypersensitive site upon stimulation with glucocorticoids 
(Wiench et al., 2011).  Furthermore, knockdown of Dnmt1 increased binding of the receptor 
to previously precluded sites suggesting that methylation may act to regulate tissue-specific 
activity of certain enhancer elements.     
              
1.2.4.6.  Methylation status over large domains 
 
Unbiased maps of DNA methylation also allow the study of differential methylation of large 
domains.  In the first base-resolution methylation map of mammals it was noticed that 
amongst the high background of methylation were large regions of lower methylation 
present in somatic cells but not ES cells (Lister et al., 2009).  These regions were large 
(mean length of 153kb), covered a substantial proportion of each chromosome (mean of 
38.4% of autosomes), had a mean methylation less than 70% and were termed partially 
methylated domains (PMDs).  Interestingly, genes within fibroblast PMDs (partial 
methylation in fibroblast cells) were less expressed in fibroblasts than ES cells and were 
associated with certain repressive histone marks (Hawkins et al., 2010).  In another study, 
PMDs were identified in neuronal cells and shown to be associated with tissue-specifically 
expressed genes that were repressed in the neuronal cells studied (Schroeder  et al., 2011).  
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Conversely, genes found in broad domains of high methylation in neuronal cells were 
enriched for neuronal functions.  These studies, together with gene body methylation, 
demonstrate that the association of DNA methylation with transcription is context and 
location dependent.  Gene regulation is more frequently being linked to higher order levels 
of regulation and it will be interesting to see what future studies tell us about the function of 
methylation of large genomic domains. 
 
1.2.4.7.  Non-CpG methylation 
 
Methylation of cytosines in the non-CpG context is abundant in plant genomes (Feng et al., 
2010).  It was noticed that mouse embryonic stem (ES) cells also have significant DNA 
methylation in the non-CpG context providing an alternative to the view that DNA 
methylation in mammals is restricted to CpG dinucleotides (Ramsahoye et al., 2000).  
Subsequently, the abundance of non CpG methylation was estimated in a selection of 
animals and plants (Feng et al., 2010).  Non-CpG methylation was found to be much more 
abundant in plant species and is relatively rare in animals with about 0.3% of CHG and CHH 
sites methylated (where H is A, C or T)  in mouse embryo DNA (Feng et al., 2010).  Non-
CpG methylation has been mapped in detail in certain mammalian tissues (Lister et al., 
2009; Laurent et al., 2010, Feng et al., 2010; Li et al., 2010).  It was observed that ES cells 
are enriched for non-CpG methylation with nearly a quarter of cytosine methylation in 
human ES cells in the context of non-CpG.  In contrast, somatic cells such as mouse and 
human fibroblasts and human blood mononuclear cells have much lower non-CpG 
methylation content, with 99.98% of methylation in human fibroblasts in the CpG content 
(Lister et al., 2009; Laurent et al., 2010; Li et al., 2010).  In another study looking at 
candidate regions, mainly at differentially methylated imprinted regions, it was found that 
oocytes contain roughly 35% non-CpG methylation compared to CpG methylation while 
these regions were nearly exclusively marked by CpG methylation in sperm, blastocyst and 
the E12.5 embryo (Tomizawa et al., 2011).  This further suggests that non-CpG methylation 
is linked to the tissue of origin.  It is currently unclear if oocytes have a genome wide 
increase in non-CpG methylation or if it is locus-specific.   
 In human ES cells non-CpG methylation is reportedly depleted from gene promoters 
and 5' UTRs (un-translated region) and more abundant in gene bodies and 3' UTRs, with 
CHH methylation being enriched in exons relative to introns and 3' UTRs (Lister et al., 
2009).  Both types of non-CpG methylation in gene bodies are positively correlated with 
gene expression with a small bias for marking the antisense strand.  Like CpG methylation, 
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non-CpG methylation was depleted at protein binding sites and negatively correlates with 
gene expression when present at promoters (Lister et al., 2009).  In fact, non-CpG 
methylation broadly correlates with CpG methylation and is generally depleted from CpG 
islands and promoter regions.  In addition, genes reportedly marked by gene body non-CpG 
methylation are enriched for functions in RNA processing, RNA splicing and RNA 
metabolic processes (Lister et al., 2009).   
 The tissue-specificity and high abundance of non-CpG methylation in ES cells is 
intriguing and intuitively suggests function.  However, until further studies are conducted it 
remains possible that it is merely non-functional noise related to high de novo 
methyltransferase activity.  De novo DNA methyltransferases are expressed highly in ES 
cells (Lister et al., 2009; Laurent et al., 2010).  ES cells are derived from pluripotent tissues 
of the early embryo and are artificially maintained in an actively dividing and pluripotent 
state in cell culture that exists only transiently during development.  In fact, prolonging the 
high levels of Dnmt3 proteins by culturing mouse ES cells is thought to lead to an altered 
epigenome relative to their tissue of origin (Borgel et al., 2010).  It is therefore entirely 
possible that extensive non-CpG methylation in hES cells, reported by Lister et al., (2009), 
exists as a consequence of prolonged high levels of de novo methylation and serves no 
function.  Convincing evidence to the contrary would be extensive bisulfite sequencing from 
early embryo DNA showing non-CpG methylation, demonstrating that it is not a 
consequence of cell culture.  Very low levels of non-CpG methylation have been detected in 
somatic cell lines and tissues studied so far (Lister et al., 2009; Laurent et al., 2010; Feng et 
al., 2010; Tomizawa et al., 2011).  Non-CpG methylation in hES cells is found enriched 
precisely at regions that are thought to recruit Dnmt3s, including actively transcribing gene 
bodies which may recruit Dnmt3s through the H3K36me3 mark (discussed in 1.2.4.11).  As 
much as 98% of non-CpG methylation was found to be asymmetrical in hES cells, being 
present on only one strand, compared to 1% of CpG methylation that is asymmetrical (Lister 
et al., 2009).  This means that non-CpG methylation would not be maintained across cell 
divisions.  For these reasons, it remains possible that ES cells are generally hypermethylated 
and non-CpG methylation is part of the noise associated with prolonged high Dnmt3 activity.  
Oocytes represent a non-cultured cell type that has reported non-CpG methylation, although 
its location and abundance on a large scale has not yet been reported.  It is possible that as 
oocytes are non-dividing that non-CpG methylation accumulates as it is not diluted by DNA 
replication.  It will be interesting to see the results of future studies of non-CpG methylation 
and whether, as in plants, it has a functional consequence. 
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1.2.4.8.  Distribution of 5hmC 
 
The development of multiple mapping techniques has allowed the distribution of 5hmC to be 
studied recently.  Here I will summarise the findings of these initial studies, which have 
nearly exclusively been conducted using mouse ES cells.  Both 5hmC and the binding of the 
Tet1 protein have been mapped in mouse ES cells.  The 5hmC base has been found 
throughout the ES cell genome but is particularly enriched in gene bodies and promoter 
regions (Ficz et al., 2010; Pastor et al., 2011; Szulwach et al., 2011; Williams et al., 2011; 
Wu et al., 2011; Xu et al., 2011b).  Genome-wide, 5hmC is fairly well correlated with 5mC 
with the exception of promoter and CpG-rich regions, which are depleted for 5mC but often 
enriched for 5hmC (Szulwach et al., 2011).  Like 5mC, the 5hmC signal at gene promoters is 
inversely correlated with transcription while within gene bodies it is positively correlated 
with transcription (Pastor et al., 2011; Szulwach et al., 2011; Wu et al., 2011).  However, the 
pattern of 5hmC at promoters may be more complex.  At highly expressed genes, although 
5hmC is not present over a punctate region at the transcription start site (TSS), it is present 
either side of the TSS, suggesting that it may be actively depleted from the TSS at these 
genes (Szulwach et al., 2011).  The Tet1 protein contains a CXXC domain and is strongly 
enriched for binding at CpG-rich regions of the genome (Williams et al., 2011; Xu et al., 
2011b).  5hmC also shows a weak correlation with genomic CpG density although the 
locations of Tet1 and 5hmC are not always overlapping (Szulwach et al., 2011; Williams et 
al., 2011).  For example, Tet1 is bound to CpG-rich promoters, independent of their activity, 
while 5hmC is present at the genes at the lower expression level at this region (Wu et al., 
2011).  Further study of the location and turnover of the 5hmC base may resolve this 
discrepancy. 
 Most of the studies that have mapped 5hmC have used immunoprecipitation based 
techniques that enrich for DNA containing 5hmC.  Therefore, not much is known about the 
absolute quantity of the 5hmC base at specific loci in mammalian genomes.  One study 
suggests that 5hmC can represent as much as ~70% of all forms of cytosine at a single loci 
making it the most abundant form of cytosine at this site (Nestor et al., 2011).  Also, this 
study suggests that the absolute quantity of 5hmC at loci can vary greatly between tissues 
and does not correlate with either gene transcriptional status or expression of the TET genes, 
a feature that can be masked when using immunoprecipitation techniques (Nestor et al., 
2011).  
 As with any chromatin modification it is important to understand 5hmC in the 
context of the epigenome.  Correlations have been established between 5hmC and certain 
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histone modifications in ES cells (Szulwach et al., 2011).  Genome wide, 5hmC correlates 
well with 5mC, H3K4me1 and H3K18ac while poor correlations were observed for other 
marks tested (Szulwach et al., 2011).  Tet1 and 5hmC can be found at many genes marked 
by binding of polycomb group proteins and H3K27me3 (Wu et al., 2011; Pastor et al., 
2011).  Particularly, 5hmC is enriched at promoters marked by both H3K4me3 and 
H3K27me3, also known as the bivalent mark (Pastor et al., 2011).  The significance of this 
association is unclear but may reflect a need to maintain low 5mC at these regions (Wu et 
al., 2011).  A peak of 5hmC has also been detected at various enhancers in ES cells 
(Szulwach et al., 2011).  More of this type of study will be important to determine the 
dynamics and putative function of the 5hmC base.     
           
1.2.4.9.  Developmental dynamics of DNA methylation and demethylation 
 
DNA methylation patterns are remarkably dynamic during the mammalian life cycle but the 
mechanisms behind these dynamics have been enigmatic.  Extensive demethylation is 
thought to occur during at least two stages of the mouse life cycle, in the zygote and in the 
developing germline.  The DNA methylation patterns in mature sperm and oocytes are 
markedly different, with sperm having a generally higher 5mC content (Monk et al., 1987; 
Kafri et al., 1992; Smallwood et al., 2011).  Upon fertilisation, the paternal genome 
undergoes extensive loss of 5mC without replication of DNA suggesting that active 
demethylation may take place (Wossidlo et al., 2011; Gu et al., 2011).  DNA methylation 
dynamics at this stage are not a general feature of vertebrates, with a variable extent of 
demethylation observed in different organisms, and no observable dynamics in others 
(Macleod et al., 1999).  In mammals, the zygotic wave of demethylation of the paternal 
genome has been suggested to be involved in restoring totipotency to the genome, and is 
implicated in removing methylation from the promoters of key pluripotency genes (Farthing 
et al., 2008; Gu et al., 2011).  This demethylation is followed by extensive de novo 
methylation of the genome before the embryo implants, and also following implantation, 
leading to the global methylome that was described in a previous section (Borgel et al., 
2010).   
 The second stage of DNA demethylation in mice occurs during germ cell 
development.  Germ cell precursors, primordial germ cells (PGCs), undergo DNA 
demethylation as part of genome-wide chromatin reprogramming phases during their 
migration to, and arrival in, the developing gonads (Hajkova et al., 2008; Hajkova et al., 
2010).  One of the functions of these epigenetic reprogramming events in germ cells is 
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thought to be removal of genomic imprints, parent of origin-specific DNA methylation 
marks, so that they can be re-established in a sex-dependent manner (Hajkova et al., 2008).  
Another suggested function is in the establishment of a chromatin pattern that is compatible 
with future totipotency upon fertilisation although the full extent and precise function of 
these demethylation phases remain unclear (Hajkova et al., 2008).   
 Active DNA demethylation has long been presumed to exist in mammals, although 
the mechanisms involved have remained largely enigmatic due to the absence of a clear 
DNA demethylase.  Recent evidence suggests that the 5hmC base and DNA repair 
mechanisms may be at least part of the answer to this long standing question.  Multiple DNA 
repair components have now been implicated in DNA demethylation, including Gadd45a 
(Barreto et al., 2007), Mbd4 (Rai et al., 2008; Kim et al., 2009a) and TDG (Cortellino et al., 
2011; He et al., 2011a).  A deaminase enzyme, AID, has been implicated in demethylation of 
DNA, including during the reprogramming phase of PGC development (Popp et al., 2010; 
Bhutani et al., 2010).  These data together suggested a model for demethylation involving 
deamination of 5mC to uracil followed by subsequent base excision mediated by a 
glycosylase such as Mbd4 or TDG.  Evidence has been put forward for a role of Mbd4 in 
demethylation upon hormone-induced transcription, although Mbd4 is unlikely to play a 
major role in demethylation generally as Mbd4-/- mice are viable and fertile (Kim et al., 
2009a).  TDG has emerged as a better candidate, as Tdg-/- mice show embryonic lethality and 
have increased DNA methylation at candidate loci (Cortellino et al., 2011; Cortazar et al., 
2011).  The re-emergence of the 5hmC base has lead to further insight into repair-mediated 
active demethylation.  The 5hmC base accumulates on the paternal genome in the zygote 
during loss of 5mC, and the Tet3 protein is required for the observed dynamics of 5hmC and 
5mC during this period (Wossidlo et al., 2011).  In addition, 5hmC and Tet proteins have 
been implicated in demethylation in somatic tissues such as brain (Guo et al., 2011).  TDG 
may be the link between 5hmC and demethylation.  TDG has been implicated in excision of 
5hmC following deamination by AID and also in excision of 5caC, a further modification of 
cytosine catalysed by Tet enzymes (Cortellino et al., 2011; He et al., 2011a).  These data 
suggest models for the mechanism by which conversion of 5mC to 5hmC by Tet proteins 
initiates active demethylation.  The 5hmC base may be deaminated by AID to 5'-
hydroxymethyluracil then excised by TDG.  Or, a deamination independent reaction may 
occur where Tet enzymes catalyse 5caC which is excised by TDG.  These models are 
beginning to shed light on how DNA methylation dynamics are governed and also that active 
DNA demethylation may be a multi-step process involving Tet enzymes and DNA repair.  
However, a recent study suggests that the 5hmC that accumulates on the paternal genome in 
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the zygote is lost passively over the first few cell divisions of the early embryo and is not 
actively removed (Inoue and Zhang, 2011).  Thus, although the dynamics of modified 
cytosine bases are becoming better understood, we are a long way from a good 
comprehension of the processes involved.                   
 
1.2.4.10.  DNA methylation patterns in other organisms 
 
Advances in methylation mapping technologies have led to a leap forward in our knowledge 
of DNA methylation patterns in other organisms allowing us to better understand the 
complex evolution of DNA methylation (Zemach et al., 2010; Feng et al., 2010).  DNA 
methylation is conserved in members of most major groups of eukaryotes that have been 
studied including those of plants, fungi and animals.  Some groups appear to have lost DNA 
methylation completely including the nematode Caenorhabditis elegans and the budding 
yeast Saccharomyces cerevisiae.  Other clades appear to share some features of the DNA 
methylome and not others suggesting certain parts or functions were lost during their 
evolution.  DNA methylomes can be classified as either global or mosaic depending on their 
pattern.  An example of a global methylome is that of vertebrates where 5mC is the most 
prevalent form of cytosine in the CpG context and most CpGs in the genome are highly 
methylated (for example, Lister et al., 2009).  As previously mentioned, an example of a 
mosaic methylome is the flowering plant Arabidopsis thaliana, where most 5mC is present 
in domains at gene bodies and transposon sequences with the majority of the genome being 
low/unmethylated (Lister et al., 2008).  Two features of DNA methylomes appear to be 
evolutionarily ancient, gene body methylation and repeat/transposon methylation (Zemach et 
al., 2010; Feng et al., 2010).  These two features were likely present in the common ancestor 
of eukaryotes and are present or absent in various combinations in extant eukaryotes 
(Zemach et al., 2010).  If DNA methyltransferases are grouped into three families based on 
homology (Dnmt1/MET1, Dnmt3/DRM and CMT/DIM-2 families), presence or absence of 
different groups is also somewhat related to these methylome features.  For example, fungi, 
that have DNA methylation, have it at transposons but not gene bodies and have lost 
Dnmt3/DRM family members (Sukuki and Bird, 2008; Zemach and Zilberman, 2010).  
Invertebrate animals, that have DNA methylation, have it at gene bodies and not transposons 
and have lost the CMT/DIM-2 family member.  The exception within animals is of course 
vertebrates which appear to have reacquired transposon methylation by switching to a global 
methylome (Lister et al., 2009).  Among plants there are species that have both gene body 
and transposon methylation and species that have only transposon methylation.  This 
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suggests the following model for evolution of DNA methylation.  The last common ancestor 
of eukaryotes likely had both gene body methylation and transposon methylation and had a 
representative DNMT from each of the three protein families (Zemach et al., 2010).  
Subsequently, in different lineages, either or both features were lost and in some species 
DNA methylation was lost completely.  Animals lost transposon methylation and seem to 
have adapted new methods for transposon silencing, such as repressive histone 
modifications, as seen in extant invertebrates (Zemach and Zilberman, 2010).  Vertebrates 
seem to have reacquired transposon methylation by methylating nearly all of the genome.  
The reason for this switch to a global methylome in vertebrates is unclear but may have 
involved an increasing number of transposons in the population brought about by sexual 
reproduction.  Indeed, the complex evolution of DNA methylation patterns remains a 
mystery but it has been suggested that sexual reproduction may have been a driving force 
(Zemach and Zilberman, 2010).  DNA methylation seems to have been co-opted for gene 
regulation at promoter regions in plant and vertebrate species with promoter methylation 
negatively correlating with transcription in multiple species (Zemach et al., 2010). 
   
1.2.4.11.  Targeting of DNA methylation 
 
How specific DNA sequences are targeted for methylation remains unclear but current 
evidence supports a multifactorial system, including roles for transcription factors, chromatin 
proteins, histone modifications and non-coding RNA (ncRNA).  Here I will give examples of 
each type of mechanism for targeting of DNA methylation.  Given that vertebrates have a 
global methylome, with most of the CpGs in the genome highly methylated, with the 
exception of CpG islands, it is possible that they have evolved a 'methylation by default' 
targeting system.  Such a system would entail, not methylation targeting per se, but 
protection of regions that need to remain unmethylated, such as the majority of CpG islands.  
Given recent data, it is interesting to speculate that a combination of H3K4me3 and the 
activity of Tet proteins contributes to the maintenance of a methylation-free state at CpG 
islands amongst the methylated bulk genome, although further work is needed to confirm 
these ideas.  Also, DNA methylation has been suggested to be preferentially targeted to 
genomic regions that are transcriptionally silent, a process that may involve transcription- 
and repression-associated histone marks (discussed below)(Bird, 2002).  Although it is 
possible that a system like this may operate in vertebrates, particularly during the de novo 
methylation periods of early embryogenesis, it is clear that there are also conserved 
mechanisms for targeting methylation to specific regions. 
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 Circumstantial evidence links certain transcription factors to DNA methylation 
targeting.  The pluripotency-associated Pou5f1 gene (encoding the Oct4 protein) has been 
studied as a model for gene silencing during differentiation of embryonic stem cells.  The 
promoter of Pou5f1 is de novo methylated during this process, following transcriptional 
silencing (Feldman et al., 2006; Epsztejn-Litman et al., 2008).  A nuclear receptor, GCNF 
(germ cell nuclear factor), is required for silencing and DNA methylation of the Pou5f1 
promoter and is reported to interact with Dnmt3 proteins (Sato et al., 2006).  Although this 
implicates GCNF in targeting of DNA methylation to this locus, it is possible that GCNF is 
required for the initial transcriptional silencing of the gene which in turn is required for DNA 
methylation.  Further study would be required to elucidate the precise role of GCNF in 
Pou5f1 silencing.  Another example is E2F6, a transcriptional repressor implicated in 
targeting de novo methylation to specific germline-expressed genes in somatic cell lineages 
(Velasco et al., 2010).  Here, the Dnmt3b protein was shown to interact with E2F6 and 
E2F6-/- mice showed lack of Dnmt3b recruitment to, and reduced methylation of, target gene 
promoters (Velasco et al., 2010).   
 DNA methylation patterns have been suggested to be better associated with histone 
modifications than the underlying genetic sequence (Meissner et al., 2008).  It is emerging 
that a crosstalk between histone modifications and the DNA methylation machinery is 
crucial in targeting DNA methylation.  This crosstalk can occur at two levels, through 
protein-protein interactions between chromatin modifiers and DNMTs, or via a histone mark 
itself.  Many chromatin associated proteins have been implicated in targeting of de novo 
methylation through protein-protein interaction, including G9a and Lsh that were discussed 
previously.  The polycomb repressor complex 2 (PRC2) component, EZH2, has also been 
suggested to target DNA methylation in cancer cells by recruiting DNMTs to target genes 
(Vire et al., 2006).  However, this idea remains highly controversial as a similar effect has 
not been observed in normal tissues and is also not evident in all cancer cell lines tested 
(Denis et al., 2011).  Dnmt3 proteins appear to receive cues from histone modifications that 
influence their targeting.  One such example is targeting by the Dnmt3L protein, that binds 
specifically to H3 tails unmodified at K4 via its PHD-like domain (Ooi et al., 2007).  The 
PHD-like domains of Dnmt3 proteins have also been suggested to be recognition modules 
for specific histone signatures.  Similar to the PHD-like domain of Dnmt3L, the equivalent 
domains in Dnmt3a and Dnmt3b proteins bind preferentially to histone H3 tails that do not 
have methylation at the K4 position (Otani et al., 2009; Zhang et al., 2010b).  The 
combination of Dnmt3L and Dnmt3s inhibition by H3K4me3 could explain part of the 
reciprocal locations of this histone mark and DNA methylation on chromatin (Meissner et 
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al., 2008).  The PHD-like domain of Dnmt3a has also been implicated in recognising the 
H4R3me2 (symmetrically dimethylated arginine) modification catalysed by PRMT5 (protein 
arginine methyltransferase 5) and this interaction was suggested to influence DNA 
methylation at the silent β-globin locus (Zhao et al., 2009).  The PWWP domain of Dnmt3a 
has been shown to bind to H3K36me3 in vitro giving a potential explanation for the positive 
correlation between gene body methylation and transcription, and the binding of Dnmt3a to 
transcribed regions (Dhayalan et al., 2010).  H3K9me3 is correlated with DNA methylation 
at pericentric heterochromatin and has been implicated in targeting de novo methylation in 
three ways (Lehnertz et al., 2003).  Firstly, HP1 (heterochromatin protein 1), a K9me2/me3 
binding protein, interacts with Dnmt3b (Lehnertz et al., 2003; Geiman et al., 2004).  
Secondly, Dnmt3b interacts with a H3K9 methyltransferase responsible for K9me at 
pericentric heterochromatin, Suv39h1 (Geiman et al., 2004).  Thirdly, DNA methylation 
may be targeted to H3K9me3 by Uhrf1.  In addition to its role in maintenance of DNA 
methylation, Uhrf1 has been implicated in binding specifically to the combination of histone 
marks H3K9me3 and H3K4me0, and therefore may also be involved in directing DNA 
methylation to K9me3 (Rottach et al., 2010; Nady et al., 2011). These kind of mechanisms 
implicate the DNA methylation machinery as both 'readers' and 'writers' of chromatin 
modifications and underline the importance of chromatin crosstalk in gene regulation.  
 One emerging theme in DNA methylation targeting in mammals is RNA-mediated 
targeting.  RNA-directed DNA methylation (RdDM) is better understood in plants where it is 
thought to account for a significant proportion of DNA methylation targeting (Lister et al., 
2008).  In mammals, evidence for a similar process is starting to emerge.  One class of small 
RNA, termed piRNA (piwi interacting RNA), has been implicated in targeting DNA 
methylation to transposons in the male embryonic germline (Aravin et al., 2008; Kuramochi-
Miyagawa et al., 2008).  piRNAs are small RNAs of 26-31 nucleotides in length that are 
classified by interaction with homologs of Drosophila Piwi proteins, proteins of the 
Argonaute family (Aravin et al., 2008).  piRNAs are thought to originate from transposon 
sequences, and after processing and amplification, feedback to target silencing mechanisms 
to repeat regions (Aravin et al., 2008).  Knockout of mouse homologs of Piwi proteins 
results in phenotypes similar to Dnmt3l mutation, including failure to silence transposon 
elements in the developing germline (Kuramochi-Miyagawa et al., 2008).  DNA methylation 
is reduced at transposon sequences in Piwi-homolog mutants in mice and specifically a role 
in de novo methylation during foetal germ cell development is suggested (Aravin et al., 
2008; Kuramochi-Miyagawa et al., 2008).  The molecular mechanism of DNA methylation 
targeting by piRNAs and Piwi proteins has not been established, and to date no interaction 
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between Piwi proteins and Dnmt3 proteins has been reported.  As a piRNA-mediated 
transposon repression system exists in Drosophila, an organism with very low levels of 
DNA methylation, a sensible hypothesis might be that piRNAs guide other chromatin 
modifying complexes to transposons and DNA methylation is secondary to this event in 
mammals.  Recently, RdDM in mammals was extended beyond piRNAs in a study of 
ribosomal DNA (rDNA) silencing (Schmitz et al., 2010).  A ncRNA complementary to the 
promoter of a rDNA gene, termed pRNA, was shown to form an RNA:DNA triplex structure 
capable of recruiting DNMT3B in vitro.  Depletion or over-expression of pRNA led to 
changes in DNA methylation at the rDNA gene promoter implicating pRNA in targeting of 
de novo methylation (Schmitz et al., 2010).  As RNA could provide the crucial specificity, 
these mechanisms provide an intriguing system for DNMT targeting, and no doubt further 
studies will investigate a putative wider role for RNA:DNA triplexes and RNA based 
systems in general in targeting of epigenetic marks.                     
 
1.2.5.  The roles of DNA methylation in mammals 
 
The fundamental role of DNA methylation in mammals is generally thought to be in the 
repression of transcription.  Due to its relative stability through DNA replication, it is 
implicated as a template for maintaining patterns of transcription through time and cell 
divisions, and is thought to be a major component of epigenetic memory.  In this section I 
will discuss our knowledge of the roles of DNA methylation in transcriptional regulation 
during embryonic development and cell differentiation.  I will then focus on the molecular 
mechanisms by which this epigenetic mark is thought to influence transcription.       
 
1.2.5.1.  DNA methylation is required for embryonic development 
 
DNA methylation is required for mammalian development.  This view has arisen as mice 
with mutations in genes required for normal DNA methylation show developmental 
phenotypes (detailed in table 1.1).  In addition, a mouse with a catalytically inactive Dnmt1 
shows roughly the same developmental phenotype as mice null for Dnmt1, suggesting that 
the DNA methylation mark itself, or at least the catalytic activity of Dnmt1, is required for 
development (Takebayashi et al., 2007).  Depletion or mutation of DNA methyltransferases 
in other organisms also leads to varying developmental defects and lethality, including 
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Xenopus laevis, zebrafish and Arabidopsis thaliana (Stancheva and Meehan, 2000; 









N-allele (hypomorph): Mid-gestation lethality 
(10.5-12.5dpc); 10-20 somites; 
developmentally retarded (by 1-2 days); 
organ rudiments formed but small 
Li et al., 1992 
 
  
S- and C-alleles: Early to mid-gestation 
lethality (9.5-11.5dpc, 0-8 somites); 
developmentally retarded (by 1-2 days); 
distorted neural tube; failure to turn 





Post-natal lethality (~4 weeks); runted 





Embryonic lethality (14-18dpc); growth 
defects; neural tube defects 






Early to mid-gestation lethality (9.5-11.5dpc); 
lack somites; developmentally retarded (by 1-
2 days); distorted neural tube; failure to turn 
Okano et al., 1999 
 
Dnmt2 tRNA methylation None Goll et al., 2006 








Peri-natal lethality (0- a few weeks); runted; 
premature aging phenotypes 
Geiman et al., 2001 




Early to mid-gestation lethality; similar to 
Dnmt1-/- 
Sharif et al., 2007 
Table 1.1 - Embryonic phenotypes of mice with mutated DNA methyltransferases and 
associated proteins.   
 
The exact reason for failure of embryonic development in severely hypomethylated mice is 
unclear.  Loss of genomic imprinting could have been a feasible explanation, as imprinted 
genes often have important developmental functions, and lack of imprints in oocytes, caused 
by Dnmt3a mutation, leads to offspring that die during mid-gestation (Kaneda et al., 2004).  
However, mice lacking both Dnmt3a and Dnmt3b can reportedly maintain methylation at 
imprints during early embryogenesis and show the same phenotypes as Dnmt1 loss (Okano 
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et al., 1999).  This suggests that biallelic expression of imprinted genes is not the major 
cause of the developmental phenotypes, and also that de novo methylation is important for 
embryogenesis.  A major contributor to the phenotype of Dnmt1 loss is thought to be 
apoptosis, which is apparent in a significant proportion of cells in a Dnmt1-/- embryo and also 
in mouse embryonic fibroblasts lacking Dnmt1 (Jackson-Grusby et al., 2001; Lande-Diner et 
al., 2007).  Depletion of Dnmt1 in Xenopus laevis embryos also leads to induction of 
apoptosis, suggesting conservation of this response (Stancheva et al., 2001).  In addition to 
apoptosis, it seems plausible that transposon upregulation and gene mis-regulation contribute 
to the phenotypes.     
 
1.2.5.2.  DNA methylation is involved in cell differentiation and maintenance of cell 
identity 
 
In addition to studies of embryonic development, cell lines and adult stem cell populations 
have been used to examine to importance of DNA methylation.  Embryonic stem (ES) cells 
deficient in Dnmt1 can be maintained in the undifferentiated state (Lei et al., 1996).  In fact, 
deletion of all three catalytically active DNA methyltransferases (TKO - for triple knockout) 
in ES cells completely abrogates DNA methylation but does not induce apoptosis or 
differentiation, indicating that DNA methylation is not required for ES cell self renewal 
(Tsumura et al., 2006; Fouse et al., 2007).  However, normal levels of DNA methylation are 
required for another property of ES cells, pluripotency.  ES cells deficient in Dnmt1, or both 
Dnmt3a and Dnmt3b, have defects in differentiation (Jackson et al., 2004).  Dnmt1-/- ES cells 
can initiate differentiation, measured by silencing of Oct4 and loss of alkaline phosphatase 
staining, but show increased apoptosis and cannot terminally differentiate (Lei et al., 1996; 
Jackson et al., 2004).  The same is observed for ES cells expressing a catalytically inactive 
Dnmt1 indicating that the DNA methylation mark itself is important during differentiation 
(Damelin and Bestor, 2007).   
 A number of studies implicate DNA methylation in the memory of lineage 
commitment after differentiation.  An interesting example is the Elf5 gene promoter, which 
is methylated in embryonic but not extra-embryonic tissues following the first cell lineage 
decision of the early embryo (Ng et al., 2008).  Methylation of this region is required for 
maintaining silencing of Elf5 in the embryonic compartment, while in the extra-embryonic 
compartment Elf5 initiates a positive feedback loop that reinforces extra-embryonic 
development.  Therefore, ES cells lacking DNA methylation can contribute to the extra-
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embryonic lineages when injected into a blastocyst while wildtype ES cells rarely achieve 
this (Ng et al., 2008).  DNA methylation has also been recently linked to the maintenance 
and differentiation of multipotent adult stem cell populations.  Dnmt1 is required to maintain 
multipotent progenitors of the epidermis and hematopoietic system in the undifferentiated 
state (Broske et al., 2009; Trowbridge et al., 2009; Sen et al., 2010).  In hematopoietic stem 
cells (HSCs), loss or depletion of Dnmt1 results in cell differentiation and a skew towards 
myeloid, rather than lymphoid, cell lineages.  Interestingly, this effect is independent of 
apoptosis and is thought to at least partially involve loss of repression of myeloid-specific 
genes (Broske et al., 2009; Trowbridge et al., 2009).  Another study showed that promoter 
DNA methylation of Arx, a lineage-specific gene, in pancreatic β cells was necessary to 
maintain their identity.  Deletion of Dnmt1 resulted in loss of Arx repression and conversion 
to an α cell identity (Dhawan et al., 2011).  These studies provide evidence for the long 
standing hypothesis that DNA methylation, as a relatively stable epigenetic mark, is an 
important contributor to cell identity by influencing gene transcription.             
 
1.2.5.3.  X-inactivation and genomic imprinting: paradigms for transcriptional 
regulation by DNA methylation 
 
Two biological processes have emerged as paradigms for transcriptional regulation by DNA 
methylation, X-chromosome inactivation and genomic imprinting.  DNA methylation plays 
key roles in these mechanisms and they particularly exemplify its function in maintaining 
patterns of a transcriptional state.  They are excellent models for studying the role of 
epigenetic mechanisms in transcriptional regulation for two reasons.  Firstly, they involve 
allele-specific regulation, that cannot be explained by the presence or absence of trans acting 
transcription factors, as they exist within the same nucleus and thus are exposed to the same 
nuclear milieu.  This means that the differential expression is likely governed by epigenetic 
factors.  Secondly, they involve the memory of differential transcriptional states over long 
periods of time, in some cases for the life of the organism. 
 X-chromosome inactivation (XCI) is the process that results in large portions of one 
of the two X-chromosomes in female cells being transcriptionally inactivated (reviewed in 
Augui et al., 2011).  In the early female mouse embryo, both X-chromosomes are active until 
the 4-cell stage when the paternal X chromosome is inactivated (forming an inactive X - Xi) 
and this chromosome will remain inactive in the future extra-embryonic tissues.  In the 
pluripotent cells of the blastocyst, that will give rise to the embryo, the paternal Xi is 
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reactivated followed by a process of random XCI that occurs around the epiblast stage 
(Augui et al., 2011).  The randomly chosen Xi is subsequently maintained in this state 
throughout all subsequent daughter cells for the life of the organism.  Crucially, XCI 
involves heterochromatinisation of the Xi followed by changes in DNA methylation (for 
example, Heard et al., 2001; Hellman and Chess, 2007; Sharp et al., 2011).  Relative to the 
Xa (active X chromosome), the Xi has lower levels of total DNA methylation, including at 
gene bodies, but many CpG islands associated with transcriptional start sites become highly 
methylated, mainly at the genes that are silenced by XCI (Hellman et al., 2007; Sharp et al., 
2011; Suzuki and Bird, 2008).  It is thought that DNA methylation is not required for the 
initial establishment of XCI but is important for its maintenance.  Embryos that lack both de 
novo DNA methyltransferases can establish XCI but genetic or chemical perturbation of 
Dnmt1 in somatic cells results in reactivation of genes on the Xi (Sado et al., 2000; Sado et 
al., 2004; Csankovszki et al., 2001).  Importantly, these data suggest that methylation of 
CpG island promoters on the Xi is required to maintain gene repression over time and cell 
divisions, not to establish the initial heterochromatic state. 
 Genomic imprinting is a process that results in expression of genes from one 
chromosome only, i.e. in a parent-of-origin specific manner (reviewed in Ferguson-Smith, 
2011).  Imprinted genes occur in genomic clusters and can show complex patterns of tissue-
specific, ubiquitous and loss of imprinting in different tissues.  The mechanisms that lead to 
monoallelic expression seem to be diverse but DNA methylation has an integral role to play.  
Regions of the genome can be differentially DNA methylated on one allele relative to the 
other and this is thought to be required for imprinted expression (Ferguson-Smith, 2011).  
These differentially methylated regions (DMRs) are established in the germline of each 
parent and are subsequently maintained in the offspring on their respective alleles.  Mouse 
embryos lacking Dnmt1 cannot maintain monoallelic expression of imprinted genes and 
express them from both alleles (Lei et al., 1993).  Deletion of Dnmt3a in the female 
germline, the gene encoding the methyltransferase required for establishing imprints, results 
in loss of imprinting in offspring (Kaneda et al., 2004).  Studies of imprinting have provided 
many insights into epigenetic regulation and have highlighted the diverse ways that DNA 
methylation can influence gene expression.  Multiple genes within an imprinted gene cluster 
can be regulated simultaneously by the methylation of a single region called an imprinting 
control region (ICR)(Ferguson-Smith, 2011).  These have often been found to be the 
promoters of non-coding RNAs (ncRNAs) that, when expressed, are thought to establish 
repressive chromatin domains covering multiple genes by recruiting histone modifying 
enzymes (Nagano et al., 2008; Ferguson-Smith, 2011).  In this way, chromatin domains can 
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be demarcated by the expression of long, functional ncRNAs that can reportedly act in both 
cis and trans (Beard et al., 1995; Rinn et al., 2007).  Regulation of ncRNA has been directly 
linked with DNA methylation at autosomal imprinted genes and Xist, the ncRNA required in 
cis for XCI (Beard et al., 1995).  It seems likely that this kind of mechanism is more 
widespread in gene regulation than is currently appreciated and it is interesting to speculate 
that DNA methylation may be involved in regulating genes in this way outside of imprinted 
gene clusters.  Another role of DNA methylation in gene regulation was established by 
studying imprinted genes.  The DNA binding insulator protein, CTCF, is blocked by CpG 
methylation that overlaps its binding site and this activity is thought to be essential for the 
imprinting of H19/Igf2 genes (Bell and Felsenfeld, 2000; Hark et al., 2000).  A DMR within 
the CTCF binding site is methylated on the paternal allele and unmethylated on the maternal 
allele, resulting in CTCF binding exclusively to the maternal allele.  CTCF seems to act by 
insulating the Igf2 gene from enhancers present downstream of the H19 gene, allowing them 
to act only on H19, a situation that is reversed on the paternal allele leading to reciprocal 
expression of the two genes (Bell and Felsenfeld, 2000; Hark et al., 2000).  Despite its 
potential importance, few further studies have examined the potential role of CTCF 
exclusion by DNA methylation in regulating non-imprinted genes.                    
 
1.2.5.4.  Transposable and repetitive element silencing 
 
More than 40% of mammalian genomes are derived from retroelements, many of which are 
now dormant but a significant proportion are potentially active (Rowe et al., 2010).  
Retrotransposons can multiply in an individual genome through transcription, reverse 
transcription to generate double stranded nucleic acid, followed by reinsertion into a new 
locus (Havecker et al., 2004).  It is believed that these elements represent a potential threat to 
their individual hosts by potentially influencing the expression of nearby genes and inducing 
mutation by insertion (Karimi et al., 2011; Rebollo et al., 2011).  Epigenetic mechanisms are 
thought to contribute to retrotransposon silencing, including DNA methylation and 
H3K9me3 mediated heterochromatinisation (Rowe et al., 2010; Karimi et al., 2011; Rebollo 
et al., 2011).  Mammals include DNA methylation of retrotransposons as part of their global 
methylome but it seems that retrotransposon methylation is evolutionarily ancient and many 
extant organisms have the bulk of their methylation located at these elements (Lister et al., 
2009; Zemach and Zilberman, 2010).  It has been speculated that the emergence of a global 
methylome may have been linked to increases in abundance of retrotransposons in 
vertebrates and a subsequent need to keep them silent (Zemach and Zilberman, 2010).  
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Intercisternal A particles (IAPs), a subclass of retrotransposons, are strongly upregulated at 
the RNA level in Dnmt1-/- embryos and various retrotransposons are upregulated in mouse 
mutants that have defects in DNA methylation although, to my knowledge, an increased 
retrotransposition has not been reported in these mutants (Walsh et al., 1998; Bourc'his and 
Bestor, 2004; Huang et al., 2004; De La Fuente et al., 2006; Karimi et al., 2011).  The 
methyl-CpG-binding protein MeCP2 has also been linked to the repression of LINE-1 
retrotransposon sequences and their retrotransposition in neural progenitor cells (Muotri et 
al., 2010).  This suggests that the DNA methylation system is required for complete 
silencing of at least a subset of retrotransposons in mammals and therefore helps to restrict 
transcription to genic and functional non-coding regions of the genome.       
 
1.2.5.5.  DNA methylation of promoter regions of single copy genes 
 
It was suggested over 35 years ago that DNA methylation may act to repress transcription at 
regulatory regions (Riggs, 1975).  Since then, it has become accepted that the activity of 
gene promoter regions, important regulatory features of genes, can be modulated by DNA 
methylation.  When present, high promoter DNA methylation is inversely correlated with 
transcription and it is proposed to repress gene expression in many organisms (Weber et al., 
2007; Meissner et al., 2008; Lister et al., 2009; Zemach et al., 2010).  As discussed in 
1.2.4.3, the density of CpG motifs is related to the effect of DNA methylation in a promoter 
region, an observation that has also been made in artificial systems (Boyes and Bird, 1992).  
In support of a role for DNA methylation in gene repression, loss of DNA methylation 
results in activation of gene expression, as demonstrated in many studies.  In Xenopus laevis 
embryos, depletion of xDnmt1 results in premature activation of gene expression (Stancheva 
and Meehan, 2000).  In mouse fibroblasts, mutation of Dnmt1 reportedly results in activation 
of ~10% of genes (Jackson-Grusby et al., 2001) and in another study many tissue-specific 
genes were shown to be activated in Dnmt1 mutant fibroblasts (Lande-Diner et al., 2007).  
Mouse ES cells deficient in all three active DNMTs show upregulation of certain 
developmental genes that would normally be expressed later in development (Fouse et al., 
2008; Karimi et al., 2011).  Studies that investigate mutants of other DNMT genes or DNA 
methylation co-factors also observe illegitimate gene activation supporting a major role for 
DNA methylation in gene silencing (Xi et al., 2007a; Ng et al., 2008; Velasco et al., 2010; 
Borgel et al., 2010).   
 In mammals, as discussed in 1.2.4, DNA methylation patterns at promoter regions 
can be variable between tissues.  This supports a role for promoter DNA methylation in 
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repressing lineage-specific genes and hence contributing to an epigenetic memory.  One 
example is at genes involved in maintaining pluripotency in the early embryo and ES cells, 
that are transcriptionally silenced followed by promoter DNA methylation during 
differentiation (Feldman et al., 2006; Epsztejn-Litman et al., 2008).  Cells lacking de novo 
methyltransferases can silence these genes but are more prone to reactivate them following 
loss of a differentiation cue (Feldman et al., 2006; Epsztejn-Litman et al., 2008).  Another 
example is a number of genes that are expressed in the germline, where they are 
unmethylated, and repressed in somatic lineages, where their promoter is methylated (Weber 
et al., 2007; Borgel et al., 2010; Velasco et al., 2010).  In mouse somatic cells and tissues 
lacking DNA methyltransferases, many of these genes are ectopically expressed (Borgel et 
al., 2010; Velasco et al., 2010).  A link between DNA methylation and germline-expressed 
genes also comes from studies of cancer, where widespread re-localisation of DNA 
methylation is observed, including hypomethylation of large intergenic regions and 
hypermethylation of certain CpG islands (Miranda and Jones, 2007; Hansen et al., 2011).  A 
set of genes that are normally expressed in the germline, sometimes called cancer testes 
antigens, are upregulated in cancers that are hypomethylated and promoter DNA methylation 
has been suggested to directly silence these genes in normal tissues (De Smet et al., 1996; 
De Smet et al., 1999).  It is interesting to speculate that many germline genes can be directly 
silenced by DNA methylation in somatic tissues because they will not lose CpG 
dinucleotides by deamination over generations.  This is because they would be unmethylated 
and expressed during the germline cycle and methylated and repressed in the somatic tissues, 
which do not contribute to the next generation.  Many CpG islands are aberrantly 
hypermethylated in a range of cancers (Miranda and Jones, 2007; Hansen et al., 2011).  This 
process is often suggested to contribute to the cancer phenotype as many of these genes can 
act as tumour suppressors.  These observations strengthen the view that DNA methylation 
acts to repress gene promoters as many of these genes can be activated by demethylation 
induced chemically or genetically in cancer cells (Miranda and Jones, 2007).  However, 
whether promoter hypermethylation is a cause or consequence of the cancer process is a 
subject of debate.  One study suggests that promoter hypermethylation, in a mouse cancer 
model of chronic lymphocytic leukaemia, is an early event and occurs before symptoms are 
observed (Chen et al., 2009).  However, DNA methylation may occur at genes that are 
already transcriptionally inactivated and may not play a role in their initial silencing (Chen et 
al., 2009; Sproul et al., 2011).  In this way, aberrant promoter DNA methylation may act to 
prevent activation of normally temporarily silent genes and hence could lead to proliferation 
by preventing activation of genes required for differentiation.              
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1.2.6.  Molecular mechanisms of action 
 
Despite the long standing connection between DNA methylation and transcriptional 
silencing, the molecular mechanisms by which it functions to repress transcription remain 
unclear.  In this section I will give an overview of the proposed mechanisms and discuss the 
evidence for each.  Current evidence supports a multifactorial effect of DNA methylation, 
although the best characterised functions can be divided into three broad groups; direct 
inhibition of sequence-specific DNA-binding proteins, recruitment of proteins that recognise 
the 5mCpG motif, and blocking the recruitment of proteins that recognise the unmodified 
CpG motif (Fig. 1.5).  I will start by discussing the evidence for these more widely accepted 
roles of DNA methylation.  As many of the proposed mechanisms involve DNA 
methylation-modulated modification of chromatin, I will discuss this apparently major role 
in section 1.2.6.4.  In addition to the more established roles of DNA methylation, I will 
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Figure 1.5 - Canonical roles of the 5mCpG dinucleotide.  i) 5mCpG can directly inhibit DNA-
protein interactions for proteins such as transcription factors (TF) and CTCF.  ii) 5mCpG is 
bound by methyl-CpG-binding proteins, exemplified by a methyl-CpG-binding domain 
protein (MBD), that can recruit histone modifying complexes (HMC) to induce/maintain a 
chromatin state.  iii) 5mCpG excludes the binding of CXXC-domain containing proteins 
(CXXC) that recognise unmethylated CpG motifs.  Many CXXC-containing proteins have 
histone modifying activity or are associated with HMCs. 
 
1.2.6.1.  Direct inhibition of protein-DNA interactions and effect on DNA structure 
and mechanics 
 
One of the proposed functions of 5mC in transcriptional regulation is direct inhibition of 
DNA-protein interactions (Fig. 1.5i).  Methylation of cytosine in the CpG context is well 
known to negatively affect the binding or activity of certain sequence-specific DNA binding 
proteins, exemplified by restriction endonucleases in bacteria.  It is easy to imagine that in 
this way DNA methylation could have a negative or positive effect on transcription by 
influencing the binding of transcription factors.  A small number of studies have suggested 
that this type of mechanism is at play in mammalian systems.  Watt and Malloy (1988) 
suggested that site-specific DNA binding of a transcription factor could be inhibited by CpG 
methylation central to the binding site.  Another example is cMyc, which is reportedly 
inhibited by CpG methylation within its cognate binding site in vitro (Prendergast and Ziff, 
1991).  Methylation of a single CpG has been linked to transcriptional repression at an rDNA 
gene by preventing the binding of an activating transcription factor (Santoro and Grummt, 
2001).  In addition, CpG methylation blocks binding of the glucocorticoid receptor to an 
enhancer region in vitro (Wiench et al., 2011).  These studies suggest that DNA methylation 
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may act to suppress transcription by preventing binding of proteins to their cognate DNA 
sequences, and in this way tissue-specific differences in DNA methylation could contribute 
to an epigenetic memory.  However, the number of factors that have been shown to be 
influenced by CpG methylation is small, so the extent of the contribution of this mechanism 
to gene regulation is unclear.  This may be in part due to a lack of large scale assays to 
approach this problem.  A recent study developed one such technique and found many new 
candidates for direct inhibition by CpG methylation, including transcription factors E2F1, 
HIF1A and components of the TFIIIC complex providing an expanding horizon for this 
mechanism of transcriptional regulation (Bartke et al., 2010). 
 Another type of DNA binding protein that can be directly inhibited by CpG 
methylation is CTCF which binds a core motif that can contain a CpG.  As discussed in 
1.2.5.3, CTCF exclusion by DNA methylation is thought to control the imprinting of the 
H19/Igf2 locus highlighting its capacity for gene regulation (Bell and Felsenfeld, 2000; Hark 
et al., 2000).  CTCF is a protein implicated in chromatin organisation with diverse putative 
roles in gene expression including insulation and boundary element formation (reviewed in 
Philips and Corces, 2009).  Therefore, the effect of CTCF exclusion by CpG methylation 
could have complex and widespread effects on gene expression.  To date, the more 
widespread role of DNA methylation in modulating CTCF binding and gene expression at 
non-imprinted genes is unclear.  Some studies have begun to investigate CpG methylation-
modulated CTCF binding at non-imprinted genes in normal tissues and cancer and have 
associated it with gene expression changes (Goto et al., 2009; Lai et al., 2010; Rodriguez et 
al., 2010; Gao et al., 2011). 
 The effect of DNA methylation on the mechanical properties of DNA is 
controversial.  A number of studies provide evidence that CpG methylation may decrease the 
flexibility of DNA in certain contexts (Geahigan et al., 2000; Meints and Drobny, 2001; 
Nathan and Crothers, 2002).  It has been suggested that decreased flexibility could underlie 
the negative effect of methylation on DNA binding of certain proteins which may need to 
manipulate flexible DNA.  DNA methylation has also been suggested to influence DNA 
strand separation dynamics, an important step in transcription (Severin et al., 2011).  As 
these studies are performed in vitro on naked DNA it is unclear what the effects of DNA 
methylation are in vivo in the presence of enzymes and in the context of nucleosomes.  
Interestingly, DNA methylation has been linked to increased compaction and rigidity of 
nucleosome arrays in vitro suggesting that DNA methylation per se may influence chromatin 
structure (Choy et al., 2010).  In this regard, a study of mouse ES cells lacking DNA 
methylation showed that some aspects of chromatin organisation were altered, but 
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compaction of bulk chromatin was unchanged (Gilbert et al., 2007).  Further studies in 
hypomethylated cells and tissues are required to determine the effect of DNA methylation on 
chromatin structure in vivo.             
 
1.2.6.2.  Methyl-CpG binding proteins 
 
Another mechanism for transcriptional regulation by DNA methylation is binding by methyl-
CpG-binding proteins (MeCPs)(Fig. 1.5ii).  Similar to proteins that 'read' histone 
modifications, it has been suggested that MeCPs play an important role in interpreting 
5mCpG.  It was first noticed that an unidentified mammalian protein complex bound 
specifically to methylated DNA, and this complex was termed MeCP1 for 'methyl-CpG-
binding protein 1' (Meehan et al., 1989).  The first MeCP itself to be identified was 
subsequently termed MeCP2, and was shown to bind to a single 5mCpG and could repress in 
vitro transcription (Lewis et al., 1992; Meehan et al., 1992).  Since then, many MeCPs have 
been identified and can be split into three groups depending on which methyl-CpG-binding 
protein domain they possess (Table 1.2).  The first methyl-binding protein domain to be 
identified was termed the MBD (for 'methyl-binding domain')(Nan et al., 1993).  Early 
studies of the structure of the MBD domain bound to 5mCpG suggested that recognition is 
achieved through a hydrophobic patch on the binding surface of the MBD and that MBD-
DNA binding would not be inhibited by core histones (Ohki et al., 2001).  Further studies 
have implicated water molecules in recognition of 5mCpG by the MBD domain of MeCP2, 
suggesting that MeCP2 recognises hydration of the major groove of methylated DNA rather 
than the methylated cytosine per se (Ho et al., 2008).  Humans and mice have four proteins 
of the MBD family that bind to methylated DNA; MeCP2, Mbd1, Mbd2 and Mbd4 (Table 
1.2).  Two human proteins with domains similar to the MBD domain were identified, MBD5 
and MBD6, but were shown to have no affinity for methylated DNA suggesting that they are 
not MeCPs (Laget et al., 2010).  A further MBD protein, Mbd3, exists in mammals and has 
important roles in gene silencing but does not bind to methylated DNA (Hendrich et al., 
2001).  Each of the MBD-containing MeCPs has affinity for symmetrical 5mCpG but some 
have additional suggested sequence preferences or binding activity.  MeCP2 has a binding 
preference for CpG flanked by runs of AT bases in vitro (Klose et al., 2005), Mbd1 can bind 
to unmethylated DNA through its CXXC domain (Jorgensen et al., 2004), and the structure 
of the MBD of Mbd2 bound to methylated DNA suggests influence of bases surrounding the 
5mCpG (Scarsdale et al., 2011).  A second protein domain that can recognise 5mCpG is the 




Mutant phenotype (mouse) Reference(s) 
MBD domain proteins 
MeCP2 Sin3a complex 
Viable and fertile; neurological 
abnormalities; model of human Rett 
syndrome (reversible) 
Lewis et al., 1992; Guy et al., 
2001; Chen et al., 2001; Nan 




Viable and fertile; behavioural 
abnormalities; reduced adult 
neurogenesis 
Cross et al., 1997; Zhao et al., 
2003; Sarraf and Stancheva, 
2004; Fujita et al., 2003; Villa 




Viable and fertile; defects in maternal 
behaviour 
Hendrich and Bird, 1998; 
Hendrich et al., 2001; Zhang 




Viable and fertile; increased C to T 
mutation rate; accelerated 
tumourigenesis on susceptible 
background 
Hendrich and Bird, 1998; 






Viable and fertile; neurological 
abnormalities; similar to MeCP2 null 
Martin Cabellero et al., 2009 




Viable and fertile; decreased tumour 
formation on susceptible background 
Prokhortchouk et al., 2001; 
Prokhortchouk et al., 2006; 
Yoon et al., 2003 
Zbtb4 Sin3a Not reported 
Filion et al., 2006; Weber et 
al., 2008 
Zbtb38 CtBP Not reported 




Early-mid-gestation lethality; similar to 
Dnmt1 null  
Sharif et al., 2007; Unoki et 
al., 2004 
Uhrf2 Unknown Not reported Pichler et al., 2011 
Table 1.2 - Associated transcriptional repressors and mouse mutant phenotypes of MeCPs. 
 
member of this family where it was suggested that two 5mCpG motifs in close proximity, 
preferably immediately adjacent, represent a preferred Kaiso binding site (Prokhortchouk et 
al., 2001).  Subsequently, two proteins with similar zinc fingers have been shown to bind to 
methylated DNA, Zbtb4 and Zbtb38, and were added to the family (Filion et al., 2006).  
Binding specificity of Kaiso family proteins has been suggested for both methylated DNA, 
and non-methylated DNA.  Kaiso reportedly binds to CTGCNA motifs and a similar activity 
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has been attributed to the Kaiso-like proteins (Sasai et al., 2010; Kim et al., 2004).  
However, the CTGCNA binding activity of Kaiso is not widely conserved and only the 
methylated DNA binding property of Kaiso is essential for Xenopus laevis development 
suggesting that this is its major function (Ruzov et al., 2004; Ruzov et al., 2009).  With the 
very large number of zinc finger proteins encoded by mammalian genomes it remains likely 
that more proteins exist that can recognise methylated DNA in this way. A third protein 
domain that recognises methylated DNA is the SRA domain of Uhrf1 and Uhrf2 (Table 1.2).  
Uhrf1 reportedly binds hemi-methylated and symmetrically methylated CpG and is 
important for maintenance methylation involving Dnmt1.  The SRA domain of Uhrf1 binds 
to methylated DNA in a distinct manner from the MBD and zinc finger domains, by flipping 
out the methylated base (Arita et al., 2008; Avvakumov et al., 2008).  Uhrf2 is relatively 
uncharacterised but contains an SRA domain with 75% similarity to that of Uhrf1 and can 
bind to hemi-methylated DNA in vitro (Pichler et al., 2011).  
 MeCPs provide a satisfying link between DNA methylation and transcriptional 
repression as nearly all of them have been suggested to induce transcriptional repression.  In 
concordance with this, all but one of the MeCPs have been found associated with repressor 
complexes with histone modifying activity (see Table 1.2).  In particular, MeCPs are well 
associated with histone deacetylase (HDAC) activity and the full repressive activity of 
MeCPs has been suggested to be dependent on this activity in many cases (Table 1.2 refs).  
An example is MeCP2 which associates with HDACs in the Sin3a complex through its 
transcription-repression domain (TRD) and inhibition of HDACs by trichostatin A (TSA) 
relieves MeCP2-mediated silencing (Nan et al., 1998; Jones et al., 1998).  MeCP2 is 
abundant in mouse brain nuclei, at near histone-octomer levels, and is bound broadly to 
chromatin showing a relatively tight dynamic range that broadly tracks methylated CpG 
density (Skene et al., 2010).  In MeCP2 null brains increased histone acetylation is observed.  
This implicates MeCP2 in suppressing transcriptional noise throughout the genome in the 
brain by reducing histone acetylation.  In support of this suggestion, increased Line1 
expression and retrotransposition has been reported in MeCP2-/- neural progenitor cells but 
not in fibroblasts (Muotri et al., 2010).  MeCP2 may also function in other ways as its 
interaction with the Sin3a complex is not stable (Klose and Bird, 2004).  Also, mapping of 
HDACs has suggested that they are not stably associated with inactive genes on mammalian 
chromatin (Wang et al., 2009b).  It is of course possible that transient recruitment of HDACs 
by MeCP2 is sufficient to establish hypoacetylation and that HDACs are not detected due to 
the transient nature of this interaction with chromatin.  MeCP2 has been associated with 
other chromatin-associated complexes such as SWI/SNF component Brahma and nuclear co-
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repressor complex (N-CoR) although some of these observations are controversial and the 
function of these interactions is currently unclear (Harikrishnan et al., 2005; Kokura et al., 
2001; Hu et al., 2006).  Another example of a suggested transcriptional repression role of 
MeCPs is that of Mbd1.  Mbd1 is reportedly associated with the histone H3K9 
methyltransferase Setdb1 and the H3K9me2/3 binding protein Hp1 (Sarraf and Stancheva, 
2004; Fujita et al., 2003).  This interaction is proposed to influence the copying of 
heterochromatin structure during DNA replication.  Mbd1 is proposed to form an S-phase 
specific complex with Setdb1 and Caf-1, a chromatin assembly complex, and facilitate the 
K9me3 modification of chromatin that is highly DNA methylated (Sarraf and Stancheva, 
2004).  However, Mbd1-/- mice are essentially viable and healthy so it would appear that this 
mechanism is not essential for heterochromatin assembly on a large scale in vivo (Zhao et 
al., 2003).  MeCPs have also been linked to functions outside of transcriptional repression.  
The major role of Mbd4 is thought to be mismatch repair as Mbd4 null mice show increased 
mutation rate at CpG sites (Millar et al., 2002).   
 Despite the proposed functions of MeCPs in transcriptional silencing, their overall 
contribution to DNA methylation-mediated transcriptional repression remains unclear.  Their 
role is confounded by studies that show that genetic ablation of individual MeCPs in mice 
does not lead to overt developmental phenotypes like those of DNA methyltransferase 
mutant mice (Table 1.2).  The exception is Uhrf1, the absence of which leads to phenotypes 
very similar to Dnmt1 null mice, attributable to its major role in maintenance of DNA 
methylation (Sharif et al., 2007).  Knock-out of MeCP2 in mice leads to neurological 
abnormalities that resemble Rett syndrome, a human neurological disorder caused by 
mutations in MECP2 (Guy et al., 2001).  Intriguingly, re-expression of MeCP2 in null mice 
in adults rescues the neurological phenotypes indicating that MeCP2 loss does not lead to 
irreversible defects in neural development but instead is required for brain function (Guy et 
al., 2007).  The discrepancy between DNA methyltransferase null phenotypes and MeCP 
null phenotypes suggests that single MeCPs cannot explain transcriptional repression by the 
DNA methylation system.  Instead, data suggests that individual MeCPs contribute, to 
different extents, to DNA methylation-dependent repression.  Mbd2 deletion results in low 
level expression of Xist, a transcript that is strongly upregulated in a Dnmt1 mutant, while no 
mis-expression is observed in cells lacking Mbd1, MeCP2 or Kaiso (Barr et al., 2007).  Also, 
Mbd2 null cells have a reduced ability to silence methylated reporter plasmids whereas 
MeCP2 null cells have only a very small defect in this property (Guy et al., 2001).  It is 
possible that, owing to the number of known MeCPs, functional redundancy between MeCPs 
masks phenotypes of individual MeCP mutants.  This possibility has been partially 
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investigated by generation of mice lacking three MeCPs; MeCP2, Mbd2 and Kaiso (Martin 
Cabellero et al., 2009).  The phenotype of these mice is very similar to lack of MeCP2 alone 
suggesting that these three proteins do not compensate for each other.  In order to address the 
question of redundancy fully, more MeCPs will have to be mutated simultaneously.  A 
further possibility is that a major MeCP is yet to be mutated in mouse.  This could include 
the Zbtb4 or Zbtb38 proteins, which have not yet been knocked out, or as yet unidentified 
MeCPs.  It is of course also possible that MeCPs merely contribute to repression by DNA 
methylation and that other mechanisms play a role forming a multilayered repression system 
to ensure that repression is achieved.  This idea is supported by the growing number of 
suggested mechanisms for DNA methylation-mediated repression.            
 
1.2.6.3.  Recognition of the unmodified CpG motif 
 
A third mechanism by which DNA methylation is suggested to influence genome regulation 
is by differentiating CpG islands from bulk chromatin.  The CpG dinucleotide alone has been 
suggested to behave as the shortest known DNA binding motif, as it forms a binding site for 
proteins with a CXXC domain when unmethylated (Fig. 1.5iii)(Bird, 2011).  The CXXC 
domain is a structure that is capable of binding to DNA with at least one CpG dinucleotide, 
but importantly binding is inhibited by CpG methylation (Voo et al., 2000; Lee et al.,  2001).  
This type of mechanism could conceivably come under the 'direct inhibition' section but I 
have decided to discuss it distinctly here and reserve the direct inhibition section for proteins 
that recognise longer sequence motifs.  The structure of the CXXC domain bound to DNA 
suggested that this binding affinity is achieved through base specific contacts that occur 
exclusively with the CpG dinucleotide and that methylation of the cytosine likely results in 
steric hindrance of binding (Cierpicki et al., 2010; Xu et al., 2011a).  As most of the 
genome's CpGs are in the methylated state in vertebrates, a high density of unmodified CpG 
dinucleotides exists exclusively at CpG islands, differentiating them from bulk chromatin.  
Recently, the functions of CXXC domain containing proteins in establishing the unique 
chromatin state at CpG islands have been investigated.  Interestingly, many CXXC-domain 
containing proteins have histone or DNA modifying activity, or are associated with proteins 
that do, suggesting that targeting chromatin modification may be a major function of these 
proteins.  One such protein, Cfp1 (also known as Cxxc1), is bound to unmethylated CpG 
islands in mouse cells (Thomson et al., 2010).  Cfp1 is associated with the Set1 H3K4me3 
methyltransferase complex and is required for normal K4me3 abundance (Thomson et al., 
2010).  Cfp1 binds and targets K4 methylation to a newly integrated CpG rich region 
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suggesting that unmethylated CpG dinucleotides are all that is required for its binding.  This 
connection provides a simple explanation for the co-localisation of K4me3 and unmethylated 
CpG islands.  Further study will shed more light on the functions of this protein in epigenetic 
regulation as it has also been linked to maintaining normal levels of DNA methylation, 
possibly indirectly through an effect on Dnmt1 protein abundance (Carlone et al., 2005; 
Butler et al., 2009).  Another example of a CXXC protein is Kdm2a, a lysine demethylase 
that acts on H3K36me2/3 (Blackledge et al., 2010).  Kdm2a is recruited to unmethylated 
CpG islands and is required to keep them depleted of H3K36me2/3.  These studies suggest 
that one of the functions of methylation is to allow CXXC proteins to discriminate 
unmethylated CpG islands from both methylated CpG islands and bulk chromatin.  The 
effect of this mechanism on gene regulation is currently unknown but one is likely to exist as 
both the K4me3 and K36me3 have been implicated in the regulation of transcription 
(reviewed in Kouzarides, 2007).  Furthermore, this mechanism is likely to be more 
widespread as other proteins with CXXC domains that have suggested roles in gene 
expression exist.  Of particular interest, the Mll1 and Mll2/4 proteins contain CXXC 
domains and are involved in transcriptional activation as part of the trithorax complexes 
(Terranova et al., 2006).  In addition, the Tet1 protein binds to CpG islands in ES cells, 
presumably through its CXXC domain (Wu et al., 2011).  Investigation of other CXXC 
domain containing proteins will inform us more about how the unique chromatin at CpG 
islands is established and about this facet of genome regulation by DNA methylation.    
 
1.2.6.4.  Maintaining chromatin states 
 
One of the major functions of DNA methylation seems to be in contributing to the 
establishment and maintenance of chromatin states.  This is illustrated by the endpoint of two 
of the mechanisms described in figure 1.5 being modification of histones.  As discussed 
above, MeCPs and CXXC proteins can link DNA methylation to other modifications of 
chromatin.  Other links have been made between DNA methylation and histone 
modifications and I will discuss them here. 
 Eukaryotic cells face a major challenge during DNA replication when they have to 
dissemble and reassemble chromatin to allow passage of the replication fork, a process that 
is not well understood (for example Gruss and Sogo, 1992).  Correct reassembly of 
chromatin states is essential for all processes that rely on chromatin structure for a stable 
memory.  Two extremes of chromatin state are often described; euchromatin and 
heterochromatin, which are broadly characterised by more open, transcriptionally permissive 
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and more closed, transcriptionally non-permissive chromatin structures respectively, in 
addition to characteristic histone marks (Beisel and Paro, 2011).  How patterns of 
euchromatin and heterochromatin are maintained over cell division is not entirely clear but 
DNA methylation, owing to its simple mechanism for propagation during DNA replication, 
has been implicated in this process.  The most convincing model of nucleosome behaviour 
during replication suggests that nucleosomes from the parental strand are distributed evenly 
on the two daughter strands following transit of the replication fork (Gruss and Sogo, 1992).  
This means that with no propagation mechanisms, histone marks would be diluted at each S-
phase.  DNA methylation may contribute to the propagation of certain histone marks via the 
Dnmt1 protein itself during its role as maintenance methyltransferase (Fig. 1.6i).  Dnmt1 was 
suggested to interact with HDAC2 and the two proteins co-localise at replication foci during 
S-phase (Rountree et al., 2000).  During S-phase, euchromatic regions tend to replicate early 
and heterochromatic regions tend to replicate late, a process thought to provide a means for 
compartmentalising the genome (Rountree et al., 2000).  Interestingly, HDAC2 was shown 
to co-localise with Dnmt1 at replication foci only during late S-phase implicating this 
mechanism in keeping heterochromatin hypoacetylated.  However, this idea is difficult to 
address experimentally as null mutations in Dnmt1 become DNA hypomethylated and would 
therefore be expected to lose MeCP binding, which would be expected to lead to 
hyperacetylation itself.  A subtle mutation in Dnmt1 that would ablate interaction with 
HDAC2 may shed light on this putative mechanism.  In support of a role for Dnmt1 and 
histone deacetylation in maintaining late replication timing, Dnmt1 mutant cells reportedly 
show premature replication of regions of constitutive heterochromatin at pericentric regions 
(Casas-Delucchi et al., 2011).  Dnmt1 also interacts directly with G9a, the histone 
methyltransferase responsible for the majority of K9me2/3 in euchromatic regions (Esteve et 
al., 2006).  Dnmt1 and G9a co-localise with K9me2 foci during S-phase and Dnmt1 is 
required for normal G9a localisation to replication foci and K9me2 at target regions (Esteve 
et al., 2006).  This suggests that Dnmt1 recruits G9a to regions of high DNA methylation 
through its interaction with PCNA, Uhrf1 and hemi-methylated DNA to contribute to 
chromatin propagation at these regions.  These mechanisms implicate Dnmt1 as a 'reader' of 
DNA methylation patterns by recruiting histone modifying enzymes to DNA methylated 
regions following DNA replication (Fig. 1.6i).  It is possible that propagation of other 
chromatin states is influenced by Dnmt1 as interactions have been reported with other 
chromatin-associated proteins such as Suv39h1 and HP1 (Esteve et al., 2006; Smallwood et 
al., 2007).  In this way, the role of the DNA methylation mark can be viewed as a DNA 
replication-stable template for histone mark propagation by recruiting Dnmt1 and associated 
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factors following passage of the replication fork (Fig. 1.6i).  It should be noted that DNA 
methylation is not implicated in transmission of all heterochromatin, for example, the 
H3K27me3 mark is thought to be self-propagated by polycomb proteins (Margueron et al., 
2009).  Also, organisms that have very low levels of, or completely lack, DNA methylation, 
such as Drosophila, C. elegans, budding and fission yeast, can maintain heterochromatin 
over cell divisions.  Fission yeast may have evolved specialised targeting of constitutive 
heterochromatin involving targeting by small ncRNA, a process that is also linked to DNA 
replication (Li et al., 2011a).  It therefore seems likely that DNA methylation in vertebrates 
is required to merely contribute to propagation of certain histone states, a role that is perhaps 
necessary for larger genomes with more complex patterns of heterochromatin. 
 DNA methylation has also been linked to the deposition of histone variants in 
chromatin.  In Arabidopsis thaliana, the locations of DNA methylation and the histone 
variant H2A.Z are negatively-correlated (Zilberman et al., 2008).  In addition, these 
epigenetic components appear to be mutually exclusive as DNA methylation changes 
induced by mutation of the plant maintenance methyltransferase, MET1, lead to reciprocal 
changes in H2A.Z location, and loss of H2A.Z leads to hypermethylation (Zilberman et al., 
2008).  The anti-correlation between DNA methylation and H2A.Z is thought to be 
evolutionarily ancient as, in addition to plants, it has been observed in animals.  Mapping of 
pufferfish DNA methylation and H2A.Z showed a very striking negative-correlation 
(Zemach et al., 2010).  In mammals, changes in H2A.Z and DNA methylation during 
oncogenesis are inversely correlated implying a similar relationship, and acetylation of 
H2A.Z is also negatively-correlated with DNA methylation (Valdes-Mora et al., 2011; 
Conerly et al., 2010).  The function of H2A.Z in gene regulation is controversial but among 
other things it has been linked to maintaining activity of expressed genes, perhaps through its 
propensity to dissociate from chromatin leaving a nucleosome depleted region (Zhang et al., 
2005).  As unmethylated CpG islands have been linked to nucleosome destabilisation, it is 
tempting to speculate that a function of DNA methylation is to prevent the deposition of 
H2A.Z, thereby promoting a higher density of nucleosomes (Tazi and Bird, 1990; Ramirez-
Carrozzi et al., 2009).  It should be noted, however, that it is currently unclear if CpG islands 
are intrinsically nucleosome destabilising or if this association arises because vertebrates 
often have a nucleosome depleted region at gene promoter regions (Deaton and Bird, 2011).  
Further study of the functions of H2A.Z and the molecular mechanisms behind its mutual 
antagonism with DNA methylation are needed to shed light on this interesting putative 
function of DNA methylation.  
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Figure 1.6 - Putative roles of DNA methylation in chromatin structure and gene regulation.  
i) Dnmt1 may act a 'methylation reader' by recruiting histone modifying complexes (HMC) 
during maintenance methylation.  Nucleosomes are thought to be shared between the two 
daughter strands after DNA replication leading to a dilution of histone marks.  DNA 
methylation may provide a template for re-establishing a certain chromatin state after DNA 
replication by recruiting Dnmt1/Uhrf1 and associated proteins to hemi-methylated DNA.  ii) 
Tissue-specific DNA methylation at CTCF binding sites may lead to differential binding and 
complex effects on the expression of genes in the region.  Similar to the imprinted H19/Igf2 
locus.  iii) Methylation at a tDMR (tissue-specific differentially methylated region) could 
directly control the expression of ncRNAs with roles in regulating gene expression in cis or 
trans.  ncRNAs may contribute to initiation/maintenance of a chromatin state by recruiting 
histone modifying complexes (HMCs) leading to complex effects on local gene expression.  
Similar to the Xist ncRNA in XCI.  iv) DNA methylation may inhibit the binding of polycomb 
group proteins (PcG) to chromatin, directly or indirectly, contributing to their distribution.  
As PcG proteins are involved in gene repression, in this way DNA methylation may lead to 
gene activation.  
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1.2.6.5.  Other roles for DNA methylation? 
 
Recent studies are providing intriguing evidence that the effects of DNA methylation are 
likely more numerous and complex than currently appreciated (examples of putative 
mechanisms are shown in fig. 1.6ii-iv).  A recent study used in vitro assembled nucleosomes 
with either methylated or unmethylated biotinylated DNA coupled with SILAC (Stable 
Isotope Labelling with Amino acids in Cell culture) to 'fish' for proteins that are 
differentially bound by methylated/unmethylated DNA on nucleosomes (Bartke et al., 2010).  
Using only two types of DNA, excluding the possibility of finding many sequence-specific 
DNA binding factors, they were able to identify many new candidates for methylation-
modulated binding.  Proteins that preferentially bound methylated DNA included zinc finger 
protein ZHX1, and transcription factors FOXA1, PAX6 and HOXC10.  Negatively affected 
proteins included transcription factors in addition to chromatin associated proteins such as 
the PRC2 complex, BCOR complex and CXXC-containing CXXC5 providing new 
candidates for direct inhibition.  These proteins must be viewed as candidates for 
methylation-regulated binding to chromatin as these experiments do not infer whether the 
effect is direct or indirect.  Further studies using this technique may use a wider variety of 
DNA sequences and combinations of histone marks and DNA methylation to provide 
important information about cross-talk between epigenetic modifications of chromatin.      
 It will be interesting to learn if mechanisms of DNA methylation-mediated 
regulation at imprinted genes are also applicable to the rest of the genome.  For example, 
blocking of CTCF binding by DNA methylation (as discussed in 1.2.6.1).  Mapping of 
CTCF in mammalian cell lines has shown that although many CTCF binding sites are 
conserved between cell types, a proportion appear to cell-type specific (Kim et al., 2007).  In 
addition, a large proportion of CTCF binding sites contain a CpG dinucleotide (Kim et al., 
2007).  This suggests the possibility that differential DNA methylation at these sites could 
control CTCF binding in a tissue-specific manner leading to potentially complex effects on 
regulation of the genome (Fig. 1.6ii).  Some studies have begun to test this idea, including a 
study of the Pax6 locus where CTCF binding was shown to be anti-correlated with DNA 
methylation throughout ES cell differentiation (Gao et al., 2011).  With the advent of base-
resolution methylation maps and detailed CTCF binding profiles it will be interesting to test 
this hypothesis on a larger scale.  Another concept that has emerged from imprinted genes is 
DNA methylation controlling a locus indirectly by regulating the expression of a functional 
ncRNA.  Xist is an example of a lincRNA (long intergenic non-coding RNA) that has long 
been known to be regulated by DNA methylation and is responsible for in cis inactivation of 
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large regions of one X-chromosome, a process that may involve direct targeting of histone 
modifying complexes (Beard et al., 2005; Augui et al., 2011).  LincRNAs are numerous in 
mammals, have been implicated in both activation and repression of gene expression by 
association with HMCs and can reportedly act in both cis and trans (Rinn et al., 2007; Wang 
et al., 2011; Cabili et al., 2011).  It remains untested if DNA methylation regulates ncRNAs 
in a tissue-specific manner, out with of imprinted genes, that can influence chromatin 
structure either in cis or trans.  One possibility is that 'orphan' CpG islands (CGIs) represent 
promoters for some of these functional ncRNAs.  Orphan CGIs are methylated more 
frequently in a tissue-specific manner than gene-associated CGIs and many show hints of 
promoter function (Illingworth et al., 2008; Illingworth et al., 2010).  A recent study showed 
lincRNA expression to be highly tissue-specific in keeping with this speculation (Cabili et 
al., 2011).  
 A handful of studies have suggested a putative role for DNA methylation in the 
regulation of the H3K27me3 mark mediated by the PRC2 (polycomb repressor complex 2) 
complex (Fig. 1.6iv).  This will be discussed in the next section, following a brief 
introduction to the polycomb group proteins. 
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1.3.  Polycomb group proteins 
 
 
Another epigenetic system that has a major function in gene regulation in multicellular 
organisms is the polycomb repression system.  Polycomb group (PcG) and trithorax group 
(TrxG) proteins form multimeric complexes with chromatin modifying activity and are 
thought to act antagonistically with each other to coordinate transcriptional memory (Cavalli 
and Paro, 1999; Czermin et al., 2002; Boyer et al., 2006; Bracken et al., 2006; reviewed in 
Schuettengruber et al., 2007).  PcG repression fulfils the strictest definition of an 'epigenetic 
mechanism' as it is transmitted through cell divisions (Hansen et al., 2008).  These protein 
complexes have been implicated in many interesting biological processes including gene 
regulation, lineage specification, genomic imprinting, stem cell identity and cancer, 
provoking intense recent study of their functions.  In this section I describe PcG proteins and 
their role in epigenetic regulation of gene expression.  This section is less detailed than 
section 1.2 as DNA methylation was the initial focus of this thesis project. 
 PcG and TrxG proteins are thought to have opposing roles in gene regulation; PcG 
proteins are involved in maintaining lineage-specific gene repression while TrxG proteins 
are involved in maintaining lineage-specific gene expression (Cavalli and Paro, 1999; Boyer 
et al., 2006; Bracken et al., 2006; reviewed in Schuettengruber et al., 2007).  A key 
suggestion is that these proteins are required specifically to maintain the expression status of 
their target genes, not to initiate patterns of expression (Cavalli and Paro, 1999).  This 
strongly implicates these complexes in forming part of the epigenetic memory of gene 
expression states that is thought to be essential for development of complex multi-cellular 
organisms.  Most PcG and TrxG genes were originally identified in Drosophila as mutations 
that cause or modify homeotic phenotypes; body axis translocations caused by mis-
expression of homeotic (Hox) genes (reviewed in Schuettengruber et al., 2007).  The next 
section will describe the known PcG and TrxG proteins and protein complexes in fly and 
their orthologs in mammals.     
 
1.3.1.  PcG and TrxG proteins in fly and man 
 
PcG and TrxG proteins are well conserved throughout eukaryotes (reviewed in 
Schuettengruber et al., 2007).  PcG genes are found in a wide variety of multi-cellular 
eukaryotes, and even some single-celled eukaryotes, but are noticeably absent from the 
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single celled organisms S. pombe and S. cerevisiae (Schuettengruber et al., 2007).  The 
protein products of PcG genes form complexes.  In Drosophila at least four major PcG 
protein complexes exist; PRC2 (polycomb repressor complex 2), PRC1, PhoRC (Pho-
repressive complex) and PR-DUB (Polycomb repressive de-ubiquitinase) complexes, of 
which PRC2 and PRC1 have been most studied (Schuettengruber et al., 2007; Scheuermann 
et al., 2010).  The components and formation of the PRC2 and PRC1 complex are well 
conserved in humans.  A PR-DUB complex has been reported in humans with similar 
activity suggesting it too is conserved (Scheuermann et al., 2010; Bott et al., 2011).  Human 
homologs of PhoRC components have been suggested but their contribution to PcG protein-
complexes and functions are not clear (Schuettengruber et al., 2007).  Fly PRC2 and PRC1 
core complex components are shown in table 1.3 together with their human orthologs and 
suggested functions.  The Drosophila PRC2 complex consists of four core components; E(z) 
(enhancer of zeste), Esc (extra sex combs), Su(z)12 (suppressor of zeste 12) and N55 (table 
1.3).  In mammals, the PRC2 and PRC1 core components are conserved but there are 
multiple possible members of certain PRC1 components that are thought to have arisen 
through gene duplication.  For example, fly Pc has at least five homologs in human, giving 
multiple possible configurations for the human PRC1 complex and adding to the complexity.  
Other proteins have been associated with the PRC2 and PRC1 complexes but will not be 
discussed here (Schwarz and Pirrotta, 2007; Margueron and Reinberg, 2011).  Fly TrxG 
complexes include the nucleosome remodelling SWI/SNF complex and proteins with histone 
modifying activity; Trx has methyltransferase activity for H3K4 and Ash1 has reported 
methyltransferase activity for multiple histone sites (Schwarz and Pirrotta, 2007).  The 
human homologs of Drosophila Trx are the MLL proteins and although they seem to be 
functionally homologous to the fly protein, they do not form the same complexes (Schwarz 
and Pirrotta, 2007).  Herein, for simplicity I will refer to polycomb and trithorax proteins by 
their names in mice, which are the same as human.  
 Both PRC2 and PRC1 harbour histone modifying activity that is bestowed by their 
Ezh2/Ezh1 and Ring1b/Ring1a subunits respectively (Cao et al., 2002; Czermin et al., 2002; 
de Napoles et al., 2004; Wang et al., 2004).  A general model for PcG function is the 
sequential recruitment model, whereby PRC2 is targeted to a chromosomal region, catalyses 
H3K27me3, which forms a binding site for the PRC1 complex through its CBX component 
that possesses a chromodomain (Cao et al., 2002; Wang et al., 2004b).  This model is 
supported by the enrichment of PRC1 binding to genomic regions where H3K27me3 is 
abundant (Cao et al., 2002).  However, PRC2 and PRC1 are at least partially independent as 
PRC1 is found at many locations without H3K27me3 and the two complexes have many 
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non-overlapping gene targets for repression (Leeb et al., 2010; Ku et al., 2008).  Both PRC2 
and PRC1 complexes play important roles during embryogenesis as mutation of polycomb 
genes in mouse leads to a range of phenotypes, from early embryonic lethality in PRC2 
components, to developmental arrest during gastrulation or skeletal abnormalities for PRC1 
components (Voncken et al., 2003; O'Carrol et al., 2001; van der Lugt et al., 1994).  The 
molecular basis for these phenotypes is largely attributed to the fact that many important 
genes are targeted for repression by PcG proteins during development.  The major genomic 
targets of PcG proteins will be discussed in the next section.      
   
Complex Fly Human Function Reference(s) 
PcG complexes   
PRC2 E(z) EZH2; EZH1 H3K27me3 deposition 
Cao et al., 2002; Czermin 
et al., 2002 
 Esc EED 
Binding/propagation of 
H3K27me3  
Margueron et al., 2009 
 Su(z)12 SUZ12 PRC2 activity Cao and Zhang, 2004 
 N55 RpAp48; RpAp46 Histone binding Song et al., 2008 
PRC1 dRing RING1A; RING1B H2A K119ub deposition 
de Napoles et al., 2004; 
Wang et al., 2004a 
 Pc 
CBX2; CBX4; CBX6; 
CBX7; CBX8 
Chromatin binding; K27me3 
binding 
Cao et al., 2002 
 Ph PHC1; PHC2; PHC3 
Unknown but required for 
PRC1 function 
Isono et al., 2005 
 Psc BMI1; MEL18; NSPC1 Co-factor for dRing 
Cao et al., 2005; Elderkin 
et al., 2007; Wu et al., 
2008  
Table 1.3 - PRC2 and PRC1 core complex components in fly and man.  Only the core 
components are shown.  The fly protein is shown with its homologous human proteins and 
suggested function.  Adapted from Schwarz and Pirrotta (2007) and Schuettengruber et al., 
(2007). 
  
 1.3.2.  PRC2 targets and the H3K27me3 mark 
 
PRC2 component mapping in mammalian cells has shown that this complex has a strong 
enrichment for binding at genes with roles in embryonic development (Bracken et al., 2006; 
Lee et al., 2006; Boyer et al., 2006; Schuettengruber et al., 2009).  PRC2 marks many tissue-
specific genes that encode transcription factors involved in lineage commitment, such as the 
Hox (homeobox) genes.  The H3K27me3 (K27me3) histone mark is a signature of the PRC2 
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complex as Ezh2, and to a lesser extent Ezh1, are the only endogenous proteins known to 
deposit this mark in vivo (Czermin et al., 2002; Margueron and Reinberg, 2011).  Therefore, 
K27me3 is often used as a surrogate for mapping PRC2-repressed chromatin.  Globally, 
K27me3 is enriched at gene promoters and those marked by K27me3 tend to be low or silent 
in expression implicating it in gene repression (Mikkelsen et al., 2007; Barski et al., 2007).  
In keeping with this idea, mutation of PRC2 components results in loss of K27me3 and 
upregulation of lineage-specific genes in ES cells (Cao and Zhang, 2004; Boyer et al., 2006).  
In addition to marking individual gene promoters, K27me3 can form large blocks of 
modified chromatin (Lee et al., 2006; Barski et al., 2007; Pauler et al., 2009).  Blocks of 
K27me3 are sometimes referred to as facultative heterochromatin, in contrast to constitutive 
heterochromatin that is characterised by H3K9me3 and H4K20me3 (Margueron and 
Reinberg, 2011; Beisel and Paro, 2011).  K27me3 blocks are found in gene-rich regions of 
chromatin, interspersed with gene-poor blocks of H3K9me3 and H4K20me3 (Pauler et al., 
2009).  This difference is illustrated by the α- and β-globin genes.  In non-expressing cell 
types the α-globin genes, which are located in a gene-dense region, are marked and repressed 
by K27me3, while the β-globin genes, which are located in a gene-poor region, are not and 
are silenced by other mechanisms (Garrick et al., 2008).  Recently, K27me3 was also found 
enriched at enhancers (Rada-Iglesias et al., 2011).  Specifically, K27me3 marks 'poised' 
enhancers in ES cells that would become active later in development implicating it in the 
regulation of distal regulatory elements.  A key aspect of repression by K27me3 is that it is 
flexible and so is suited to regulating genes involved in lineage commitment.  Upon lineage 
commitment, many genes show dynamic patterns of K27me3, including gains and losses, 
which are reflected by changes in their expression status (Mikkelsen et al., 2007; Mohn et 
al., 2008).  In ES cells, before lineage commitment is initiated, a large number of 
developmental gene promoters are marked by both the transcription initiation-associated 
H3K4me3 (K4me3) and the polycomb-associated K27me3 histone marks, together termed 
the 'bivalent mark' (Bernstein et al., 2006; Mikkelsen et al., 2007; Mohn et al., 2008).  This 
chromatin configuration has been associated with a 'poised' RNA polymerase II that carries 
phosphorylation at serine 5 of its C-terminal domain and may be restrained from elongation 
by polycomb proteins through their modification of chromatin (Stock et al., 2007).  Upon 
differentiation, many of these promoters resolve to either K4me3 or K27me3 marks alone in 
a lineage-specific manner, although some remain bivalently marked (Mikkelsen et al., 2007; 
Mohn et al., 2008).  Although the bivalent mark is also present in zebrafish, it is very rare in 
the Drosophila embryo suggesting that this feature of PcG/TrxG regulation is not always 
conserved (Schuettengruber et al., 2009; Vastenhouw et al., 2010).       
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1.3.2.1.  Hox genes 
 
Hox genes, encoding homeobox transcription factors, are major targets of regulation by PcG 
and TrxG proteins and are often used as a model to study repression by polycomb (for 
example Cao et al., 2002; Cao et al., 2005).  As mentioned previously, study of phenotypes 
in fly that result in mis-regulation of Hox genes resulted in the discovery of PcG and TrxG 
proteins.  Hox genes encode sequence-specific transcription factors that regulate the 
formation of a body plan during development (reviewed in Soshnikova and Duboule, 2009a).  
In particular, Hox genes are required to establish and maintain body axes like the anterior-
posterior axis of the embryo and during digit development.  Hox genes have proved 
interesting from an evolution of body plan perspective and also in regard to gene regulation 
(Soshnikova and Duboule, 2009a).  Hox genes are arranged into genomic clusters in many 
organisms, and in mammals they exist in four clusters on different chromosomes, termed 
HoxA-D clusters.  Two fascinating aspects of Hox regulation are their temporal and spatial 
expression patterns.  Firstly, Hox genes are expressed in the early embryo in the order that 
they are positioned within their cluster, a behaviour termed temporal co-linearity 
(Soshnikova and Duboule, 2009b).  Temporal co-linearity is thought to involve the clustered 
arrangement of Hox genes as histone marks have been observed to spread across the cluster 
corresponding with expression changes, and a mouse with a split HoxD cluster shows defects 
in this process (Soshnikova and Duboule, 2009b).  Spatially, Hox genes are also expressed in 
a pattern according to their position within their cluster during development, termed spatial 
co-linearity (Soshnikova and Duboule, 2009a).  The clustered arrangement of Hox genes 
does not seem to be essential for this process as Hox transgenes are expressed in the correct 
tissues, but PcG proteins are thought to be important (Simon et al., 1992; Schwarz and 
Pirrotta, 2007).  Some elements of this spatial co-linearity are preserved in adult cells where 
it is suggested that a pattern of Hox expression maintains tissue identity (Rinn et al., 2009; 
Wang et al., 2011).  Hox genes are also tightly regulated and required for lineage 
commitment of adult multipotent cells and are strongly linked to differentiation decisions, 
for example in haematopoiesis (He et al., 2011b).  Together, these features suggest that a 
'Hox code' is important to maintain a sense of positional or lineage identity and that 
regulation of this code is crucial in cell differentiation. 
 PcG and TrxG proteins are strongly linked to Hox regulation, and maintain 
repression and activation of Hox genes respectively (Simon et al., 1992; Boyer et al., 2006; 
Wang et al., 2009c).  The K27me3 modification marks a large domain encompassing the 
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individual Hox clusters in undifferentiated mouse ES cells whilst their promoter regions, 
among other punctate regions, are marked by H3K4me3 (Boyer et al., 2006; Lee et al., 2006; 
Soshnikova and Duboule, 2009b).  In differentiated tissue, domains of K27me3 and 
H3K4me3 within a cluster often demarcate the expression of Hox genes, with low K27me3 
and high H3K4me3 marking regions of higher active expression (Soshnikova and Duboule, 
2009b; Rinn et al., 2007; Wang et al., 2011).  Upregulation of Hox genes is observed in a 
range of tissues and cell types when polycomb proteins are mutated, suggesting that the PcG 
system is critical for Hox gene regulation (Simon et al., 1992; Cao and Zhang, 2004; Cao et 
al., 2005; Boyer et al., 2006; Fujimura et al., 2006; Stock et al., 2007; Chamberlain et al., 
2008; Eskeland et al., 2010).  Defects in expression of Hox genes are also observed in 
mutants of MLL proteins (Terranova et al., 2006; Wang et al., 2009c).  In particular, Mll1 is 
required for normal levels of H3K4me3, RNA Pol II (Pol II) targeting and expression of Hox 
genes in mouse fibroblasts, supporting the opposing roles of PcG and TrxG proteins in gene 
regulation (Wang et al., 2009c).        
 
1.3.3.  Mechanisms of repression by PcG complexes 
 
PcG proteins are well associated with maintaining gene repression but the mechanisms by 
which they achieve this are unclear.  Here I will briefly discuss the multiple mechanisms that 
have been suggested recently.  The sequential recruitment model predicts that PRC2 inhibits 
transcription by recruiting PRC1 (Wang et al., 2004).  However, as discussed above this may 
not always be the case as PRC1 and PRC2 binding are often non-overlapping (Ku et al., 
2008).  In addition, many organisms, such as A. thaliana and C. elegans, have PRC2 
components and K27me3 but no K27me3 binding Cbx ortholog to interpret it, suggesting 
that PRC2 may contribute to gene regulation through PRC1-indepenedent mechanisms 
(Schuettengruber et al., 2007).  PcG proteins have been suggested to inhibit transcript 
elongation by Pol II.  Many PcG target genes are bound by PolII when repressed suggesting 
that polycomb does not act to inhibit Pol II initiation (Stock et al., 2007).  Instead, it has 
been suggested that PRC1, potentially through its H2AK119 ubiquitin-transferase activity, 
acts to inhibit Pol II elongation (Stock et al., 2007).  This model is yet to be tested 
biochemically.  Secondly, PcG systems may act to inhibit the formation of a more active 
chromatin state.  A long-standing idea is that PcG and TrxG binding to chromatin are 
mutually exclusive, thus one action of PcG silencing may be to prevent TrxG-mediated 
transcriptional activation (reviewed in Schuettengruber et al., 2007).  However, the 
relationship between PcG and TrxG proteins is likely to be more complex, as bivalently 
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marked chromatin is present in mammals and PcG and TrxG proteins physically interact and 
are co-bound at many sites in Drosophila (Schuettengruber et al., 2009; Strubbe et al., 
2011).  PRC2 is also implicated in histone deacetylation.  The PRC2 component Eed 
interacts with HDACs, and this is thought to contribute to its repressive activity (van der 
Vlag and Otte, 1999).  The histone H3 tail can be acetylated at lysine 27 (K27ac), the 
position of tri-methylation mediated by PRC2.  K27ac and K27me3 are mutually exclusive 
modifications and K27ac has been linked to transcriptional activity (Tie et al., 2009; Pasini 
et al., 2010b).  Thus, one of the functions of PRC2 could be to induce and maintain 
hypoacetylation at its target chromatin.  Thirdly, PcG proteins have been linked to the 
organisation of chromatin structure, such as the extent of chromatin compaction.  Loss of 
Ring1b in mouse ES cells results in decompaction of chromatin and transcriptional 
upregulation of Hox genes (Eskeland et al., 2010).  These effects are rescued by a 
catalytically inactive Ring1b, suggesting that the H2AK119Ub mark is not required for 
chromatin compaction at this locus (Eskeland et al., 2010).  Furthermore, it has been 
suggested that PcG proteins form foci in the nucleus, termed PcG bodies, suggesting a higher 
level of nuclear organisation of their target chromatin (Hodgson and Brock, 2011).  This idea 
has been recently expanded by the observation that PcG-bound genes form interactions with 
other PcG-bound genes both in cis and in trans (Bantignies et al., 2011; Tolhuis et al., 2011).  
Mutation of a PcG binding site has a subtle negative effect on these interactions suggesting 
that polycomb proteins may play a role in this level of nuclear organisation (Bantignies et 
al., 2011).  The formation of higher order chromatin structures at PcG targets may be linked 
to insulator elements which are suggested to form chromosomal contacts as part of their 
function (Comet et al., 2011; Li et al., 2011b).  Intriguingly in this regard, the PRC2 
component Suz12 has been shown to interact with CTCF, a protein implicated in chromatin 
architecture and chromatin interactions (Li et al., 2008; Philips and Corces, 2009).  Also, 
cohesin components have been shown to associate with PRC2 and are required for 
polycomb-mediated repression of reporters (Strubbe et al., 2011).  However, currently the 
cause and consequence relationships between PcG repression and nuclear architecture are 
unclear but it is interesting to speculate that PcG bodies act as nuclear repression domains, in 
the same way that transcription factories act as gene expression domains (Hodgson and 





1.3.4.  PRC2 targeting and maintenance of K27me3 
 
How are PcG complexes targeted?  This aspect of the polycomb system is not well 
understood and represents a major challenge in the field.  None of the PRC2 or PRC1 core 
complex components in table 1.3 have sequence-specific DNA binding activity that is 
reported, although some interacting proteins may have such a property (Schuettengruber and 
Cavalli, 2009).  In Drosophila, DNA sequence elements that are thought to contribute to 
polycomb recruitment have been identified (Figure 1.7i)(Cavalli and Paro, 1998; reviewed in 
Schuettengruber and Cavalli, 2009).  These elements, termed polycomb response elements 
(PREs), are thought to be bound by sequence-specific DNA-binding proteins, such as Pho 
and Phol (Pho-like), that recruit PcG proteins.  However, the extent of PcG targeting in this 
way is unclear as mutation of these DNA-binding proteins in fly does not lead to obvious 
PcG phenotypes, and no single factor binding site is capable of recruiting PcG complexes 
(Schuettengruber and Cavalli, 2009).  In mammals, the search for PREs has produced few 
results so far, although a couple of PRE-like elements have been described (Sing et al., 2009; 
Woo et al., 2010).  These elements are reported to recruit PcG-repression in the tissues tested 
and both implicated the mammalian homolog of Pho, YY1, in this process (Sing et al., 2009; 
Woo et al., 2010).  In addition, mammalian YY1 can act to silence PcG targets in a 
Drosophila reporter system making it an attractive candidate for vertebrate polycomb 
targeting factor (Atchison et al., 2003).  However, studies of YY1 binding in mammalian 
cells show that it binds to many non-PcG target genes (Xi et al., 2007b).  In fact, 
paradoxically, YY1 binding motifs are enriched in CpG islands that are not bound by PRC2 
complex components in mouse ES cells (Ku et al., 2008).  Other accessory proteins have 
been implicated in targeting of the PRC2 complex through recruitment, such as Jarid2 and 
fly Pcl2 (polycomb-like 2)(Pasini et al., 2010a; Casanova et al., 2011).  In the search for 
DNA sequence motifs at mammalian PcG binding sites, no clear enrichments have been 
found, but a link has been made with CpG islands (Figure 1.7i).  It was noticed that the PcG-
bound α-globin locus contains CpG islands while the non-PcG-bound β-globin locus does 
not (Garrick et al., 2008).  This correlation is valid on a larger scale as PcG binding sites are 
very often found in CpG islands with high levels of sequence conservation (Tanay et al., 
2007; Ku et al., 2008; Mendenhall et al., 2010).  This idea was functionally tested by 
inserting CpG-rich DNA from a variety of sources into the mammalian genome.  CpG-rich 
regions that were depleted of activating transcription factor binding sites accrued PcG, 
suggesting that the default state of CpG-rich DNA may be PcG marking in ES cells 
(Mendenhall et al., 2010; Lynch et al., 2011).  Although Ezh2 binding maps to CG-rich 
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regions, the K27me3 modification reportedly shows a broader distribution and is in fact 
depleted from CGI island chromatin (Barski et al., 2007; Mendenhall et al., 2010; Thomson 
et al., 2010).  Instead, K27me3 appears to be enriched in regions flanking CGIs suggesting a 
'spreading' mechanism from PRC2 binding sites (Mikkelsen et al., 2007; Schuettengruber et 
al., 2009).  A major role for ncRNA in PcG targeting is emerging, providing another 
potential source of sequence-specificity.  Xist, the ncRNA required for XCI, contains a PRC2 
binding secondary structure and is thought to recruit PRC2 to the X chromosome that is to be 
inactivated (Zhao et al., 2008).  An RNA-based targeting mechanism looks to be more 
widespread as PRC2 associates with a large number of ncRNAs (Figure 1.7i)(Zhao et al., 
2010; Kanhere et al., 2010).  Many polycomb-bound genes produce small RNAs from their 
5' end that have been implicated in PRC2 targeting (Kanhere et al., 2010).  An RNA-based 
targeting system has been proposed to function in both cis, for example at the 5' end of 
genes, and trans, such as the HOTAIR ncRNA that reportedly recruits PcG to the HoxD locus 
despite being expressed from the HoxC cluster (Rinn et al., 2007).  However, the importance 
of the homologous Hotair transcript in mouse is in question as its absence does not lead to 
obvious phenotypes usually associated with Hox gene mis-expression (Schorderet and 
Duboule, 2011).  Further study of these mechanisms is required to firmly establish a role for 
RNA-based targeting of PcG proteins.  Non-coding RNA expression has also been 
associated with negative regulation of PcG binding and this will be discussed in section 
1.3.5. 
 In order to provide a component of transcriptional memory, repression by PcG 
proteins must be transmitted through cell divisions, particularly S-phase when chromatin is 
disassembled.  Recently, it has been suggested that this property is fulfilled by the ability of 
the PRC2 complex to bind its own mark, K27me3 (Hansen et al., 2008; Margueron et al., 
2009).  This model suggests that following DNA-replication, PRC2 is recruited to chromatin 
by existing K27me3, which is directly bound by the C-terminus of Eed (Margueron et al., 
2009).  This binding allosterically activates the catalytic function of PRC2 leading to 
deposition of K27me3 on neighbouring newly synthesised histones that are incorporated into 
chromatin.  This form of propagation may also explain the spreading of the K27me3 mark 
observed during ES cell differentiation (Hawkins et al., 2010).  PRC1 and MLL components 
have been observed to remain chromatin bound during in vitro DNA replication and M-
phase respectively, suggesting that they are not necessarily displaced from chromatin during 
these periods (Francis et al., 2009; Blobel et al., 2009).       
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1.3.5.  Relief from polycomb-mediated silencing and polycomb inhibition 
 
One aspect of PcG biology that is important for the work in this thesis is how the flexibility 
of repression by PcG proteins is achieved.  How are PcG-repressed genes activated, and, 
what is inhibitory to PcG repression?  These questions are also relevant to the above section 
on how PcG proteins are targeted as they involve ways that the cell protects a region from 
PcG repression.  Recently, multiple mechanisms have been suggested in answer to these 
questions.  Firstly, the histone marks associated with the PRC2 and PRC1 complexes are 
reversible (Figure 1.7ii).  UTX and JMJD3 are K27me3 demethylases implicated in 
reversing PcG-mediated repression and activation of Hox genes (Agger et al., 2007; Lan et 
al., 2007; Seenundun et al., 2010).  UTX interacts with MLL2/4 providing a potential 
explanation for PcG and TrxG antagonism (Issaeva et al., 2007).  It is not yet clear which 
mechanisms govern removal of K27me3 from regulatory regions.  Interestingly, a distant 
enhancer at the α-globin locus has been implicated in recruiting the K27me3 demethylase 
JMJD3 to a gene promoter, as deletion of the enhancer results in persistence of promoter 
K27me3 (Vernimmen et al., 2011).  The H2AK119 ubiquitination mark catalysed by PRC1 
is also thought to be reversible, via the de-ubiquitinase PR-DUB complex (Scheuermann et 
al., 2010).  Paradoxically, mutation of PR-DUB results in the expected increase in 
H2AK119ub but concomitant derepression of PcG target genes, suggesting a more complex 
role for this modification in gene regulation (Scheuermann et al., 2010).  Also in support of a 
role for H2AK119ub in gene activation, ZRF1 was identified as a protein that binds to this 




Figure 1.7 - Targeting and dynamics of PcG repression.  i) Polycomb response elements 
(PREs) have been characterised in Drosophila as binding sites for PcG proteins although few 
have been identified in mammals where CpG islands have been linked to PcG targeting.  
Non-coding RNA (ncRNA) may direct PcG to certain loci.  ii) PcG mediated histone marks are 
reversible, exemplified by a histone demethylase UTX that removes K27me3.  iii) 
Transcription of ncRNA across a PcG binding site is thought to relieve polycomb binding and 
repression.  iv) Certain marks on the histone H3 tail are inhibitory to PcG binding and/or 
function.                    
 
Transcription is thought to have a dramatic effect on PcG binding and repression.  In studies 
of transcriptional memory of reporter genes induced by fly PREs, it was noticed that a 
transient burst of transcription at a PRE was enough to ablate PcG proteins and induce a 
memory of active transcription of the nearby reporter gene (Figure 1.7iii)(Cavalli and Paro, 
1998; Cavalli and Paro, 1999).  These fundamental observations were supported by further 
studies that suggested that transcription through PRE elements results in their loss of 
silencing activity in reporter constructs (Bender and Fitzgerald, 2002; Hogga and Karch, 
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2002; Rank et al., 2002).  Next, endogenous intergenic RNAs were identified that covered 
PREs, and their expression was shown to negatively correlate with the repression induced by 
the PRE, implying a role in activation (Schmitt et al., 2005).  Mammalian and fly Hox 
clusters have been particularly associated with this type of ncRNA, and its expression has 
been correlated with gene activation during spatial and temporal co-linear activation (Sessa 
et al., 2007; Rinn et al., 2007; Sasaki et al., 2007).  In mammals, there is abundant antisense 
ncRNA expression, in a pattern that resembles the neighbouring Hox genes on the sense 
strand, further suggesting a role in gene activation (Sessa et al., 2007; Rinn et al., 2007).  
The molecular function of this transcription is unclear.  Specific ncRNAs, in both fly and 
vertebrates, have been suggested to directly bind to TrxG proteins and positively influence 
their recruitment in cis to genomic regions (Sanchez-Elsner et al., 2006; Wang et al., 2011).   
 The binding and activity of the PRC2 complex is also inhibited by certain histone 
modifications (Figure 1.7iv).  PRC2 activity is inhibited in vitro on nucleosomes containing 
H3K4me3 or H3K36me3 (Schmitges et al., 2011; Yuan et al., 2011).  The effect of K4me3 
may be explained by reduced binding of the RpAp48/RpAp46 subunit of the PRC2 complex 
to histones containing K4me3 and/or by allosteric inhibition of the complex (Schmitges et 
al., 2011).  The molecular basis behind PRC2 inhibition by H3K36me3 is unclear but this 
effect is conserved for human and fly PRC2 (Schmitges et al., 2011).  The effect of 
H3K36me3 is intriguing, given the link between ncRNA and PcG erasure, as this is a marker 
of elongating transcription.  Another suggested chromatin-based mechanism for PcG 
displacement is phosphorylation of serine 28 (H3S28Ph), the adjacent amino acid to the 
polycomb-deposited K27me3 mark on the histone H3 tail.  Phosphorylation by Msk of this 
residue is reported to induce dissociation of PRC2 and gene activation if targeted to a PcG 
marked gene (Gehani et al., 2010; Lau et al., 2011).  However, the importance of this 
mechanism in gene regulation is not yet clear as no physiological targets of H3S28Ph have 
been identified.  In addition to these chromatin marks, DNA methylation has been linked to 
PcG displacement and this will be discussed in the next section. 
 
1.3.6.  Links between polycomb repression and DNA methylation 
 
During the course of this project, intriguing links have been made between the polycomb 
system and DNA methylation in the literature.  Generally speaking, promoters marked by 
K27me3 have low levels of DNA methylation and, genome-wide, K27me3 is depleted from 
regions with high levels of DNA methylation (Meissner et al., 2008; Hawkins et al., 2010).  
Large regions with lower than normal DNA methylation levels (partially methylated 
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domains - PMDs) often reflect a block of K27me3 modification in human cells (Lister et al., 
2009; Hawkins et al., 2010).  This negative correlation is also observed during chromatin 
dynamics when cells differentiate.  For example, K27me3 domains are often broader in 
IMR90 fibroblasts than hES cells.  Regions where this K27me3 'spreading' has occurred are 
also DNA hypomethylated in IMR90 cells relative to hES cells (Hawkins et al., 2010).  This 
negative correlation has also been observed in Arabidopsis tissues implying functional 
conservation (Weinhofer et al., 2010).  A negative correlation of these two epigenetic marks 
has also been observed at an imprinted locus where they are proposed to be mutually 
exclusive, each marking one allele (Lindroth et al., 2008).  These observations alone do not 
tell us about cause/consequence relationships between the two modifications but a few 
reports suggest that a causal link exists.  Mutation of Dnmt3a results in postnatal 
neurogenesis defects (Wu et al., 2010).  Specifically, in Dnmt3a null neural stem cells 
(NSCs) transcriptional down-regulation occurs of many genes crucial for neural 
differentiation (Wu et al., 2010).  Dnmt3a was shown to bind to and methylate regions 
flanking CpG island promoters and within the gene body of active genes (Wu et al., 2010).  
Loss of DNA methylation at these regions in Dnmt3a null cells was accompanied by 
increased binding of PRC2 proteins, increased K27me3 and transcriptional down-regulation.  
In addition, in vitro chromatin binding assays, performed by two independent groups, 
showed reduced PRC2 binding to heavily methylated DNA (Wu et al., 2010; Bartke et al., 
2010).  In a recent report, mapping of K27me3 in DNA hypomethylated mouse ES cells 
lacking Dnmt3a and Dnmt3b showed de novo targeting of this mark to previously DNA 
methylated CpG-rich regions (Lynch et al., 2011).  A reciprocal effect has been observed 
more indirectly by studying proteins involved in active demethylation.  Depletion of Tet1 in 
ES cells and loss of Tdg in mouse fibroblasts leads to local increases in DNA methylation, 
decreased PRC2 binding and increased expression of many genes (Wu et al., 2011; Cortazar 
et al., 2011).  These studies together suggest that dense DNA methylation may be inhibitory 
to PcG binding and could play a role in its targeting.  This raises many questions including to 
what extent this mechanism is operative in other systems as well as how this effect is 
mediated at the molecular level.  This handful of studies points towards a novel role for 
DNA methylation in genome regulation by modulating the targeting of PcG proteins to 
chromatin.  As these studies were published during the course of this thesis project, they 
influenced the interpretation of my results and planning of experiments along the way. 
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1.4.  Thesis aims 
 
 
When I began this project, I identified the mechanisms by which DNA methylation 
contributes to genome regulation as one of the largest and important gaps in our knowledge.  
At the time it was often stated that the effects of DNA methylation were mediated by two 
mechanisms; recruiting methyl-CpG binding proteins and inhibiting transcription factor 
binding.  I reasoned that the effects of DNA methylation were likely more numerous and 
complex than currently appreciated for the following reasons: 
• Evidence suggests that MeCPs and inhibition of transcription factors each contribute 
to genome regulation by DNA methylation but neither can explain the severe 
phenotypes observed in DNA methyltransferase mutant embryos and cells.  This is 
because loss of MeCPs results in relatively mild phenotypes and the number of 
transcription factor binding events affected by DNA methylation in vivo is very low.  
One interpretation of these observations is that DNA methylation affects the genome 
through additional mechanisms.  
• An increasing variety of proteins were being identified, that were affected by DNA 
methylation in their binding to DNA, with diverse roles in genome regulation 
• Numerous links were being drawn between DNA methylation and histone 
modifications suggesting extensive cross-talk that was not well understood   
• Studies had suggested that other, non-canonical, roles of DNA methylation exist that 
are poorly understood, such as modulation of CTCF binding and regulation of 
lincRNAs (Fig. 1.6)  
 
Therefore, my broad thesis aim was: 
1. To investigate novel roles of DNA methylation in genome regulation.   
 
Given the links between DNA methylation and histone modifications I became focussed 
on epigenetic cross-talk.  In particular, the effect of experimental DNA hypomethylation 
on chromatin structure has not been well addressed.  During the course of my project 
interesting links were emerging between DNA methylation and the PcG system, both in 
my work and in the literature.  Therefore, a more specific aim that emerged during the 
project was: 
2. To investigate the role of DNA methylation on PcG targeting and repression. 
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Chapter 2: Materials and Methods 
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2.1.  Microbiological techniques 
 
 
2.1.1.  Transformation of bacteria 
 
Chemically competent DH5α Escherichia coli (E. coli)(library or sub-cloning 
efficiency)(Invitrogen) were mixed with an appropriate amount of plasmid and incubated on 
ice for 10-30min.  Bacteria were heat shocked by incubation at 42°C for 40sec, placed on ice 
for 2min, then 500µl SOC media (Invitrogen) was added followed by aseptic spreading onto 
L-agar plates supplemented with the appropriate antibiotic (ampicillin at 50mg/ml; 
kanamycin at 50mg/ml; chloramphenicol at 13mg/ml)(L-agar plates were prepared by HGU 
technical services).  Where blue/white selection was required, 80µl of X-gal (25mg/ml in 
dimethylformamide) was spread on plates and allowed to dry prior to bacterial plating.  
Plates were inverted and incubated at 37°C overnight.  
 
2.1.2.  Growth of bacteria and isolation of plasmid DNA 
 
To propagate plasmid DNA, single colonies of transformed bacteria were picked and used to 
inoculate 3ml LB (Luria-Bertani) broth supplemented with the appropriate antibiotic at the 
concentrations supplied above which was incubated at 37°C overnight with shaking at 
>225rpm (LB broth was prepared by HGU technical services).  For maxi-preparations, 1.5ml 
of this culture was used to inoculate 150ml of LB supplemented with antibiotics and 
incubated in the same way for a further 16hr.  Plasmid DNA was isolated from bacterial 
cultures using 'Nucleospin Plasmid' kit for 3ml cultures (Machery-Nagal) or 'GenElute HP 
Endotoxin-free Maxiprep Kit' for 150ml cultures (Sigma) according to manufacturer's 
instructions. Bacterial artificial chromosomes (BACs) were isolated from pelleted (1.5ml 
overnight culture) bacteria using the following method.  Pellet was resuspended in 200ul P1 
buffer (50mM glucose; 25mM Tris pH8; 10mM EDTA; 0.25mg/ml lysozyme (Sigma)) then 
cells were lysed by alkaline lysis by adding 400µl lysis buffer (200mM NaOH; 1% SDS 
w/v) and incubating on ice for 5min.  Reaction was neutralised by adding 300µl acetate 
buffer (3M Potassium acetate; 11.5% glacial acetic acid v/v) and incubation on ice for 5min.  
Mixture was clarified by centrifugation at 13k*g at 4°C for 5min and the supernatant was 
used for phenol chloroform extraction.  
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2.2.  DNA preparation and manipulation 
 
 
2.2.1.  Isolation of genomic DNA from mammalian cells 
 
Genomic DNA was isolated from mammalian cells using either the 'DNeasy Blood and 
Tissues Kit' (Qiagen) according to manufacturer's instructions or the following method.  Cell 
pellet (~107 cells) was resuspended in 300µl TE buffer and lysed by the addition of 300µl 
lysis buffer (20mM Tris pH8; 4mM EDTA; 20mM NaCl; 1% SDS w/v) and 80µg of 
proteinase K (proK) and incubation for >6hr at 55°C.  Genomic DNA was isolated by phenol 
chloroform extraction.  Where RNA-free genomic DNA was required, preps were treated 
with RNase cocktail (Ambion)(1µl RNase cocktail added with incubation at 37°C for 
30min).  
 
2.2.2.  Restriction digest of genomic DNA 
 
1.5 μg of RNA-free genomic DNA was incubated with restriction endonucleases HpaII 
(Roche), MspI (Roche) or HpyCHIV (NEB) according to the manufacturer's instructions for 
2hrs.  Digested DNA was resolved on a 1.5% agarose gel, stained using SYBR Gold DNA 
stain (Invitrogen) or ethidium bromide according to the manufacturer's instructions, then 
visualised using a FLA-5100 phosphoimager (Fuji). 
 
2.2.3.  Agarose gel electrophoresis and DNA extraction from agarose 
 
Nucleic acids were resolved by electrophoresis through 0.7-2% agarose-TBE gels (Hi-pure 
low EEO agarose - Sigma) supplemented with 0.4µg/ml ethidium bromide where necessary.  
DNA samples were loaded by adding either 6x loading buffer (Promega) or orange G 
loading buffer (50% glycerol v/v; 5mM EDTA pH8; 0.3% orange G w/v).  DNA size 
markers 1kb ladder (Invitrogen), 100bp ladder (Promega) and GeneRuler DNA ladder mix 
(Fermentas) were used to size fragments.  DNA was extracted from agarose gel slices using 
'Nucleospin Extract II' kit (Machery-Nagal) according to manufacturer's instructions. 
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2.2.4.  Phenol-chloroform extraction and ethanol precipitation 
 
The isolate DNA from mixtures an equal volume of 25:24:1 phenol:chloroform:isoamyl 
alcohol (Sigma) was added to at least 100µl of sample, mixed, allowed to settle then 
centrifuged (16k*g for 15min at room temperature).  The DNA-containing aqueous phase 
was carefully taken and an equal volume of chloroform was added then the sample was 
mixed and centrifuged (5min at 16k*g at room temperature) and the aqueous phase taken to 
remove residual phenol.  DNA was precipitated from the aqueous phase by adding 1/10 
volume of 3M sodium acetate (Sigma) and 2.5 volumes of ice cold ethanol and incubating 
for 5min at room temperature or longer at -20°C if required.  When precipitating small 
quantities of DNA, inert carriers like glycogen or GlycoBlue (Ambion) were added before 
precipitation according to manufacturer's instructions.  Precipitated material was pelleted by 
centrifugation (16k*g for >15min at room temperature) and the pellet was washed at least 
once in 75% ethanol to remove salts and resuspended in distilled ultra-filtered water (MilliQ 
water) of TE buffer (10mM Tris pH8; 1mM EDTA). 
 
2.2.5.  DNA quantification and assessment 
 
Nucleic acids were quantified and their purity was assessed using spectrophotometry.  The 
'Nanodrop ND-1000' was used to quantify both dsDNA and ssRNA samples.  The A260 was 
measured and used to calculate the concentration of the sample (as an OD of 1 at 260nm = 
50µg/ml of dsDNA).  A260/A230 and A260/A280 ratios were also calculated to estimate to 
purity of nucleic acids.   
  
2.2.6.  pGEM-T Easy cloning 
 
Taq polymerases often leave a dA 3' overhang on the end of PCR products.  PCR products 
can therefore be cloned into a vector with 5' dT overhangs.  PCR products were ligated with 
pGEM T Easy vector (Promega) according to the manufacturer's instructions but the ligation 




2.3.  RNA preparation and analysis 
 
 
2.3.1.  Isolation of RNA from mammalian cells 
 
Generally, the utmost care was taken when handling RNA.  Clean gloves were worn, pipettes 
and work surfaces were rinsed with RNase Zap (Ambion), and RNase-free filtered pipette 
tips, eppendorf tubes and water were used throughout.  RNA was isolated from mammalian 
cells and tissues using 'Trizol' reagent (Invitrogen) according to manufacturer's instructions.  
Briefly, Trizol was added to adherent cells directly onto the culture surface to minimise 
chance of RNA degradation.  1ml of Trizol was added per 25cm2 of culture surface for 
mouse embryonic fibroblasts at >70% confluence.  Mixture was incubated at room 
temperature for 5min to allow dissociation of protein-RNA complexes then 1/10 volume of 
bromochloropropane (BCP) was added and the sample was mixed vigorously by hand.  After 
allowing the mixture to settle it was centrifuged (12k*g for 15min at 4°C) to separate the 
organic, inter- and aqueous phases.  The RNA-containing aqueous phase was removed 
carefully to prevent contamination from the DNA-containing interphase.  RNA was 
precipitated from the aqueous phase (in the presence of glycogen carrier if appropriate) by 
the addition of 0.5 initial volume of isopropanol for 10min at room temperature.  RNA was 
pelleted by centrifugation (12k*g for 10 mins at 4°C) then the pellet was washed in 75% 
before resuspension in RNase-free water (DEPC treated water - Sigma).  RNA concentration 
was determined by spectrophotometry using Nanodrop ND-1000 on RNA settings.  RNA 
integrity was determined by ethidium bromide agarose gel electrophoresis looking for the 
integrity of the abundant ribosomal RNA fragments or by Bioanalyser RNA1000 chip 
(Agilent)(Bioanalyser analysis performed by HGU technical services).  RNA was stored at -
80°C.      
 
2.3.2.  Preparation of cDNA 
 
Where possible, RNA was treated with DNase to remove any DNA contamination using 
'TURBO DNase-free' (Ambion) according to manufacturer's instructions.  Occasionally, 
when RNA quantities were limiting, the DNase step was not performed.  In these 
circumstances, extra attention was paid to ensure no DNA contamination in subsequent 
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reactions using negative controls such as -RT (no reverse transcriptase).  Between 100ng and 
5µg of total RNA was used as a template for cDNA (complimentary DNA) synthesis by 
reverse transcription primed by either oligo-dT or random heximers (both Promega) using 
SuperscriptII or SuperscriptIII (Invitrogen) according to manufacturer's instructions.  RNase 
inhibitor (RNaseIn - Promega) was added to the reaction to ensure no degradation of the 
RNA template in the early stages of the reaction.  Negative control cDNA reactions were 
performed without the addition of the reverse transcriptase to control for DNA and aerosol 
contamination in downstream experiments using non-intron-spanning primers.  cDNA was 
stored at -20°C. 
 
2.3.3.  RT-PCR 
 
The presence of specific transcripts in steady-state cellular RNA was semi-quantitatively 
assessed by polymerase chain reaction (PCR) using cDNA as a template.  Primers used for 
RT-PCR (Table 2.1) were designed using the 'Primer3' program 
(http://frodo.wi.mit.edu/primer3/) using the default settings to give a Ta (annealing 
temperature) of 55°C, a product size of <400bp and skipping a large intron where possible to 
avoid genomic DNA contamination.  Primers were screened for the formation of multiple 
bands or extensive primer-dimers indicated by small size smears on the gel.  PCR 
amplification was performed from cDNA in 20μl reactions as follows:  1x PCR buffer 
(Invitrogen), 2mM MgCl2, dNTPs (0.5mM each), 150nM each primer, 0.6u Taq (Thermus 
aquaticus) DNA polymerase (Invitrogen) and an appropriate volume of cDNA.  The amount 
of cDNA template used depends on the amount of RNA used in the cDNA synthesis reaction 
and the abundance of the template in the cDNA pool.  Reactions were incubated in a 
thermocycler using the following program; 95°C for 5min followed by 25-35 cycles of 95°C 
for 20sec, 55ºC for 20sec, 72°C for 30sec.  Reactions were then incubated for 72°C for 5 min 
to complete any polymerase elongations.  PCR products were resolved by agarose gel 
electrophoresis and visualised using ethidium bromide staining and UV trans-illumination. 
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2.4.  Protein preparation and analysis 
 
 
2.4.1.  Cell extracts 
 
Whole cell extracts were prepared by lysing cells in Laemmli buffer (60mM Tris pH6.8; 
10% glycerol; 2% SDS w/v; 0.01% bromphenol blue w/v; 10mM DTT).  The lysis mixture 
was sonicated using an 'Soniprep 150' probe sonicator (MSE)(3 pulses of 30s at 10µm 
amplitude), centrifuged to remove debris (5min at 20k*g at room temperature) and then 
boiled at 95°C for 5min to ensure denaturation of proteins.  For soluble chromatin extracts 
the input for N-ChIP (see 2.6.1) was used.  2x Laemmli buffer was added and extract was 
boiled at 95°C for 5min to ensure denaturation of proteins.  Protein concentration of extracts 
was measured in duplicate by methanol precipitation from Laemmli buffer followed by 
Bradford assay.  An aliquot of extract was made up to 150µl with dH20 then 600µl 
methanol, 150µl chloroform and 450µl dH20 were sequentially added and vortex mixed.  
The samples were centrifuged (15k*g for 2min at room temperature) and the aqueous phase 
was discarded.  650µl methanol was added and the sample was mixed by inversion.  
Precipitated protein was pelleted by centrifugation (15k*g for 2min at room temperature) 
and the pellet was air dried, resuspended in 50µl 1M NaOH and protein concentration was 
measured against BSA (bovine serum albumin) standards using Bradford reagent (BioRad) 
according to manufacturer's instructions.  Dilution factor was taken into account when 
calculating protein concentration of extracts.      
 
2.4.2.  SDS-PAGE 
 
Protein was resolved by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE).  Precast NuPAGE 4-12% gradient gels (Invitrogen) were loaded with samples in 
Laemmli buffer and pre-stained protein ladder (Fermentas) for sizing.  Gels were run in a 




2.4.3.  Western blotting 
 
Following electrophoresis gels were equilibrated in transfer buffer (25mM Tris; 200mM 
glycine; 20% methanol v/v) for 5min then transferred to polyvinylidene fluoride (PVDF) 
membrane (BioRad) using the GenieBlotter (Idea Scientific) according to manufacturer's 
instructions.  Membranes were blocked with PBS (phospho-buffered saline) with 0.1% 
Tween20 (Sigma) and 5% non-fat dry milk proteins (Marvel)(PBST-milk) for at least 30min.  
Primary antibody (α-H3, Abcam, ab1791-100, 1:1000; α-H3K4me3, Upstate, 07-473, 
1:1000; α-H3K27me3, Upstate, 07-449, 1:1000; α-H3K4me2, Upstate, 07-030, 1:1000; α-
H4K20me3, Abcam, ab9053-100, 1:1000; α-H2AK119ub, Upstate, 05-678, 1:1000; α-Ezh2, 
Upstate, 17-662, 1:1000; α-Actinβ, Abcam, ab3280, 1:5000; α-Eed, Upstate, 05-1320, 
1:5000; α-Suz12, Cell signalling, D39F6#3737S, 1:1000; α-H3K27ac, Abcam, ab4729, 
1:1000; α-H3S28ph, Upstate, 07-145, 10µg) and secondary antibody (α-rabbit IgG-HRP 
(horse-radish peroxidase) conjugate, Sigma, 1:80,000; α-mouse IgG-HRP conjugate, Sigma, 
1:10,000; α-mouse IgM-HRP conjugate, Sigma, 1:5000) incubations were performed in 
PBST-milk for at least 1hr each at room temperature, although often an overnight incubation 
at 4°C was used for the primary antibody.  Membrane was washed extensively with PBST 
between incubations then antibody bound regions detected using 'SuperSignal Western Pico 
Reagent' chemi-luminescence reagent (Pierce) and 'ECL Hyperfilm' (Amersham). 
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2.5.  Mammalian cell culture 
 
 
2.5.1.  Culture of mouse embryonic fibroblasts 
 
Dnmt1+/+ and Dnmt1-/- (as abbreviated for clarity) mouse embryonic fibroblasts are of the 
genotype trp53-/- and trp53-/-;dnmt1n/n respectively and were a gift from Howard Cedar 
(Lande-Diner et al., 2007).  All mouse embryonic fibroblasts were cultured on cell culture 
grade tissue culture flasks (Gibco) in a humidified atmosphere at 37°C and 5% CO2 in 
Dulbecco's Modified Eagle Media (DMEM - Gibco) supplemented with 10% foetal calf 
serum (HGU technical services), 1x non-essential amino acids (Sigma), 1mM sodium 
pyruvate (Sigma), 1000U/ml penicillin and 650µg/ml streptomycin.  Cells were passaged 
every two days or when necessary by rinsing with PBS to remove media and adding 1x 
trypsin-EDTA v/v (Sigma) and incubating for 2min at 37°C to allow cells to become 
dislodged with gentle agitation and then seeding into fresh flasks and media (~1:6 split ratio 
for cells used here).  Passage number of cells was kept as low as possible.  Aliquots of cells 
were frozen in liquid nitrogen in 1ml culture media supplemented with 10% dimethyl 
sulfoxide (DMSO) v/v after >1hr at -20°C and >5hr at -80°C.  Upon recovery from liquid 
nitrogen storage, cells were thawed quickly by placing in a 37°C water bath then added drop 
wise to 10ml of culture media, pelleted by centrifugation to remove DMSO, and resuspended 
in fresh media and seeded.  For treatment with 5-Aza-2'-deoxycytidine (5-Aza dC), 5-Aza 
dC (Sigma) was dissolved in DMSO at 10mM.  5-Aza dC or DMSO (control) was added to 
fresh culture media which was used to replace culture media of cells at 40-60% confluency 
to allow cells to divide in order to incorporate the drug into DNA.  As 5-Aza dC is unstable 
in solution, media was changed daily and fresh drug added.      
 
2.5.2.  Derivation of mouse embryonic fibroblasts 
Mouse embryos (CD1 E12.5) were dissected from the uterus and their deciduas, decapitated 
and stripped of visceral organs in ice cold PBS supplemented with pen-strep.  Carcasses 
were minced with a scalpel and placed in 1x trypsin-EDTA (Sigma) solution at 37ºC for 
30min to dissociate tissues.  Solution was pipette mixed, sedimented by centrifugation at 
500*g for 3min before the supernatant was plated in culture media.  Tissue from multiple 
embryos was pooled. 
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2.6.  Experimental procedures 
 
 
2.6.1.  Native chromatin immunoprecipitation (N-ChIP) 
 
The following buffers and solutions were used during this protocol: NBA (85mM NaCl; 
5.5% sucrose w/v; 10mM Tris pH7.5; 0.2mM EDTA; 0.2mM PMSF 
(phenylmethanesulfonylfluoride); 1mM DTT; complete EDTA-free protease inhibitor tablet 
(Roche)), NBB (as NBA supplemented with 0.15% NP40 (Sigma) v/v), NBR (85mM NaCl; 
5.5% sucrose w/v; 10mM Tris pH7.5; 3mM MgCl2; 1.5mM CaCl2; 0.2mM PMSF; 1mM 
DTT; complete EDTA-free protease inhibitor tablet (Roche)), STOP buffer (215mM NaCl; 
10mM Tris pH8; 20mM EDTA; 5.5 % sucrose w/v, 2% TritonX 100 (Sigma); 0.2mM 
PMSF; complete EDTA-free protease inhibitor tablet (Roche)), N-ChIP wash buffer 
(150mM NaCl; 10mM Tris pH8; 2mM EDTA; 1% NP40; 1% sodium deoxycholate w/v), 
elution buffer (0.1M NaHCO3, 1% SDS), block solution (1x PBS, 0.5% BSA w/v), 
micrococcal nuclease buffer (50% glycerol v/v (Sigma), 10mM Tris pH7.6 and 50mM 
NaCl), sonication buffer (2M NaCl and 5M urea).  All steps were performed on ice or at 4°C 
where possible unless otherwise stated.  Approximately 5*106 cells were harvested per IP.  
Cells were cultured in 25cm diameter dishes to facilitate harvesting.  Cells were harvested at 
<90% confluency using a large cell scraper, pelleted by centrifugation (600*g for 4min at 
4°C), rinsed twice in ice cold PBS and resuspended well in 5ml NBA buffer.  Cell 
membranes were punctured by addition of 5ml NBB and incubation on ice for 4min.  Nuclei 
were pelleted by centrifugation (2600*g for 4min at 4°C), resuspended in 10ml NBR to 
remove residual NBB buffer, pelleted and then resuspended in 1ml NBR (or variable 
depending on pellet size).  Chromatin content was inferred by approximating DNA content 
and averaging across triplicates: 5µl of nuclei suspension was treated with DNase (RQ1, 
Promega) in 95µl NBR for 10min at room temp before adding 400µl sonication buffer, to 
disrupt DNA:chromatin interactions, followed by measuring the A260 by spectrophotometry 
against an NBR blank.  According to the average measurement nuclei were distributed into 
500µl aliquots in NBR each containing 400µg DNA by this measurement.  For ChIP-seq, 
where smaller fragments are required, aliquots of 300µg DNA in 500µl were used.  Nuclei 
aliquots were incubated at room temperature for 2min with 1µl RNase cocktail (Ambion) 
then digested with 25U of Mnase (micrococcal nuclease)(Worthington) for exactly 10min at 
room temperature.  Concentration of Mnase required to produce appropriate fragment size 
85
was titrated on each cell line used.  The Mnase reaction was stopped by the addition of 500µl 
stop buffer and tubes were placed on ice overnight.  The size range of chromatin fragments 
was confirmed for every replicate by performing the following.  20µl released chromatin was 
centrifuged (16k*g for 5min at 4°C) to remove nuclear debris and the supernatant was 
treated with 40µg proteinase K (proK) for 30 min at 55ºC.  Sample was mixed with Orange 
G loading dye and run on a 1.3% agarose gel stained with ethidium bromide against a 123bp 
ladder (Invitrogen).  Mono- di- and tri-nucleosome sized fragments should be the most 
abundant species.  The following day, the released chromatin was centrifuged (16k*g for 
5min at 4°C) and the supernatant was collected and pooled for each cell line or condition 
used.  100µl of each was set aside as input and either stored at -20ºC or one ice for the rest of 
the day.  Protein-A Dynabeads (Invitrogen) were washed twice in block solution.  Chromatin 
was pre-cleared by incubating with 15µl Dynabeads for 2 hr at 4ºC on rotating wheel.  In 
parallel, antibodies (rabbit IgG, Santa Cruz, sc-2027, 10µg; α-H3K4me3, Upstate, 07-473, 
5µg; α-H3K27me3, Upstate, 07-449, 10µg; α-H3K27ac, Abcam, ab4729, 10µg; α-H3S28ph, 
Upstate, 07-145, 10µg) were bound to beads by incubating 30µl Dynabeads in 200 µl block 
solution with antibody on rotating wheel at 4ºC for 2 hr.  Antibody bound beads were 
washed once with block solution before addition of pre-cleared chromatin.  
Immunoprecipitation was performed for 3 hr on rotating wheel at 4ºC.  Beads were washed 
three times in N-ChIP wash buffer for 10min at 4ºC on rotating wheel and then rinsed in TE.  
DNA was eluted in one of two ways.  100µl elution buffer warmed to 37ºC was added to 
beads and they were rotated for 15 min at room temp.  Elution was repeated using 50µl 
elution buffer and the two elutions were pooled.  DNA was isolated from eluate and inputs 
by treatment with 40µg proK for 1hr at 55ºC and purification using PCR clean up kit 
(Qiagen) according to manufacturer’s instructions.  Alternatively, when maximum DNA 
yields were required, beads were resuspended in 200µl ProK digestion buffer (50mM Tris 
pH8; 10mM EDTA; 0.5% SDS w/v), 40µg ProK was added to bead suspension and to 
inputs, and reactions were incubated at 56°C overnight with intermittent agitation, then DNA 
was isolated using PCR clean up kit (Qiagen).  DNA was eluted from columns in 50µl dH20 
and quantified by Nanodrop ND-1000 spectrophotometry.  Controls for N-ChIP experiments 
included a species matched IgG to control for background, negative and positive genomic 
regions to show specificity, and the use of input DNA to control for technical variations 
between cell lines or treatments.  Antibodies were tested by western blot for recognition of 
histone-sized proteins only and by specific enrichment at positive control regions by N-ChIP.  
Enrichments were measured by qPCR (see 2.6.4) and/or microarray (see 2.7 and 2.8).   
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2.6.2.   Cross-linked chromatin immunoprecipitation (X-ChIP) 
 
The following buffers and solutions were used during this protocol: Cytoplasmic lysis buffer 
(5mM PIPES ph8; 85mM KCl; 0.5% NP40 v/v (Sigma); complete EDTA-free protease 
inhibitor tablet (Roche)), PBS-RIPA (1xPBS; 1% NP40 v/v; 0.5% sodium deoxycholate w/v; 
0.1% SDS w/v; complete EDTA-free protease inhibitor tablet (Roche)), X-ChIP wash buffer 
(150mM NaCl; 10mM Tris pH8; 2mM EDTA; 1% NP40; 0.1% sodium deoxycholate w/v), 
LiCl wash buffer (100mM Tris pH7.5; 500mM LiCl; 1% NP40; 1% sodium deoxycholate), 
block solution (1x PBS, 0.5% BSA w/v), sonication buffer (2M NaCl and 5M urea).  All 
steps were performed on ice or at 4°C where possible unless otherwise stated.  
Approximately 5*106 cells were harvested per IP.  Cells were cultured in 25cm diameter 
dishes to facilitate fixation and harvesting.  Formaldehyde (36.5% from Sigma) was added to 
1% final concentration directly to culture media and dishes were incubated at room 
temperature with mild agitation for exactly 10min.  Formaldehyde was quenched by the 
addition of glycine to 125mM final concentration and dished were incubated for 3min at 
room temperature.  Cells were rinsed twice in ice cold PBS before being dislodged with a 
large cell scraper in ice cold PBS with added protease inhibitors (complete EDTA-free 
protease inhibitor tablet (Roche)).  Cells were pelleted by centrifugation (600*g for 4min at 
4°C) and fully resuspended in 5ml cytoplasmic lysis buffer and left on ice for 10min.  Nuclei 
were pelleted by centrifugation (2600*g for 4min at 4°C) and fully resuspended in 600µl 
PBS-RIPA and incubated on ice for at least 20min.  Extract was sonicated using a 'Soniprep 
150' probe sonicator (MSE) at 6µm amplitude for 30sec on/off cycles for 5 cycles while on 
ice between sonications (this was determined by testing a range of sonication conditions).  
Extract was centrifuged (8k*g for 3min at 4°C) to remove nuclear debris and the 
supernatants from the same cell lines or treatments were combined.  The size range of 
chromatin fragments was confirmed for every replicate by performing the following.  15µl 
extract was treated with 1µl RNase cocktail (Ambion) at 37°C for 15min then with 40µg 
proteinase K (proK) for >1hr at 65ºC to reverse cross-links.  Sample was centrifuged (16k*g 
for 3min at room temperature) then the supernatant was mixed with Orange G loading dye 
and resolved on a 1.3% agarose gel stained with ethidium bromide against DNA ladders.  
The DNA smear should be between 200 and 1000bp.  Chromatin content was inferred by 
approximating DNA content and averaging across triplicates: 5µl of nuclei suspension was 
added to 495µl sonication buffer, to disrupt DNA:chromatin interactions, followed by 
measuring the A260 by spectrophotometry against an sonication buffer blank.  According to 
the average measurement extract was distributed into 1ml aliquots in PBS-RIPA each 
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containing 300µg DNA by this measurement.  100ul of extract for each cell line or treatment 
was put aside as input and stored on ice.  Antibody (mouse IgG, Santa Cruz, sc-2025, 5µg; 
α-Ezh2, Upstate, 17-662, 5µg) was added to each tube and they were incubated on a rotating 
platform at 4°C overnight.  35µl sheep α-mouse IgG conjugated Dynabeads (M280 - 
Invitrogen) were washed twice in block solution and added to antibody-extract solution and 
tubes were rotated at 4°C for 2hr.  Beads were washed for 10min rotating at 4°C once in 
PBS-RIPA, once in X-ChIP wash buffer and once in LiCl wash buffer before being rinsed in 
TE.  Beads were resuspended in 200µl ProK digestion buffer (50mM Tris pH8; 10mM 
EDTA; 0.5% SDS w/v) and treated, together with inputs, with 1µl RNase cocktail (Ambion) 
for 20min at 37°C.  40µg ProK was added to bead suspension and to inputs, and reactions 
were incubated at 65°C for the rest of the day, then NaCl was added to 200mM and tubes 
were incubated overnight at 65°C with intermittent agitation to reverse cross-links.  DNA 
was isolated using PCR clean up kit (Qiagen) and eluted from columns in 50µl dH20 and 
quantified by Nanodrop ND-1000 spectrophotometry.  Controls for X-ChIP experiments 
included a species matched IgG to control for background, negative and positive genomic 
regions to show specificity, and the use of input DNA to control for technical variations 
between cell lines or treatments.  Antibodies were tested by western blot for recognition of 
proteins of the expected size and by specific enrichment at positive control regions by X-
ChIP.  Enrichments were measured by qPCR (see 2.6.4). 
 
 2.6.3.  Methylated DNA immunoprecipitation (MeDIP) 
 
The following buffers are used during this protocol: Block solution (1x PBS, 0.5% BSA 
w/v), 10x IP buffer (100mM sodium phosphate pH7; 1.4M NaCl; 0.5% TritonX-100 v/v), 
ProK digestion buffer (50mM Tris pH8; 10mM EDTA; 0.5% SDS w/v).  20µg of genomic 
DNA (see 2.2.1) was diluted in 400µl TE and sonicated in 1.5ml eppendorf tubes using a 
'Bioruptor' water bath sonicator (Diagenode) for 6 cycles of 30sec on/off on the 'high' setting 
with a shallow volume of ice in the water bath to prevent overheating.  Ice was replaced 
regularly.  5µl was loaded on a 2% agarose gel containing ethidium bromide to check that 
the fragment size of each replicate was between 300 and 1000bp after sonication.  400ng of 
sonicated DNA is put aside as input.  4µg DNA is diluted in 450µl TE for each 
immunoprecipitation (IP) to be performed.  Sonicated DNA (including input) was denatured 
by heating to 100°C for 10min then quick chilling on ice, to facilitate recognition by 5-mC 
antibody.  51µl of 10x IP buffer was added along with 10µg  of antibody (mouse IgG, Santa 
Cruz, sc-2025; α-5mC, Eurogentec, #BI-MECY-1000) and tubes were rotated for 3hr at 4°C.  
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40µl of sheep α-mouse IgG-conjugated Dynabeads (M280, Invitrogen) per IP were washed 
twice in block solution then added to DNA-antibody mixture and tube were rotated for a 
further 2hr at 4°C.  Beads were washed 3 times with 1ml 1x IP buffer each for 10min at 
room temperature.  Beads were resuspended in 200µl ProK digestion buffer, 60µg ProK was 
added and tubes were incubated for >2hr at 56°C with intermittent agitation.  DNA from IPs 
and inputs was isolated using PCR clean up kit (Qiagen) and eluted in TE or dH20.  Controls 
used for MeDIP include a species matched IgG to control for background, positive and 
negative control regions, and the use of input DNA that has been treated the same way as IP 
DNA.  Enrichments were measured by qPCR (see 2.6.4) and/or microarray (see 2.7 and 2.8).  
 
2.6.4.  Quantitative polymerase chain reaction (qPCR) 
 
DNA and cDNA was quantified using quantitative real-time polymerase chain reaction 
(qPCR).  Reactions were performed in duplicate in white 96-well plates (Eurogentec) in 
either a CFX96 (BioRad) or LightCycler (Roche) and were 20µl in total composed of 10µl 
'2x Brilliant II qPCR master mix' (Agilent), 150nM each primer, DNA or cDNA template in 
MilliQ dH20.  Reactions were performed using the following program: 95°C for 5min, then 
cycles of 94°C for 15sec, 55°C for 20sec and 72°C for 20sec, followed by a melt curve 
ramping from 60-95°C.  Fluorescence signal of the SYBR green dye was measured after 
each cycle of PCR.  Primers for qPCR were designed using the 'Primer3' program 
(http://frodo.wi.mit.edu/primer3/) to produce primers with an annealing temperature of 55°C 
and a product size of <150bp.  For cDNA, primers were designed to span a large intron 
where possible to avoid genomic DNA contamination.  All primers used are shown in table 
2.1.  All primers were screened for poor efficiency and the formation of primer dimers or 
secondary bands by serial dilution and melt-curve analyses.  For analysis of cDNA, a 
standard curve was generated by 10-fold serial dilution of a cDNA sample from a tissue 
where the gene is suitably abundant.  This is also performed for a housekeeping gene, such 
as actb, to normalise for loading and overall efficiency of the cDNA synthesis reaction.  
When normalising to a loading control gene one must take into account its error in the 
calculation of relative quantities.  This was done by propagation of errors as described at 
"http://ion.chem.usu.edu/~sbialkow/Classes/3600/Overheads/Propagation/Prop.html".  This 
method allows for the relative quantity of cDNA species to be calculated between cell lines 
or treatments.  When analysing DNA in immunoprecipitation experiments, such as N-ChIP, 
X-ChIP and MeDIP, relative quantitation was also performed.  A standard curve was 
produced using 10-fold serial dilutions of the input DNA which itself is known to be 10% of 
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the material used for each IP.  In this way the amount of DNA template in each IP sample 
can be expressed relative to the amount in the input, controlling for overall variations in 
amount of material used in different treatments.  Where technical or biological replicates 
were performed, the qPCR error (error between the two qPCR replicates) was ignored and 
the standard error was calculated between the technical or biological replicates.  Where only 
one technical or biological replicate was performed the error is calculated as the qPCR error.  
Error bars denote the standard error of the mean (S.E.M) for each sample, propagated if 
necessary.   
    
Primer pair name Application Target Sequence (5'-3') 
RT_Hoxc4 cDNA - CTACCCTGAGCGTCAGTATAGC 
CGCAGAGCGACTGTGATTTCT 
RT_Hoxc5 cDNA - CATGAGCCACGAGACGGATG 
CGAGTGAGGTAGCGGTTAAAATG 
RT_Hoxc6 cDNA - AATTCCACCGCCTATGATCCA 
ACATTCTCCTGTGGCGAATAAAA 
RT_Hoxc8 cDNA - CTTCGTCAACCCCCTGTTTTC 
GTCTTGGACGTGGTGCGAG 
RT_Hoxc9 cDNA - ACTCGCTCATCTCTCACGACA 
AGGACGGAAAATCGCTACAGT 
RT_Hoxc10 cDNA - ATGACATGCCCTCGCAATGTA 
CCCCGCAGTTGAAGTCACTC 
RT_Hoxc11 cDNA - GAGAACACGAATCCCAGCTC 
CGGATCTGGAATTTCGAATAAG 
RT_Hoxc12 cDNA - ATGGGCGAGCATAATCTCCTG 
CGTGGGTAGGACAGCGAAG 
RT_Hoxc13 cDNA - TACCAGCACTGGGCTCTTTC 
CTCACTTCGGGCTGTAGAGG 
RT_Hoxa11 cDNA - TTTGATGAGCGTGGTCCCTG 
AGGAGTAGGAGTATGTCATTGGG 
RT_Hoxa13 cDNA - CTGCCCTACGGCTACTTCG 
CGGTGTCCATGTACTTGTCG 
RT_Hoxa10 cDNA - TAGAGGTTGAGATCTTTCTCAG 
TCCCTGATTAAACACAGCCCAG 
RT_Hoxb9 cDNA - AGGAAGCGAGGACAAAGAGAG 
CTTGTCTCTCACTCAGATTGA 
RT_Actin cDNA Actb AGAGCTATGAGCTGCCTGACG 
TGTGTTGGCATAGAGGTCTTTACG 
RT_Vax2 cDNA - AGTATGTGGTGGGCCGAGAG 
CTGGTCCTTCTTCTGCTTGG 
RT_Foxq1 cDNA - TTCGGAAAAGCGTCTCTCTC 
GAGGTCGTAGGAAGCGAGTG 
RT_Wnt10a cDNA - CCTCACAGAGACATCCATGC 
CCGTGGCATTTGCACTTAC 
RT_Hand2 cDNA - TCAAGGCGGAGATCAAGAAG 
TGGTTTTCTTGTCGTTGCTG 
RT_Tex19 cDNA Tex19.1 AAAATGGGCCACCCACATCTC 
CCACTGGCCCTTGGACCAGAC 
RT_Gapdh cDNA - ACCCAGAAGACTGTGGATGG 
GGTCCTCAGTGTAGCCCAAG 
ChIP_Hoxc4 DNA Promoter CATCGATCCGAAATTTCCTC 
TACAGCTCCTGGTGGTGATG 
ChIP_Hoxc5 DNA Promoter CGGCTTCCATCACTAACCTC 
ATGCGCTCTTCCCAAATAAG 
ChIP_Hoxc8 DNA Promoter CCTATTACGACTGCCGGTTC 
CGTGGTGGAAGAAGTCTTGG 
ChIP_Hoxc9 DNA Promoter TCAGTCTGGGCTCCAAAGTC 
AGAGGTAGCCTCCCCAGAAC 
ChIP_Hoxc10 DNA Promoter GCTAGGTGGCGCTGTTACTC 
CCAATGGGATTTGAAAATGG 
ChIP_Hoxc12 DNA Promoter AAATCTGTTCCTGCCTTTCG 
TCTACTCACGTGGGCGCTAC 
ChIP_Hoxc13 DNA Promoter AGACCCAGGCTTAGCATCAC 
TAAGAAATCCGGCGACTCC 
ChIP_Actin DNA Actb promoter GAATGTGGCTGCAAAGAGTCTAC 
CTTCGCTCTCTCGTGGCTAGTA 
ChIP_Cphx DNA Promoter AGATTGGGTGGGGTGCTTAG 
CCTCCAATCTCAGACCTTGC 
ChIP_Chdh DNA Promoter TCAGCTAAACGGATGGGAAC 
90
GGGCCATGTTGCTAGTGTTG 
ChIP_Sytl3 DNA Promoter CTGGGGAAATTTTGCTACCC 
TAAATGATGCATGGCTGCTG 
ChIP_Vax2 DNA Promoter CCTCCCCTTGTCTCTCTTCC 
CTGGGGTTCCAGGACTCTG 
ChIP_Tex19 DNA Promoter CGACTTTTCCAAACAAGATGTG 
AGTCACTCTGGCTCTGAAGG 
ChIP_Tbr1 DNA Promoter AGCTAACCAATGGCAAGAGC 
TTCCCTGGGAGAAGAGATTG 
ChIP_Gata6 DNA Promoter CCTTCCCATACACCACAACC 
CCCCTCCTTCCAAATTAAGC 
ChIP_Zic5 DNA Promoter AGCCTGAACCAGAGCCAATC 
ACATTTGAGCTGCACAGTGG 
ChIP_Hand2 DNA Promoter CTCGGCAATTAGCAACGTG 
CGCTCGGGTTAATATATGTCG 
ChIP_Wnt10a DNA Promoter TTCAACCAGGAGGGTGAGAG 
GGGTGCTTTGAGACATGACC 
ChIP_Pcdh18 DNA 









ChIP_Dazl DNA Promoter CCACCTTCGAGGTTTTACCA 
TCTCCCCACTTCTCTGTGCT 
ChIP_Gapdh_prom DNA Promoter TCCCTAGACCCGTACAGTGC 
CTCTGCTCCTCCCTGTTCC 
ChIP_Gapdh_exon DNA Exon CAGCTCTCCCCATACATACA 
CATTTCTTATCTTACCCTGCC 













DNA CTCF binding site (intergenic) GCGCTGTTGCTCAATGTTAG 
CAGGGCCTTTCTGACTGAAG 
cMyc - 5kb DNA 5kb upstream of c-Myc gene CAGGCAATGTAGGTTCTTGG 
CGATGTGATCCCTTCCCATA 
cMyc_5' DNA Promoter CAAGGAAGCATCTTCCCAGA 
TACTGGCCACAGAGACCACA 
Pax6_6a DNA 50kb upstream of Pax6 CCAGTGCTCTGGGCTACAAT 
AAGACGCCAGGAAGAGGATT 




BS Promoter TGAGGAGTGGTTTTAGAAATAA 
TAAAACCAAATATCCAACCA 




BS Proximal promoter GTTTTTTGTTGTTTTGGGAT 
CTATTCACTCTAAACAAACT 




BS Distal promoter TTATTAAAGAGATAGGGAAGAAG 
ATCCCAAAACAACAAAAAAC 
BS_Pcdhb18_CGI BS 











BS_Hoxc4 BS Promoter TATATGGTGAAAGTAATTTTATAGGGT 
AAAATAATCAAAAACTAACTAACTACAAAC 
BS_Hoxc4 (nested) BS Promoter ATTTTAGAAATTAATGATTATGAGTT 
TCAAAAACTAACTAACTACAAACTAAC 
BS_Hoxc9 BS Promoter GTTTGTTTGTTTGTTTGAGATTTT 
CCCAAAACCAAAATTACCCTATACT 
BS_Hoxc9 (nested) BS Promoter GATAATTTAGGTTGGGAGGGAGTAT 
CCCTATACTCTAATTCAATAACTCTAAAC 
BS_Hoxc10_intra BS CpG island 1st exon TTAAGGAGGAGAATGTTTGTTGTATG 
TTCAAAACCTTTAAATTCCTTAAACC 




BS_Hoxc11 BS Promoter TTTTTTTYGTTTTGTGGAATGGAG 
CAACTAAACAAATAAAAATTAAAAATAC 
BS_Hoxc11 (nested) BS Promoter TTTTGTGGAATGGAGAGGAGG 
TAAAAATTAAAAATACAACTCCCTC 
BS_Hoxc13 BS Promoter GTTTTTAAAAAGTTGGAGTAG 
TAACTACCCCCAAATAAATAAC 
BS_Hoxc13 (nested) BS Promoter AAGTTGGAGTAGATTATGTTATGA 
CAAATAAATAACCATAACCC 
BS_Hoxa10 BS Promoter GTGTAAATTAGAGTGGGTGGT 
CAAAACATCAAAAAAAAAAACT 
BS_Hoxa10 (nested) BS Promoter GTGGAGTTTAGGATTYGTTTTTTT 
CAAAAAAAAAAACTCCTACTACC 
BS_Hoxc4-up BS 















BS Intergenic GGGTGTTTTTTTATYGGATTTTT 
CATCTTTCTATCCAAATCTA 




BS Intergenic AGGAATTAAGGTTAGGAGAGA 
CATAAAAACRACAAACAAAAAAAC 




BS Intergenic GGGAAGAAGTTAAGATTTTTTTT 
CTACAAATAACATATCATACC 




BS Intergenic GAGTTGTTAGATTTTTGTGT 
CAAAACCTTCTCCCTATCTC 




BS Promoter TATAGGTTGATTTTTTAGTAAATAAG 
ACTAACATCTTTTTTCCCCCATC 




BS Intergenic AGAGTAAATTGTAATTTTGA 
CAAAACCACCAATTTACCCC 
Table 2.1 - Primer sequences.  cDNA: Primers used for expression analysis from cDNA.  
DNA: Primers used for DNA analysis including MeDIP, N-ChIP and X-ChIP.  BS: Primers used 
for bisulfite sequencing.  For bisulfite sequencing some primers contain mixed bases.  Y: 
Pyrimidine (C or T).  R: Purine (G or A). 
 
2.6.5.  Bisulfite sequencing 
 
500ng genomic DNA was bisulfite treated using 'EZ Methylation Gold' kit (Zymo research) 
according to the manufacturer’s instructions.  Bisulfite primers were designed using a 
combination of the 'Bisearch' algorithm (http://bisearch.enzim.hu/) and by eye approaches 
and primers were designed to have a C or G base at their 3' end where possible to facilitate 
priming (Table 2.1).  PCR amplification was performed in 20μl reactions as follows: 1x PCR 
buffer (Invitrogen), 2mM MgCl2, 0.5mM each dNTPs, 150nM each primer, 0.6 units Taq 
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polymerase (Invitrogen) and 1-2μl bisulfite treated DNA.  Reactions were incubated in a 
thermocycler at 94°C for 1 min followed by 35 cycles of 94°C for 10 sec, 50ºC for 35 sec 
and 72°C for 30 sec.  Reactions were then incubated for 72°C for 5 min.  A negative control 
reaction containing dH20 in place of bisulfite-converted DNA was used for each set of 
reactions.  PCR clean up of the first reaction was performed using 'Nucleospin Extract II' kit 
(Zymo research) according to manufacturer’s instructions and DNA was eluted in 15 µl 
water.  Nested PCR was performed as above using up to 10µl of eluted DNA from the first 
reaction and the products were resolved on a 1.5% agarose gel.  Gel extraction, cloning into 
pGEM T Easy vector, transformation into bacteria and blue/white screening was performed 
as described in sections 2.1 and 2.2.  Up to 24 individual white colonies were picked per 
reaction and grown overnight in 1ml LB broth supplemented with 50µg/ml ampicillin in 96-
well blocks.  Plasmid DNA was isolated by miniprep and sequenced using SP6 sequencing 
primer by robot (performed by HGU technical services).  Each sequence was imported into 
the 'BioEdit' program (http://www.mbio.ncsu.edu/bioedit/bioedit.html) and aligned to a 
reference sequence for the region, created by in silico bisulfite treatment, using the 
'ClustalW' inbuilt program.  The methylation status of each CpG dinucleotides from each 
bacterial clone was assessed by presence or absence of C to T conversion in te PCR product 
and visualised using 'QUMA' online program (Kumaki et al., 
2008)(http://quma.cdb.riken.jp/).  Quality control steps were performed, such as checking 
that >95% of C, in the non-CpG context, had been converted to T.  Care was taken to 
exclude any clonality in the sequences by looking for sequence variances in each clone, 
especially if their methylation pattern is identical.  This is possible as the C to T conversion 
rate of the bisulfite reaction is not 100% leaving remaining Cs at different locations.  Where 
an ambiguous base was called, the chromatogram was studied and the sequence edited if an 
obvious signal had been  missed.  The overall percentage CpG methylation was calculated 
for each region.  
 
2.6.6.  Immunofluorescence of fixed cells 
 
Mouse embryonic fibroblasts were seeded on gelatinised glass coverslips at a density of 
2*105 cells per well of a 6-well plate and cultured for 24hr.  Cells were washed twice in PBS 
then fixed in 4% formaldehyde (v/v in PBS)(Sigma) for 10min at room temperature with 
gentle rocking.  Cells were rinsed 3 times in PBS to remove formaldehyde and then 
permealised by adding 0.1% TritonX-100 (v/v in PBS)(Sigma) for 5min at room temperature 
followed by 2 rinses in PBS.  Coverslips were transferred to a humidified chamber and 100µl 
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of block solution (PBS; 0.5% BSA w/v; 0.1% Tween20 v/v (Sigma); 10% goat serum v/v) 
was added to cover the culture surface of the coverslips and then coverslips were incubated 
for 30min at room temperature.  Goat serum was added to the block solution as the 
secondary antibodies used were raised in goat, therefore minimising background signal 
produced by secondary antibody binding.  Primary antibodies (α-H3K27me3, Upstate, 07-
449; α-H3K4me3, Abcam, ab1012; α-Ezh2, Upstate, 17-662; α-Bmi1, Upstate, 05-637) were 
diluted 1:100 in block solution and 100µl was added to coverslips.  Thin, clean plastic strips 
were used to cover the coverslips to prevent them drying and coverslips were incubated 
overnight at 4°C.  Coverslips were washed 3 times for 5min in PBS with 0.1% Tween20 v/v 
(Sigma).  Secondary antibodies (Goat α-rabbit IgG-Alexafluor Red conjugate (Invitrogen); 
Goat α-mouse IgG-Alexafluor Green conjugate (Invitrogen)) were diluted 1:2000 in block 
solution with 2µg/ml DAPI (4',6-diamidino-2-phenylindole) and added to coverslips in the 
dark for 1hr at room temperature.  Coverslips were washed 3 times for 5min in PBS with 
0.1% Tween20 v/v (Sigma) protected from light.  Coverslips were mounted in 'Vectashield' 
mounting media (Vector Laboratories) with added 250ng/ml DAPI and viewed using 2 or 3 
colour fluorescence microscopy using defined exposure settings.  Fluorescence images were 
taken using a Hamamatsu Orca AG CCD camera (Hamamatsu Photonics), Zeiss Axioplan II 
fluorescence microscope with Plan-neofluar objectives and Chroma #83000 triple band pass 
filter set (Chroma Technology).  Images were captured using defined exposure settings to be 
directly comparable and fluorescence signal was quantified using 'IP Lab' software and 
normalised to DAPI signal. 
 
2.6.7.  Fluorescence in situ hybridisation (FISH) and interprobe distance 
measurement 
 
FISH was performed with a lot of help from Shelagh Boyle.  BAC clones that span the 
mouse HoxA cluster were obtained as bacterial stab cultures from 'BACPAC', which were 
cultured and the plasmid DNA was isolated as per section 2.1 (Clones IDs: WI1-2560F9 and 
WI1-2081I16).  The BACs were labeled with biotin-16-dUTP (Roche) or digoxigenen-11-
dUTP (Roche) by nick translation as follows: A 20µl reaction was set-up containing 50mM 
Tris pH7.5, 10mM MgSO4, 0.1mM DTT, 50µg/ml BSA fraction V (Sigma), 62.5µM each 
dATP, dCTP and dGTP, either 62.5µM bio-16-dUTP or 37.5µM digoxigenen-11-dUTP and 
25µM dTTP, 500-1000ng BAC, 1µl of 1:500 dilution of DNaseI (Invitrogen) and 1µl DNA 
polymeraseI (Invitrogen).  Reaction was incubated at 16°C for 90min then stopped by adding 
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SDS to 2% w/v and EDTA to 60µM and the DNA was purified using a 'QuickSpin' column 
(Pharmacia).  Labeling of BACs was checked using α-dig-alkaline phosphatase (AP) 
conjugated antibody and streptavidin-AP  and BCIP/NBT AP substrate kit (Vector 
laboratories) against standards.  Cell nuclei were prepared by cytoplasmic lysis in hypotonic 
solution (70mM KCl; 9.5mM trisodium citrate) for 10min at room temperature then fixed in 
3:1 methanol:acetic acid for 1hr at room temperature.  Fixed nuclei were dropped onto glass 
slides and aged for at least 24hr at room temperature.  20x SSC (saline-sodium citrate) buffer 
was prepared (3M NaCl; 300mM trisodium citrate; pH7 with HCl).  Per slide, 100ng each 
labeled BAC and 5ug sonicated salmon sperm DNA (Sigma) were consolidated and dried in 
a SpeedVac then resuspended in 15µl hybridisation mix (50% deionised formamide v/v 
(Sigma); 10% 20x SSC v/v; 10% dextran sulfate v/v (Millipore); 1% Tween20 (Sigma)).  
Slides were treated with 100µg/ml RNaseA in 2x SSC buffer at 37°C for 1hr then washed 
and dehydrated through 70%, 90% and 100% EtOH for 2min each.  Slides were warmed in a 
70°C oven for 5min, denatured in 70% formamide in 2x SSC buffer pH7.5 for 1-1.5min then 
transfer to ice cold 70% EtOH and dehydrated as before.  Probe and competitor DNA was 
denatured at 70°C for 5min then incubated at 37°C for 15min.  10µl was pipetted onto 
coverslips which were added to pre-warmed slides then sealed using TipTop Rubber solution 
(Rema) and incubated in a humidified chamber at 37°C overnight.  Slides were washed 4 
times for 3min in 2x SSC at 45°C then 4 times in 0.1x SSC at 60°C.  Slides were briefly 
blocked in 40µl blocking buffer (5% non-fat dried milk powder w/v (Marvel) in 4x SSC 
buffer) for 5min at room temperature then each antibody incubation was performed in 40µl 
block solution at 37°C in a humidified chamber.  Between antibody incubations slides were 
washed 3 times for 2min in 4x SSC with 0.1% Tween20 (Sigma) at 37°C.  After the final 
wash coverslips were mounted on slides using 25µl 'Vectashield' (Vector Laboratories) with 
250ng/ml DAPI.  Antibody incubations were performed in the following order with washes 
between them: Sheep α-digoxigenin-FITC (1:20)(Roche); both α-sheep IgG-FITC 
(1:100)(Vector Laboratories) and Avidin-TxRd (1:500) (Vector Laboratories); α-avidin-
biotin (1:100)(Vector Laboratories); Avidin-TxRd (1:500).  Three colour fluorescence 
images were taken using a Hamamatsu Orca AG CCD camera (Hamamatsu Photonics), 
Zeiss Axioplan II fluorescence microscope with Plan-neofluar objectives and Chroma 
#83000 triple band pass filter set (Chroma Technology).  Interprobe distance was measured 
in pixels using custom scripts written for 'IP Lab' software (written by Paul Perry), converted 
to µm and normalised to nuclear area as measured by DAPI signal.  Final values were 
expressed as d(interprobe distance in µm)2/r(nuclear radius in µm)2. 
  
95
2.7.  Nimblegen arrays 
 
Analyses by microarray for cDNA, N-ChIP and MeDIP were performed using Nimblegen 
arrays in house and by outsourcing to a service centre (Microarray Core Facility, VU 
University Medical Centre, Amsterdam).  Data analysis was performed in house (see section 
2.8).  
 
2.7.1.  Whole genome amplification 
 
Whole genome amplification of immunoprecipitated and input DNA was performed using 
'WGA2' kit (Sigma) with the following adaptations.  The initial 'fragmentation' step 
(fragmentation buffer was added but the critical heat step was not performed) was skipped as 
DNA was already fragmented by either Mnase digestion or sonication.  10ng of both input 
and immunoprecipitated DNA were used as template for amplification.  Following genome 
amplification, qPCR analysis was performed on a handful of control loci where the 
enrichments were known and compared to pre-amplification DNA to check for amplification 
biases.  No major differences were observed (data not shown). 
 
2.7.2.  Labelling, hybridisation and scanning 
 
All sample preparations and quality control steps were performed as per Nimblegen guides 
for single-colour cDNA arrays and two-colour arrays.  For MeDIP, the Nimblegen ChIP-
chip guide was followed.  All experiments were performed in triplicate.  For 
immunoprecipitation techniques, input DNA was arrayed along with enriched DNA by 
labelling them with two independent dyes, Cy3 and Cy5.  Input DNA was used as appose to 
IgG or any other 'mock' IP as these techniques rely on very small quantities of DNA which 
may result in more noise, although the choice between input and mock is contentious.  
Briefly, for cDNA array, double-stranded cDNA was synthesised using oligo-dT primers 
(using 'Double-stranded cDNA synthesis kit' - Invitrogen) according to manufacturer's 
instructions.  Double-stranded cDNA was run on a Bioanalyser RNA1000 chip to check size 
and integrity of components (Agilent).  Double-stranded cDNA was labelled with Cy3 
nonamers using 'Single Colour Labelling kit' (Nimblegen) and hybridised to custom-
designed arrays (Nimblegen).  As each slide contains three arrays the treatments were 
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distributed over the two slides (i.e. array 1 = two replicates of treatment 1 and one replicate 
of treatment 2) to minimise systematic variation.  Amplified N-ChIP (H3K36me3 N-ChIP) 
and MeDIP samples were labelled with Cy5 or Cy3 nonamers using 'Two colour labelling 
kit' (Nimblegen).  One of the three replicates included a dye swap to minimise variation 
introduced by dye biases.  Labelled input and IP samples were consolidated and hybridised 
to custom-designed arrays (Nimblegen).  For H3K27me3 and H3K4me3 N-ChIP DNA, 
samples were amplified using WGA2 (Sigma) and sent to B. Ylstra at the microarray facility 
of the VU University Medical Centre/ Cancer Centre Amsterdam for labelling, hybridisation 
and scanning of arrays.  The microarrays used are detailed in table 2.2.  Details of the tiled 
regions covered on the custom tiling array are provided in appendix 1.  Microarrays were 
washed using 'Microarray Wash kit' (Nimblegen) and scanned using an MS200 scanner 
(Nimblegen) according to the manufacturer's instructions.  Array images were processed and 
data was outputted using 'Nimblescan' software (Nimblegen).  
 






3 arrays on one 
slide; 
720K probes each 
array 
 
20,404 RefSeq promoters; 
-3200bp to +800bp relative to 
TSS on average 
 
Median probe spacing = 100bp; 
Probe length = 50-75mer; Build = 
MM9 
Custom tiling array 
("Hox-plus")(Designed 
by Wendy Bickmore's 
lab) 
HX3; 
3 arrays on one 
slide; 
720K probes each 
array 
80 tiled regions; 556 gene 
promoters; includes all 4 
extended Hox clusters; enriched 
for developmental genes and PcG 
targets (see appendix 1 for 
details) 
Tiled (overlapping) probe layout for 
high resolution; 4 replicates of each 
probe on each array for robust 
measurements; Probe length = 50-
75mer; Build = MM9 
Table 2.2 - Nimblegen microarrays used for this project 
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2.8.  Bioinformatic analyses and data processing 
 
In general, the R language (http://www.r-project.org/)(version 2.12.1) and added packages 
were used for most methods in this section. 
 
2.8.1.  Data acquisition 
 
In general data from published work was acquired through the Gene Expression Omnibus 
(GEO)(http://www.ncbi.nlm.nih.gov/geo/) or directly from supplementary data.  
Dnmt1+/+/Dnmt1-/- MEF and Dnmt1+/+ + 5-aza dC gene expression microarray data was 
inherited from a previous PhD student in the lab, Jamie Hackett.  This data was generated 
using 'MouseWG-6 v2.0 BeadChip' array (Illumina) and had been processed and normalised 
by J. Hackett (Hackett et al., in submission).  Promoter DNA methylation data from MEFs 
was downloaded as a supplementary file with Meissner et al., (2008) and was generated 
using reduced representation bisulfite sequencing.  Promoter K4me3/K27me3 and CpG 
density was downloaded as a supplementary file with Mikkelsen et al., (2007), histone marks 
were defined using ChIP-seq and promoter CpG density was defined according to Weber et 
al., (2007).  This gene level data was integrated with my data by merging on official gene 
symbol.      
 
2.8.2.  Statistical tests and plots 
 
Fisher's exact and Chi-squared tests were used to assess distribution of samples among 
categories where there are two categories and >2 caetgores respectively, and were both 
performed using 'GraphPad Quick Calcs' (http://www.graphpad.com/quickcalcs/index.cfm).  
Mann-Whitney-U (MWU) test (also known as Wilcoxon-Rank-Sum test) is a non-parametric 
test that was used to test if two independent samples are equally large, and was performed 
using R.  MWU test was used where sample size was sufficiently large and a normal 
distribution of samples could not be assumed.  For small numbers of samples or where 
normality could be assumed a two-tailed Student's T-test was performed to test if 
independent samples are equally large.  When assessing the correlation between two sets of 
paired samples a Pearson correlation test was performed using R or only the R-value 
(Pearson correlation co-efficient) or R2-value was calculated.  For calculating the probability 
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that a single value is part of a defined normal distribution the pnorm function in R was used.  
Gene ontology (GO) analysis was performed using 'Babelomics 4.2' 
(http://babelomics.bioinfo.cipf.es/), specifically the 'FATIGO' program.  This program 
performs a two-tailed Fisher's exact test on the GO terms from two lists of genes that are 
provided by the user.  As multiple hypotheses are questioned, the p-value is corrected by the 
false discovery rate (FDR) procedure of Benjamini and Hochberg.  Bar and line charts were 
drawn in R and Microsoft Excel with error bars representing standard error of the mean.  Bar 
plots showing microarray data at the probe level were generated in the UCSC browser 
(http://genome.ucsc.edu/).  Scatter plots were drawn in R and Microsoft Excel.  Boxplots 
were drawn in R using the default settings for whisker length and box height: Box vertical 
extremities represent upper and lower quartiles so the height of the box is the inter-quartile 
range (IQR).  Black line within the box is the median.  Upper and lower whiskers are defined 
as the upper quartile plus 1.5 times the IQR and lower quartile minus 1.5 times IQR 
respectively (default method).  The whiskers were set as the sample maximum and minimum 
if these values are smaller or larger, respectively, than the values calculated using the default 
method above.  Points that lie outside of the whiskers (outliers) were not plotted.  Heatmaps 
were 'manually' drawn in R using the image function.  For clustering of genes in R, the 
Euclidean distance between all genes was calculated and hierarchical clustering was 
performed using the 'Ward' method.       
 
2.8.3.  Genome annotations and annotation of microarray probes 
 
Genome annotations were all derived from the Mus musculus (mm9) build (UCSC).  The 
locations of genes, gene clusters, exons, introns and transcription start sites were all taken or 
derived from the 'RefGene_mm9' table downloaded from the UCSC browser.  The locations 
of two types of CpG islands were annotated.  One type is the CpG islands defined by the 
UCSC browser by sequence characteristics and these were defined based on a download 
from the UCSC browser.  The other was experimentally determined in Illingworth et al., 
(2008) and was derived from a supplementary file of the publication.  Genes were deemed to 
be in 'tandem' if they appear next to each other in the 'RefGene_mm9' table and are on the 
same chromosome.  Microarray probes were annotated based on their overlap with genomic 
features.  A probe that shows any overlap with any part of a feature was annotated with that 
feature.  For example, genic probes were defined as overlapping any transcript in the 
'RefGene_mm9' table and the rest of the probes were annotated as 'intergenic'.  The 
transcriptionally 'active' and 'inactive' portions of the Hox clusters were determined 
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arbitrarily based on cDNA array data.  Promoter-associated probes on the Hox-plus custom 
tiled array were defined by any overlap with a tiled region covered by the promoter array and 
not overlapping a transcription start site or gene.  This left probes that were up to 3.5kb 
upstream of a gene but were not overlapping the gene body.     
 
2.8.4.  cDNA tiled microarray data processing and analysis 
 
Data from the six arrays for cDNA (three replicates of each treatment) were normalised 
using the Robust Multichip Average (RMA) method (Bolstad et al., 2003) within 
'Nimblescan' software (Nimblegen).  RMA is commonly used for normalisation of 
expression arrays and works by subtracting background then adjusting the scale of data by 
quantile normalisation, manipulating the distribution of the data so that the quantiles match 
between samples (Bolstad et al., 2003).  This reduces systematic variation introduced by 
using multiple arrays.  Subsequent data analysis was performed using R.  As the Hox-plus 
custom arrays contain four copies of each probe, the mean of probe replicates was calculated 
and used in subsequent analyses.  To define probes that have significantly higher or lower 
signals between treatments a two-tailed Student's T-test was performed for every probe 
between the treatments.  Probes that have a p<0.05 and are in groups of three consecutive 
probes with p<0.05 were defined as different.  This spatial method was preferred to a 
multiple testing approach for p-value correction as it will remove spurious signals produced 
by single probes, an important factor when considering data from tiled probes.  Also, as a 
large number of hypotheses were tested, multiple testing correction may result in a lower 
number of probes making a certain cut-off.  The false discovery rate (FDR) of the 3 
consecutive probe method was estimated by permutation of sample replicates.  The estimated 
FDR before the 3 consecutive probe method was very high at 46.5% but was reduced to 
0.5% following application of the method, suggesting that it is reliable.  For visual 
representation of cDNA array data the mean value for each probe was calculated for the 
three technical replicates.  To reduce noise in the visual representations, the values were 
smoothed by taking the median of the signal from 5 probes and applying it to the central 
probe using a sliding window (zoo package in R).  These probe values were visualised in the 




2.8.5.  Two colour microarray data processing and analysis 
 
Processing of two-colour microarray data was performed in R using modified scripts that 
were originally written by Tobias Straub (LMU, Munich) for analysis of protein-DNA 
interactions by ChIP-chip (downloaded from http://genome1.bio.med.uni-
muenchen.de/downloads.htm).  Data processing included quality control, intra-array 
normalisation and inter-array normalisation.  The first step was quality control.  For arrays 
  
 
Figure 2.1 - Correlations between array signals.  Scatter plots (upper right) and Pearson 
correlation co-efficients (lower left) were produced for all array signals.  Note good 
correlations within input samples and enrichment samples but not between them.  Data 
here is from MeDIP experiment and is used as an example although all two-colour arrays 
performed produced similar relationships.  
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scanned in-house, the array images were checked for artefacts such as scratches and 
hybridisation artefacts.  For arrays performed by the service centre, array images were 
recreated from the data files using R to check for artefacts.  Correlations between array 
signals between replicates were measured by scatter plot (Fig. 2.1).  This is an important step 
for two reasons.  Firstly, it is important to establish that the raw data is of good quality as no 
normalisation can account for unsatisfactory raw data.  'Good quality' data entails a good 
linear correlation between replicate input signals and between replicate enrichment signals 
but less dependence between input and enrichment values.  Secondly, the relationship 
between replicates is important for deciding which type of normalisation to apply (see 'inter-
array normalisation' below).  
  
 
Figure 2.2 - Data before and after intra-array normalisation by lowess.  MA-plots show the 
dependence of log2(IP/INP) signal on overall signal strength.  M = log2(IP/INP), A = mean of 
IP and INP.  Red line is fit by loess.  Data here is from MeDIP experiment and is used as an 
example although all two-colour arrays performed produced similar relationships.   
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 The first normalisation that was applied is to calculate the log2 ratio of 
enrichment/immunoprecipitated signal (IP) and input signal (INP)(log2(IP/INP)) and to scale 
these values around 0.  This controls for many variables such as copy number variation.  
Next, intra-array normalisation was performed to correct for differences in kinetics of the 
two dyes used.  MA-plots can be used to check for dependence of the log2(IP/INP) signal on 
overall signal strength, a signature of dye bias (Fig. 2.2).  Dye bias is often observed with 
two-colour arrays (Choi and Do, 2006) and this was the case for my data, as indicated by a 
positive relationship on the MA-plots (Fig. 2.2 upper panels).  The relationship displayed on 
the plot for replicate 3, which was a dye swap, is different from the others further supporting 
the notion that dye bias causes this effect.  Locally weighted scatter plot smoothing (lowess) 
is a standard method used to correct for dependence of M on A (Cleveland, 1979; Choi and 
Do, 2006).  This method was applied to the data using the limma package in R, producing a 
much reduced dependence (Fig. 2.2 lower panels). 
 The final normalisation step was inter-array normalisation which reduces systematic 
variation caused by, for example, the use of multiple microarray slides or the effect of 
performing experiments at different times.  As the replicate signals are well correlated 
throughout their distribution (assessed by the straight lines produced in Fig. 2.1 across the 
entire range) scale normalisation can be used for this step (Choi and Do, 2006).  Scale 
normalisation acts to adjust the distribution of samples so that they align with each other 
(Fig. 2.3).  Scale normalisation was performed using the limma package in R.  Figure 2.3 
shows that the overall signal strengths can differ between replicates and that this can be 
corrected using scale normalisation.   
 
 
Figure 2.3 - Data before and after 
inter-array normalisation.  
Boxplots of the log2 transformed 
signal intensities are shown for 
each replicate.  Note that after 
normalisation the medians of each 
sample are aligned.  Data here is 
from MeDIP experiment and is 
used as an example although all 
two-colour arrays performed 
produced similar relationships.  
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 For visualisation of data the mean of the three replicates was calculated from the 
normalised data and visualised in the UCSC browser.  For visualisation of MeDIP data, a 
smoothing sliding window approach was used to find the median of 9 consecutive probes 
and apply it to the central probe using the zoo function in R.  For H3K27me3 and H3K4me3 
promoter N-ChIP, data was analysed at the promoter level.  For this, the normalised mean 
probe signal (log2(IP/INP)) within the entire promoter tiled region for each gene was 
calculated and the difference between treatments was computed.  The distribution of these 
difference values for every promoter region was plotted and, as the number of promoters that 
were different between treatments was large, arbitrary cut-offs were used.  The upper and 
lower cut-offs were defined as the median plus or minus 4 times the median absolute 
deviation (MAD) respectively.   
 For H3K36me3 data, as the Hox-plus tiling arrays contain 4 replicates for each 
probe, the mean was calculated.  For defining probes that show significantly different 
H3K36me3 signals between treatments a two-tailed Student's T-test was applied for each 
probe.  Significantly different probes were defined as having p<0.05 and being in a group of 
3 consecutive probes each with p<0.05.  This was performed to reduce noise introduced by 
spurious signals of single probes.  An estimation of the FDR for this method by permutation 
was 0.4%.                
 
2.8.6.  HELP-tag-seq data processing and analysis 
 
HpaII tiny fragment Enrichment by Ligation-mediated PCR assay coupled with tag 
sequencing (HELP-tag-seq) was performed by the lab of J.M.Greally as part of a 
collaboration (Khulan et al., 2006; Oda et al., 2009; Suzuki et al., 2010).  This form of the 
assay is still in development so the data processing steps that I performed are detailed here. 
 During the previous generations of the HELP protocol genomic DNA is subjected to 
parallel digests with the isoschizomers MspI (non methyl-sensitive) and HpaII (methyl-
sensitive), the fragments are size fractionated, and the products are analysed by microarray 
or sequencing (Khulan et al., 2006; Oda et al., 2009).  This lead to the requirement for two 
HpaII cuts within a certain distance from each other for a site to be represented in the HpaII 
library.  The MspI digest controls for biases that can arise in PCR amplification or 
sequencing (Oda et al., 2009; Suzuki et al., 2010).  In this latest generation of the assay, 
HELP-tag-seq, a first adaptor is ligated to both ends of each fragment which contains an 
EcoP15l restriction site.  This enzyme cuts in the flanking sequence allowing a defined 
sequence 'tag' to be generated for each MspI/HpaII cut, meaning that no size fractionation is 
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performed (Suzuki et al., 2010).  This method was performed on Dnmt1+/+ MEF genomic 
DNA and the 'tags' were Illumina sequenced and mapped back to the genome by the lab of 
J.Greally.  The number of HpaII reads relative to the number of MspI reads provides a 
measure of 5mC (and technically 5hmC) against unmodified cytosine at each CCGG site 
analysed.  The relationship between HpaII tags and MspI tags was measured by the angle 
produced between the x-axis and a straight line formed by connecting the graph origin to the 
point produced by plotting the number of MspI reads against the number of HpaII reads for a 
given CCGG site (Fig. 2.4-left)(as suggested by Suzuki et al., 2010).  The angle gives an 
inverse measure of methylation as methylated sites would have less HpaII reads relative to 
MspI reads and hence a low angle.  The length of the line, 'C', formed between the point and 
the origin gives an indication of the overall number of reads for that CCGG site and hence 
can be used to score confidence of a particular angle (Fig. 2.4-left).  I examined the effect of 
increasing the cut-off for 'C' (confidence threshold) on the number of CCGG sites that can be 
analysed (Fig. 2.4-right).  At this sequencing depth, using any cut-off showed a strong effect 






Figure 2.4 - Data processing for HELP-seq.  (Left) The method used to measure relationship 
between MspI reads and HpaII reads.  For each CCGG site the number of HpaII reads is 
plotted against the number of MspI reads and the angle a is calculated.  The length of line C 
is calculated and represents a measure of sequence depth and hence confidence.  (Right) 
The number of CCGG sites remaining at each cut-off of confidence level (C). 
 
 One might expect that at some sites where only a small number of reads were 
mapped that an artificially low angle would be observed due to the potential of HpaII reads 
representing a large proportion of total reads.  For example, a site with only 1 sequence read 
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in the HpaII library and none in the MspI library will give a angle of 0 (100% methylation).  
This possibility was examined by plotting the number of high-angle (>70°, low methylation) 
and low-angle (<20°, high methylation) CCGG sites with increasing cut-offs for 'C' (Fig. 
2.5).  While the high-angle (low methylation) sites showed a steady decrease in number as 
'C' was increased, the number of low-angle (high methylation) sites decreased rapidly at low 
cut-offs for 'C' suggesting that the prediction is true (Fig. 2.5).  For this reason, the cut-off 
for 'C' was set at 10 to remove the large number of 'false' methylated sites while maintaining 
a maximum possible number of sites.  As CCGG sites are enriched in CpG islands and CpG-
rich regions of the genome, we would expect the majority of sites to be hypomethylated, and 
indeed this has been observed in previous studies (Brunner et al., 2009).  Using a cut-off of 
C=10 produces the expected bias towards hypomethylated sequences (Fig. 2.5).    
 
 
Figure 2.5 - The effect of 
increasing confidence thresholds 
on the number of high-methylated 
and low-methylated sites.  The 
number of CCGG sites remaining 
at increasing cut-offs of 
confidence (C) for high-methylated 
(angle<20) and low-methylated 
(angle>70) CCGG sites.   
 
 The range of the angle values for all CCGG sites was stretched from 90 (0 - 90) to 
be a more intuitive 100 (0 - 100) giving an 'adjusted angle' (performed by J.M.Greally lab).  I 
assigned a 'methylation score' (from 0-100) to each CCGG site by subtracting the 'adjusted 
angle' from 100 to make interpretation more intuitive.  CCGG sites were annotated in the 
same way as microarray probes (described in section 2.8.3).  CCGG sites were annotated as 
within a promoter if they were within -1000 and +500bp of a transcription start site in the 
'RefGene_mm9' table (UCSC).  Promoter level methylation was calculated by taking the 
mean and standard deviation of the methylation score of CCGG sites within promoter 
regions.  Standard deviation between sites within a promoter region was generally low (data 
not shown) so promoters that contain only one CCGG site measured were included in 
promoter analyses.    
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 As this assay is in development I felt it important to validate the results.  I performed 
bisulfite sequencing on 16 CCGG sites in Dnmt1+/+ MEF DNA from a range of methylation 
levels and compared the results to those achieved with HELP-tag-seq (Fig. 2.6).  Although 
there was a clear correlation between the two methods they showed considerable variation, 
as indicated by an R2 value of 0.24 (Fig. 2.6).  The source of this variation is unclear.  
Approximately 18 sequences were analysed for each CCGG for bisulfite sequencing, 
meaning that some variation may arise here.  Similar correlations were observed in published 
validations of HELP based methods with bisulfite sequencing (Thompson et al., 2008; 
Brunner et al., 2009; Suzuki et al., 2010).  A particularly poor correlation was observed 
between HELP-tag-seq data and both bisulfite conversion-based Illumina Infinium array and 
methyl-DNA immunoprecipitation data (Brunner et al., 2009).  It is currently unclear from 
where this variation arises.  Considerable variation has been observed between technical 
replicates indicating that experimental noise may contribute to variability for this assay (Ball 
et al., 2009).  It is suggested that CCGG sites with low DNA methylation levels show greater 
noise using this assay (Ball et al., 2009).  One possibility is that decreased noise could be 
achieved with increased sequence depth, although this remains to be tested (Ball et al., 
2009).  In conclusion, HELP-tag-seq data, at the sequence depth achieved here, should be 
interpreted with caution and, where possible, important data should be validated using an 
independent method.    
 
 
Figure 2.6 - Comparison of 
HELP-tag-seq and bisulfite 
sequencing at individual CCGG 
sites. Correlation is assessed 
by Pearson's R2 value. 
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Chapter 3 - Derepression and loss of H3K27me3 at PcG 
target genes in DNA hypomethylated somatic cells 
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3.1.  Introduction 
 
It is widely accepted that DNA methylation affects transcription, but, how it does so is less 
clear.  I first set out to investigate the pattern of gene mis-expression in experimentally 
hypomethylated cells, with the long-term aim of finding evidence for non-canonical 
functions of DNA methylation in gene regulation.  A large number of genes are reportedly 
mis-expressed in mouse tissues and cell lines with mutations in DNA methyltransferases, 
suggesting that DNA methylation is an integral component of gene regulation in mammals 
(Jackson-Grusby et al., 2001; Lande-Diner et al., 2007; Fouse et al., 2008; Sen et al., 2010).  
An extensive cross-talk between DNA methylation and other epigenetic systems is emerging 
implicating DNA methylation in additional levels of chromatin organisation (Zemach et al., 
2010; Bartke et al., 2010).  Also, non-promoter functions of DNA methylation in gene 
regulation have been postulated suggesting that this epigenetic mark is more than the 
occasional repressor of gene promoters.  These include a conserved but unknown function of 
DNA methylation at gene bodies and a putative interaction with the polycomb system of 
gene repression (Lister et al., 2009; Wu et al., 2010).  The links with the PcG proteins are 
particularly interesting from a gene regulation standpoint as these proteins are thought to 
have a major role in shaping gene expression patterns.  Therefore, in this chapter I focussed 
initially on the emerging link between DNA methylation and PcG repression.  During the 
course of this chapter I uncovered an unexpected relationship between DNA methylation and 
PcG repression at classic polycomb targets the Hox genes. 
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3.2.  Results 
 
 
3.2.1.  Dnmt1-/- MEFs are severely DNA hypomethylated 
  
In order to study the role of DNA methylation on gene regulation and chromatin structure I 
required an appropriate experimental system.  I chose to study mouse embryonic fibroblasts 
(MEFs) that are homozygous for a mutation in Dnmt1, the gene encoding the major 
maintenance DNA methyltransferase (Lande-Diner et al., 2007).  This mutation (Dnmt1n/n) 
was introduced by targeted recombination by Li et al. (1992) and was designed to ablate 
Dnmt1 coding potential.  In fact this mutation appears to allow expression of a truncated 
form of Dnmt1 protein, albeit at greatly reduced levels, so is likely a severe hypomorphic 
allele (Li et al., 1992).  This mutation is embryonic lethal when homozygous at around 
11dpc and viable MEFs cannot be generated (Li et al., 1992; Lande-Diner et al., 2007).  This 
allele has been previously combined with homozygosity for a null allele of Trp53 (Trp53-/-), 
encoding the p53 protein, which allowed for the derivation of viable MEFs, probably due to 
suppression of apoptosis (Jackson-Grusby et al., 2001; Lande-Diner et al., 2007).  Trp53-/-, 
Dnmt1n/n MEFs are therefore compared to Trp53-/-, Dnmt1+/+ sibling matched mouse 
embryonic fibroblast cells as control (Lande-Diner et al., 2007).  For brevity, the genotype of 
these cell lines will be referred to as Dnmt1+/+ (Trp53-/-, Dnmt1+/+) and Dnmt1-/- (Trp53-/-, 
Dnmt1n/n) herein.  There are a number of advantages to studying these cells.  They have been 
suggested to exhibit severe DNA hypomethylation yet are viable in culture (Lande-Diner et 
al., 2007; Hackett, 2010, PhD thesis).  To my knowledge they represent the only long term 
viable somatic cells with a severe mutation in Dnmt1.  Mouse ES cells are of course viable in 
the undifferentiated state lacking detectable DNA methylation, but initiate apoptosis upon 
differentiation (Jackson et al., 2004).  Importantly, despite Trp53 mutation these cells are 
thought to be non-transformed as they do not grow in three dimensional culture in matrigel 
(Hackett, 2010, PhD thesis).  These cells therefore represent a valuable model to study the 
role of DNA methylation in somatic cells as they are severely hypomethylated, non-
transformed and viable in culture (Lande-Diner et al., 2007; Hackett, 2010, PhD thesis).  
Despite the advantages, I was also aware of the disadvantages of this cell line system, 
including the potential variation introduced by the heterogeneity of MEFs.  Therefore, I 
decided to supplement studies using these cells with use of a small molecule inhibitor of 
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DNMTs on cultured cells, and also by studying mouse embryos with Dnmt1 mutation 
(Chong et al., 2007).  These experiments will be described later in the chapter. 
 I began by confirming that Dnmt1-/- MEFs are indeed DNA hypomethylated 
compared to controls.  Firstly I performed methylation-sensitive restriction digest on 
genomic DNA isolated from these cells along with DNA from Dnmt1+/+ MEFs and primary 
wildtype MEFs (Fig. 3.1A).  Increased smearing and the appearance of smaller molecular 
weight fragments was observed for Dnmt1-/- MEF DNA using methylation sensitive 
endonucleases HpaII and HpyCH4IV, indicating hypomethylation at CCGG and ACGT sites 
(Fig. 3.1A).  The appearance of low molecular weight fragments (marked by arrows) in 
HpyCH4IV digest of Dnmt1-/- MEF DNA is consistent with hypomethylation of gamma 
satellite DNA (Fig. 3.1A; Abdurashitov et al., 2009).  HpaII digested DNA from Dnmt1-/- 
MEFs produced a similar pattern to that digested with its methylation insensitive 
isoschizomer, MspI, suggesting severe hypomethylation at these sites.  To quantify 
hypomethylation at certain loci I performed bisulfite sequencing for the promoter regions of 
Pou5f1, Tex19.1 and Tex19.2 which have been shown to be highly methylated in somatic 
tissues (Hackett, 2010, PhD thesis).  All three of these loci showed greater than 60% less 
CpG methylation in Dnmt1-/- MEFs relative to controls (Fig. 3.1B to D).  By restriction 
digest and bisulfite sequencing of selected loci, Dnmt1+/+ MEFs and primary WT MEFs 
showed no gross difference in DNA methylation status indicating that Trp53 mutation does 
not cause widespread changes in DNA methylation (Fig. 3.1A to D).  Together, these data 
suggest that Dnmt1-/- MEFs are severely DNA hypomethylated, at least at the loci and sites 
assessed here, and therefore provide an adequate resource for studies of the roles of DNA 
methylation.        
 
3.2.2.  Many genes upregulated in experimentally hypomethylated cells are PcG 
targets 
 
I reasoned that studying the characteristics of genes that are upregulated in DNA 
hypomethylated cells may help to elucidate the mechanisms by which DNA methylation 
facilitates transcriptional repression.  I was particularly interested in the histone 
modifications that these genes are associated with as I postulated that it may be possible to 
uncover novel links between DNA methylation and chromatin structure using this approach.  
My starting point was expression microarray data for Dnmt1+/+ and Dnmt1-/- MEFs that I 
inherited from J.Hackett, a previous PhD student in the lab.  He used these cells, among 
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Figure 3.1 - Dnmt1-/- mouse embryonic fibroblasts are severely DNA 
hypomethylated
A.  Digest of genomic DNA from wildtype primary mouse embryonic fibroblasts (WT MEF), 
Dnmt1+/+ and Dnmt1-/- MEFs with restriction endonucleases. MspI and HpaII are isoschizomers that 
cut at CCGG with HpaII being inhibited by CpG methylation and MspI not. HpyCH4IV cuts at ACGT 
and is blocked by CpG methylation. The presence of low molecular weight DNA for Dnmt1-/- MEFs is 
indicative of hypomethylation at these sites. Arrows mark the position of low molecular weight bands 
visible in HpyCH4IV digest of Dnmt1-/- MEF DNA indicative of hypomethylation at gamma-satellite 
DNA (Abdurashitov et al., 2009).  B to D.  Bisulfite sequencing for gene promoter regions that are 
thought to be highly DNA methylated in somatic tissues. Filled circles represent methylated CpGs 
while unfilled circles represent unmethylated CpGs. The location of each region in relation to the 















































































other experimentally hypomethylated cells, to identify genes that are expressed in the 
germline that utilise promoter DNA methylation for repression in somatic lineages (Hackett 
et al., in submission).  I confirmed that one such gene, Tex19.1, is de-repressed in Dnmt1-/- 
MEFs by RT-PCR, serving as a positive control (Fig. 3.2A).  In total, 779 genes were 
identified as being >2-fold upregulated in Dnmt1-/- relative to Dnmt1+/+ MEFs (Fig. 3.2B).  
This list contained many germline expressed genes, genes on the X chromosome and 
imprinted genes consistent with current knowledge (Li et al., 1993; Jackson-Grusby et al., 
2001; Lande-Diner et al., 2007; Borgel et al., 2010; Velasco et al., 2010).  I noticed that 
among the upregulated genes were multiple genes from the Hox clusters and other classic 
targets of the polycomb repression system that are normally marked by the PRC2-associated 
K27me3 histone mark in a variety of tissues, including MEFs (Mikkelsen et al., 2007).  In 
order to characterise this observation in more detail, I used published K27me3 ChIP-seq 
mapping data from Mikkelsen et al. (2007) to ask how many of the upregulated genes are 
normally K27me3 marked in MEFs.  I found that 157 of the 779 (about 20%) upregulated 
genes are K27me3 marked at their promoter regions in MEFs according to Mikkelsen et al. 
(2007)(Fig. 3.2B).  This represents a modest but highly statistically significant enrichment 
over what would be expected by chance as <15% of all genes are marked by K27me3 in 
MEFs according to this study (p<0.0001, Fisher's exact, Fig. 3.2C).  This observation was 
initially puzzling as dense DNA methylation and the PcG-mediated K27me3 mark have been 
suggested to be exclusive modifications (Lister et al., 2009; Hawkins et al., 2010; Lindroth 
et al., 2008).  In order to assess the promoter DNA methylation level of these genes I 
obtained published promoter DNA methylation data for MEFs that was generated by reduced 
representation bisulfite sequencing from Meissner et al. (2008).  Taking the genes that 
overlap between the three datasets I plotted a heatmap of relative expression in Dnmt1-/- 
MEFs, promoter DNA methylation and K27me3 status of genes that are >2-fold upregulated 
in Dnmt1-/- MEFs (Fig. 3.2D).  This plot showed that the following is true for these 
overlapped genes:  1) Only a small proportion have high levels of promoter DNA 
methylation in MEFs according to Meissner et al. (2008).  Consistent with previous 
observations regarding dense CpG methylation and the K27me3 mark, these genes are not 
marked by K27me3 (indicated on Fig. 3.2D).  2) There is no obvious correlation between 
promoter DNA methylation level and relative expression in Dnmt1-/- MEFs.  3) Many of 
these genes do not have high promoter DNA methylation and instead are marked by the 
PRC2-associated K27me3 mark in MEFs (Fig. 3.2D).  This indicates that many genes 
upregulated in Dnmt1-/- MEFs are not 'canonical' DNA methylation regulated genes but may 
be targets of the PcG proteins.  As one would expect many secondary gene expression 
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Figure 3.2 - Many genes upregulated in hypomethylated MEFs are 
marked by K27me3
A.  RT-PCR showing de-repression of the Tex19.1 gene in Dnmt1-/- MEFs.  This gene was used as a 
positive control as it is suggested to require promoter DNA methylation for repression in somatic cells 
(Hackett et al., in submission).  B.  Many genes that are >2-fold upregulated in Dnmt1-/- MEFs are 
marked by promoter K27me3 in MEFs.  C.  Proportion of upregulated genes, and all genes, that are 
marked by K27me3 in MEFs. * p<0.0001, Fisher’s exact.  D.  Heatmap showing relative expression as 
determined by microarray (left panel), promoter DNA methylation in MEFs (middle panel) and 
promoter K27me3 status in MEFs (right panel) of genes upregulated > 2-fold in Dnmt1-/- MEFs. Genes 
(rows) are ordered by promoter DNA methylation.  E.  Boxplot showing the relative expression of genes 
that are both >2-fold upregulated in Dnmt1-/- MEFs and marked by H3K27me3 in MEFs, in Dnmt1+/+ 
MEFs treated with demethylating agent 5-aza-dC (AZA). P-value shown was generated from a Mann-
Whitney U test.  Gene promoter K27me3 and DNA methylation data from MEFs used in this figure was 
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changes in Dnmt1-/- MEFs, this observation by itself is of course not conclusive.  However, 
given the links between DNA methylation and PcG proteins, described in chapter 1, I 
decided to investigate this further.  
 When using cell lines to study gene expression, particularly MEFs which are 
originally a heterogeneous population, it is often essential to use another system in parallel.  
This was particularly necessary in my case when studying Hox genes and other PcG target 
genes that show highly tissue-specific expression patterns.  For this reason, expression 
microarray data from Dnmt1+/+ MEFs treated with demethylating agent 5-aza-2'-
deoxycytidine (5-aza-dC) was also studied (data inherited from J. Hackett, Hackett et al., in 
submission).  5-aza-dC is an analogue of cytosine that is incorporated into DNA of dividing 
cells.  DNMTs are irreversibly bound by 5-aza-dC leading to the degradation of bound 
DNMTs, but also of free DNMTs, causing passive loss of DNA methylation over cell 
divisions (Patel et al., 2010).  I found that, as a group, genes that are K27me3 marked at their 
promoter in MEFs and >2-fold upregulated in Dnmt1-/- relative to Dnmt1+/+ MEFs are 
upregulated in 5-aza-dC treated Dnmt1+/+ MEFs by expression microarray (Fig. 3.2E, see 
Fig. 3.2B for gene set used).  Importantly, although all of these genes were not observed to 
be upregulated upon 5-aza-dC treatment, upregulation was observed for certain tissue-
specific genes (confirmed in a later figure).  Together, these data suggest that many tissue-
specific PcG target genes are de-repressed in DNA hypomethylated MEFs.     
 
3.2.3.  The 'Hox code' is perturbed in Dnmt1-/- MEFs 
  
In order to investigate the putative link between DNA methylation and PcG repression in 
more detail I concentrated on the Hox genes, as many of these genes showed upregulation in 
Dnmt1-/- MEFs by microarray and they represent well characterised PcG target genes 
(Soshnikova and Duboule, 2009a).  I performed RT-PCR and qRT-PCR on selected Hox 
genes from all four genomic clusters in Dnmt1+/+ and Dnmt1-/- MEFs (Fig. 3.3A and B).  
These results confirmed findings from the expression microarray but also showed that the 
number of Hox genes that are mis-regulated in Dnmt1-/- MEFs is larger than that suggested 
by microarray.  The position of Hox genes within their cluster is thought to be important for 
their regulation as tissues and cells often show sub-domains of Hox clusters that share a 
transcriptional state (Soshnikova and Duboule, 2009b; Rinn et al., 2007).  For this reason I 
examined the expression of Hox genes in relation to their position within their clusters.  The 
HoxA, HoxD and HoxC clusters showed evidence of a cluster location effect as Hox9-13 
genes were strongly de-repressed (Fig. 3.3A and B).  In fact, the HoxA cluster showed 
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Figure 3.3 - Altered Hox gene expression in Dnmt1-/- MEFs 
A.  RT-PCR for Hox genes in Dnmt1+/+ and Dnmt1-/- MEFs. A dilution series of cDNA was used. -RT is 
a no reverse transcriptase control.  B.  qRT-PCR for Hox genes in Dnmt1+/+ and Dnmt1-/- MEFs. Error 
bars represent standard error of the mean of technical replicates.  C.  Summary of gene expression from 
expression microarray data (as described in previous figure) for the HoxA cluster in Dnmt1-/- relative to 
Dnmt1+/+ MEFs.  D.  Figure taken from Cao et al. (2005) showing RT-PCR for HoxA genes in Bmi1+/+ 
and Bmi-/- MEFs. * and underlined indicates down-regulation and up-regulation respectively in Bmi-/- 
relative to Bmi1+/+ as interpreted by Cao et al.  E.  Schematic of cDNA-custom tiling array experiment.  
F and G.  cDNA signal from custom tiling microarray at control genes for Dnmt1+/+ and Dnmt1-/- MEFs. 
Arbitrary units on the y-axis for probe signal. Position of RefSeq genes is shown above in blue.  H to K.  
As ‘F’ and ‘G’ but for the four Hox gene clusters. Probes that are significantly higher or lower in 
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decreased expression of many Hoxa1-6 and increased expression of Hoxa7-13 genes in 
Dnmt1-/- MEFs by expression microarray (Fig. 3.3C).  I noticed that the pattern of Hox gene 
mis-expression observed in Dnmt1-/- MEFs was very similar to that observed in mutants in 
the polycomb gene, Bmi1, in MEFs (Cao et al., 2005)(example for HoxA cluster, Fig. 3.3C 
and D).  In order to characterise the expression changes at Hox clusters in more detail I 
analysed cDNA from Dnmt1+/+ and Dnmt1-/- MEFs using a custom Nimblegen tiling 
microarray containing all four Hox clusters represented by densely tiled probes 
(experimental overview shown in Fig. 3.3E).  This microarray will be referred to as the 
'custom tiling array' herein to avoid confusion with the other microarray formats used.  This 
array was designed by the lab of Wendy Bickmore to contain densely tiled probes for a total 
of 556 genomic regions, enriched in PcG target genes and controls, including all four Hox 
clusters (a list of tiled regions covered on this array is provided in Appendix 1, the array 
format is summarised in the Methods section).  Three replicates were performed and probes 
with significantly different signals were identified (see Methods for details).  This 
experiment confirmed a cluster location effect on relative expression of the Hox genes in 
Dnmt1-/- MEFs.  At the HoxA, HoxC and HoxD clusters, genes from approximately half of 
the clusters (~Hox1-7) are expressed in Dnmt1+/+ while genes from the entire clusters are 
expressed in Dnmt1-/- MEFs (Fig. 3.3H to J).  Some of the Hox1-7 genes show decreased 
expression in Dnmt1-/- MEFs at the HoxA and HoxD clusters, while this was not observed at 
the HoxC cluster where all genes show increased expression in Dnmt1-/- MEFs (Fig. 3.3H to 
J).  This analysis also confirmed the striking de-repression of Hox9-13 genes at the HoxA, 
HoxC and HoxD clusters in Dnmt1-/- MEFs (Fig. 3.3H to J).  A similar expression pattern 
was not observed at the HoxB cluster where many genes show decreased expression in 
Dnmt1-/- MEFs and no probes showed significant increased expression (Fig. 3.3K).  Overall, 
the expression changes observed in Dnmt1-/- MEFs at the HoxA, HoxC and HoxD clusters are 
very similar to those reported in Bmi1-/- MEFs by Cao et al. (2005).  As Hox genes are 
known to require PcG proteins for repression, I hypothesised that PcG-mediated repression 
at Hox genes is lost in Dnmt1-/- MEFs.   
            
3.2.4.  Loss of polycomb-associated K27me3 at HoxC in Dnmt1-/- MEFs 
 
As PcG proteins are major regulators of Hox gene expression, and given the similarities 
between Dnmt1 and Bmi1 mutation in Hox gene mis-regulation, I investigated the presence 
of the polycomb-associated H3K27me3 and TrxG-associated H3K4me3 (K4me3) marks at 
the HoxC cluster.  The K27me3 mark is frequently used as a marker for repression by the 
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PRC2 complex and K4me3 catalysed by TrxG complexes is thought to be involved in 
activation of Hox genes (Terranova et al., 2006).  In order to measure the presence of histone 
marks, I used native chromatin immunoprecipitation followed by qPCR for primers at the 
promoter region of each gene (N-ChIP-qPCR).  N-ChIP was used as it has certain benefits 
over techniques involving cross-linked chromatin, such as reduced background and 
avoidance of potential artefacts introduced by the cross-linking procedure (O'Neill and 
Turner, 2003).  First, I checked that chromatin from Dnmt1+/+ and Dnmt1-/- MEFs was 
digested with similar efficiency by micrococcal nuclease (Mnase) as marked differences here 
would result in incomparable results.  Bulk soluble chromatin from the two cell lines showed 
no gross differences in digestion by a titration of Mnase (Fig. 3.4A, a single representative 
digest is shown).  Positive and negative control regions for each chromatin mark were tested, 
along with pull-downs with non-specific IgG, to ensure that N-ChIP was working effectively 
and background was low (Fig. 3.4B and C).  The positive control regions showed similar 
enrichments between the two cell lines suggesting that N-ChIP from these cell lines are 
comparable (Fig. 3.4B and C).  Hox clusters are marked by large 'blocks' of K27me3 in ES 
cells and MEFs (Mikkelsen et al., 2007; Pauler et al., 2009).  At the HoxC cluster, as 
expected, all promoter regions tested showed strong enrichment for K27me3 in Dnmt1+/+ 
MEFs.  However, a striking loss of K27me3 was observed in Dnmt1-/- MEFs that occurred at 
all promoters tested (Fig. 3.4D).  The enrichment for K27me3 at these regions in Dnmt1-/- 
MEFs was comparable to that observed with non-specific IgG (data not shown).  This 
observation is reproducible as many replicates of N-ChIP showed the same result and also 
using two different antibodies for K27me3 (data not shown).  In contrast, a small enrichment 
over the negative control for K4me3 was observed at HoxC promoters in Dnmt1+/+ MEFs 
(Fig. 3.4E).  In Dnmt1-/- MEFs K4me3 was unchanged over Hoxc4, Hoxc5 and Hoxc8 
promoters but was increased over Hoxc10 and Hoxc13, which also show strong 
transcriptional derepression in Dnmt1-/- MEFs (Fig. 3.4D and Fig. 3.3I).  These results 
suggest that PcG and TrxG regulation of the HoxC cluster is altered in Dnmt1-/- MEFs. 
 
3.2.5.  Treatment of cells with demethylating agent 5-aza-dC partially recapitulates 
the effect of Dnmt1 mutation 
 
As MEFs are a heterogeneous population of cells I felt that it was crucial to replicate these 
observations using another system to ensure that they were not artefacts of cell origin.  The 
demethylating agent, 5-aza-dC can be used as an independent method to induce 
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Figure 3.4 - Loss of polycomb-associated H3K27me3 at HoxC genes in 
Dnmt1-/- MEFs
A.  Representative agarose gel showing DNA extracted from chromatin preparation digested with 
miccrococcal nuclease for N-ChIP.  B and C.  Positive and negative controls for H3K27me3 and 
H3K4me3 N-ChIP. Error bars represent standard error of the mean.  D and E.  N-ChIP-qPCR at 
promoter regions of HoxC genes for H3K27me3 and H3K4me3 respectively. Error bars represent 


































































































hypomethylation and Dnmt1 depletion (Patel et al., 2010).  One of the advantages of 5-aza-
dC treatment is that the same cells can be compared with and without the drug, ruling out 
any effects of caused by heterogeneity of cells.  First, Dnmt1+/+ MEFs were cultured with or 
without (DMSO control) two different concentrations of 5-aza-dC and gene expression was 
measured by qRT-PCR.  The expression of selected genes that are K27me3 marked and 
upregulated in Dnmt1-/- MEFs, including HoxC genes, was measured upon 3 day treatment 
with 5-aza-dC (Fig. 3.5A).  Some, but not all, of these genes showed increased expression 
with 5-aza-dC treatment at both concentrations of the drug.  It should be noted that none of 
the expression changes are significantly different by two-tailed Student's t-test, probably 
owing to a large variability in response to the drug and inaccuracy introduced when 
quantifying low abundance transcripts.  Importantly however, treatment with 5-aza-dC 
resulted in statistically significant reduction of K27me3 at many of the promoters tested 
while K27me3 enrichment at control genes was either unchanged or increased (Fig. 3.5B).  
Small increases in K4me3 were observed at some promoters tested but none were found to 
be statically significant (Fig. 3.5C).  To exclude the possibility that these observations are an 
artefact of Dnmt1+/+ MEFs, owing for example to their lack of p53, I treated an independent 
mouse embryonic fibroblast cell line (NIH3T3 cells) with 5-aza-dC.  This experiment was 
more difficult to perform as, at the concentrations of drug used, a higher proportion of cell 
death was observed.  Consequently, 2 day drug treatments were performed, so the results 
may be expected to show a smaller effect than in Dnmt1+/+ MEFs.  Nevertheless, upon 
treatment with 5-aza-dC increased expression was observed at the positive control gene 
Tex19.1 as well as the Hox genes tested (Fig. 3.6A).  No statistics were conducted as only 
one replicate was performed.  N-ChIP for K27me3 showed decreased enrichment of the 
mark at most promoters test but no decrease of a control promoter Cphx (Fig. 3.5B).  N-ChIP 
for K4me3 showed an increased enrichment at some HoxC promoters but not all upon 5-aza-
dC treatment.  Also, the changes in K4me3 in these cells did not necessarily correspond to 
those observed in Dnmt1+/+ MEFs.  Together, these results suggest that the effect of Dnmt1 
mutation on K27me3 can be at least partially recapitulated by treating cells with 
hypomethylating agent 5-aza-dC.  Further validation here is required, particularly for the 
gene expression assays.    
 
3.2.6.  Polycomb target genes are mis-expressed in Dnmt1-mutant embryos 
 
Many polycomb-target genes have important roles in embryonic development (Boyer et al., 
2006; Bracken et al., 2006).  I chose to investigate the effect of Dnmt1 mutation on the 
122
Figure 3.5 - Treatment of Dnmt1+/+ MEFs with demethylating agent 
5-aza-dC partially recapitulates the effect of Dnmt1 mutation at 
selected PcG target genes
A.  qRT-PCR for selected genes, that are up-regulated in Dnmt1-/- MEFs, in Dnmt1+/+ MEFs treated with 
varying concentrations of 5-aza-dC (AZA). Error bars represent standard error of the mean. Only 
positive error bars are shown as scale is logarithmic (n=3). None of these changes are significant by 
two-tailed Student’s t-test (p<0.05).  B and C.  N-ChIP-qPCR for H3K27me3 and H3K4me3 resectively 
in Dnmt1+/+ MEFs treated with 5-aza-dC. Error bars represent +/- standard error of the mean (n=2). * 



































































































































































Figure 3.6 - Treatment of NIH3T3 MEFs with demethylating agent 
5-aza-dC partially recapitulates the effect of Dnmt1 mutation at 
selected Hox genes
A.  qRT-PCR for selected Hox genes, that are up-regulated in Dnmt1-/- MEFs, in NIH3T3 cells treated 
with 5-aza-dC (AZA). Tex19.1 is used as a positive control. Error bars represent standard error of the 
mean of qPCR technical replicates. Only positive error bars are displayed due to log scale. (n=1).  B and 
C.  N-ChIP-qPCR for H3K27me3 and H3K4me3 respectively in NIH3T3 cells treated with 5-aza-dC. 
Error bars represent standard error of the mean of qPCR technical replicates. (n=1).
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expression of PcG target genes in mouse embryos for two reasons; 1) for further 
confirmation of a role for Dnmt1 in their regulation using a non-cell line system, 2) to 
investigate if their mis-expression correlates with the developmental phenotype of Dnmt1-
mutant embryos.  Severe mutation in Dnmt1 results in embryonic lethality and 
developmental arrest with a failure to properly specify somites along the body axis (Lei et 
al,. 1996).  The cause of these phenotypes are unknown but it is compatible with mis-
expression of developmental genes, such as Hox genes, that are required for these processes.  
In order to address this we established a collaboration with N.Youngson and E.Whitelaw 
(QIMR, Brisbane) who had generated mice carrying a point mutation in Dnmt1 (MommeD2 
allele, or MD2)(Chong et al., 2007).  The point mutation is within the part of the gene that 
encodes one of the BAH domains and results in hypomorphic Dnmt1 expression due to 
protein instability (Chong et al., 2007).  This mutation is embryonic lethal when 
homozygous.  Mice heterozygous for MD2 were crossed and the offspring were dissected, 
genotyped and imaged by N.Youngson.  At 9.5dpc, when other mutations in Dnmt1 show 
developmental retardation, MD2/MD2 embryos showed a similar phenotype and 
superficially appeared to have failed to specify a proper body axis (Fig. 3.7A).  +/MD2 
embryos were indistinguishable from +/+ at this stage.  As gene expression in MD2/MD2 
and +/MD2 embryos at this stage would be incomparable due to the extreme morphological 
differences caused by developmental defects in the MD2/MD2 embryos, we looked earlier in 
development, at 7.5dpc.  At this stage, +/MD2 and MD2/MD2 embryos were 
indistinguishable at by gross morphology (Fig. 3.7A).  Therefore, we decided to investigate 
the expression of PcG target genes at this stage, before the developmental phenotype became 
apparent (at least at this resolution).  Using three +/MD2 and three MD2/MD2 embryos I 
analysed gene expression from total embryo RNA that was extracted by N.Youngson.  All 
but one of the PcG target genes shown in figure 3.7B showed increased mean expression in 
MD2/MD2 relative to +/MD2 embryos but only two were statistically significant by 
Student's t-test.  The expression of these genes showed considerable variability between 
individuals leading to lack of statistical significance.  This probably arises through both 
variation in dissection of embryos at this early stage and also through temporal 
developmental variation between individual embryos.  Analysis of more embryos may allow 
significance to be reached.  The expression of Tex19.1 was also examined as it was 
suspected to be a positive control for hypomethylation.  Surprisingly this gene did not show 
strong upregulation in MD2/MD2 embryos.  In retrospect, this is likely due to the fact that 
Tex19.1 is normally expressed in some embryonic and extra-embryonic tissues at this stage 
and so is not strongly de-repressed (Hackett, 2010, PhD thesis; Hackett et al., in submission).  
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Figure 3.7 - Polycomb target genes are mis-expressed in Dnmt1-mutant 
embryos
A.  Representative pictures of embryos at 7.5dpc and 9.5dpc that are heterozygous or homozygous for 
the MommeD2 point mutation in Dnmt1 (MD2). (Performed by N. Youngson, QIMR). Mutation 
described in Chong et al. (2007).  B. qRT-PCR showing relative expression of the indicated polycomb 
target genes in 7.5dpc embryos that are heterozygous or homozygous for the MD2 point mutation. Error 









































These data provide suggestive evidence that Dnmt1 may be required in the early mouse 
embryo for repression of key developmental genes that are known PcG targets. 
 
3.2.7.  Derivation of 'anterior trunk' MEFs and treatment with 5-aza-dC 
 
Analysis of Hox gene mis-expression in Dnmt1-/- MEFs showed that Hox9-13 genes from 
three of the Hox clusters are strongly de-repressed (Fig. 3.3).  These genes are normally 
expressed in the very posterior portion of the mouse embryo in a nested fashion dependent 
on their position within the cluster (Peterson et al., 1994; Nordemeer et al., 2011).  MEFs are 
derived from decapitated, but otherwise whole, embryos and so the vast majority of cells 
would be expected to represent anterior regions as the Hox9-13 expressing posterior regions 
represent a small proportion of the embryo.  This suggests that Dnmt1 and/or DNA 
methylation may be required to maintain repression of these genes in anterior portions of the 
embryo.  To test this hypothesis I decided to investigate the effect of 5-aza-dC treatment on 
MEFs derived from the anterior trunk portion of the embryo.  I dissected 12.5 dpc wildtype 
CD1 embryos from their deciduas and extra-embryonic tissue, decapitated them and then 
removed the posterior trunk by cutting above the hind limb buds (Fig. 3.8A).  Using the 
remaining anterior trunk segment I derived MEFs (anterior trunk MEFs, or, ant-MEFs).  I 
performed RT-PCR to check for expression of HoxC genes in ant-MEFs (Fig. 3.8B first 
column).  As expected these cells express high levels of the more anterior-expressed Hoxc5, 
Hoxc6 and Hoxc8 and low levels of the more posterior-expressed Hoxc9, Hoxc10 and 
Hoxc12 genes suggesting that they maintain their positional identity in culture.  Next, I 
treated ant-MEFs with 1µM 5-aza-dC for three days.  This higher dose of 5-aza-dC was 
applied as I expected these primary MEFs to divide much slower, and hence incorporate less 
of the drug, than the immortal fibroblasts used in the previous treatments with 5-aza-dC.  5-
aza-dC treatment resulted in increased expression of Hoxc9 and Hoxc12 by RT-PCR (Fig. 
3.8B).  As the most posterior-expressed HoxC gene, Hoxc13 relative expression was 
measured by qRT-PCR in triplicate.  A statistically significant two-fold increase in Hoxc13 
was observed in ant-MEFs treated with 5-aza-dC (Fig. 3.8C, p<0.05 by two-tailed Student's 
t-test).  This suggests that Dnmt1 and/or DNA methylation may contribute to the repression 
of posterior-expressed HoxC genes in anterior tissues of the developing mouse embryo.         
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Figure 3.8 - Treatment of ‘anterior trunk’ MEFs with 5-aza-dC
A.  Representation of a 12.5 dpc mouse embryo indicating the portion of the embryo used to derive 
‘anterior trunk’ mouse embryonic fibroblasts (ant-MEFs).  B.  RT-PCR for HoxC genes in ant-MEFs 
with and without treatment with 5-aza-dC. Dnmt1-/- cDNA used as a positive control. -RT is a no reverse 
transcriptase control.  C.  qRT-PCR for Hoxc13 in ant-MEFs with and without 5-aza-dC treatment for 













































































3.3.  Discussion 
 
 
In this chapter, I aimed to gain further insight into the mechanisms by which DNA 
methylation affects gene repression.  I have shown that normal levels of Dnmt1 are required 
for the repression of certain PcG target genes in mouse embryonic fibroblasts and possibly 
embryos.  Initially, I integrated data for promoter K27me3 and DNA methylation, and gene 
expression in Dnmt1-/- relative to Dnmt1+/+ MEFs.  The caveat of this analysis is that these 
datasets were generated by different labs using 'MEF' cells.  MEFs are a heterogeneous cell 
population and would be expected to comprise different cell populations depending on the 
embryonic stage used for derivation and hence may not be directly comparable.  For this 
reason, the analyses in section 3.2.1 were intended only to provide clues which would then 
be followed up experimentally.  Later in this thesis I describe K27me3 and DNA methylation 
mapping in Dnmt1+/+ MEFs, addressing this problem. 
 I focussed my subsequent observations on the Hox genes and showed that many of 
them are mis-expressed in Dnmt1-/- MEFs, cells treated with hypomethylating agent 5-aza-
dC and in Dnmt1-mutant embryos.  Importantly, Hox mis-expression was observed in 
multiple experimental contexts, supporting a bona fide role for Dnmt1 in the regulation of 
these genes.  This was particularly important as using the MEFs alone it would have been 
entirely feasible that gene expression differences could be attributed to different tissues of 
origin or sub-populations of cells within the culture.  The fact that treatment with 5-aza-dC 
causes similar changes to Dnmt1 mutation also tells us something about the mechanism 
involved.  When studying gene expression and chromatin patterns in mutant MEFs we are 
studying an endpoint and it is difficult to infer when the changes have arisen or what has 
caused them.  Dnmt1+/+ MEFs have an established chromatin and expression state at Hox 
genes but these can be altered by 5-aza-dC treatment supporting a direct role for Dnmt1 in 
this process.  In respect to expression of the Hox genes studied, the Dnmt1-/- MEF cell line 
used here appears to show similar effects to other experimentally hypomethylated cell lines 
and embryos, making them a valuable tool to study the function of Dnmt1 and DNA 
methylation.   
 The observations presented here link DNA methylation to Hox gene regulation and 
other PcG target genes but this is not the first time this connection has been made.  
Mutations of Dnmt3b that are associated with ICF syndrome in humans lead to a homeotic 
phenotype when expressed in mice accompanied by mis-expression of Hox genes (Velasco 
et al., 2010).  Nearly half of genes mis-expressed in cells from ICF patients with DNMT3B 
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mutations are normally PcG targets and include key developmental genes (Jin et al., 2008; 
Jin et al., 2009).  It could be conceived that mild mis-expression of some of these genes 
could contribute to the phenotypes of ICF syndrome, which include developmental 
abnormalities of cranio-facial development.  Also, mutation of DNMT3A is frequent in 
patients of certain leukaemias, where decreased DNA methylation and increased expression 
of some Hox genes has been observed (Yan et al., 2011).  Mutation of Lsh, a gene encoding 
a supposed DNA methylation co-factor, leads to decreased DNA methylation and mis-
expression of certain Hox genes in cell lines and tissues (Xi et al., 2007; Tao et al., 2010).  It 
should be noted however, that as the DNMTs have reported functions out with of DNA 
methylation, it cannot be formally excluded at this stage that these non-catalytic roles are 
important here.  It seems likely however, that the DNA methylation mark is involved, as Hox 
gene mis-expression is observed in the multiple contexts described above where decreased 
DNA methylation is observed.  Despite these observations, the cause of Hox and other PcG 
target gene mis-expression in mutants of the DNA methylation machinery is not understood.  
The results presented here are novel amongst previously published work for two reasons; 1) 
Hox mis-expression has not yet been reported in the detail included here or in such a 
severely hypomethylated cell system as the Dnmt1-/- MEFs, and, 2) striking losses in 
polycomb-associated K27me3 have not been reported in hypomethylated cells.  This second 
point is important as it offers a potential explanation for Hox mis-expression when cells are 
hypomethylated.  At this point it is not clear whether K27me3 loss is upstream and the cause 
of Hox mis-expression or if it is merely a consequence of transcriptional upregulation.  It is 
clear from the literature however, that loss of PcG binding at Hox genes causes dramatic 
mis-expression (Cao and Zhang, 2004).  The cause and consequence relationships here 
remain to be tested but the results presented in this chapter suggest a further link between 
DNA methylation and Hox gene regulation. 
 Hox genes were observed to be upregulated in mouse embryos depleted in Dnmt1 
before the onset of gross morphological phenotypes.  This is an interesting suggestion as the 
cause of the developmental phenotypes in Dnmt1-mutants is not clear.  At least part of the 
phenotype has been attributed to increased apoptosis in the developing embryo (Jackson-
Grusby et al., 2001).  Developmental phenotypes such as failure to specify somites and 
incomplete closure of the neural tube are also observed (Lei et al., 1996).  One possibility for 
these phenotypes is mis-expression of developmental genes, although to date this has not 
been studied directly in the embryo to my knowledge.  It is interesting to speculate that mis-
expression of developmental genes, such as Hox genes, contributes to these phenotypes as 
they have important roles in these processes (Soshnikova and Duboule, 2009a).  In this 
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regard, the experiment shown in figure 3.8 suggests that Dnmt1 may be required for 
repression of normally posterior-expressed HoxC genes in anterior tissues.  The embryo 
observations presented in this chapter are preliminary for a number of reasons.  Firstly, in 
situ hybridisation would need to be performed on Dnmt1-mutant embryos to better 
characterise mis-expression of Hox genes.  Secondly, a much more thorough analysis of the 
phenotype is required to make sure that the structures of the mutant embryo at 7.5dpc are 
comparable.  It would be interesting to examine Hox gene mis-expression at multiple time 
points during early embryogenesis and correlate this with the emergence of certain body axis 
phenotypes.  This kind of study may be more easily achieved in another vertebrate model 
organism such as zebrafish or Xenopus laevis where somites and body axis phenotypes are 
more easily visible.  This would also address the question of evolutionary conservation of 
this mechanism among vertebrates.  Interestingly in this regard, treatment of zebrafish 
embryos with 5-aza-dC and depletion of xDnmt1 in Xenopus laevis reportedly result in body 
plan and somite patterning defects (Martin et al., 1999; Stancheva and Meehan, 2000).  
Further characterisation of ant-MEF response to 5-aza-dC could prove informative, including 
N-ChIP to investigate K27me3 levels upon treatment.  N-ChIP of Dnmt1-mutant embryos 
would also be informative to connect de-repression to K27me3 changes.  For these 
experiments a conditional knock-out allele for Dnmt1 may provide a cleaner experimental 
approach.       
 The effects of hypomethylation on K27me3 and K4me3 described here at Hox genes 
are intriguing.  At this point, it is not clear if these changes will be specific to Hox clusters, a 
small number of genes, or if they represent a more widespread effect of hypomethylation.  
As a large number of PcG targets were found to be upregulated in Dnmt1-/- MEFs by 
expression microarray, and upon 5-aza-dC treatment, this remains a possibility.  It is 
interesting to speculate that a major role of DNA methylation may be in shaping these two 
histone marks, a question that will be addressed in the following chapter.       
131




4.1.  Introduction 
 
 
DNA methylation has been strongly linked with patterns of histone modification and has 
been suggested to contribute to the maintenance of certain chromatin states.  Understanding 
the interplay between epigenetic marks is a big problem in the field and is key to 
understanding their role in gene regulation.  One histone mark that has been linked to DNA 
methylation is H3K4me3 (K4me3), a modification associated with gene promoter regions 
and unmethylated CpG islands (Mikkelsen et al., 2007; Barski et al., 2007; Thomson et al., 
2010).  DNA methylation at CpG-rich promoter regions has been observed to be negatively 
correlated with K4me3 (Meissner et al., 2008).  A candidate for a protein that links DNA 
methylation and K4me3 is Cfp1, which has been suggested to bind to unmethylated CpG 
motifs through its CXXC domain and recruit the K4 methylase Set1 complex (Thomson et 
al., 2010).  The role of DNA methylation in shaping K4me3 patterns is yet to be fully 
addressed.  A second histone modification that has been linked to DNA methylation patterns 
is H3K27me3 (K27me3), the mark deposited by the PRC2 complex.  This mark has also 
been negatively correlated with DNA methylation in a number of studies (see section 1.3.6).  
The underlying mechanisms for these observations are not understood and the interplay 
between these two epigenetic layers remains to be fully characterised.  In particular, many of 
the studies linking DNA methylation to these histone modifications have done so by 
correlation and few direct tests have been performed, particularly for K27me3.         
 The results presented in chapter 3 demonstrate changes in the histone marks 
K27me3 and K4me3 at HoxC gene promoters in severely hypomethylated Dnmt1-/- MEFs.  
One possible explanation for these results is that DNA methylation is required for correct 
targeting of these histone marks to these regions.  Chapter 3 investigates candidate genes and 
therefore does not address the possibility that K27me3 and K4me3 patterns are more widely 
affected in hypomethylated cells.  In this chapter I address this problem by mapping K27me3 
and K4me3 at gene promoter regions on a large scale in Dnmt1+/+ and Dnmt1-/- MEFs.  
Promoter DNA methylation mapping in Dnmt1+/+ MEFs is also performed.  By integrating 
this data with expression microarray findings I study the relationships between gene 
expression, DNA methylation and histone modification changes in DNA hypomethylated 
cells.  These results suggest a major role for an intact DNA methylation system in shaping 
the patterns of these key modifications of chromatin, and in turn, their modulation of gene 
expression.        
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4.2.  Results 
 
4.2.1.  Global abundance of histone marks and PcG proteins 
 
Before mapping histone marks in Dnmt1+/+ and Dnmt1-/- MEFs I analysed their global 
abundance.  This is important as changes in histone marks, such as the loss of K27me3 
observed at the HoxC cluster in Dnmt1-/- MEFs (chapter 3), could be attributable to a global 
decrease in K27me3 levels.  In order to assess the global abundance of histone marks I 
performed immunofluorescence (IF) on cells and western blot analyses of nuclear lysates.  
DAPI staining of DNA in Dnmt1+/+ and Dnmt1-/- MEFs showed the expected 'bright-spots', 
or chromocenters, that are characteristic of mouse cells and represent mainly densely stained 
pericentric heterochromatin regions (Fig. 4.1A).  The chromocenters were not examined in 
detail but no drastic changes were observed in Dnmt1-/- MEFs (Fig. 4.1A).  K4me3 and 
K27me3 signals were exclusively nuclear and both formed foci, although this was more 
apparent for K4me3 under these conditions.  The observation that was consistent among 
cells was that both K4me3 and K27me3 signal was higher in Dnmt1-/- than Dnmt1+/+ MEFs 
(Fig. 4.1A, true for >90% of cells).  This increased signal was apparent as an increased 
general nuclear signal rather than a change in sub-nuclear staining.  Changes in the number 
or size of the larger K4me3 foci, as suggested by the image in figure 4.1A, were not a 
consistent observation.  The fluorescence signal was calculated from fields of cells and 
normalised to DAPI signal in order to quantify this increase.  Both K4me3 and K27me3 
showed a modestly increased signal in Dnmt1-/- MEFs using this method (Fig. 4.1B).  A 
western blot of histone marks from soluble chromatin from nuclear lysate also suggested 
increased levels of K4me3 and K27me3 in Dnmt1-/- MEFs (Fig. 4.1C).  Western blot for 
H3K4me2 showed no change while H4K20me3 was decreased in Dnmt1-/- MEFs (Fig. 
4.1C).  H2AK119ub produced a very weak signal that was difficult to compare against 
background (Fig. 4.1C).  Next, I performed western blot for PRC2 components in whole cell 
lysates from Dnmt1+/+ and Dnmt1-/- MEFs which showed no major changes in levels of these 
proteins (Fig. 4.1D).  IF using antibodies against the PRC2 component Ezh2 and the PRC1 
component Bmi1 showed no major changes in Dnmt1-/- MEFs, with both proteins showing a 
similar speckled localisation (Fig. 4.1E).  Together, these results suggest that the loss of 
K27me3 from the HoxC genes is not due to global loss of K27me3 or changes in PRC2 core 
protein levels.  They also suggest that overall levels of K27me3 and K4me3 are slightly 
increased in Dnmt1-/- MEFs.  
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4.2.2.  Changes in histone marks occur at a large number of developmental gene 
promoters in Dnmt1-/- MEFs 
 
Loss of K27me3 at HoxC genes (chapter 3) appears to be specific to certain loci as no 
difference was observed at a control region by N-ChIP-qPCR (chapter 3), and globally by 
western blot and IF.  In order to investigate the changes in K27me3 and K4me3 at gene 
promoters on a larger scale I performed N-ChIP coupled with microarray (N-ChIP-chip) 
analysis using a microarray covering a large number of promoter regions.  This array is 
available commercially from Nimblegen (details of array format in Methods) and contains 
about 20,000 RefSeq promoter regions tiled with a median probe spacing of 100bp.  Herein, 
this microarray format will be referred to as the 'promoter array'.  Normalisation and data 
processing for N-ChIP-chip is described in chapter 2.  In order to check that this technique 
can be used to accurately assess enrichment of these histone marks at specific regions, I 
picked representative promoters that show a range of enrichments by microarray and 
validated them by N-ChIP-qPCR.  The promoter array produced results very similar to those 
of N-ChIP-qPCR for detection of K27me3 and K4me3 enrichments in Dnmt1+/+ MEFs, as 
assessed by Pearson's correlation (R2=0.826 and 0.876 respectively)(Fig. 4.2A and B).  The 
accuracy of the microarray technique in detecting differences in enrichment between the 
Dnmt1+/+ and Dnmt1-/- MEF cells was also assessed.  The results matched those of N-ChIP-
qPCR well for K27me3 differences (R2=0.947)(Fig. 4.2C).  These validations suggest that 
the microarray technique used, including DNA amplification steps, can be used to accurately 
map enrichments and cell line differences in histone marks.   
 A large number of promoters showed differential K27me3 or K4me3 in Dnmt1-/- 
MEFs (Fig. 4.2D and E upper).  Thresholds were set in order to define lists of promoters that 
were most strongly changed by calculating the difference between the cell lines for each 
promoter region then selecting difference values that varied from the median difference 
value by more than four median absolute deviations (see chapter 2 for details)(upper and 
lower thresholds are shown as dashed green and red lines respectively).  These thresholds 
were used to define 'gain' and 'loss' promoters described herein and refer to signal in Dnmt1-/- 
relative to Dnmt1+/+ MEFs.  This stringent method provided a list of 41 promoters with 
increased K27me3 and, a surprisingly large, 591 that showed decreased K27me3 in Dnmt1-/- 
MEFs (Fig. 4.2D upper).  For K4me3, 294 promoters showed an increase and 41 showed a 
decrease in Dnmt1-/- MEFs (Fig. 4.2E upper).  A full list of genes in each category is 
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Figure 4.2 - Mapping histone modifications at promoters by N-ChIP-
chip
A and B.  Scatter plots showing the correlation between N-ChIP-chip and N-ChIP-qPCR for detecting 
K27me3 and K4me3 enrichments at gene promoters.  C.  Scatter plot showing correlation between 
N-ChIP-chip and N-ChIP-qPCR for detecting differences in K27me3 at gene promoters between 
Dnmt1+/+ and Dnmt1-/- MEFs.  D and E.  (Above) Scatter plots of K27me3 and K4me3 signal respec-
tively of all arrayed promoters in Dnmt1+/+ and Dnmt1-/- as measured by ChIP-chip on Nimblegen 
promoter array.  Red and green dashed lines indicate lower and upper thresholds for change respectively 
(see methods). Numbers of gene promoters that exceed these thresholds are given as ‘gain’ or ‘loss’ in 
Dnmt1-/- relative to Dnmt1+/+. Genes in the HoxA and HoxC clusters are plotted in blue. (Below) Differ-
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provided in appendix 2.  Plotting the points representing promoters of genes in the HoxA and 
HoxC clusters in blue revealed that these promoters are among the most changed for both 
histone marks, showing striking loss of K27me3 and gain of K4me3 in Dnmt1-/- MEFs (Fig. 
4.2D and E upper).  Overall, the K27me3 mark showed a greater variation at promoters in 
Dnmt1-/- MEFs than the K4me3 mark as assessed by their R2 values (0.7 and 0.84 
respectively).  What is clear for K27me3 is that promoters with the highest enrichment in 
Dnmt1+/+ MEFs show the largest variation and a tendency for K27me3 loss, as indicated by 
the decreased dependence and increased skewing at higher values of x (Fig. 4.2D upper).  
This is supported by plotting the difference between the two cell lines as a function of the 
signal in Dnmt1+/+ which shows a negative effect of Dnmt1+/+ signal on difference at 
positive values of x (Fig. 4.2D lower).  These observations suggest that promoters normally 
highly bound by PcG, require an intact DNA methylation system for full PcG binding.  The 
large number of promoters that lose K27me3 in Dnmt1-/- MEFs suggests that this effect is 
widespread.  For the K4me3 mark, it is clear that promoters that have low signal in Dnmt1+/+ 
MEFs show a greater variation in Dnmt1-/- MEFs with a tendency for K4me3 gain (Fig. 4.2E 
upper and lower).  This suggests that many promoters that are not normally marked by 
K4me3 are dependent on an intact DNA methylation system to prevent accumulation of this 
mark.  
 Among the list of K27me3 loss genes (promoters that show decreased K27me3 in 
Dnmt1-/- MEFs below the set threshold) were many genes with known roles in embryonic 
development.  Among these genes were representatives from each of the four Hox clusters.  
The microarray signal at HoxC promoters was checked to make sure that it matches the 
results of N-ChIP-qPCR.  A large enrichment of K27me3 is observed at HoxC promoters in 
Dnmt1+/+ and this enrichment is lost in Dnmt1-/- MEFs while increased K4me3 is observed 
for Hoxc9-13, confirming the findings by N-ChIP-qPCR (Fig. 4.3B).  Interestingly, similar 
results were observed for the HoxA and HoxD cluster promoters with decreased K27me3 
observed throughout the clusters and K4me3 increases observed at Hox9-13 (Fig. 4.3A and 
C).  The HoxB cluster showed a different pattern with strongly decreased K27me3 observed 
at Hoxb2-8 promoters and no increases observed for K4me3 (Fig. 4.3D).  Many promoters of 
genes not in Hox clusters also showed striking loss of K27me3 in Dnmt1-/- MEFs, as 
illustrated by the Vax2, Tbr1 and Zic5 promoters (Fig. 4.3E to G).  To show that many PcG 
targets are not affected and to validate some of the losses of K27me3 at developmental gene 
promoters, N-ChIP-qPCR was performed.  In agreement with the microarray, K27me3 at 
Cdhd, Cphx and Sytl3 promoters was unchanged in Dnmt1-/- MEFs while at Tbr1, Vax2 
Gata6 and Zic5 striking loss of K27me3 was observed (Fig. 4.3H). 
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Figure 4.3 - Examples of changes in promoter histone modification 
status in Dnmt1-/- MEFs
A to D.  Promoter N-ChIP-chip data displayed in the UCSC browser for H3K27me3 and H3K4me3 in 
Dnmt1+/+ and Dnmt1-/- MEFs for Hox clusters. Location of RefSeq genes are shown above in blue. 
Dashed horizontal line indicates y=0. Plots represent the mean normalised log2 ratio of IP over input for 
each probe over three replicates (see Methods).  E to G.  As ‘A to D’ but for Vax2, Tbr1 and Zic5 promot-
ers.  H.  N-ChIP-qPCR for examples of non-changing and changing promoters for H3K27me3 in 









































































































































































































































































































































































































 To test for an enrichment in functions in embryonic development among genes that 
show altered histone marks in Dnmt1-/- MEFs, Gene Ontology (GO) analysis was performed.  
No significant enrichments were observed for K27me3 gain genes or K4me3 loss genes (data 
not shown).  K27me3 loss genes were highly enriched for GO terms involved in embryonic 
development and functions in transcriptional regulation (Fig. 4.4A, top 10 terms are shown).  
Importantly, as PcG proteins are known to mark many genes with functions in development, 
this enrichment analysis was performed against a list of genes marked by K27me3 in 
Dnmt1+/+ MEFs (see Methods for details).  The same terms were found to be significantly 
enriched when tested against the genome as background (data not shown).  K4me3 gain 
genes showed significant enrichments for GO terms related to certain aspects of embryonic 
development such as body axis pattern formation (Fig. 4.4B, top 10 terms are shown).  Both 
K27me3 loss and K4me3 gain genes showed enrichment for GO terms that are attached to 
Hox genes, enrichment for the interpro protein domain homeobox (HOX) and nuclear 
localisation of the encoded protein (data not shown).  Overall, GO analysis suggested that 
both of these gene sets are strongly enriched for transcription factors that have important 
functions in embryonic development.  By way of confirmation, three genes were chosen that 
encode proteins with key roles in embryonic development, and show K27me3 loss in Dnmt1-
/- MEFs by ChIP-chip.  Vax2 and Hand2 are transcription factors with important roles in 
morphogenesis of the eye and various organs respectively (Alfano et al., 2011; Galli et al., 
2010).  Wnt10a is a secreted morphogen involved in the development of multiple structures 
through the Wnt-signalling pathway (Wang and Shackleford, 1996).  N-ChIP-qPCR 
confirmed that these promoters lose K27me3 in Dnmt1-/- MEFs (Fig. 4.4C).  To check if 
K27me3 loss at these genes correlates with increased expression in hypomethylated cells I 
performed qRT-PCR in Dnmt1-/- and Dnmt1+/+ MEFs and in NIH3T3 MEFs treated with 5-
aza-dC.  All three genes showed increased expression in hypomethylated cells (Fig. 4.4D 
and E).      
 In summary, in Dnmt1-/- MEFs a large number of gene promoters have altered 
histone modifications.  The bulk of K27me3 changes involve loss of the modification at 
genes that are normally highly K27me3 marked, many of which have key functions in 
embryonic development.  The bulk of K4me3 changes involve gain of the modification at 





Figure 4.4- Many genes with changing histone modification status in 
Dnmt1-/- MEFs have functions in development
A and B.  GO enrichment analysis (see Methods) of genes that lose K27me3 or gain K4me3 respectively 
in Dnmt1-/- MEFs.  Plotted are the Bonferroni corrected log10 transformed p-values for enrichment as 
calculated using Babelomics4.  C. N-ChIP-qPCR for K27me3 at the promoters of selected developmen-
tal genes in Dnmt1+/+ and Dnmt1-/- MEFs.  Error bars indicate standard error of the mean.  D and E.  
Relative expression of selected developmental genes measured by qRT-PCR in Dnmt1-/- relative to 
Dnmt1+/+ MEFs and AZA treated relative to control MEFs respectively.  Error bars represent standard 
error of the mean.   
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4.2.3.  The relationship between changes in promoter histone modifications and 
gene expression 
 
In order to assess the relationship between changes in K27me3 and K4me3 at gene 
promoters and gene expression, I integrated my promoter N-ChIP-chip data with data from 
an expression microarray performed on the same cells (performed by J.Hackett).  Firstly, to 
make sure the expected patterns were present, I plotted the signal for each histone 
modification for genes at different expression levels.  As expected, promoter K27me3 was 
more abundant at genes with low expression levels and the inverse was true for K4me3 (Fig. 
4.5A and B).  As K27me3 is thought to be involved in PcG-mediated gene silencing I plotted 
the relative expression of genes that lose and gain K27me3 in Dnmt1-/- MEFs.  Generally, 
genes that lose promoter K27me3 are upregulated in Dnmt1-/- MEFs while genes that gain 
K27me3 showed no change (Fig. 4.5C).  K4me3 is thought to be involved in gene activation 
through transcription initiation (Kouzarides, 2007).  Generally, genes that gain K4me3 are 
also upregulated in Dnmt1-/- MEFs while genes that lose K4me3 are downregulated (Fig. 
4.5D).  When K27me3 loss and K4me3 gain genes are compared, a greater increase in gene 
expression is observed for K4me3 gain genes than K27me3 loss genes overall (Fig. 4.5E).  
Genes that both lose K27me3 and gain K4me3 show a further increase in expression 
suggesting that these two histone marks function at least partially independently (Fig. 4.5E).  
These results alone suggest that changes in histone marks are associated with changes in 
gene expression.  The small number of genes that show increased K27me3 in Dnmt1-/- MEFs 
are generally not downregulated at the level of gene expression indicating that they are not 
de novo repressed by PcG proteins.  
 In order to begin to address the mechanism that drives the histone mark changes in 
Dnmt1-/- MEFs I investigated their relationship with gene expression changes in more detail.  
One explanation for these changes is that DNA methylation, or Dnmt1, loss leads to changes 
in transcription which then influences these marks.  To test this possibility a heatmap was 
plotted for K27me3, K4me3 and gene expression changes for all genes in Dnmt1+/+ and 
Dnmt1-/- MEFs (Fig. 4.6A).  Hierarchical clustering of genes was performed which separated 
them into six major groups based on these characteristics (gene groups are summarised in 
Table 4.1 below).  Of note, genes showing the most K27me3 loss and K4me3 gain were 
clustered into two groups, groups 1 and 2 (Fig. 4.6A, Table 4.1).  Group 1 genes are 
upregulated at the level of gene expression while group 2 genes show no change in 
expression (Fig. 4.6A and D, Table 4.1).  Interestingly, group 2 genes show the greatest loss 
of K27me3 and the greatest gain of K4me3 of all the six groups despite no change in 
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Figure 4.5 - Relationship between histone modification changes and 
gene expression changes
A and B.  Boxplots showing signal of K27me3 and K4me3 respectively, as measured by promoter 
ChIP-chip, in Dnmt1+/+ MEFs of genes split into deciles based on their expression in Dnmt1+/+ 
MEFs.  Red spots indicate the mean of each group.  C and D.  Boxplots showing log2 relative expres-
sion of genes in Dnmt1-/- relative to Dnmt1+/+ MEFs.  Genes are split into groups depending on their 
histone modification change in Dnmt1-/- MEFs as measured by ChIP-chip (C shows groups based on 
K27me3 changes, D shows groups based on K4me3 changes, E shows groups based on both K4me3 























































































































































































































































Figure 4.6 - Heatmap and hierarchical clustering of genes shows uncou-
pling of histone marks and gene expression 
A.  Heatmap showing changes in K27me3, K4me3 and RNA expression in Dnmt1-/- relative to 
Dnmt1+/+ MEFs (see Methods).  Dendogram shows results of hierarchical clustering by which genes 
were classified into 6 groups (see Methods).  B, C and D.  Boxplots showing K27me3, K4me3 and 
RNA expression changes respectively of the groups classified in ‘A’.  P-values are from Mann-
Whitney U tests between the indicated groups.  E.  Selected GO terms that are significantly enriched 
in group 2 relative to group 1.  F.  UCSC browser image displaying data for the HoxB cluster from 
K27me3 N-ChIP-chip (promoter array) and cDNA microarray (custom tiling array) experiments in 
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expression (Fig. 4.6A,B,C and D, Table 4.1).  This suggests that K27me3 loss and K4me3 
gain can be uncoupled from transcriptional changes.  This is important for the following 
reasons; 1) it suggests that changes in gene transcription do not cause all of the observed 
changes in histone marks, and, 2) it suggests that changes in histone marks are not sufficient 
to cause changes in gene expression.  In order to investigate the difference between group 1 
(upregulated) and group 2 (not upregulated) genes I looked for enrichments in GO terms 
between the groups (Fig. 4.6E).  No terms were found to be enriched in group 1 over group 
2, including a search for transcription factor motifs (data not shown).  Many terms were 
enriched in group 2 over group 1, most of which were related to neural development (Fig. 
4.6E).  This suggests that many genes that lose K27me3 and gain K4me3 but are not 
transcriptionally upregulated have functions in neural development.  An example of such 
genes are the Hoxb2-7 genes which lose K27me3 in Dnmt1-/- MEFs but are not 
transcriptionally upregulated and, in fact some are downregulated (Fig. 4.6F).  These results 
suggest that transcriptional changes are not upstream of changes in promoter K27me3 and 










change in Dnmt1-/- 
General RNA 





1 - - - +++ +++ 1021 Hoxc9, Hoxc13, Vax2 
2 - - +++ none 2472 Gata1, Foxn1, Wnt8a  
3 - none --- 1135 Lefty1, Hoxb9, Wnt4 
4 none none + 2094 Magea9, Tex24, Klf1 
5 none none _ 2550 Twist1, Ets2, Med12 
6 none none none 4891 Taf1b, Suz12, Bmi1 
Table 4.1 - Summary of gene groups defined by hierarchical clustering in Fig. 4.6. + and - 
indicate increase and decrease respectively. Multiple + or - (e.g. +++) indicates a greater 
difference. 
 
4.2.4.  Relationship between promoter K27me3 and K4me3 changes 
 
K4me3 has been suggested to inhibit the binding and activity of the PRC2 complex in vitro 
(Schmitges et al., 2011).  I reasoned that one potential mechanism for K27me3 loss in 
Dnmt1-/- MEFs is increased K4me3.  To test this possibility I examined the relationship 
between K27me3 and K4me3 changes at gene promoters.  Although significantly correlated 
(by Pearson's correlation test), plotting K27me3 loss and K4me3 gain produced an R value 
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of 0.283 meaning that only 8% of the variation in K27me3 can be explained by variation in 
K4me3 at gene promoters (Fig. 4.7A, R2=0.08).  As this plot contains all analysed gene 
promoters, which may have diluted a larger dependence, I performed the same analysis using 
only genes that are marked by K27me3 in Dnmt1+/+ MEFs (Fig. 4.7B).  Again although the 
two variables are significantly correlated, only 2.7% of the variation in K27me3 could be 
explained by variation in K4me3 (Fig. 4.7B, R2=0.027).  These results suggest that promoter 
K27me3 and K4me3 changes in Dnmt1-/- MEFs are at least partially independent.  As an 
example of independence, the HoxB locus is shown (Fig. 4.7C).  Hoxb2-7 show a striking 
decrease in K27me3 in Dnmt1-/- MEFs but no increases in K4me3 are observed.  It is of 
course a possibility that increases in K4me3 outside of promoter regions assayed here are 
responsible for K27me3 loss or that more subtle changes are involved that were missed by 
averaging across the whole promoter region. 
 
4.2.5.  Relationship between histone mark changes and DNA methylation at 
promoters 
 
In order to investigate what the mechanism behind the changes in promoter histone marks is 
in Dnmt1-/- MEFs I examined promoter DNA methylation levels.  First, as promoter CpG 
content has been linked to both DNA methylation and histone modifications, I assessed the 
promoter structure of different groups of genes (Weber et al., 2007; Mikkelsen et al., 2007).  
K27me3 loss genes are enriched for HCPs (High CpG content Promoters), with almost 80% 
having a HCP, and are depleted for both ICPs (Intermediate CpG content Promoters) and 
LCPs (Low CpG content Promoters)(Fig. 4.8A).  Importantly, this comparison was made 
with K27me3 marked genes in Dnmt1+/+ MEFs to control for any bias of PcG marked genes.  
K27me3 gain genes are enriched for ICPs and LCPs and depleted for HCPs when compared 
to all genes (Fig. 4.8A).  Both K4me3 gain and K4me3 loss genes are enriched for ICPs and 
depleted for HCPs (Fig. 4.8B).  These results are interesting as a very high proportion of 
HCPs are thought to be unmethylated whereas ICPs are thought to be methylated more 
frequently and show a greater variation in methylation between tissues (Weber et al., 2007). 
 In order to map promoter methylation in Dnmt1+/+ MEFs, we established a 
collaboration with the lab of J.Greally (Albert Einstein College of Medicine, NY) who 
performed HELP-tag-seq (HpaII tiny fragment Enrichment by Ligation-mediated PCR 
followed by Tag Sequencing).  HELP-tag-seq involves digestion of genomic DNA with the 
isoschizomers HpaII (methylation sensitive) and MspI (not methylation sensitive) followed 
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Figure 4.7 - Relationship between K27me3 and K4me3 changes at 
promoters
A.  Scatter plot showing relationship of changes in histone modifications (at the promoter level) at all 
assayed promoters in Dnmt1-/- relative to Dnmt1+/+ MEFs as measured by N-ChIP-chip on promoter 
arrays.  Scale on each axis is the difference in log2(IP/INP)(see Methods) for each histone modifica-
tion between Dnmt1-/- relative to Dnmt1+/+ MEFs.  R-value and p-value for correlation were calculated 
using a Pearson’s product moment test.  B.  As ‘A’ but using only genes that are marked by K27me3 in 
Dnmt1+/+ MEFs (log2(IP/INP) of > 0.5).  C.  UCSC browser image showing promoter N-ChIP-chip 




























































Figure 4.8 - Promoter structure and DNA methylation
A and B.  Promoter CpG content classified as HCP (High CpG density promoter), ICP (Intermediate) 
or LCP (Low) (according to Mikkelsen et al., 2007) for K27me3 and K4me3 gene categories respec-
tively. ** and * represent p<0.001 and p<0.01 respectively by chi-squared test between indicated 
categories.  C and D.  Promoter DNA methylation level as measured by HELP-seq for K27me3 and 
K4me3 gene categories respectively.  P-values calculated by Mann-Whitney U test between indicated 
groups.  N-values indicate the number of genes in each category.  E and F.  As ‘C and D’ but using 




















































































































































































































by sequencing of the ends by Illumina sequencing (see Methods for full description)(Khulan 
et al., 2006; Oda et al., 2009; Suzuki et al., 2010).  Depending on sequence coverage, this 
method allows detection of methylation at potentially >1 million CCGG sites in the mouse 
genome.  See chapter 2 for data processing and validation of HELP-tag-seq data.  Chapter 2 
suggests that this procedure, which is still in development, is associated with a considerable 
amount of noise, at least at the sequence depth achieved here.  For this reason, the HELP-
tag-seq data here should be interpreted with caution.  DNA methylation at regions of interest, 
ox gene clusters, is assessed in further detail in chapter 5.  Nevertheless, the DNA 
methylation status of 13,095 promoters was estimated using this HELP-tag-seq at the 
sequence depth achieved.  Using this method, K27me3 loss genes do not have a higher 
promoter DNA methylation level in Dnmt1+/+ MEFs than genes marked by K27me3 (Fig. 
4.8C).  K27me3 gain genes have more DNA methylation at their promoters than all genes, 
although the number of these genes where DNA methylation data is available is low (Fig. 
4.8C).  K4me3 gain genes have more promoter DNA methylation than all genes while 
K4me3 loss genes are not different from all genes (Fig. 4.8D).  Importantly, these trends 
were repeated using published promoter DNA methylation data (reduced representation 
bisulfite sequencing) for wildtype MEFs (Fig. 4.8E and F)(Meissner et al., 2008).  K27me3 
gain and K4me3 loss genes are not represented in this data so could not be included in this 
analysis.  These observations together suggest that K27me3 loss occurs mainly at HCPs that 
have low DNA methylation, and K27me3 gain and K4me3 gain occurs mainly at ICPs that 
have higher than average DNA methylation. 
 DNA methylation has been suggested to prevent K27me3 targeting to promoter 
proximal regions of some genes in neural stem cells (Wu et al., 2010).  A similar process 
may be involved in K27me3 increases at K27me3 gain genes in Dnmt1-/- MEFs.  As K27me3 
gain genes have more promoter DNA methylation than genes on average, loss of this 
methylation in Dnmt1-/- MEFs could lead to increased K27me3.  To study this relationship I 
chose to investigate the Pcdhb cluster which shows increased K27me3 in Dnmt1-/- MEFs by 
promoter N-ChIP-chip (Fig. 4.9A).  I confirmed increases in K27me3 at two genes of this 
cluster, Pcdhb18 and Pcdhb20, by N-ChIP-qPCR while a control gene, Sytl3, showed no 
major change (Fig. 4.9B).  Both of these genes contain an intragenic CpG island.  To assess 
the DNA methylation status of the intragenic CpG islands I performed MeDIP-qPCR in 
Dnmt1+/+ MEFs  (Fig. 4.9C).  Both of these loci showed a large enrichment for methylated 
DNA relative to CpG-rich negative (Actb) and positive (Dazl) controls suggesting that they 
are highly methylated.  This was confirmed for the intragenic CpG island of Pcdhb18 by 
bisulfite sequencing (Fig. 4.9D).  This region in Dnmt1-/- MEFs showed markedly reduced 
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Figure 4.9 - Candidate K27me3 gain genes have high levels of DNA 
methylation
A.  UCSC browser image showing K27me3 promoter ChIP-chip data at the Pcdhb gene cluster in 
Dnmt1+/+ and Dnmt1-/- MEFs.  B.  ChIP-qPCR for K27me3 at control and Pcdhb genes in Dnmt1+/+ and 
Dnmt1-/- MEFs. Error bars indicate standard error of the mean.  C.  MeDIP-qPCR for control and 
Pcdhb genes in Dnmt1+/+ MEFs.  D.  Bisulfite sequencing for the Pcdhb18 intragenic CpG island in 
Dnmt1+/+ and Dnmt1-/- MEFs.  E.  ChIP-qPCR for Ezh2 in Dnmt1+/+ and Dnmt1-/- MEFs at control and 







































































































DNA methylation (Fig. 4.9D).  In order to assess if increased K27me3 is caused by increased 
binding of the PRC2 complex to this CpG island, X-ChIP (cross-linked ChIP) for Ezh2 was 
performed (Fig. 4.9E).  Increased Ezh2 binding was observed at the intragenic CpG island of 
Pcdhb18 in Dnmt1-/- MEFs but not at the intragenic CpG island of Pcdhb20 or a control gene 
(Fig. 4.9E).  Together, these data suggest that candidate K27me3 gain genes contain highly 
methylated CpG-rich regions and, at one tested region, increased binding of the PRC2 
complex occurs when it is hypomethylated in Dnmt1-/- MEFs.  
 
4.2.6.  Genomic organisation of K27me3 loss genes 
 
I noticed that many K27me3 loss genes are next to each other in the genome.  This included 
genes at all four Hox clusters and other genes that are located in genomic clusters.  To test if 
this observation represents a general characteristic of K27me3 genes I investigated the 
genomic location of K27me3 genes.  By plotting chromosome ideograms it was apparent 
that many genes that lose K27me3 in Dnmt1-/- MEFs exist in clusters in the genome or are 
neighboured by genes that also lose K27me3 (Fig. 4.10A).  To calculate if this represents a 
statistically significant characteristic I counted the number of pairs of K27me3 genes that 
occur in tandem in the genome (Fig. 4.10B)(see Methods for details).  In order compare this 
number to what would be expected by chance, I sampled genes randomly from the genome 
and counted the number of pairs over 1000 permutations (Fig. 4.10B).  I also did this for 
genes that are K27me3 marked to control for an effect of being a PcG target.  The number of 
gene pairs in K27me3 loss genes is significantly higher than what would be expected by 
chance (Fig. 4.10B).  To exclude that the Hox clusters were causing this effect, the analysis 
was repeated using a genome where the genes from all four Hox clusters had been removed 
(Fig. 4.10C).  These results suggest that K27me3 loss in Dnmt1-/- MEFs may frequently 
occur over large genomic domains encompassing multiple genes, as is observed at the Hox 
clusters.    
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Figure 4.10 - K27me3 loss genes are found in tandem in the genome 
more often than would be expected by chance
A.  Chromosome ideogram of chr6 showing positions of gene promoters marked by K27me3 in 
Dnmt1+/+ (red) and gene promoters that lose K27me3 in Dnmt1-/- (blue) as measured by N-ChIP-chip 
(promoter array).  * indicates positions of blue gene promoters that are in tandem (see Methods).  Note 
that gene promoters in close proximity appear as a thicker blue line. Centomeric (Cen.) and telomeric 
(Tel.) ends of the chromosome are marked. A portion of chr6 is magnified below.  B.  Boxplot 
showing number of genes found in tandem in K27me3 loss genes (one value) and randomly selected 
genes from K27me3 marked genes and all genes (1000 samples - see methods).  C.  As ‘B’ but 
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4.3.  Discussion 
 
 
The results presented in this chapter suggest that an intact DNA methylation system is 
required for proper localisation of the histone marks K27me3 and K4me3.  The implications 
of these findings for our understanding of the roles of DNA methylation in genome 
regulation are discussed in this section under the following headings.  
 
4.3.1.  Is an intact DNA methylation pattern required for PRC2 targeting? 
 
How the PRC2 complex is targeted to genomic regions is unknown and represents an 
outstanding problem in the field (Schuettengruber and Cavalli, 2009).  The results presented 
in this chapter implicate an intact DNA methylation system in this process and could 
therefore inform us about PRC2 targeting in mammals.  The most surprising observation in 
this chapter is that decreased K27me3, a signature of PRC2 binding, is observed at many 
gene promoters in severely DNA hypomethylated Dnmt1-/- MEFs, but globally, K27me3 is 
not decreased.  This suggests that the K27me3 mark is not globally decreased in Dnmt1-/- 
MEFs but instead is redistributed to different regions of chromatin.  The genes that lose 
K27me3 in Dnmt1-/- MEFs are among the most highly enriched for K27me3 in Dnmt1+/+ 
MEFs and the vast majority are associated with a CpG-rich promoter that contains low levels 
of DNA methylation.  This is consistent with a redistribution of the K27me3 mark away 
from its normal targets.  I think that this model best explains the observations of this chapter 
and it will be discussed briefly here and in more detail in chapter 6. 
 Recently, studies of PRC2-targeting in mammals have implicated CpG islands in the 
recruitment of the PRC2 complex (Fig. 1.7i)(Tanay et al., 2007; Ku et al., 2008; Mendenhall 
et al., 2010).  DNA methylation has also been suggested to have a negative effect on the 
binding and/or activity of the PRC2 complex on chromatin (Bartke et al., 2010; Wu et al., 
2010; Lynch et al., 2011).  It is possible that DNA methylation is required to differentiate 
CpG island chromatin from surrounding regions and also from DNA methylated CpG 
islands.  In severely DNA hypomethylated cells the PRC2 complex may therefore be titrated 
from its normal binding sites by de novo binding to previously DNA methylated regions 
(discussed further in chapter 6).  In a recent publication it was suggested that K27me3 is 
found in ectopic peaks in mouse ES cells lacking Dnmt3a and Dnmt3b (Lynch et al., 2011).  
Many of these ectopic peaks are found in CpG-rich regions that are highly methylated in 
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wildtype ES cells, supporting this idea.  However, in this study, only modest reduction in 
K27me3 from Hox gene clusters was observed, in contrast to the large reduction in this mark 
observed at Hox gene clusters in Dnmt1-/- MEFs (Lynch et al., 2011).  Possible reasons for 
the discrepancy between the two different hypomethylated cell types will be discussed in 
chapter 6.  These observations together suggest that the DNA methylation pattern has a 
major influence on the genomic binding of the PRC2 complex, and in this way may 
influence the expression of many developmentally important genes.  For example, tissue-
specific differences in DNA methylation may control the expression of genes through 
modulation of PRC2 binding to regions of chromatin.  Tissue-specific DNA methylation of 
CpG islands may be important here. 
 It is clear from my data that certain gene promoters show larger reductions in 
K27me3 than others.  Among these genes are the developmentally important Hox genes.  
How might these differences arise?  Are there additional factors that influence K27me3 loss 
at these genes?  The processes that have been implicated in PRC2 targeting and relief from 
PRC2 binding were shown in figure 1.7.  Locus-specific loss of PRC2 binding could 
therefore arise by altering any of these putative mechanisms.  DNA binding proteins have 
been implicated in PRC2 targeting through binding to polycomb response elements 
(PREs)(Fig. 1.7i), although it is unclear how much this process is operative in mammals as 
no mammalian DNA binding protein has yet been identified that clearly performs a similar 
function.  It is possible that proteins required for PRC2 targeting to specific regions are mis-
regulated in Dnmt1-/- MEFs which causes the observed mis-targeting.  The same is true for 
ncRNA which may be required for targeting of the PRC2 complex to certain regions.  Given 
that not much is known about either of these mechanisms, testing these possibilities would 
be difficult.  K27me3 patterns are also shaped by K27me3 demethylases (Fig. 1.7ii).  It is 
possible that these proteins are differentially targeted in Dnmt1-/- MEFs to the genes that lose 
K27me3.  In this respect not much is known about the targeting of these proteins.  UTX, a 
K27me3 demethylase, has a reported interaction with MLL2 and so may be targeted by TrxG 
complexes (Issaeva et al., 2007). 
 K27me3 and PRC2 binding is thought to be inhibited by transcription across certain 
PRC2 binding sites (Fig. 1.7iii)(for example, Schmitt et al., 2005).  Loss of PRC2 binding in 
Dnmt1-/- MEFs could conceivably be influenced by intergenic transcription, as DNA 
methylation is well associated with transcriptional repression and has previously been 
implicated in reducing transcriptional noise and in regulating alternative promoter usage 
(Bird, 1995; Skene et al., 2010; Maunakea et al., 2010).  Interestingly, abundant intergenic 
transcription has been reported within Hox gene clusters, often correlating with loss of 
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PRC2-mediated repression of nearby Hox genes (Rinn et al., 2007; Sasaki et al., 2007; Sessa 
et al., 2007).  Hox clusters contain many orphan CpG islands, some of which have been 
reported to be DNA methylated in a tissue-specific manner.  One hypothesis could be that 
these orphan CpG islands represent the promoters of ncRNA with functions in activation of 
local Hox genes by PRC2 removal.  This idea could be tested by initially examining the 
DNA methylation status of Hox orphan CpG islands in MEFs and the expression of 
intergenic RNA in Dnmt1-/- MEFs, followed by more functional tests. 
 PRC2 binding and activity has been suggested to be influenced by the presence of 
other histone modifications (Fig. 1.7iv)(Schmitges et al., 2011; Lau et al., 2011).  DNA 
methylation may be required for the correct patterning of these histone modifications and 
therefore contribute to PRC2 targeting in this way.  One such modification is K4me3 which 
is reportedly inhibitory to PRC2 binding/catalytic activity in vitro (Schmitges et al., 2011).  
One possibility is that K4me3 accumulates at certain loci in Dnmt1-/- MEFs, possibly through 
increased binding of the methylation-sensitive CXXC-containing Cfp1 or MLL proteins.  
However, correlating K27me3 and K4me3 changes suggested that this is not the case for the 
majority of promoter K27me3 changes.  This analysis uses only promoter data for K4me3 so 
it remains possible that increases in K4me3 outside of the regions assayed contribute to 
K27me3 loss.  More detailed analysis of K4me3 changes in Dnmt1-/- MEFs would need to be 
performed to address this possibility fully. 
 I observed that K27me3 loss genes occur next to each other in the genome much 
more often than would be expected by chance.  This observation is intriguing given the links 
between PRC2 bound regions and higher order chromatin organisation.  PRC2-bound genes 
are often found within the same nuclear space and reportedly interact with nearby PRC2 
marked genes (for example, Bantignies et al., 2011).  CTCF is a DNA binding protein 
implicated in mediating chromatin contacts that is affected by DNA methylation (Philips and 
Corces, 2009).  CTCF has been suggested to interact with PRC2 component Suz12 and has 
been implicated in targeting PRC2 and also in the regulation of Hox genes (Li et al., 2008; 
Soshnikova et al., 2010; Kim et al., 2011).  One model for K27me3 loss could involve 
differential binding of CTCF resulting in altered chromatin conformation.  This could be 
tested initially by examining the binding of CTCF by ChIP. 
 Also, mapping of K27me3 in cells treated with 5-aza-dC would help to strengthen 
this observation by providing a second hypomethylated system.  It should be added that at 
this stage it cannot be excluded that these effects are not mediated by reduction in DNA 
methylation levels and are a result of loss of Dnmt1 protein itself, as it has suggested non-
catalytic functions.  In this regard, Dnmt1 has been reported to form a complex with 
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polycomb protein Bmi1 and Dmap1 (Dnmt1 associated protein 1) and is suggested to be 
required for proper location of Bmi1 to PRC2 bodies (Hernandez-Munoz et al., 2005; 
Negishi et al., 2007).  Depletion of Dmap1 is also suggested to induce the expression of 
some PRC2 target genes including certain Hox genes (Negishi et al., 2007).  Bmi1 is a 
component of a subset of PRC1 complexes and has not yet been linked to the function of 
PRC2 and K27me3.  Dnmt1 has also been linked, somewhat controversially, to the PRC2 
complex directly and an interaction with Ezh2 has been proposed (Vire et al., 2006).  The 
role of these interactions in PRC2 function are yet to be addressed.  It would be interesting to 
try to rescue the K27me3 defects in Dnmt1-/- MEFs by expressing wildtype and catalytically 
inactive Dnmt1.  In my opinion, given the published links between 5mCpG and inhibition of 
PRC2 binding, it seems likely that the DNA methylation mark itself is involved here.  
Although further investigation of the effect of hypomethylation on PRC2 targeting is clearly 
required, the results presented in this chapter implicate an intact DNA methylation system in 
maintaining repression of a large number of developmental genes by somehow facilitating 
PRC2 targeting to these regions.  This represents a putative 'non-canonical' role for DNA 
methylation in gene regulation as it involves genes that have low levels of DNA methylation 
at their promoters.  It will be interesting to investigate this further, particularly with respect 
to the molecular mechanism involved.       
 
4.3.2.  DNA methylation prevents accumulation of K4me3 at developmental genes? 
 
K4me3 and K4me2 are well associated with regions of high CG-density and low DNA 
methylation suggesting a functional link between the two epigenetic marks (Weber et al., 
2007; Lister et al., 2009; Hawkins et al., 2010; Thomson et al., 2010).  Indeed, mapping of 
DNA methylation and K4me2/3 has shown a strong negative correlation in human cell types 
(Hawkins et al., 2010).  Certain proteins involved in K4me3 deposition contain non-methyl 
CpG binding CXXC domains and therefore may be involved in this link.  One such protein, 
Cfp1, binds to unmethylated CpG islands in ES cells, interacts with the Set1 H3K4 
methylase complex and may be involved in recruitment to these regions (Thomson et al., 
2010).  The H3K4 methylases MLL1 and MLL2 also contain CXXC domains.  The K4me3 
mark is thought to be generally associated with transcriptional initiation and is recognised by 
many proteins involved in establishing a transcriptionally active chromatin state 
(Kouzarides, 2007).  In this way, DNA methylation of promoter regions may act to maintain 
a repressed state by providing mitotically heritable prevention of transcription initiation 
signals.  To my knowledge, no study has addressed this possibility by investigating the effect 
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of DNA hypomethylation on K4me3 localisation on a large scale in non-cancer cells.  A 
study of candidate loci in Dnmt1+/+ and Dnmt1-/- MEFs revealed that some promoters have 
increased K4me3 in Dnmt1-/- MEFs, warranting a more in depth analysis (Lande-Diner et al., 
2007).    
 In this chapter many gene promoters were found to show increased K4me3 in 
hypomethylated Dnmt1-/- MEFs.  In particular, increased K4me3 was observed at promoters 
that are depleted for this mark in Dnmt1+/+ MEFs, many of which have high levels of DNA 
methylation.  These genes are enriched for functions in certain aspects of embryonic 
development.  These results support a role for promoter DNA methylation in preventing 
K4me3 deposition at repressed genes.  However, in this thesis I have not focussed on K4me3 
changes as I decided to investigate the more novel link with K27me3 in further detail.  It 
would be interesting to analyse my data in more detail in respect to K4me3 changes.  One 
analysis that may be interesting would be to take promoters with high and low DNA 
methylation and compare data for K4me3 change when hypomethylated in Dnmt1-/- MEFs.  
It may also be interesting to look at non K27me3 targets alone, as K4me3 could conceivably 
be influenced by changes in K27me3.  It would be important to investigate DNA methylation 
loss in Dnmt1-/- MEFs in more detail and correlate this with K4me3 changes.  The problem 
that could be addressed by studying these questions is whether K4me3 gain is universal at 
normally DNA methylated regions when DNA methylation is lost, or if there is additional 
specificity involved.  We may expect, based on the suggested involvement of CXXC 
proteins, that the underlying CpG content of a DNA methylated region may influence this 
effect.  Multiple enzymes are thought to be responsible for K4me3 in mammals including 
five MLL proteins, two Set1 proteins and Ash1 (Kouzarides, 2007).  It is possible that 
recruitment of a subset of these proteins is affected by DNA methylation, and hence more 
specific K4me3 changes would be observed.  MLL proteins have reported specificity, 
including Mll1 which is thought to be responsible for K4me3 at less than 5% of promoters in 
MEFs, including Hox genes (Wang et al., 2009c).  As Hox genes are among the genes 
showing the greatest increase of K4me3 in Dnmt1-/- MEFs, and Mll1 contains a CXXC 
domain, it may be interesting to investigate this protein further.  Another possibility is that 
all DNA methylated regions with sufficient CpG content will show increased K4me3 when 
hypomethylated.  This would suggest a universal effect of DNA methylation on K4me3 
prevention, implicating a general non-methyl CpG binding protein, such as Cfp1, in the 
process.  Further analysis outside of gene promoters would be interesting, such as at orphan 
CpG islands, as these regions are more often DNA methylated than promoter proximal CpG 
islands (Illingworth et al., 2008; Illingworth et al., 2010).  The use of another experimentally 
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hypomethylated system, such as 5-aza-dC treatment, would compliment this approach.  In 
summary, data presented in this chapter support a role for promoter DNA methylation in 
K4me3 prevention but more detailed analysis is required to make any further conclusions.           
 
4.3.3.  Uncoupling of histone modifications and gene expression 
 
It is open for debate whether histone modifications represent a cause or consequence of a 
transcription state.  By analysing gene expression and histone modification changes in detail, 
in this chapter I make an interesting observation that these two features can be uncoupled.  
There are a large number of genes that show strongly increased K4me3 and strongly 
decreased K27me3 in Dnmt1-/- MEFs but are not changed in expression status.  This suggests 
two points that are important for this chapter; 1) large changes in these histone modifications 
are not sufficient to cause gene expression changes, and, 2) the observed changes in histone 
modifications are not caused by changes in gene transcription.  The first point highlights the 
importance of factors other than these histone modifications in gene expression.  It could be 
reasoned, for example, that efficient expression of a gene requires transcription factors that 
may not be present in the cell tested.  In this respect, it is noteworthy that genes that lose 
K27me3 and gain K4me3 but are not changed in expression are enriched for functions in 
neural development.  Fibroblasts would not be expected to contain many of the transcription 
factors necessary for neural development as a large number of them would be expected to be 
neural-specific.  This could explain why these genes are not changed in expression but others 
are.  Another possible explanation could be the persistence of other epigenetic marks at these 
genes that are capable of maintaining repression on their own.  Many PRC2 marked genes 
reportedly are bound by an initiated form of RNA polymerase which is suggested to be 
restrained somehow from proper elongation by PcG proteins (Stock et al., 2007).  It would 
be interesting to study the binding of differentially phosphorylated forms of RNA PolII at 
genes that lose K27me3 in Dnmt1-/- MEFs.  If RNA PolII is indeed engaged at these genes 
then it suggests that K27me3 loss is not sufficient for polymerase release.  The second point 
is important in relation to the mechanisms causing histone modification changes in Dnmt1-/- 
MEFs.  It suggests that these changes are not secondary to increased gene transcription but 
occur independently. 
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Chapter 5 - Studying the role of DNA methylation in 
Hox gene regulation 
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5.1.  Introduction 
 
 
The data presented in chapter 3, together with published work, links DNA methylation to the 
regulation of Hox genes and other targets of the PRC2 complex, supporting a functional link 
between the two epigenetic mechanisms (Velasco et al., 2010; Tao et al., 2010; Tao et al., 
2011).  Although a handful of studies have suggested that an intact DNA methylation system 
is required for the repression of certain PRC2-bound genes, the mechanistic link is unclear.  
A better comprehension of this interplay is integral to our understanding of these two 
mechanisms and how they influence tissue-specific gene regulation.  In this chapter I aim to 
better understand the role that the DNA methylation system plays in repression of PRC2-
bound genes.  To do this I focus on the Hox gene clusters which are frequently studied as 
PRC2 targets and were shown in chapter 3 to be mis-regulated in a DNA hypomethylated 
cell model. 
 In chapter 4 I demonstrated that the PRC2 signature histone mark, K27me3, is 
redistributed in DNA hypomethylated cells, suggesting that the DNA methylation mark is 
involved in targeting of the PRC2 complex to specific regions of chromatin.  The K27me3 
mark at Hox clusters is severely reduced in the hypomethylated Dnmt1-/- MEFs despite a 
global increase in this mark in these cells.  As the PRC2 complex is thought to be required 
for Hox gene repression, the loss of PRC2-mediated repression of Hox genes in Dnmt1-/- 
MEFs could at least partially explain their observed mis-expression in this context.  
However, it is not clear how DNA methylation contributes to the distribution of the K27me3 
mark.  It is also not clear why the K27me3 mark at some regions, such as Hox genes, should 
be so severely lost in Dnmt1-/- MEFs.  It remains possible that other factors link DNA 
methylation to Hox gene repression.  I reasoned that studying Hox clusters in more detail in 
relation to these points may help to inform us about how DNA methylation contributes to the 
regulation of these genes and also how it influences the distribution of the K27me3 mark. 
 To understand the relationship between DNA methylation, K27me3 and Hox gene 
regulation, I felt it important to characterise DNA methylation patterns at Hox clusters in 
more detail.  Generally, our knowledge of DNA methylation patterns at Hox clusters is 
limited.  Evidence suggests a complex tissue-specific and cluster-specific pattern of DNA 
methylation exists at Hox clusters.  Hox clusters contain many CpG islands, both promoter 
associated and orphan (Illingworth et al., 2008). Around gene promoter regions, DNA 
methylation at CpG islands appears to be low in most tissues but may show some tissue-
specific variation (Illingworth et al., 2008; Xi et al., 2007; Tao et al., 2010).  Some Hox 
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cluster orphan CpG islands are methylated in a tissue-specific manner, but the function of 
these elements and their methylation status is unclear (Illingworth et al., 2008).  Also, there 
appears to differences in DNA methylation between Hox clusters in certain tissues, 
indicating that they are not always subject to the same regulatory processes (Avraham et al., 
2010).  In multiple cancers, Hox gene promoters are reportedly targets for aberrant de novo 
DNA methylation (Rauch et al., 2007; Avraham et al., 2010).  Overall, the DNA methylation 
pattern at Hox clusters is complex and not well understood.  In this chapter, I first set out to 
map DNA methylation at Hox clusters in MEFs.  I also aim to study some of the putative 
PRC2 targeting mechanisms that were described in chapter 1 (Fig. 1.7), in order to identify 
potential links between these processes and DNA methylation.                
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5.2.  Results 
 
 
5.2.1.  Characterising DNA methylation patterns at Hox clusters in Dnmt1+/+ and 
Dnmt1-/- MEFs 
 
In order to characterise the distribution of DNA methylation at Hox clusters in MEFs I first 
performed methyl-DNA-immunoprecipitation (MeDIP).  MeDIP involves 
immunoprecipitation of DNA with an antibody that recognises 5mCpG and has been 
successfully used to map DNA methylation patterns on a large scale when performed in 
combination with microarray (MeDIP-chip) or next generation sequencing (MeDIP-seq)(for 
example, Borgel et al., 2010).  I planned to analyse immunoprecipitated DNA using a 
custom tiled microarray covering all four entire Hox clusters allowing the interrogation of 
intergenic and intragenic regions.  Advantages of the MeDIP-chip technique include its 
ability to differentiate between 5mC and 5hmC, and its low cost in relation to some other 
DNA methylation mapping techniques.  Disadvantages of this technique include the strong 
effect of sequence biases on signal which can make interpretation sometimes less intuitive 
(Pelizzola et al., 2008; Down et al., 2008; reviewed in Laird, 2010).  Genomic DNA was 
sonicated to give a range of fragment lengths between ~200 and 1000bp (Fig. 5.1A).  
MeDIP-qPCR for control regions was performed at genes where promoter DNA methylation 
data was available.  A reduced representation bisulfite sequencing study in wildtype MEFs 
by Meissner et al. (2008) was used, together with my HELP-tag-seq analysis on Dnmt1+/+ 
MEFs, to pick gene promoters at each end of the methylation spectrum.  Actb and Vax2 
promoters are each associated with CpG islands and have low level DNA methylation in 
MEFs in these datasets.  The Dazl promoter is associated with a CpG island and is highly 
methylated in MEFs according to this data.  The Tex19.1 promoter is CpG-rich, but not 
associated with a CpG island (by UCSC sequence based classification), and is not included 
in either of these datasets but is known to be highly methylated in MEFs (shown by bisulfite 
sequencing in chapter 3).  These promoter regions were assayed by MeDIP-qPCR and 
showed the expected pattern of enrichment, suggesting that the MeDIP procedure used here 
can successfully differentiate between regions with different methylation levels, at least at 
each extreme (Fig. 5.1B).  Next, MeDIP enriched and input DNA was analysed in triplicate 
using a high-probe-density custom-designed Nimblegen tiling microarray representing all 
four Hox clusters and other selected genomic regions (the same microarray used in chapter 3 
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Figure 5.1 - MeDIP-chip can be used to approximate DNA methylation 
levels
A.  Sonicated DNA from Dnmt1+/+ MEFs sized on an agarose gel.  B.  MeDIP-qPCR for control gene 
promoters in Dnmt1+/+ MEFs. Error bars represent +/- standard error of the mean. The methylation level 
measured by HELP-seq and RRBS (from Meissner et al., 2008) are shown below graph.  C.  UCSC 
browser image showing MeDIP-chip signal (log2(IP/INP)) in Dnmt1+/+ MEFs.  D.  Bisulfite sequencing 
for indicated regions of the Pou5f1 and Tex19.1 promoters. Filled and open circles indicate methylated 
and unmethylated CpG dinucleotides respectively. The percentage of CpGs that are methylated in each 






















































to analyse cDNA signal).  For experimental setup, microarray details and data normalisation 
techniques employed see chapter 2.  The microarray signal at methylated regions where I 
have previously performed bisulfite sequencing was assessed as control (Fig. 5.1C).  Both 
the Pou5f1 and Tex19.1 promoter showed an enrichment in MeDIP-chip signal as expected 
(Fig. 5.1C).  The DNA methylation status of these regions by bisulfite sequencing in 
Dnmt1+/+ MEFs is also shown (Fig. 5.1D).  I did not perform MeDIP on Dnmt1-/- MEF DNA 
as preliminary experiments indicated that this technique does not allow inter-sample 
comparison of methylation patterns where one sample is severely hypomethylated relative to 
another (data not shown).  
 I next investigated the DNA methylation status at promoters of Hox genes.  I 
measured the signal in immunoprecipitated DNA as a percentage of input using MeDIP-
qPCR of HoxC promoters in Dnmt1+/+ MEFs (Fig. 5.2A).  Each of the analysed promoters 
showed an enrichment between that of the Actb and Dazl promoters.  The Hoxc10 promoter 
showed the highest signal by MeDIP-qPCR of the analysed HoxC genes (Fig. 5.2A).  By 
MeDIP-chip in Dnmt1+/+ MEFs most Hox promoters showed a peak of signal that 
encompassed the transcription start site (Fig. 5.2B to G upper). However, peaks were 
observed at all CpG-rich regions within Hox clusters (Fig. 5.3).  I performed bisulfite 
sequencing of selected promoter regions of HoxC and HoxA genes in Dnmt1+/+ and Dnmt1-/- 
MEFs in order to confirm the observations made by MeDIP-chip and also to quantify DNA 
methylation in both cell lines.  I felt this was necessary as MeDIP is very sensitive to CpG 
density and so cannot by itself be used quantitatively (Pelizzola et al., 2008; Down et al., 
2008; reviewed in Laird, 2010).  In Dnmt1+/+ MEFs the regions analysed showed between 
19% and 55% overall methylation (Fig. 5.2B to G lower).  This suggests that the patterns 
observed by MeDIP-chip are highly influenced by local CpG-content as even low to 
intermediate DNA methylation content appears as a peak if present in CpG-rich regions.  In 
Dnmt1-/- MEFs, every Hox promoter region, apart from Hoxc4, showed the expected 
hypomethylation by bisulfite sequencing (Fig. 5.2B to G lower).  Bizarrely, the Hoxc4 
promoter is hypermethylated in Dnmt1-/- MEFs, an observation that was repeated to ensure it 
was not an experimental error (Fig. 5.2B lower).  These results suggest that in Dnmt1+/+ 
MEFs, the Hox gene promoters analysed contain an intermediate level of DNA methylation, 
and, at most regions, the vast majority of this DNA methylation is lost in Dnmt1-/- MEFs. 
 I next analysed DNA methylation at intergenic regions of Hox clusters, focussing on 
orphan CpG islands (CpG islands not associated with the 5' end of annotated genes).  Some 
orphan CpG islands within Hox clusters have been shown to be methylated in a tissue-
specific manner (Illingworth et al., 2008).  I used two definitions of CpG islands to 
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determine their locations in Hox clusters.  The first was from the UCSC browser and is based 
on DNA sequence characteristics.  The second is from Illingworth et al., (2008 and 2010) 
and is based on enrichment in at least one tissue studied using a CXXC-domain enrichment 
technique.  I included the latter CpG island list as the UCSC method is thought to exclude 
many regions that show characteristics of annotated CpG islands in the mouse genome 
(Illingworth et al., 2008; 2010).  By MeDIP-chip in Dnmt1+/+ MEFs, most orphan CpG 
islands defined using the two methods showed enriched signal relative to flanking regions 
(Fig. 5.3A to C upper).  As MeDIP signal is strongly affected by CpG content, I also assayed 
DNA methylation at many orphan CpG islands by bisulfite sequencing.  These regions 
showed between 42% and 60% overall methylation in Dnmt1+/+ MEFs confirming that they 
contain considerable DNA methylation in these cells (Fig. 5.3A to C lower).  In Dnmt1-/- 
MEFs, DNA methylation was much reduced at these regions, apart from two, Hoxc4 Up and 
Hoxc13-c12, which did not show decreased methylation (Fig. 5.3A to C lower).  These 
results suggest that intergenic CpG islands within HoxC and HoxA clusters contain an 
intermediate level of DNA methylation in Dnmt1+/+ MEFs. 
 The HoxA, HoxC and HoxD clusters show active and inactive portions in Dnmt1+/+ 
MEFs in regard to gene expression (shown in chapter 3).  If local DNA methylation patterns 
are important for this expression pattern then one might expect differences in DNA 
methylation between the two parts of the clusters.  I investigated this possibility at the HoxA 
cluster by MeDIP-chip.  I used the cDNA custom tiling array data from chapter 3 to 
arbitrarily split the HoxA cluster into two parts, an 'active' Hoxa1-a7 portion and an 'inactive' 
Hoxa9-13 portion (Fig. 5.4A).  Plotting the cDNA signal at exonic probes for the two 
portions of the cluster confirms the difference in activity (Fig. 5.4B, p<2.2e-16 by Mann-
Whitney U test).  By eye, no gross difference in MeDIP-chip signal are observed between 
the two portions of the cluster (Fig. 5.4A).  This is confirmed by plotting the MeDIP-chip 
signal for every probe in each portion, and for probes covering the promoter region of each 
gene (Fig. 5.4C and D, p>0.05 by Mann Whitney U test).  This suggests that the inactive 
portion of the HoxA cluster in Dnmt1+/+ MEFs is not more DNA methylated than the active 
portion, and that an overall difference in DNA methylation content does not influence the 
partitioned expression of this cluster. 
 
5.2.2.  Low levels of DNA methylation at Hox CpG islands in primary MEFs suggests 
culture-induced hypermethylation in Dnmt1+/+ MEFs  
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Figure 5.4 - The inactive portion of the HoxA cluster shows no enrich-
ment for DNA methylation in Dnmt1+/+ MEFs
A.  UCSC browser image showing MeDIP data from tiling array for HoxA cluster. Location of RefSeq 
genes (blue), UCSC CpG islands (green rectangles) and Illingworth CpG islands (red rectangles)(see 
Methods) are shown. Partition of cluster into ‘active’ and ‘inactive’ portions based on cDNA data is 
shown below (red and green bars).  B to D.  Comparison of probe signals from the ‘active’ and ‘inactive’ 
portions of the cluster for cDNA at exonic probes (B) DNA methylation by MeDIP (C) and DNA meth-
ylation by MeDIP at promoter regions only (D). ** and ‘ns’ indicate p<2.2e-16 and p>0.1 respectively 











































































































































DNA methylation patterns have been suggested to change in cell culture and during aging, 
particularly increasing at silent developmental genes and those marked by K27me3 
(Meissner et al., 2008; Borgel et al., 2010; Rakyan et al., 2010).  Hox genes also appear to be 
susceptible to hypermethylation in a variety of cancers (Rauch et al., 2007; Avraham et al., 
2010).  I thought it possible that some of the DNA methylation observed in figures 5.2 and 
5.3 at Hox CpG islands has been acquired in cell culture.  I felt that this was possible as an 
intermediate DNA methylation content of CpG islands, as observed in figures 5.2 and 5.3, is 
thought to be rare in normal cells, as the vast majority of CpGs are thought to show a 
bimodal distribution of DNA methylation (Meissner et al., 2008; Lister et al., 2009).  To 
address this possibility I isolated genomic DNA from primary (passage 1) MEFs and 
performed bisulfite sequencing of many of the same loci as analysed in Dnmt1+/+ MEFs (Fig. 
5.5).  I included both promoter regions and intergenic CpG islands in this analysis.  All of 
the regions analysed, apart from the Hoxc9 promoter, show lower levels of DNA methylation 
in primary MEFs than in the cultured Dnmt1+/+ MEFs (Table 5.1).  Further DNA 
methylation analysis will need to be performed to understand this difference.  This data 
suggest that most of the DNA methylation observed in Dnmt1+/+ MEFs was accrued in cell 
culture and is not representative of their tissue of origin.   
 
Region Location 
DNA methylation in 
Dnmt1+/+ MEFs (%) 
(cultured) 
DNA methylation in p1 
MEFs (%) 
(primary) 
Hoxc13 Promoter 55.2 0.6 
Hoxc10 Promoter 43.5 16.2 
Hoxc9 Promoter 19.4 21.4 
Hoxc4 Promoter 30.5 5 
Hoxa10 Promoter 27.8 2.4 
Hoxc13-c12 Intergenic 42 17.4 
Hoxc10-c9 Intergenic 40 1.9 
Hoxc4 Up Intergenic 57.6 7.9 
Hoxa9-a10 Intergenic 60 25.3 
Table 5.1 - DNA methylation as measured by bisulfite sequencing in cultured Dnmt1+/+ MEFs 
and primary MEFs at selected regions. Regions with lower methylation in primary MEFs 
than Dnmt1+/+ MEFs are coloured red. The location of the intergenic CpG island regions 
analysed are shown in figure 5.3. 
 
In conclusion to this part of the chapter, despite efforts to characterise DNA methylation 
patterns at Hox genes in MEFs, data presented here suggest that Dnmt1+/+ MEFs have 
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accumulated DNA methylation in culture and so may not represent a good model to study 
DNA methylation patterns.  I suggest that in primary MEFs, promoter associated and orphan 
CpG islands within HoxA and HoxC clusters are hypomethylated.  Further investigation is 
required to determine the pattern of DNA methylation within Hox clusters in normal MEFs 
and primary tissues, and to connect this with the regulation of these gene clusters. 
 
5.2.3.  The association of PRC2 component Ezh2 with HoxC genes is attenuated in 
Dnmt1-/- MEFs  
 
In order to begin to investigate the mechanism of K27me3 loss at Hox genes in DNA 
hypomethylated MEFs, I first investigated the binding of Ezh2 to chromatin at target genes.  
Ezh2 is a core and catalytic subunit of the PRC2 complex and remains bound to PRC2 
repressed chromatin (Bracken et al., 2006).  I reasoned that lack of K27me3 at Hox genes in 
Dnmt1-/- MEFs could be due to; 1) impaired PRC2 binding to these regions, or, 2) reduced 
PRC2 catalytic activity at these regions despite no change in PRC2 binding.  To differentiate 
between these two possibilities I performed formaldehyde cross-linking of cells followed by 
chromatin immunoprecipitation (X-ChIP) for Ezh2.  Chromatin was sonicated to give 
fragments approximately 200 - 1000bp in length (Fig. 5.6A).  X-ChIP-qPCR showed low 
enrichment for Ezh2 at the negative control Actb promoter compared with positive control 
Hox genes in Dnmt1+/+ MEFs suggesting that detection of Ezh2 binding using this technique 
is specific (Fig. 5.6B).  Three gene promoters that show no decrease in K27me3 in Dnmt1-/- 
MEFs also show no decrease in Ezh2 binding (Fig. 5.6B).  All of the HoxC and Vax2 genes 
analysed showed decreased association with Ezh2 in Dnmt1-/- MEFs, and five were 
significantly lower by two-tailed Student's t-test (Fig. 5.6B, p<0.05).  This result indicates 
that association of the PRC2 complex with Hox promoter chromatin is attenuated in Dnmt1-/- 
MEFs.  The enrichment of Ezh2 at many of the assayed genes in Dnmt1-/- MEFs approaches 
that of the negative control Actb promoter suggesting a strong reduction in binding (Fig. 
5.6B).  This is consistent with the observed loss of the K27me3 mark at these regions and 
suggests that K27me3 loss may be due to loss of PRC2 complex binding to these regions of 
chromatin.   
  
5.2.4.  The involvement of the CTCF protein and boundary elements? 
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Figure 5.6 - The association of PRC2 component Ezh2 with Hox genes is 
attenuated in Dnmt1-/- MEFs
A.  DNA from sonicated cross-linked chromatin was extracted and sized on an agarose gel.  B.  
X-ChIP-qPCR for control and target gene promoters after Ezh2 immunoprecipitation from Dnmt1+/+ 
and Dnmt1-/- MEFs.  Error bars indicate +/- standard error of the mean (n=2). * indicates p<0.05 by 
































































CTCF is a DNA binding protein that has been implicated in mediating chromatin contacts 
and forming boundary and insulator elements (Philips and Corces, 2009).  The formation of 
intra-chromosomal loops has been linked to PRC2 binding and gene regulation, although this 
process is not well understood.  For example, CTCF has been suggested to interact with the 
PRC2 component Suz12 and may recruit PRC2 to allow K27me3 to spread within a 
chromosomal loop, to mediate imprinting of the Igf2 gene (Li et al., 2008; Zhang et al., 
2011b).  CTCF is bound to multiple positions in Hox clusters and has been suggested to 
partition the different domains of the clusters through its activity as an insulator (Kim et al., 
2011; Soshnikova et al., 2010).  Several factors made me want to investigate CTCF binding 
in my system: 1) Analysis in chapter 4 suggested that K27me3 is often lost from multiple 
genes in tandem in Dnmt1-/- MEFs.  One explanation for this observation could be that 
CTCF-mediated chromatin loops are lost which may normally act to recruit/restrict K27me3.  
2) CTCF depletion has been reported to result in altered K27me3 and expression of Hox 
genes in a manner that depends on their location within the cluster (Kim et al., 2011; 
Soshnikova et al., 2010).  3) The pattern of gene expression and histone mark changes at 
Hox clusters in Dnmt1-/- MEFs occurs around a particular CTCF binding site.  Increased 
cDNA and K4me3 was observed at Hoxa9-13 genes (Fig. 5.7).  A postulated boundary 
element, termed CBS5, exists between Hoxa7 and Hoxa9 where CTCF is bound in many cell 
types (Kim et al., 2011)(Fig. 5.7).  Similar patterns of expression and histone modification 
changes are observed at the HoxC and HoxD clusters where a homologous CTCF binding 
site has also been found (Kim et al., 2007; Soshnikova et al., 2010).  The HoxA CBS5 locus 
has been suggested to form an intra-chromosomal loop with a downstream element, acting to 
partition the cluster (Kim et al., 2011).  One possibility is that the activity of this boundary 
element is lost in Dnmt1-/- MEFs contributing to the observed changes.  To address this 
hypothesis I examined CTCF binding to this element by X-ChIP.  I used primers for control 
regions that were expected to be constitutively bound by CTCF (c-Myc 5' and Pax6 6a) or 
not bound by CTCF (c-Myc -5kb) to ensure that the assay was effective (A. Buckle, personal 
communication)(Fig. 5.7B and C).  Large enrichment for CTCF binding was observed at 
both the HoxA CBS5 and HoxC c8-c9 loci in Dnmt1+/+ MEFs, relative to the positive 
controls, suggesting that CTCF is bound to both of these loci in these cells.  Reduced CTCF 
binding was observed in Dnmt1-/- MEFs at the HoxA CBS5 and HoxC c8-c9 loci, while no 
decreases were observed at the control genes (Fig. 5.7C).  This experiment was performed 
only once and will need to be repeated before conclusions are drawn.  However, this 
suggests that CTCF binding to HoxA and HoxC boundary elements is reduced in Dnmt1-/- 
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Figure 5.7 - Broad histone modification and transciptional changes 
occur around a proposed boundary element in Hox clusters
A.  UCSC browser images of cDNA-chip (custom tiled array) and N-ChIP-chip (promoter array) data 
at the HoxA cluster in Dnmt1+/+ and Dnmt1-/- MEFs. Position of Refseq genes (blue) are shown.  Loca-
tions of putative CTCF binding sites are shown as grey and black dashed lines.  The location of the 
CBS5 boundary element is shown as a black dashed line (Kim et al., 2011).  B. Primer binding locations 
relative to the transcription start site of indicated genes. The name of the primer pair is shown below the 
location of the amplicon (red arrows).  C.  X-ChIP-qPCR for CTCF in Dnmt1+/+ and Dnmt1-/- MEFs.  






































































































































































MEFs, correlating with the spreading of K4me3 and gene expression into the normally 
repressed Hox9-13 domains. 
 Altered CTCF binding may be expected to affect the higher order chromatin 
organisation of the Hox clusters.  The higher order chromatin organisation at Hox clusters, as 
with all loci, is currently not well understood.  Chromatin conformation assays have begun to 
shed light on this aspect of chromatin biology.  Hox clusters appear to form multiple intra-
cluster contacts in undifferentiated pluripotent cells when the entire clusters are silent 
(Ferraiuolo et al., 2010).  Upon differentiation, a change in chromatin organisation is 
suggested to occur, including an overall decompaction of the loci (Eskeland et al., 2010).  In 
some differentiated cells, Hox clusters may form a partitioned chromatin organisation with 
actively transcribed portions of the cluster forming an active 'chromatin hub' (Noordermeer 
et al., 2011).  Polycomb protein binding and the K27me3 mark have also been suggested to 
influence higher order chromatin organisation (Eskeland et al., 2010; Bantignies et al., 
2011).  In order to investigate a potential change in chromatin organisation in Dnmt1-/- 
MEFs, I performed two-dimensional fluorescence in situ hybridisation (2D FISH) using 
labelled probes that span the HoxA cluster (performed with help from S. Boyle)(Fig. 5.8A).  
The vast majority of Dnmt1+/+ and Dnmt1-/- MEFs showed four pairs of spots indicating that 
they each contain four copies of this locus (e.g. Fig. 5.8B).  I measured the interprobe 
distance of >120 spot pairs as a measure of chromatin compaction.  No significant difference 
was observed between the two cell types (Fig. 5.8C).  This suggests that at this resolution, no 
difference in chromatin compaction is observed in Dnmt1-/- MEFs, despite the observed 
changes in histone marks and gene expression.  Further work is required here to determine 
the cause and effect of reduced CTCF binding to these sites.   
 
5.2.5.  Increased intergenic transcription and H3K36me3 are associated with 
K27me3 loss 
 
Non-coding RNA (ncRNA) transcription has been suggested to inhibit PcG repression and 
alter nearby gene expression in certain contexts, particularly within Hox clusters (Cavalli and 
Paro, 1998; Cavalli and Paro, 1999; Bender et al., 2002; Hogga et al., 2002; Rank et al., 
2002; Schmitt et al., 2005; Sanchez-Elsner et al., 2006; Dinger et al., 2008; Wang et al., 
2011; Bertani et al., 2011).  The precise mechanisms by which ncRNA modulates Hox 
expression is unclear.  Certain ncRNA has been suggested to act by recruiting TrxG proteins 
to stimulate transcriptional activation of nearby genes (Sanchez-Elsner et al., 2006; Wang et 
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Figure 5.8 - Chromatin compaction by FISH of the HoxA locus is 
unchanged in Dnmt1-/- MEFs
A.  Probe binding locations relative to the HoxA cluster.  B.  Representative FISH images using the 
probes in ‘A’ on Dnmt1+/+ and Dnmt1-/- MEFs. Note that both nuclei have four copies of the probe 
binding sites.  C.  Boxplot showing interprobe distance normalised to nuclear area.  ‘N’ represents the 






































































Location of probe binding sites (black rectangles)
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al., 2011; Bertani et al., 2011).  Also, a 'sweeping' mechanism has been suggested where the 
act of ncRNA transcription itself causes dissociation of PcG complexes (Hekimoglu and 
Ringrose, 2009).  As DNA methylation has a well established role in repression of 
transcription, I hypothesised that de-repression of ncRNA may contribute to K27me3 loss in 
Dnmt1-/- MEFs.  To address this idea, I analysed the cDNA custom tiled microarray used in 
chapter 3 in more detail.  This microarray consists of densely tiled probes covering all four 
Hox clusters and so can be used to identify changes in intergenic transcription.  A similar 
approach was successfully used in human cells by Rinn et al., (2007).  I was aware of certain 
limitations while performing this experiment.  Firstly, cDNA was synthesised using oligo-dT 
priming, meaning that not all RNA would be represented.  Multiple previously identified 
ncRNAs within Hox clusters have been shown to be spliced and poly-adenylated so I felt this 
to be only a minor limitation (Rinn et al., 2007; Wang et al., 2011; Bertani et al., 2011).  
Secondly, the microarray and cDNA synthesis technique used here results in loss of strand 
information.  I reasoned that any ncRNA observed could be investigated and mapped in 
more detail subsequently.  Thirdly, as with any cDNA experiment, the levels of steady state 
RNA are measured as appose to transcription itself. 
 Further examination of cDNA custom tiled microarray results showed that extensive 
increases in intergenic transcription are observed within Hox clusters in Dnmt1-/- MEFs.  I 
used the position of RefSeq genes to identify genic and intergenic regions.  Probes with 
significantly increased signal in Dnmt1-/- MEFs were identified by finding groups of three 
consecutive probes with p<0.05 by two-tailed Student's t-test (see chapter 2 for details).  
Significantly increased signal was observed at the HoxC, HoxA and HoxD clusters in Dnmt1-
/- MEFs (Fig. 5.9A to C).  An annotated non-coding antisense transcript from the HoxA 
cluster, Hoxa11as (Hoxa11 antisense), also showed significant upregulation in Dnmt1-/- 
MEFs (Fig. 5.9B).  The HoxD cluster shows less widespread increase in intergenic cDNA 
signal than the HoxA and HoxC clusters, correlating with the less severe reductions in 
K27me3 at this cluster in Dnmt1-/- MEFs (Fig. 5.9A to C and chapter 4).  As mentioned in 
chapter 4, no probes in the HoxB cluster show increased signal in Dnmt1-/- MEFs.  I 
calculated the proportion of Hox clusters that show significantly increased signal in Dnmt1-/- 
MEFs.  About 20% and 40% of the probes in the HoxA and HoxC clusters respectively are 
significantly upregulated in Dnmt1-/- MEFs, compared to around 3% of all probes on this 
array (Fig. 5.9D).  Similar proportions were observed using only intergenic probes (Fig. 
5.9E).  These results suggest that many intergenic ncRNAs from within Hox clusters are 
upregulated in Dnmt1-/- MEFs. 
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Figure 5.9 - Profiling cDNA using tiling arrays reveals increased inter-
genic transcription in Hox clusters in Dnmt1-/- 
A.  UCSC browser images showing cDNA array signals (custom tiled array) for a portion of the HoxC 
cluster in Dnmt1+/+ and Dnmt1-/- MEFs. RefSeq genes are shown in blue. Dashed vertical lines indicate 
the start and stop positions of RefSeq genes. Black bars (bottom) indicate probes with significantly 
increased signals in Dnmt1-/- relative to Dnmt1+/+ MEFs (see Methods).  B.  As ‘A’ but showing data for 
a portion of the HoxA cluster.  C.  As ‘A’ but for a portion of the HoxD cluster.  D.  Proportion of probes 
with significantly different cDNA signals in Dnmt1-/- MEFs within Hox clusters.  ** denotes p<0.0001 
by chi-squared test between indicated samples. Note that the key (right) is for both ‘D’ and ‘E’.  E.  As 
‘D’ but for intergenic probes only.       
A
B









































































































 Although ncRNA transcription has been linked with gene activation and relief from 
PcG repression, how it does this remains unclear (Hekimoglu and Ringrose, 2009).  
Recently, the H3K36me3 histone mark has been suggested to be a potent PRC2 antagonist 
(Schmitges et al., 2011; Yuan et al., 2011).  The H3K36me3 and K27me3 marks rarely exist 
on the same nucleosomes in human cells and, in vitro, activity of the PRC2 complex on 
nucleosomes is inhibited by pre-installed H3K36me3 (Schmitges et al., 2011; Yuan et al., 
2011).  As H3K36me3 is a mark associated with transcription units, specifically, elongating 
RNA polymerase II, it has been postulated that this antagonism prevents K27me3 spreading 
into actively transcribed regions.  I hypothesised that intergenic transcription may contribute 
to PRC2 displacement/inhibition by increasing the level of intergenic H3K36me3 within Hox 
clusters.  To begin to test this hypothesis I performed N-ChIP for the H3K36me3 mark in 
Dnmt1+/+ and Dnmt1-/- MEFs.  I confirmed that the N-ChIP was successful by assaying 
enrichment at control regions by N-ChIP-qPCR (Fig. 5.10A).  The Gapdh promoter and 
exonic region would be expected to be negative and positive respectively in both cell types, 
and this pattern was observed by N-ChIP-qPCR (Fig. 5.10A).  The exonic region of Tex19.1 
would be expected to be positive in Dnmt1-/- and negative in Dnmt1+/+ MEFs, where the gene 
is expressed and repressed respectively.  As N-ChIP for H3K36me3 appeared to have been 
successful, I labelled the DNA and hybridised to the custom tiled microarray.  After 
normalisation, I checked the enrichment of all exonic and intergenic probes in Dnmt1+/+ 
MEFs.  As expected, exonic probes showed an overall higher signal while intergenic probes 
showed an overall lower signal than all probes (Fig. 5.10B, p<0.0001 by Mann-Whitney U 
test).  Also as expected, exonic probes show a positive relationship between cDNA signal 
and K36me3, although considerable variation was observed suggesting that H3K36me3 and 
expression are not constitutively tightly correlated (Fig. 5.10C).  Overall, these results 
suggest that N-ChIP-chip for H3K36me3 performed here can effectively be used to profile 
levels of this histone mark. 
 The signal for H3K36me3 N-ChIP-chip was compared between Dnmt1+/+ and 
Dnmt1-/- MEFs (Fig. 5.11A).  Overall, a greater variation between the two cell types was 
observed for probes of the HoxA and HoxC clusters than for all probes, as assessed by 
Pearson's correlation co-efficients (Fig. 5.11A, R=0.851: All probes, R=0.571: HoxC, 
R=0.614: HoxA).  In particular, many probes from the HoxC and HoxA clusters show 
increased signal in Dnmt1-/- relative to Dnmt1+/+ MEFs (Fig. 5.11A).  In Dnmt1+/+ MEFs, a 
clear partition in H3K36me3 signal, as observed for cDNA, was not apparent (see HoxC 
cluster in Fig. 5.11B for example).  This further suggests that H3K36me3 and cDNA signal 
are not always tightly correlated.  However, by examining the signal within these clusters it 
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Figure 5.10- Mapping H3K36me3 using custom tiled arrays
A.  ChIP-qPCR for contol regions in Dnmt1+/+ and Dnmt1-/- MEFs.  Error bars indicate standard error of 
the mean.  B.  Boxplot showing mean signals from the tiling array in Dnmt1+/+ MEFs for exonic, 
intergenic and all probes. ** denotes p<0.00000001 by Mann-Whitney-U test between indicated 
groups.  C.  Scatter plot showing correlation between K36me3 and cDNA signal in Dnmt1+/+ MEFs at 























































Figure 5.11 - H3K36me3 at Hox clusters increases in the absence of 
Dnmt1
A.  Scatter plots of K36me3 signal as measured by ChIP-chip on Dnmt1+/+ and Dnmt1-/- MEFs at Hox 
clusters and all probes. Dashed lines are y=x. R-values are from Pearson’s correlations.  B.  UCSC 
browser image showing K36me3 signal at the HoxC cluster in Dnmt1+/+ and Dnmt1-/- MEFs. Position of 
RefSeq genes are shown in blue. Dashed vertical lines indicate start and stop positions of RefSeq genes. 
Black bars (bottom) indicate probes that show significant increase in signal in Dnmt1-/- MEFs (see 
Methods). Amplicon of primers used in ‘D’ are shown as red blocks (bottom).  C.  As ‘B’ but showing 
a portion of the HoxA cluster.  D.  ChIP-qPCR validation of ChIP-chip data for two regions that show 
increased K36me3 in Dnmt1-/- MEFs and one region that shows no change. Error bars represent +/- 
standard error of the mean (n=3). Primer binding locations are shown in ‘B’ and ‘C’. * denotes p<0.05 
by Student’s t-test.  E.  Boxplot showing difference in K36me3 between Dnmt1+/+ and Dnmt1-/- MEFs 
as measured by ChIP-chip (custom tiled array) at various annotations within Hox clusters. * indicates 
that all annotations tested within Hox clusters have significantly higher K36me3 signal than the equiva-
lent annotation using all probes (p<0.005, Mann-Whitney-U test).  F.  Proportions of Hox cluster probes 
that show significantly different K36me3 signal between Dnmt1+/+ and Dnmt1-/- MEFs. ** denotes a 
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Significantly increased K36me3 in Dnmt1-/-
K36me3 Dnmt1+/+
K36me3 Dnmt1-/-
Primer amplicon used for validation in fig. 5.13d (and CTCF binding site)
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is clear to see that, similar to cDNA, many intergenic regions show increased H3K36me3 
signal in Dnmt1-/- MEFs (Fig. 5.11B and C).  I confirmed increased H3K36me3 in Dnmt1-/- 
MEFs at two of these loci by N-ChIP-qPCR (Fig. 5.11D, amplicon locations shown in Fig. 
5.11B and C, p<0.05 by two-tailed Student's t-test).  Of note, the tested regions included the 
CTCF binding sites examined in figure 5.7.  By microarray, both of these regions show 
increased H3K36me3 in Dnmt1-/- MEFs, although this is observed in the flanking regions to 
the CBS5 CTCF binding site in the HoxA cluster, and so is not observed by N-ChIP-qPCR 
using these primers (Fig. 5.11B and C).  Dividing HoxA and HoxC clusters into different 
annotations shows that increased H3K36me3 signal is observed at all of the analysed 
annotations in Dnmt1-/- MEFs, including intergenic and promoter regions (Fig. 5.11E, 
p<0.005 by Mann-Whitney U test compared to all probes).  Greater than 20% of probes from 
HoxA and HoxC clusters have significantly increased H3K36me3 signal in Dnmt1-/- MEFs 
while less than 4% of all probes show this trend (Fig. 5.11F, p<0.0001 by chi-squared test).  
A similar proportion of intergenic probes show significantly increased signal, suggesting 
that, like cDNA, H3K36me3 is increased in many intergenic regions of Hox clusters in 
Dnmt1-/- MEFs (Fig. 5.11G). 
 I next tested if changes in cDNA signal and H3K36me3 within Hox clusters are 
correlated.  This would be expected if increases in transcription cause H3K36me3 increase.  
For all intergenic probes on the custom tiled array, a fairly weak correlation between cDNA 
difference and K36me3 difference (each between Dnmt1+/+ and Dnmt1-/- MEFs) is observed 
(Fig. 5.12A, R=0.175).  Within the intergenic probes of the HoxA and HoxC clusters, a 
slightly better correlation is observed, but this correlation is still weak (Fig. 5.12A, R=0.222: 
HoxC, R=0.465: HoxA).  This further suggests that these two signals are not constitutively 
associated.  This could potentially be explained by the presence of transcripts that are not 
detected using this method, or additional factors that influence the H3K36me3 mark. 
 There are about 70 genes on the custom tiled array that are K27me3 targets in 
Dnmt1+/+ MEFs (defined by having an average promoter log2(IP/INP) > 0.5) and many of 
these genes are suggested to lose promoter K27me3 in Dnmt1-/- MEFs (by promoter array, 
described in chapter 4).  In order to test if increased intergenic transcription and H3K36me3 
are associated with K27me3 loss, I plotted a heatmap of the ~70 K27me3 target genes (Fig. 
5.12B).  I scored each gene for whether they are associated with increased cDNA or 
H3K36me3 signal (three consecutive probes with p<0.05 by Student's t-test) in exonic, 
intronic and intergenic regions.  Intergenic regions associated with each gene were defined 
as up to 3kb away and not within any other RefSeq transcript.  The heatmap was ordered by 
the difference in K27me3 between Dnmt1+/+ and Dnmt1-/- MEFs.  The threshold for K27me3 
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Figure 5.12 - Intergenic transcription and K36me3 are correlated and 
both are associated with K27me3 loss in Dnmt1-/-
A.  Scatter plots showing relationship between cDNA signal difference and K36me3 ChIP signal differ-
ence (between Dnmt1+/+ and Dnmt1-/-) for intergenic probes on tiling array. Dashed blue line was fitted 
by regression. R-value was calculated by Pearson’s correlation.  B.  Heatmap showing association of 
K27me3, K36me3 and cDNA changes at all K27me3 targets on the custom tiled microarray . K27me3 
panel shows difference in K27me3 at gene promoters as measured by N-ChIP-chip (promoter array). 
cDNA (red) and K36me3 (green) panels show if the gene is associated with probes from the custom tiled 
array which show significantly increased signal in Dnmt1-/-. Intergenic was defined as <3kb from TSS 
and not within a RefSeq gene. The dashed line represents the threshold for K27me3 loss defined in 
chapter 4. The p-values (bottom) are from a Fisher’s exact test between groups defined by the K27me3 
loss threshold. The gene names are shown to the right of the heatmap. C.  Scatter plot for K36me3 differ-
ence and K27me3 difference between Dnmt1+/+ and Dnmt1-/- MEFs for all genes covered by the custom 
tiled array. K36me3 difference was calculated by taking an average of the non-genic promoter-
associated probes for each gene from the custom tiled array. K27me3 difference comes from the 
promoter array described in chapter 4. R-value is from a Pearson’s correlation. Genes marked by 
K27me3 in Dnmt1+/+, and the R-value for these points, are plotted in blue. D. As ‘C’ but for non-genic 
promoter cDNA signal.  E.  UCSC browser image showing N-ChIP-chip data for K27me3 (promoter 
array) and K36me3 (custom tiled array) at the HoxB cluster. The position of RefSeq genes are shown 
(blue). Black bars (bottom) indicate probes that are significantly increased in K36me3 signal in 

















































































































































































































































































loss as defined in chapter 4 is shown on the heatmap as a horizontal dashed line.  Genes 
above this line are defined as having lost K27me3 in Dnmt1-/- MEFs, allowing statistical 
testing of any association by categorical Fisher's exact test.  Genes at the top of this heatmap, 
those which show the most K27me3 loss in Dnmt1-/- MEFs, are frequently associated with 
increased cDNA and H3K36me3 in exonic, intronic and intergenic regions (Fig. 5.12B).  
This observation is confirmed by Fisher's exact test for each annotation.  The lowest p-value 
by Fisher's exact test, for both cDNA and H3K36me3, was observed for intergenic regions, 
suggesting that intergenic changes in these features correlate better with K27me3 loss than 
gene-associated changes, for these genes using this analysis (Fig. 5.12B).  
 I addressed this idea using a second analysis.  For each gene on the custom tiled 
array, I calculated the mean probe signal change for cDNA and H3K36me3, between 
Dnmt1+/+ and Dnmt1-/- MEFs, within upstream promoter regions.  Each upstream promoter 
region was defined as up to 3kb upstream of the gene transcription start site and not within 
another RefSeq transcript.  This provides only non-coding, intergenic probes for each region.  
The difference in H3K36me3 and cDNA within this upstream region for each gene was 
calculated and plotted against the K27me3 change associated with each gene from promoter 
arrays.  This allows the promoter-associated H3K36me3 and cDNA change to be correlated 
with promoter K27me3 changes for these genes.  Increase of either H3K36me3 or cDNA in 
upstream promoter regions is correlated with K27me3 loss in Dnmt1-/- MEFs (Fig. 5.12C and 
D, R=0.424: K36me3, R=0.398: cDNA).  This analysis contains all genes with sufficient 
coverage on the custom tiled microarray.  Plotting only the ~70 genes that are K27me3 
targets in Dnmt1+/+ MEFs (in blue), also showed a correlation, with slightly better R values 
(Fig. 5.12C and D, R=0.515: K36me3, R=0.467: cDNA).  These observations suggest that 
promoter-associated transcription and H3K36me3 are increased at many of the assayed 
genes in Dnmt1-/- MEFs.  Increased promoter-associated cDNA and H3K36me3 correlates 
with loss of the PRC2-mediated K27me3 modification from these gene promoters.  As 
H3K36me3 is a suggested PRC2 antagonist, these observations are consistent with a model 
where intergenic transcription contributes to loss of PRC2-mediated gene repression in 
Dnmt1-/- MEFs, although of course does not prove it.  At this point it is equally likely that the 
observed increases in cDNA and H3K36me3 are a consequence of loss of PRC2-mediated 
repression.  Further, more functional, studies are required to differentiate between the two 
possibilities.  It is interesting to note that decreased K27me3 is observed at the Hoxb2-b7 
region of the HoxB cluster despite no observed increase in cDNA in this region (Fig. 5.12E, 
cDNA was shown in chapter 4).  This region does, however, show increased H3K36me3 in 
Dnmt1-/- MEFs, despite decreased H3K36me3 in flanking regions (Fig. 5.12E).  This could 
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indicate that transcription does not cause increased K36me3 and K27me3 loss, at least at this 
locus, or that transcripts that are not detected (for example those that are not poly-
adenylated), are upregulated.  Further study of this locus could help to differentiate between 
the two possibilities.     
         
 
5.3.  Discussion 
 
 
In this chapter I have begun to investigate the mechanisms by which DNA methylation 
contributes to Hox gene regulation.  By doing this I also aimed to better understand the role 
that DNA methylation plays in targeting the K27me3 histone modification to chromatin, a 
function that was suggested from my work presented in chapters 3 and 4.  A discussion of 
the outcome of these experiments is presented under the following headings.   
 
5.3.1.  The DNA methylation pattern at Hox genes and its role in gene regulation 
 
I first set out to characterise the DNA methylation pattern within Hox clusters in the type of 
cells that were used as the primary model during this work, mouse embryonic fibroblasts.  I 
used more than one method to investigate DNA methylation patterns, as many of the existing 
high throughput techniques have certain limitations (Laird et al., 2010).  I used MeDIP-chip 
to profile DNA methylation at Hox clusters in Dnmt1+/+ MEFs.  Using this technique I 
established that promoter regions of Hox genes contain an 'intermediate' level of enrichment 
in Dnmt1+/+ MEFs.  In fact, a peak in enrichment was observed at nearly all CpG islands 
using this technique in DNA from these cells.  The MeDIP technique is subject to significant 
biases, for example in CpG density, which can lead to misleading signals (Down et al., 2008; 
Pelizzola et al., 2008).  For example, even low level DNA methylation in a very CpG-rich 
region can produce an enrichment in signal relative to the highly methylated, but CpG-poor, 
flanking regions.  Techniques have been developed to try to account for these biases in 
MeDIP (Down et al., 2008; Pelizzola et al., 2008).  For future MeDIP-chip experiments, one 
of these correction methods could be used to make the output more intuitive.  For example, 
MeDIP on a genome that has been in vitro methylated to completion using the SssI CpG 
methyltransferase can be performed.  When performed in parallel with samples, this can be 
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used to model the relationship between enrichment and CpG density, which in turn can be 
used to correct data from parallel MeDIP-chip experiments (Pelizzola et al., 2008).   
 In this chapter, I performed bisulfite sequencing as an independent method to verify 
DNA methylation at certain loci.  This combination of a relatively large scale method, 
MeDIP-chip, with the smaller scale, but more quantitative, bisulfite sequencing, was 
designed to provide reliable DNA methylation data within Hox clusters.  Bisulfite 
sequencing of Hox promoters confirmed that they contain an 'intermediate' level of DNA 
methylation.  This in itself could be considered somewhat surprising as the frequency 
distribution of CpG methylation in mammals is reportedly bimodal, with the majority of 
CpGs being either frequently or infrequently DNA methylated (Meissner et al., 2008).  
However, a similar observation has been reported for Hox gene promoter CpGs in MEFs, 
and also in some primary tissues (Xi et al., 2007; Tao et al., 2010).  I also wanted to 
establish DNA methylation patterns in intergenic regions, particularly at the many orphan 
CpG islands within Hox clusters that have been reported to show tissue-specific methylation 
patterns (Illingworth et al., 2008).  These regions also showed an intermediate DNA 
methylation in Dnmt1+/+ MEFs. 
 The intermediate patterns of DNA methylation that I observed prompted me to 
investigate the DNA methylation status of some of the same regions in primary MEFs.  I felt 
that this was important given that DNA methylation patterns have been suggested to change 
in cell culture, and K27me3 marked genes are particularly susceptible to hypermethylation in 
a variety of situations (Meissner et al., 2008; Rakyan et al., 2010).  DNA methylation was 
observed to be much reduced in primary MEFs at nearly all regions analysed.  This result 
means that currently, I cannot draw any conclusions about the DNA methylation pattern of 
Hox clusters from Dnmt1+/+ MEFs.  Further investigation is required to determine if the 
DNA methylation observed in Dnmt1+/+ MEFs indeed represents hypermethylation accrued 
in culture.  If this turns out to be the case then previously published work on DNA 
methylation in Hox clusters using cells in culture will also have to be reconsidered.  Further 
study using primary tissues would be useful here.  A further complication to this analysis is 
the observation of some regions within Hox clusters that do not show the expected 
hypomethylation in Dnmt1-/- MEFs, and the couple of regions that even have increased 
methylation in these cells.  As Dnmt1 levels are thought to be severely decreased in these 
cells, presumably, this effect is mediated by increased targeting of de novo 
methyltransferases to these regions (Li et al., 1992; Hackett, 2010, PhD thesis).  As the 
processes required to target these proteins in normal cells is not well understood, the cause 
behind this effect remains obscure.  One could speculate that increased H3K36me3 and 
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ncRNA transcription, as both have been linked to targeting DNMT3 proteins, could mediate 
this effect (Schmitz et al., 2010; Dhayalan et al., 2010).  However, as H3K36me3 and cDNA 
increases were observed to occur at many regions in Hox clusters, it is unclear why DNA 
methylation should be increased at only specific regions if this were the cause.  Another 
possibility that cannot be formally excluded is the presence of 5hmC which cannot be 
differentiated from 5mC using bisulfite sequencing (Nestor et al., 2010).    
 Currently, a detailed knowledge of the normal DNA methylation pattern at Hox 
clusters represents a significant gap in our understanding of the mechanisms at play here.  
Therefore, immediate future work should focus on this aspect in order to better understand 
the putative role of DNA methylation in K27me3 targeting.  MeDIP-chip could be 
performed using DNA from primary MEFs and/or tissue to begin to address this issue.            
 
5.3.2.  Involvement of CTCF and chromatin loops? 
 
A number of observations led up to the investigation of CTCF protein binding to putative 
boundary elements within Hox clusters.  For example, an apparent spreading of the K4me3 
histone mark and cDNA signal into the normally repressed Hox9-13 domain was observed at 
three of the four Hox clusters in Dnmt1-/- MEFs.  CTCF was observed to be bound to an 
element between the Hoxc8 and Hoxc9, and Hoxa7 and Hoxa9 (there is no Hox8 gene in the 
HoxA cluster), genes in Dnmt1+/+ MEFs when the two halves of these clusters appear to be 
partitioned.  The boundary element activity of this region has been tested by Kim et al. 
(2011) where it was shown to insulate a reporter gene from a silencing signal.  Also, proper 
K27me3 and gene expression patterns at the HOXA locus reportedly depend on CTCF in 
human foetal lung fibroblasts  (Kim et al., 2011).  Chromatin conformation capture (3C) 
assay suggested that this element interacts with a downstream region of the HoxA cluster, 
implying formation of an intra-chromosomal loop that may be important for the cluster 
partitioning in differentiated cells (Kim et al., 2011)(Fig. 5.14).  Interestingly, reduced CTCF 
association with this region was detected in Dnmt1-/- MEFs, where the cluster partition 
appears to be lost (Fig. 5.14).  It would be interesting to examine this observation in more 
detail.  Firstly, the X-ChIP assay would need to be repeated as only one experiment has been 
performed so far.  Also, the global levels of CTCF would need to be checked by western 
blot, although the equal binding to control regions observed by X-ChIP suggests that global 
levels of this protein are not affected in Dnmt1-/- MEFs.  No difference was observed in locus 
chromatin compaction by 2D FISH.  It would be interesting to investigate if the CTCF 
binding site does indeed form an intra-chromosomal loop in MEFs by 3C assay, and what 
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happens to this interaction in Dnmt1-/- MEFs (model shown in Fig. 5.14).  Importantly, 
functional experiments would be required to test if ablation of CTCF binding to this site 
recapitulates any of the observed changes at Hox clusters.  This could be performed by 
depletion of CTCF or by expression of a dominant negative CTCF protein, as performed by 
Zhang et al. (2011).  However, CTCF depletion reportedly leads to apoptosis, at least in the 
developing limb bud (Soshnikova et al., 2011).  Alternatively, to avoid global effects 
mediated by these methods, single CTCF binding sites may be disrupted by complementary 
locked nucleic acids, a novel approach reported by Ling et al. (2011). 
 
Figure 5.14 - CTCF-
mediated partitioning of 
Hox clusters.  A model for 
how a CTCF-mediated 
intra-chromosomal loop 
partitions a Hox cluster 
and prevents spreading 
of 'active' chromatin, 
represented by K4me3.  
Looping proposed by Kim 
et al. (2011).  In Dnmt1-/- 
MEFs, binding of CTCF 
and the loop structure 
may be lost allowing 
spreading of active 
chromatin marks and 
activation of the normally 
repressed Hox9-13 genes. 
 
 How would DNA methylation loss lead to loss of CTCF binding?  This question 
would have to be addressed next if altered CTCF binding is a contributor to the observed 
effect of DNA hypomethylation on Hox cluster regulation.  Although CpG methylation is 
thought to directly influence CTCF binding to certain cognate sites, it is suggested to have a 
negative effect.  How DNA methylation would be required for CTCF binding is therefore 
unknown.  Intriguingly, transcription of a ncRNA has been suggested to cause CTCF 
displacement in the activation of an LPS-induced gene (Lefevre et al., 2008).  In this respect, 
I observed an increase in cDNA and K36me3 signal in Dnmt1-/- MEFs, by custom tiled 
microarray, at the Hoxc8-c9 CTCF binding site.  However, a similar increase was not 
observed at the paralogous elements in the HoxA and HoxD clusters, although increased 
H3K36me3 was observed in regions flanking this element at the HoxA CBS5 site.  Further 
investigation into this possibility is required. 
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5.3.3.  Involvement of ncRNA? 
 
In this chapter, I correlate increased expression of intergenic ncRNA with loss of K27me3 in 
Dnmt1-/- MEFs.  Transcription through a PRC2 binding site has been linked with 
displacement of the complex and stable activation of nearby genes (Cavalli and Paro, 1998; 
Cavalli and Paro, 1999; Schmitt et al., 2005; Sanchez-Elsner et al., 2006).  How ncRNA 
transcription influences chromatin regulation has been a mystery in recent years but 
mechanisms for ncRNA-modulation of chromatin modifications are beginning to emerge.  A 
handful of studies have linked ncRNAs from mammalian Hox clusters to gene activation in 
cis (Rinn et al., 2007; Dinger et al., 2008; Wang et al., 2011; Bertani et al., 2011).  Some of 
these ncRNAs are suggested to bind and recruit TrxG proteins, like Wdr5 and Mll1 (Dinger 
et al., 2008; Wang et al., 2011; Bertani et al., 2011).  In fly, induction of transcription across 
a PRE using an exogenous promoter relieves PcG-mediated silencing (Schmitt et al., 2005).  
A 'sweeping' mechanism has been proposed to explain this where the act of transcription 
itself results in dissociation of PcG complexes as chromatin is disassembled (Hekimoglu and 
Ringrose, 2009).  Although the mechanism of action is still being established, the large 
number of studies that now link ncRNA transcription to gene activation in cis suggests a 
bona fide role for this type of gene regulation strategy.  Motivated by these studies, I 
hypothesised that ncRNA transcription could be a factor influencing K27me3 profiles at Hox 
genes in Dnmt1-/- MEFs.  This could occur in two ways; 1) DNA methylation may directly 
repress some of these transcripts and, hence, in this way be required for a correct pattern of 
chromatin marks and regulation of Hox clusters, or, 2) ncRNA may be increased in 
hypomethylated cells indirectly from the DNA methylation mark and contribute to PRC2 
displacement at certain loci.  I observed striking and abundant increases in intergenic 
transcription in Dnmt1-/- MEFs which correlate with K27me3 loss for genes represented on 
the custom tiled array.  I observed upregulation of cDNA signal at the annotated ncRNA 
Hoxa11as, but did not find a similar increase in regions around the ncRNAs reported to 
interact with TrxG proteins, such as Mistral (Bertani et al., 2011) and HOTTIP (Wang et al., 
2011) despite these RNAs being reportedly poly-adenylated.   
 The transcription body associated histone mark H3K36me3 has recently been shown 
to inhibit the activity of the PRC2 complex in vitro (Schmitges et al., 2011).  I reasoned that 
increased intergenic transcription may inhibit PRC2, at least partially, through this histone 
modification.  Consistent with this, H3K36me3 was observed to be increased in intergenic 
regions and also correlates with K27me3 loss (model shown in Fig. 5.15).  However, 
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whether this data is consistent with a major role for intergenic transcription and H3K36me3 
in K27me3 loss in Dnmt1-/- MEFs is unclear.  For example, a considerable amount of 
H3K36me3 was observed at certain regions in Dnmt1+/+ MEFs that are also marked by 
K27me3, such as the HoxB cluster and parts of the HoxA cluster.  This suggests that PRC2 is 
able to establish K27me3 at these regions despite marking by H3K36me3.  Also, the HoxB 
cluster shows loss of K27me3 from a defined region yet shows no evidence for increased 
intergenic transcription, in fact most of the cluster appears to be less expressed in Dnmt1-/- 
MEFs.  This region does however show increased H3K36me3, despite flanking regions 
showing loss of this modification in Dnmt1-/- MEFs.  Therefore, it remains unclear if this 
data is consistent with a universal role for intergenic transcription and H3K36me3 in 
K27me3 loss.  It is possible that certain regions are important for PRC2 recruitment which 
would then allow spreading of this complex and its K27me3 mark, as has been suggested in 
flies for example at PRE elements (Schwartz  et al., 2010).  This would mean that 
transcription at these specific regions would be important, rather than the clusters in general. 
 
 
Fig. 5.15 - A model for how 
increased ncRNA 
transcription at Hox clusters 
could contribute to K27me3 
loss in Dnmt1-/- MEFs. In 
Dnmt1+/+ MEFs, intergenic 
DNA methylation prevents 
expression of intergenic 
transcripts and the region is 
bound by the PRC2 complex 
and marked by K27me3. 
Increased ncRNA 
transcription occurs in 
Dnmt1-/- MEFs and may 
directly interfere with PRC2 
binding or inhibit PRC2 
activity through increasing 




 The limitation with this part of the project currently is that it is all correlative and no 
functional data has been generated.  It is equally feasible that intergenic transcription and 
H3K36me3 increases are a consequence of loss of K27me3.  These two possibilities will be 
difficult to separate as they would be expected to be intimately linked.  Future experiments 
in this direction could involve the use of a transcription inhibitor on cells in culture.  The 
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experiment would involve inhibition of transcription in Dnmt1-/- MEFs and assays for 
K27me3 level.  This experiment is far from perfect as the time required for re-establishment 
of K27me3 marks is unknown and cells would not be expected to survive long in culture in 
the presence of a transcriptional inhibitor.  Perhaps a better approach would be depletion of 
H3K36 methylases in Dnmt1-/- MEFs, although this would only test the role of this histone 
mark and not transcription per se.  There are four methyltransferases in mammals that have 
been suggested to mediate H3K36 methylation (Table 5.2).  Setd2, Nsd1 and Smyd2 are 
accepted as H3K36 methyltransferases but the in vivo substrate of Ash1l, the homolog of fly 
TrxG protein Ash1, is controversial (Yuan et al., 2011).  If H3K36me3 is required for 
normal Hox expression patterns then loss of the enzyme responsible would be expected to 
cause a developmental phenotype in mouse.  Knockout of Setd2 or Nsd1 results in 
embryonic lethality and mouse embryos null for Nsd1 fail to establish expression of Hoxa1 
and Hoxb1 (Hu et al., 2010; Rayasam et al., 2003).  Smyd2 is dispensable for embryonic 
development so is unlikely to play a major role in H3K36me3 at Hox clusters (Diehl et al., 
2010).  Ash1l has not been mutated in mouse as yet but interestingly, its homolog in fly has 
been linked to preventing the K27me3 mark (Papp and Mueller, 2006; Schwartz et al., 
2010).  All of these genes are deemed to be significantly present in Dnmt1+/+ MEFs by 
expression microarray (Table 5.2).  Therefore, it may be interesting to deplete each of the 
Setd2, Nsd1 and Ash1l proteins in Dnmt1-/- MEFs and examine the effect on K27me3.    
 
K36 methylase Knockout phenotype 
(mouse) 
Expressed in 




Setd2 Lethal at ~10 dpc Y Hu et al., 2010 
Nsd1 Post-implantation lethal Y (low) Rayasam et al., 2003 
Smyd2 Dispensable; subtle heart and 
lung phenotypes 
Y Diehl et al., 2010 
(Ash1l)? Not analysed Y (low) Yuan et al., 2011 
Table 5.2 - Proposed mammalian H3K36 methylases.  The in vivo substrate of Ash1l is 
debated.   
 
Whether the ncRNAs involved are directly repressed by DNA methylation remains 
unknown.  To investigate this possibility, mapping of these transcripts, together with a better 
understanding of DNA methylation patterns at intergenic regions in Hox clusters, would be a 
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good starting point.  More functional assays, such as region cloning and promoter assays 
coupled with in vitro CpG methylation, may prove informative. 
 Currently, I favour the idea that ncRNA transcription may contribute to loss of 
polycomb repression at certain loci, such as the HoxA and HoxC loci, and may explain why 
these regions are so drastically affected in Dnmt1-/- MEFs, but does not represent the primary 
cause of K27me3 loss.  A general requirement of normal PRC2 targeting may be an intact 
DNA methylation pattern, leading to a redistribution of K27me3 at many loci in DNA 
hypomethylated cells.  K27me3 loss may be exacerbated at certain loci, such as HoxA and 
HoxC clusters, because they are more sensitive to this effect.  Increased intergenic 
transcription could contribute to this increased sensitivity, rather than represent the primary 
cause of K27me3 loss.  Certain non-coding transcripts may also bind and recruit TrxG 
proteins to Hox genes, promoting their expression.  
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Chapter 6:  General discussion 
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6.1.  DNA methylation: A regulator of PRC2 targeting? 
 
My aim for this project was to investigate novel functions of DNA methylation in genome 
regulation.  I began by studying gene expression changes in a somatic cell line system that 
exhibits severe DNA hypomethylation.  This led me to investigate the role of DNA 
methylation in the regulation of genes of the Hox clusters, genes encoding transcription 
factors with important roles in embryonic development.  As Hox genes are major targets of 
the PcG repressor proteins, I became interested in the effect of DNA hypomethylation on the 
genomic distribution of the K27me3 histone mark, a surrogate for repression by the PRC2 
complex.  Finally, I returned to the Hox clusters to begin to study the mechanisms behind 
their mis-expression and the redistribution of K27me3 in DNA hypomethylated cells.  The 
main findings of this work are as follows: 
• Many PRC2 target genes are de-repressed in severely DNA hypomethylated Dnmt1-
/- mouse embryonic fibroblasts (MEFs) and MEFs treated with hypomethylating 
agent 5-aza-dC. 
• The organised regulation of Hox cluster genes is affected in Dnmt1-/- MEFs, co-
incident with a striking loss of the PRC2-associated K27me3 histone modification 
and dissociation of the PRC2 component Ezh2. 
• Posterior-expressed Hox gene regulation is also disrupted by treatment of anterior 
embryonic cells with demethylating agent 5-aza-dC and in Dnmt1 mutant early 
mouse embryos. 
• The distribution of the PRC2-associated K27me3 mark is severely altered in Dnmt1-
/- MEFs, with loss of the mark from many gene promoters that are normally PRC2 
targets, yet increase in the global levels of the mark.  Preliminary evidence suggests 
that K27me3 may be re-targeted in Dnmt1-/- MEFs to some regions that normally 
have high levels of DNA methylation. 
• K27me3 loss at Hox genes in Dnmt1-/- MEFs correlates with an apparent increase in 
intergenic transcription, as inferred by increased intergenic cDNA and transcription-
unit-associated H3K36me3 histone modification. 
 
 The most interesting aspect of this work, in my opinion, is the link between DNA 
methylation and K27me3 targeting.  At gene promoter regions I observed striking loss of the 
K27me3 mark in Dnmt1-/- MEFs at a large number of genes that are normally highly marked 
by this modification.  By integrating promoter DNA methylation data, I suggest that the 
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majority of these genes are associated with a CpG island at their promoter region that 
contains low level DNA methylation in MEFs.  Also, I observe a small number of promoter 
regions that show increased K27me3 in Dnmt1-/- MEFs and present preliminary evidence 
that these promoters are normally associated with DNA methylation.  Despite a striking loss 
of K27me3 observed at many of the normally most highly marked promoters, globally an 
increase in the K27me3 modification was observed in Dnmt1-/- MEFs by western blot and 
immunofluorescence (IF).  This poses an interesting question; where is the K27me3 
modification in Dnmt1-/- MEFs?  Addressing this question will be crucial to understanding 
the reason for K27me3 changes in these cells (discussed in the future work section).  The 
observed increase in global K27me3 suggests that hypomethylation leads to increased levels 
of this mark at regions outside of gene promoters.  This could potentially involve intergenic 
and gene body regions as both are thought to be highly DNA methylated in wildtype cells.  I 
propose a working model for the mechanism that drives the observed K27me3 changes in 
DNA hypomethylated cells, based on redistribution of K27me3 through altered PRC2 
binding throughout the genome (Fig. 6.1).     
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Fig. 6.1 - A working model for H3K27me3 redistribution in DNA hypomethylated cells.  In 
normal cells PRC2 binding is inhibited by DNA methylation and is targeted by a process 
involving unmethylated CpG islands (based on data from Mendenhall et al., 2010; Wu et al., 
2010; Bartke et al., 2010; Lynch et al., 2011).  When DNA methylation is severely reduced, 
as in Dnmt1-/- MEFs, the K27me3 mark is lost from many polycomb-target gene promoters 
while global levels of this mark are not decreased.  This implies that K27me3 is increased at 
regions outside of gene promoters.  I propose that the depletion from normal targets is in 
part caused by titration of the PRC2 complex due to increased binding elsewhere in the 
genome. In this model, derepression of some PRC2-targets occurs as a consequence of loss 
of H3K27me3 and PRC2 binding.   
 
Cytosine in CpG dinucleotides of the bulk genome are thought to be highly methylated in 
mammals, with stretches of low level DNA methylation thought to only occur at CpGs 
within CpG islands (Cooper et al., 1983; Bird et al., 1985; Meissner et al., 2008; Lister et al., 
2009).  Recent evidence suggests that PRC2 binding to chromatin is inhibited by DNA 
methylation, suggesting that the role of DNA methylation in K27me3 targeting may be a 
direct one (Wu et al., 2010; Bartke et al., 2010).  Therefore, the 'global' DNA methylation 
pattern in mammals may help to restrict K27me3 patterns.  Hypomethylation of bulk DNA in 
Dnmt1-/- MEFs may allow PRC2 binding at regions where it was previously inhibited.  Only 
a small proportion of the genome is made up of CpG islands so it is possible that a small 
increase in PRC2 binding at all normally DNA methylated regions could lead to the overall 
increase in the K27me3 modification globally observed in Dnmt1-/- MEFs.  Alternatively, 
increased K27me3 binding may only be observed at certain regions that are normally DNA 
methylated and also compatible somehow with PRC2 binding.  Many studies have now 
found negative correlations between the locations of DNA methylation and K27me3 across 
the genome, consistent with a high level of DNA methylation being inhibitory to PRC2 
binding (Wu et al., 2010; Lister et al., 2009; Hawkins et al., 2010; Lindroth et al., 2008).  
This idea is also supported by a recent study that suggests DNA methylation of CpG-rich 
regions can prevent PRC2 targeting in mouse ES cells (Lynch et al., 2011).  The other side 
to this working model is the reduced K27me3 observed in Dnmt1-/- MEFs at normally 
K27me3 marked promoters.  There have been several links drawn recently between PRC2 
targeting in mammals and CpG islands (Branciamore et al., 2010; Mendenhall et al., 2010).  
It has been suggested that the default state of a CpG island devoid of activating transcription 
factor binding sites in mouse ES cells, and possibly in differentiated cells, is PRC2 binding 
(Mendenhall et al., 2010; Lynch et al., 2011).  This was concluded as exogenous CpG-rich 
DNA that was inserted into these cells recruited the PRC2 complex and the K27me3 mark 
(Mendenhall et al., 2010; Lynch et al., 2011).  A role for CpG islands in PRC2 recruitment is 
supported by the observation that Ezh2 associates with GC-rich DNA in mouse ES cells and 
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that many K27me3 marked regions are associated with one or more CpG islands (Tanay et 
al., 2007; Ku et al., 2008; Mendenhall et al., 2010; Branciamore et al., 2010).  My data 
suggests that K27me3 is lost in Dnmt1-/- MEFs at promoters that contain a CpG island with 
low level DNA methylation.  My working model predicts that this effect may arise due to a 
titration of the PRC2 complex from normal binding sites by increased binding throughout the 
bulk genome.  This working model can be tested with the experiments proposed in the future 
work section of this discussion. 
 It is possible that the mechanisms proposed in chapter 5, involving intergenic 
transcription, altered CTCF binding and altered MLL occupancy, also contribute to the 
redistribution of K27me3 at some loci in Dnmt1-/- MEFs.  These mechanisms were discussed 
in the discussion section of chapter 5 and will not be repeated here.  Are MeCPs required as 
interpreters of the 5mCpG signal in order to properly target K27me3?  The mouse 
phenotypes of knockout of MeCPs studied so far are not compatible with gross changes in 
K27me3 distribution or PRC2 target mis-expression where severe embryonic phenotypes 
would be expected (for example, Guy et al., 2001; Zhao et al., 2003).  However, a role for 
MeCPs cannot be formally excluded as the possibility of redundancy among MeCPs has not 
yet been comprehensively excluded.  If MeCPs are not involved then alternative 
interpretation of 5mC may be required.  This could come directly from a core PRC2 
component or an accessory protein.  An in vitro assembled PRC2 complex consisting of only 
Ezh2, Eed, Suz12, RbAp48 and Aebp2 has been suggested to be inhibited in its binding to in 
vitro assembled chromatin by DNA methylation (Wu et al., 2010).  This suggests that one or 
more PRC2 components used in this assay are directly inhibited by DNA methylation.  A 
candidate for the negative effect of DNA methylation is Aebp2 which interacts with PRC2 
components and contains a DNA binding zinc finger domain (Cao and Zhang, 2004; Kim et 
al., 2009b).  It has not yet been reported whether the Aebp2-DNA interaction is influenced 
by DNA methylation.  Using homologene (NCBI), a homolog of Aebp2 does not seem to 
exist in Drosophila and C. elegans, although this would have to confirmed using more 
detailed analysis.  It would be interesting to perform in vitro chromatin binding experiments, 
with and without DNA methylation, using different components of the PRC2 complex, such 
as with and without Aebp2, to find out which proteins are important for this effect.  Also, 
examining the effect of Aebp2 depletion on PcG targeting in vivo would be interesting as a 
mouse lacking Aebp2 has not yet been generated.  It will be interesting to find out more 
about the apparent inhibition of PRC2 binding by DNA methylation, in particular by 
studying the proteins and mechanisms of inhibition that are involved.  
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 The results presented in this thesis suggest that the DNA methylation system may 
play a major role in targeting PRC2 and the K27me3 mark to specific regions of chromatin.  
Support for this idea in the literature comes from studies investigating K27me3 in DNA 
hypomethylated mouse mutant systems.  Interestingly, treatment of the human cancer cell 
line, 293T, with demethylating agent 5-azacytidine (a similar demethylating agent to 5-aza-
dC) resulted in loss of K27me3 from a large number of gene promoters that before treatment 
were highly marked by this modification (Komashko et al., 2010).  Also in this study, the 
global levels of the K27me3 mark were shown to be increased by western blot in cells 
treated with 5-azacytidine (Komashko et al., 2010).  Although this study uses cancer cells, 
which would be expected to have a drastically different DNA methylation profile from 
normal cells, it provides an encouraging independent validation of the observations made in 
this thesis.  Reduced K27me3 has been reported at a small number of PcG target genes in 
Lsh-/- MEFs, which exhibit reduced DNA methylation at these regions (Xi et al., 2007; Tao 
et al., 2011).  Also, cells from ICF patients carrying DNMT3B mutations display reduced 
K27me3 and PRC2 association at a small number of assayed gene promoter regions when 
compared to controls (Jin et al., 2008).  In this study, small decreases in DNA methylation 
were observed at these promoters but, of note, they are suggested to contain very little DNA 
methylation in control cells (Jin et al., 2008).  This appears similar to my observations in 
Dnmt1-/- MEFs, where gene promoters that show the greatest loss of K27me3 are associated 
with CpG island promoters with apparent low level DNA methylation normally.  Reduced 
DNA methylation has also been suggested to lead to increased K27me3 at certain regions.  
Knockout of Dnmt3a in mouse neural stem cells reportedly results in decreased expression 
of many genes required for neurogenesis (Wu et al., 2010).  Here, decreased DNA 
methylation from regions flanking promoter CpG islands was suggested to lead to increased 
binding of the PRC2 complex, increased K27me3 and inhibition of transcription (Wu et al., 
2010).  In support of this idea, the PRC2 complex was shown to be inhibited by DNA 
methylation in an in vitro chromatin methylation assay (Wu et al., 2010).  In this study, 
many gene promoters also showed decreased K27me3 and were transcriptionally 
upregulated in Dnmt3a mutant neural stem cells, but this was not reported in detail as it was 
not a focus of the paper (Wu et al., 2010).  In addition, western blot for K27me3 in Dnmt3a 
mutant neural stem cells hinted that overall levels of this modification may be slightly 
increased relative to wildtype cells (Wu et al., 2010).  As a form of validation, it will be 
interesting in the future to analyse the data from Wu et al. (2010) in more detail in respect of 
K27me3 changes, particularly in at the promoters found in my study to lose K27me3 in 
Dnmt1-/- MEFs.  In a recent paper, DNA hypomethylated Dnmt3a;Dnmt3b-deficient ES cells 
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were shown to exhibit de novo marking of normally-methylated CpG-rich regions with 
K27me3, supporting this idea (Lynch et al., 2011).  Together, these studies support my data 
suggesting for a role of DNA methylation in correct targeting of the PRC2 complex to 
chromatin.  Importantly, these data are consistent with my working model where widespread 
loss of DNA methylation leads to redistribution of K27me3 patterns, from PRC2 targets that 
are normally marked by low level DNA methylation, to non-PRC2 targets that are normally 
marked by high level DNA methylation (Fig. 6.1).   
 
6.2.  A potential new role for DNA methylation: Implications for gene regulation in 
development and disease 
 
What do these observations tell us about the roles of DNA methylation in the cell?  
Primarily, they suggest that an intact DNA methylation system is required for the correct 
distribution of the PRC2-associated K27me3 histone mark.  If true, this suggestion supports 
a major role for DNA methylation in gene regulation out with of canonical promoter DNA 
methylation-mediated gene repression.  Crucially, it means that genes associated with an 
unmethylated CpG island at their 5' end can still be dependent on DNA methylation for 
repression.  This considerably widens the scope for genes that can be regulated by DNA 
methylation, to include many highly tissue-specific genes with crucial roles in embryonic 
development that would not classically be associated with regulation by DNA methylation.  
This could help to explain the relatively large number of genes that are reportedly 
upregulated when Dnmt1 is mutated in somatic cells, despite the relatively small number of 
genes that are thought to be associated with DNA methylation at their promoter regions 
(Jackson-Grusby et al., 2001; Lande-Diner et al., 2007; Shen et al., 2007; Illingworth et al., 
2008; Meissner et al., 2008).  It could also contribute to an explanation for the phenotype of 
severe Dnmt1 mutation in mouse, where development is arrested and several structures fail 
to form (Lei et al., 1996).  In support of a role of DNA methylation in the regulation of PcG 
target genes, Hox gene mis-expression has previously been associated with DNA 
hypomethylation in multiple mouse mutant contexts, but the reason for this effect has 
remained unclear (Xi et al., 2007; Tao et al., 2010; Velasco et al., 2010).  An example is 
upregulation of certain HoxA genes in mice carrying compound heterozygous mutations in 
Dnmt3b, which occurs together with a homeotic skeletal transformation that is characteristic 
of Hox gene mis-expression (Velasco et al., 2010).  These observations could potentially be 
explained by a role for DNA methylation in PRC2 targeting to Hox clusters, as oppose to a 
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canonical promoter repression role of DNA methylation.  It will be interesting to investigate 
the cause of Hox gene mis-expression in more detail when DNA methylation is altered, 
particularly to try to dissect different roles that DNA methylation may play at different loci.   
 If true, this new role for DNA methylation could have implications for aberrant gene 
regulation in disease.  It has been observed that many genes found to be mis-regulated in 
patients with ICF syndrome, caused by DNMT3B mutations, are associated with CpG island 
promoters with low level DNA methylation in normal cells (Jin et al., 2008).  Furthermore, 
many of these genes are PRC2 targets and appear to have reduced K27me3 and association 
with the PRC2 component Suz12 in ICF patient cells, correlating with increased 
transcription (Jin et al., 2008).  Mis-expression of some of these genes, with their roles in 
neurogenesis, embryonic development and immune function, is consistent with some of the 
phenotypes of ICF syndrome.  Here, PRC2 targeting may be directly influenced by altered 
DNA methylation patterns in ICF patients, providing an explanation for mis-expression of 
these genes that would not normally be connected with regulation by DNA methylation.  
PcG target genes often play central roles in cell fate decisions, and, repression of lineage-
specific genes in multipotent progenitors by PcG proteins is thought to be crucial for 
maintenance of the stem cell state (Boyer et al., 2006; Bracken et al., 2010).  Recently, 
Dnmt1 was shown to be required for maintaining adult mouse stem cell populations in the 
multipotent state (Broske et al., 2009; Trowbridge et al., 2009; Sen et al., 2010).  
Specifically, depletion of Dnmt1 in hematopoietic stem cells and epidermal progenitors 
resulted in premature differentiation and differentiation skews towards certain cell lineages 
(Broske et al., 2009; Trowbridge et al., 2009; Sen et al., 2010).  Although loss of canonical 
promoter DNA methylation-mediated repression may account for some of the observed 
effects, it is interesting to speculate that an effect on PcG target genes may contribute to 
these phenotypes.  Altered DNA methylation patterns have also been linked to certain 
leukaemias.  For example, mutations in DNMT3A and TET2 have both been associated with 
certain types of leukaemia, where DNA methylation changes have been reported (Ley et al., 
2010; Yan et al., 2011; Ko et al., 2010; Ko et al., 2011).  One report suggests that DNA 
methylation patterns are altered at Hox genes in patients with DNMT3A mutations and that 
many Hox genes are differentially expressed (Yan et al., 2011).  It is interesting to speculate 
here that K27me3 changes are driving expression changes at these genes as a consequence of 
DNA methylation changes.  Redistribution of DNA methylation patterns have been reported 
in a variety of cancers and in some cases are thought to contribute to the cancer phenotype 
(Irizarry et al., 2009; Chen et al., 2009).  If my working model is correct then these changes 
would be expected to cause rearrangement of PRC2 binding and the K27me3 mark in cancer.  
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As PRC2 and K27me3 are well associated with the regulation of transcription, this could 
contribute to the aberrant epigenome that is observed in cancer (Boyer et al., 2006; Bracken 
et al., 2006; Wu et al., 2010).       
 These findings are also interesting from a polycomb research standpoint.  How PcG 
proteins are targeted to specific regions of the genome is not well understood and represents 
a major question in this area of research.  There is a growing connection in the literature 
between the DNA methylation and polycomb systems but exactly how they are related is 
unclear.  Much of the recent emphasis has been on a putative role for the PRC2 complex in 
targeting DNA methylation, either during cellular differentiation or in cancer (Mohn et al., 
2008; Vire et al., 2006).  However, epigenomic studies have suggested that the distribution 
of DNA methylation and K27me3 marks are in fact negatively related suggesting that this 
mechanism is not widespread (Lister et al., 2009; Hawkins et al., 2010).  The data presented 
in this thesis add to the growing connection between the two epigenetic systems, and further 
suggest that an extensive interplay exists between them.  Specifically, it is becoming 
apparent that the DNA methylation mark may act as a major factor in determining PRC2 
binding throughout the genome.  A better comprehension of this process will be crucial to 
understanding how PcG complexes are targeted in mammals.   
 
6.3.  How is PRC2 targeted in organisms lacking CpG methylation? 
 
An important evolutionary question is raised by this work.  Assuming CpG methylation does 
play a major role in targeting of the PRC2 complex and the K27me3 mark in mouse cells, 
how is PRC2 targeted in organisms lacking CpG methylation?  Drosophila melanogaster 
and Caenorhabditis elegans each contain no CpG methylation yet utilise PcG complexes in 
transcriptional repression.  It is therefore interesting to consider PRC2 targeting in these 
organisms in order to understand how a role for DNA methylation in this process could have 
evolved.  In C. elegans, although PcG homologs have been implicated in gene regulation and 
cell fate decisions, relatively little is known about the PcG system (Yuzyuk et al., 2009).  In 
comparison, much of the early work on PcG proteins was performed using Drosophila as a 
model organism and it is well established that PcG proteins are responsible for repression of 
many genes, including Hox gene orthologs, that have major roles in embryonic development 
(Schwarz and Pirrotta, 2007).  In fact, the mammalian orthologs of many of these 
developmental regulators are also PcG targets, suggesting a distant conservation of 
regulatory mechanisms at these genes (Schwarz and Pirrotta, 2007).  The Drosophila 
genome does not encode homologs of mammalian Dnmt1 or Dnmt3 proteins and, although 
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the extent and location of DNA methylation in this organism is a subject of debate, it is clear 
that DNA methylation is not at all abundant and that CpG methylation is not present at all 
(Suzuki and Bird, 2008; Phalke et al., 2009; Schaefer et al., 2010b).  For these reasons I will 
focus on Drosophila as an example of an organism with no CpG methylation.  Why would 
processes so well conserved as targeting PRC2 to developmental genes differ between fly 
and mammals? 
 First of all it must be stated that our understanding of PRC2 targeting in any 
organism is limited and so any argument presented here is based on a certain amount of 
speculation.  However, in Drosophila a link with sequence-specific DNA binding factors in 
PcG targeting is much better established than in mammals.  In particular, the Drosophila Pho 
protein is bound to PcG repressed regions and may be involved in targeting PcG complexes 
(Schuettengruber et al., 2009).  DNA elements, known as polycomb response elements 
(PREs), are capable of recruiting PcG complexes and inducing stable repression of adjacent 
reporter genes in Drosophila (Cavalli and Paro, 1998; Cavalli and Paro, 1999).  The search 
for PREs in mammalian genomes has so far produced few results.  A couple of PRE-like 
elements have been reported in mammals which have some of the characteristics of fly PREs 
(Sing et al., 2009; Woo et al., 2010).  The closest mammalian protein to a homolog of fly 
Pho is YY1.  YY1 has been implicated in activity of the PRE-like element described in Woo 
et al. (2010).  However, a wider role of YY1 in PRC2 targeting in mammals seems unlikely 
as a clear overlap between YY1 binding motifs and PRC2 binding sites has not been 
observed (Xi et al., 2007; Margueron and Reinberg, 2011).  In fact YY1 binding motifs are 
enriched in CpG islands that are not bound by PRC2 complex components in mouse ES cells 
(Ku et al., 2008).  There is also a difference in the pattern of PcG protein binding between 
fly and mammals.  In fly, all PRC2 and PRC1 components that have been mapped so far, 
with the exception of Pc, bind in sharp peaks at PREs and the K27me3 mark is found spread 
from these sites in large blocks (Schuettengruber et al., 2009).  In mammals, PRC2 
components are bound in a pattern more similar to the K27me3 mark, in regions covering 
small or large domains of chromatin, but not in sharp peaks (Boyer et al., 2006; Lee et al., 
2006; Bracken et al., 2006).  These apparent differences suggest that targeting mechanisms 
may be different between fly and mammals (Schuettengruber and Cavalli, 2009).  Perhaps in 
fly, PRC2 targeting is more reliant on PRE-like mechanisms where the proteins are recruited 
to defined genomic loci from which the K27me3 mark can spread.  
 The only DNA sequences that have been convincingly associated with PRC2 
binding sites in mammals so far is CpG islands (Tanay et al., 2007; Ku et al., 2008; 
Mendenhall et al., 2010).  Certain CpG islands that represent targets of PRC2 binding in ES 
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cells show evidence for strong conservation of CpG density suggesting that these regions are 
important, possibly for PRC2 recruitment (Tanay et al., 2007; Branciamore et al., 2010).  
CpG depletion from the bulk genome is thought to have occurred mainly via spontaneous 
deamination of 5mC to uracil and subsequent failure to repair (Bird et al., 1985).  It should 
also be noted that the GC content of CpG islands is higher than the rest of the genome, which 
cannot be explained by the increased CpG content alone (Bird, 2011).  The Drosophila 
genome, with no CpG methylation, does not show CpG depletion and so relative to 
vertebrate genomes, in some ways is like one big CpG island (Bird, 2011).  Also, the 
Drosophila genome does not show evidence for selection of high CpG content within Hox 
gene coding regions that is observed in vertebrate genomes (Branciamore et al., 2010).  It is 
tempting to speculate that binding of the PRC2 complex in Drosophila is potentially more 
permissive, whereas in vertebrates, binding may be guided by CpG islands.  CpG islands 
may be preferred binding sites of the PRC2 complex in vertebrates for a number of reasons, 
such as their low DNA methylation, high GC content or another aspect of their unique 
chromatin state.  As the Drosophila genome contains no CpG methylation and displays no 
depletion of CpG dinucleotides or GC content it may be more compatible with PRC2 
binding.  Perhaps for this reason PRC2 recruitment in Drosophila is more reliant on a PRE-
like mechanism as they have lost CpG methylation during their evolution.  Evidence for 
PRC2 inhibition by DNA methylation in distantly related species would be very interesting 
here.  Interestingly, correlative evidence for this process in Arabidopsis has been reported, 
where the presence of DNA methylation in vegetative tissues at genes that are PRC2 
homolog targets in endosperm, correlates with lack of PRC2 binding in vegetative tissues 
(Weinhofer et al., 2010).   
 
6.4.  Future work 
 
In terms of immediate future work I think it will be important to map DNA methylation in 
primary cells and tissues with special attention paid to the Hox clusters.  This will be 
important to understand the reason for their mis-expression in DNA hypomethylated cells.  
In order to test the working model of K27me3 redistribution in hypomethylated cells (Fig. 
6.1), it will be crucial to determine where increases in the K27me3 mark have occurred in 
Dnmt1-/- MEFs, and how these changes relate to DNA methylation status.  As K27me3 
increase appears to be rare at gene promoter regions, a more genome wide approach here is 
required.  ChIP-chip using genome wide tiled microarrays or ChIP-seq (ChIP followed by 
sequencing) for the K27me3 mark would be useful here as regions outside promoters can be 
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studied.  Studying the characteristics of regions that gain K27me3 in Dnmt1-/- MEFs, 
including their DNA methylation status in normal and Dnmt1-/- cells, will hopefully provide 
key information on the processes driving K27me3 redistribution in these cells. 
 To ask if the DNA methylation mark itself is important it will be interesting to 
attempt to rescue the defects in K27me3 targeting in Dnmt1-/- MEFs by reintroducing 
wildtype and catalytic inactive Dnmt1 proteins.  This is an experiment that I have been 
attempting for a while but so far have been unsuccessful.  A rescue with wildtype Dnmt1 
would also help to exclude that changes are due to an artefact of the Dnmt1-/- MEF cell line.  
However, it should be noted that even if Dnmt1 protein levels are re-established in these 
cells, it is not known if DNA methylation will be fully restored.  Rescue of DNA 
methylation levels has been achieved by Dnmt1 expression in ES cells deficient for Dnmt1 
(Damelin and Bestor, 2007; Takebayashi et al., 2007).  ES cells appear to possess a high 
level of Dnmt3 proteins and de novo methyltransferase activity, perhaps allowing them to be 
able to re-establish methylation patterns (Xie et al., 1999; Okano et al., 1998a).  It remains to 
be seen if the same will be true for MEFs where de novo methyltransferase levels are 
expected to be lower.   
 Importantly, multiple experimental systems were used during this project, suggesting 
against the possibility that differences in gene expression and histone modifications observed 
in Dnmt1-/- MEFs represent artefacts of this cell line.  However, I think that this study would 
benefit from a more extensive validation of the observations using another DNA 
hypomethylated system.  For example, a more detailed analysis of K27me3 distribution in 
cells treated with 5-aza-dC would help to confirm observations made using Dnmt1-/- MEFs.  
It may be interesting to investigate ES cells lacking all three active DNMTs as these cells are 
nearly completely lacking CpG methylation (Tsumura et al., 2006).  Knockout of different 
combinations of DNA methyltransferases in ES cells results in different patterns of 
hypomethylation potentially allowing dissection of the effect of DNA methylation on PRC2 
targeting (Jackson et al., 2004).   
 In the longer term, ideally, I would like to use a more physiologically relevant 
system for DNA hypomethylation, to confirm the observations made using in vitro cell 
models.  This could include more work using Dnmt1 mutant embryos.  The use of 
conditional knockout cell lines established from mouse embryos, or defined cell populations 
such as haematopoietic stem cells could prove useful here and provide a more physiological 
angle to the study.  It may also be interesting to examine the effect of DNA methylation on 
PRC2 targeting in other organisms.  Distant vertebrates, such as zebrafish or Xenopus laevis, 
could be used here to study this effect in other organisms with global methylation patterns, 
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and provide information about conservation of this mechanism.  Finally, I think it would be 
interesting to examine the effect of an altered DNA methylome in cancer, on the PRC2 
complex and K27me3 mark.  Following my model, as DNA methylation patterns are 
drastically redistributed in certain cancers, this would be expected to cause substantial 
changes in binding of the PRC2 complex to chromatin, and hence contribute to the 'cancer 
epigenome'. 
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Appendix 1 - Summary of custom tiling array design 
 
Locus Length of tiled region 
(bp) 
Coordinates in UCSC Genome Browser on Mouse July 2007 (NCBI37/mm9) 
Assembly 
Hoxa 818,585 chr6:51,781,416-52,600,000 
Hoxb 755,001 chr11:95,845,224-96,600,224 
Hoxc 702,398 chr15:102,400,000-103,102,397 
Hoxd 668,990 chr2:74,241,352-74,910,341 
Hba 237,547 chr11:32,087,454-32,325,000 
Hbb 197,639 chr7:110,861,362-111,059,000 
Shh locus 1,221,001 chr5:28,489,000-29,710,000 
Kcnq1 locus 394,001 chr7:150,256,000-150,650,000 
Dlk1 Meg locus 136,468 chr12:110,693,533-110,830,000 
Gnas locus 69,619 chr2:174,105,382-174,175,000 
H19 locus 137,587 chr7:149,730,414-149,868,000 
Mest-Kl14 locus 225,001 chr6:30,685,000-30,910,000 
Pax6 35,000 chr2:105,505,001-105,540,000 
Brachyury 150,001 chr17:8,554,691-8,704,691 
Gsc 50,001 chr12:105,687,160-105,737,160 
Hhex 40,001 chr19:37489346-37529346 
Nestin 28,077 chr3:87,765,656-87,793,732 
Lin28 27,001 chr4:133,553,000-133,580,000 
Pou5f1 9,401 chr17:35,640,600-35,650,000 
Sox2 23,606 chr3:34,540,712-34,564,317 
Nanog 10,001 chr6:122,656,000-122,666,000 
Klf4 13,200 chr4:55,536,078-55,549,277 
C-Myc 15,063 chr15:61,811,875-61,826,937 
Mirlet7-D 14,164 chr13:48,630,830-48,644,993 
Gata1 17,112 chrX:7,532,108-7,549,219 
Gata4 13,904 chr14:63,855,878-63,869,781 
Cdx2 12,700 chr5:148,110,571-148,123,270 
Asl1/Mash1 6,000 chr10:86,953,114-86,959,113 
Nkx2-9 6,000 chr12:57,709,722-57,715,721 
Myf5 6,262 chr10:106,919,672-106,925,933 
Olig2 7,038 chr16:91,223,137-91,230,174 
Magea3 8,801 chrX:151,379,200-151,388,000 
Tex19.1 8,770 chr11:121,004,657-121,013,426 
Dnmt3b 16,799 chr2:153,470,702-153,487,500 
Rpl19 6,164 chr11:97,886,000-97,892,163 
Actb 5,414 chr5:143,663,892-143,669,305 
Aard 8,426 chr15:51,869,406-51,877,831 
Adssl1 31,878 chr12:113,852,987-113,884,864 
Ankhd1 6,329 chr18:36,715,293-36,721,621 
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Aurkb 9,030 chr11:68,856,737-68,865,766 
Brd3 41,055 chr2:27,296,495-27,337,549 
Chchd7 10,373 chr4:3,862,488-3,872,860 
Chmp4b 56,637 chr2:154,473,323-154,529,959 
Crabp1 12,453 chr9:54,610,540-54,622,992 
Ctnnal1 81,381 chr4:56,810,244-56,891,624 
Ddx6 48,314 chr9:44,404,928-44,453,241 
Emilin2 88,185 chr17:71,586,819-71,675,003 
Eno1 8,210 chr4:149,609,995-149,618,204 
Fgf10 115,623 chr13:119,484,571-119,600,193 
Fus 21,830 chr7:135,107,354-135,129,183 
Gypa 25,112 chr8:83,013,758-83,038,869 
Hebp1 46,046 chr6:135,079,862-135,125,907 
Hemgn 15,293 chr4:46,404,312-46,419,604 
Hnrpa1 8,303 chr15:103,068,649-103,076,951 
Jarid1b 8,076 chr1:136,453,744-136,461,819 
Ly6a 6,777 chr15:74,823,425-74,830,201 
Ly6c1 5,724 chr15:74,874,491-74,880,214 
Mapk1ip1l 37,167 chr14:47,911,795-47,948,961 
Mlkl 39,156 chr8:113,829,174-113,868,329 
Npm3 5,490 chr19:45,820,805-45,826,294 
Nrn1 13,244 chr13:36,815,287-36,828,530 
Pcdha7 locus 1,012,030 chr18:36,996,988-38,009,017 
Pdlim2 20,183 chr14:70,560,661-70,580,843 
Ppm1b 5,838 chr17:85,352,959-85,358,796 
Ppp1cc 5,664 chr5:122,604,605-122,610,268 
Pramel4 15,290 chr4:143,646,480-143,661,769 
Prf1 9,716 chr10:60,757,991-60,767,706 
Psip1 36,768 chr4:83,097,979-83,134,746 
Shmt2 11,919 chr10:126,950,487-126,962,405 
Sif1 13,637 chr16:18,262,780-18,276,416 
Slc7a3 9,198 chrX:98,273,946-98,283,143 
Snx17 12,596 chr5:31,492,177-31,504,772 
Srebf2 86,538 chr15:81,963,276-82,049,813 
Tcfap2a 27,278 chr13:40,807,558-40,834,835 
Tle1 4,134 chr4:71,858,971-71,863,104 
Tnik 6,790 chr3:28,159,250-28,166,039 
Xlr4a 12,245 chrX:70,317,643-70,329,887 
Zbtb2 31,535 chr10:5,953,177-5,984,711 
Xist 34,292 chrX:100,649,996-100,684,287 
Total 8,200,080  
Appendix 1 - Summary of custom tiled Nimblegen microarray regions. 
 
220
Appendix 2 - Gene lists defined in chapter 4 through 
epigenomics 
 
Lists of gene promoters defined in chapter 4 as having significantly different enrichment of 
either K27me3 or K4me3 in Dnmt1-/- relative to Dnmt1+/+ MEFs as measured by promoter 
microarray.  Changes at these promoters surpasses thresholds set according to chapter 2.  
 
K27me3 lost in Dnmt1-/- MEFs (difference < -0.6815459 (for Dnmt1-/- - Dnmt1+/+)) 
Hoxa7 Hoxc6 Hoxa11as Hoxc5 Hoxc11 Hoxc10 
Hoxc9 Vax2 Zic5 Hoxc12 Hoxa9 Mir10a 
Hoxb6 2700086A05Rik Hoxa10 Mecom Hoxc8 Psmb8 
Insl3 Hoxd12 Hoxa4 Hoxb5 Hand2 Rpp25 
Hoxb2 Hoxc4 Hoxa6 Tnfsf9 Hoxb3 Pax9 
Pde1b Tbr1 Hoxa13 Mfsd7a Tcfap2a Nr4a3 
Esx1 Pitx1 Bhlhe22 Trim14 Gramd1b Mkx 
Foxf2 Gatm Shank3 Grtp1 Nmnat2 Dmrta2 
Hoxc13 Hoxd4 Hand1 Neurog3 Fam113b Ripk4 
Hoxb7 Cldn5 Dnm3 Prdm8 Gm5089 Foxq1 
Syt13 AI118078 Mfsd6 Gata4 Has3 Csf2rb2 
Pax6 Dnaja4 Csf2rb Slc6a5 Rem1 Crlf1 
Frzb Btnl7 Fam69c Gfra4 EG547347 Srgn 
Hoxd10 Ddx60 Osr2 Msx1 Uts2r Wnt2b 
Wnt10a Kcnc2 Macf1 Zbtb8b Wnt5b Clic5 
Tacc1 Nrgn Adam33 Gata2 Kcnk5 Atp6v1b1 
Fbxo39 Itpr1 Ptpn5 AI182371 Mapk15 Hoxd9 
Aim1 Ebf2 Dmrt2 Nos3 Fgf17 Tcf21 
B3gnt3 Mppe1 Ppp1r3c Isl1 T Tap1 
Slc16a12 Lmx1a Smoc2 Gpam Spink2 Panx1 
Rap1gap Phox2b Tbx4 Slc47a2 Fli1 Sox14 
Evx1 Foxd4 Tap2 Tll2 Foxa1 Spatc1 
Cck 6430571L13Rik Sim2 H2afy2 Usp18 H2-D1 
Myoc Gata6 Parp14 Il17d Fgf8 Crabp1 
Prss16 Kcna1 Selp Slmo1 Apc2 Gdf7 
Col13a1 Hspa12a Foxb2 Sele Chn2 Fabp3 
Tmed8 Cxxc5 Nr5a2 Clec11a Alx1 Phldb3 
Dpep1 Dscam Prox1 Foxb1 Sv2c Raet1e 
Map3k9 Sp5 Gdnf Sp9 Frmd5 Vipr1 
Shisa7 Esrra Lbx2 Inmt Tbx20 Enpp2 
Lhx2 Neurod1 Notum Prdm1 Ifit1 Strc 
221
Grhl2 Cldn3 Ramp1 Arg2 Olig3 Fgd4 
Tbx5 Nkx2-3 Adra1a Egflam 1500009L16Rik Epb4.1l4a 
Nrg4 Cabp2 Slc13a5 Isl2 Dlx4 Fbln7 
Herc3 Podxl Zfp385a Arhgap28 Hhipl1 Adrb1 
Hoxa2 Rgl3 Fam40b Fam83h Ppp1r1a C530028O21Rik 
Rhou Gfi1 Gal Afap1l2 Pigz Atp2b3 
Kcnq4 Cyp1b1 Acpl2 Tmem221 Ppp1r3b Sell 
Sim1 Fam89a Fezf2 F11r Tcp11l1 Eya1 
Wnt3 Irx6 Mgat4a Six3 Spats2l Ebf1 
Nphs2 Trpc1 Sectm1a Isoc2b Prlhr Ttc7b 
Slco4a1 Htr6 0610010O12Rik Islr2 Cyp26a1 Gsx2 
Zic2 Ezr Zfp503 Pdgfra 9030224M15Rik Nkain4 
Cilp2 Lrtm1 Greb1 Xlr4a Peli2 Cyp27a1 
Gbp6 Hnf1b Arhgap9 Phactr2 Dcst1 Kcns2 
Ttc9 Fam149a Neurog1 Bmyc Usp44 Nkx6-3 
Vax1 Fmo2 Nxph4 Helt 9530036O11Rik Otop1 
Sema4g Rgs20 Aldh1l1 Gm5878 Cdk5r2 AA388235 
Tbx2 Pla2g3 Ngb Kcnh2 Rax Slc16a13 
Otx2 Hoxd3 Slc6a2 Ddn Prdm6 Pdx1 
Wnt9b Pls1 Raet1a Hmx1 Cryba2 Hmx2 
Sfmbt2 Dll4 Ido1 Klf1 Prr18 Nkx2-2 
Gm266 Nkx1-2 9030612E09Rik Rln1 Higd1c Tprg 
Six6 2010015L04Rik Kcnk13 Creg2 BC089491 Antxr1 
Ptpn7 Ltb4r1 Cyb561 Nr2e1 Hpse2 Pax7 
D930020E02Rik Kis2 Dlx6os1 Gata5 Gpr162 Tcf7 
Enpp1 Il13 Nefl Anpep Kdelr1 Arx 
Fxyd6 Prdm12 Nkx6-2 Srd5a2 Adora1 Arl5c 
Clec1b Myod1 Rgs10 Selm Itga11 Hoxd11 
Gkn1 Slc6a4 Dpys Nckap1l Nppc Ccno 
Nrarp Icam2 Gm3238 Rbpms 5730409E04Rik Dbx1 
Mlkl Foxa2 F5 Dmrt3 Stc2 Ckmt1 
Hspa12b Sall1 Msx3 Tcfap2c Zbtb16 Raet1d 
Tmprss7 Ptpn22 Sox1 Gstt2 Sp8 Tcfcp2l1 
Slc32a1 Ptprf Igsf3 Slc27a2 Sectm1b 2900005J15Rik 
Spock2 Msx2 Atoh1 1200009O22Rik Rbpjl Aqp3 
Col27a1 Cd27 Kcnip2 Zar1 Pdlim3 Slc47a1 
Tnfrsf19 Rgs11 Rfx4 Klhl26 Pip5k1b Lgr6 
Pigh Kcnh5 Cybrd1 Lmbr1 Lyn Trim36 
Sigirr Gcnt1 Cd24a Sall4 Apoh Barhl1 
Tmem181a Ptp4a3 Stag3 Acta1 Pax5 Spats1 
Prok2 Parvb Wnt2 Rapgef4 Cxcr4 Atp1b2 
7420416P09Rik Ankrd43 Pla2g10 Nkx2-5 Sel1l3 C1ql2 
Il24 Calcb H2-K1 Olig2 Ica1l Nags 
Egfr Hc Pacsin3 Gcgr Nkx3-2 Lrp2 
Chst11 Rasl12 Smtnl2 Pou4f2 Rtbdn Zdhhc23 
222
Barx2 Celf6 Dock8 Kcp H2-Bl Rab19 
Tal2 Mpzl2 Gm2002 BC068157 A4galt Ptf1a 
Osbpl5 Slc9a2 Hs3st3a1 Ankrd56 Abcb9 Ntng2 
Kremen2 Tmem210 Plcb2 Ism1 Syt6 Ugt1a7c 
Calcr Rasgrp2 Sncaip Npy H2-Q1 Lrrc10b 
Kcnip3 Adcy1 Wfdc2 Gad2 Tlx1 H2-Tw3 
Hpcal4 Otp Mafb Apobec3 Icmt Nfasc 
Cgn Tex19.1 Lhx8 Bub3 Pcdhac2 Vipr2 
Shmt2 Gng4 Ppp2r2c Fam189a2 Ugt1a2 Rnf32 
Tnfrsf10b Flt4 Penk Lhx5 Hoxb13 Gdf6 
Kcnk4 Cdh1 Crip1 Abcg8 Eps8l1 Adipor2 
Nhlh2 Rab15 Kcna6 Prkg1 Mnx1 Slc16a9 
Gm12824 Gpr3 Prrxl1 Jak3 Frmd4a Mixl1 
Slc6a20a Rab17 Evx2 Nkx2-6 1110032A04Rik Disc1 
Robo2 Barx1 G630025P09Rik Bhlha9 Cacng6 Gal3st4 
Fmo5 Gm10565 Lonrf3 Dhh Wt1 Apol10b 
Spocd1 Htr2a Tubb4 Duoxa2 Klf15 Kcnh8 
Prdm16 Prr15 Gbp5 Tyro3 Cenpv Krtap5-1 
Kbtbd12 Tcfap2d Prdm13 Irf5 Pcnxl2 Lrrn2 
Hapln4 Scnn1a 2410137M14Rik 6430704M03Rik Depdc7 AI661453 
Hdc Nr1h3 Il28ra Prdm14 Esrp1 Hpse 
Sox7 Gstm4 Npm2 Tbx1 Dnajc22 Cpne7 




K27me3 gain in Dnmt1-/- MEFs (difference > 0.5656917 (for Dnmt1-/- - Dnmt1+/+)) 
Olfr648 AU015228 Ankrd7 Acot10 Snord116 Olfr461 
Gm15085 Iltifb Pcdhb20 C130026I21Rik Il23r H19 
Olfr272 Rex2 Gm428 Sp140 Rit2 Tmem176a 
Acpp Cyp7a1 Myh1 EG381936 Dbp Tmem125 
Prr23a Il22 Pcdhb18 Gm13051 Slc1a3 2610305D13Rik 
Sftpa1 Olfr649 A530032D15Rik Gm15127 2610528J11Rik Myh4 




K4me3 gain in Dnmt1-/- MEFs (difference > 0.5363075 (for Dnmt1-/- - Dnmt1+/+)) 
Hoxc10 Hoxa11as Hoxc11 Hoxa9 Hoxa10 Nostrin 
Xdh Rbmy1a1 Csf2rb2 Cort Hoxc9 Mfsd7a 
Agrn Hk3 Arhgap9 Csf2rb Rltpr Tuba3b 
Rhox4a Fyb F10 Lat Endou Irf7 
223
Arl9 Gm5105 Spink2 Oplah Olfr282 Pou6f1 
Sipa1l2 Clec11a Gpat2 Anpep Jph2 Rho 
Wfdc15a Tnfsf13b Tex13 4930511M11Rik Hand2 Spatc1 
Efnb3 Hoxd10 Mia2 Amn Tlr6 Kcnu1 
Thbs2 A430078G23Rik Gjb5 Adam33 Hnf1b Ido1 
Tex19.1 Nlrp4c Sectm1b Hoxc12 Rhox4e Sdr42e1 
Dnajb8 Actl7a Wnt10a Chad Rnf186 Slfn3 
Nat2 Cela3b 1700018B24Rik Olfr750 Dpep2 Aldh1l1 
Fam83h Clec1a Xlr4a Hsh2d Lrrc10 Hoxc13 
Sla2 Sh3d19 Sycp3 Sstr2 Olfr234 Zfhx2as 
Apob48r Lim2 Krt18 Dennd1c Spocd1 Pla2g5 
4933403G14Rik Esr1 Gbp5 Higd1c Xlr3a Slc15a3 
2610036D13Rik Col17a1 Thbd 2200002K05Rik 1700018L24Rik Syce1l 
Dcst1 Mylk3 Krt23 Aox4 Naprt1 1700039E15Rik 
Kcnn4 Csl 1700090G07Rik Sectm1a Mb Inhbe 
Sgcg Gm13011 Nphs2 Icam2 Gm1968 Aim2 
Cabp2 Xlr3c Mov10l1 Nrap Mab21l1 Vax2 
Hand1 Xlr3b Dnase1l3 Apol10b Klb Gpr37l1 
Ccdc135 Klhdc7b Gm8884 Cacng6 Cxcl1 Lypd2 
Dhx58 Lrrc25 4930563D23Rik Nrl Olfr71 Ido2 
Rhox4f Mpeg1 Cpsf4l Jakmip1 Mboat4 Ly86 
1700018B08Rik LOC100039801 Clcnka Ankrd36 Hoxd11 1700061G19Rik 
Sparcl1 Mmp27 Catsper1 Tnfrsf14 Gm12776 Crispld2 
Odf3l2 Gm7616 Hoxa7 Gtsf1l Gzmk Klk10 
Wfdc1 Isoc2b Naip6 Nat3 Krt36 Inpp5d 
Pon3 Sirt5 Apob Ccdc42 Sult2b1 Cmtm2a 
Sohlh2 Rhox4b Gm16378 Cd27 Dkk4 Anxa8 
Tmem150b Dpys Slfn4 Nhedc1 Ghrh Slc36a2 
Gatm Pi15 Apol7b Acrbp Gdf2 Rps4y2 
Qrich2 Lepr Mettl8 Phc2 Gstp2 Sult5a1 
Cpa5 Cyp26c1 C1qtnf3 BC016201 Arhgef18 Tagap 
Krt14 Prss38 Aqp6 Atp6v1e2 Rpl39l Evx1 
Blnk Stra8 Tnf Tmem232 Prkag3 C4a 
Pla2g4f Cdh5 Gdf5 Trpd52l3 Kcnj14 Oasl1 
BC027072 Htatip2 Chrna2 Hoxa13 Wfdc10 Tfpi 
Tdrd1 Slc13a5 Slc22a13 Zfp366 S100z BC054059 
Ranbp3l Kcng1 Elfn2 Pcgf5 Kiss1 Batf2 
1700094C09Rik Car6 Hdc Il12a Itgb2 Pla2g2e 
4930519G04Rik Krt17 Naip5 Arl11 Lgals9 Rab37 
Cmtm2b Gm7534 Pkd1l3 Slc24a5 Hspb3 Tcte1 
Bhlha15 Sgk2 Cdkl4 Gm1006 Nkx2-3 Sit1 
Gm12250 Syce1 Apobec4 Pdzk1 Tm6sf2 Slco4a1 
4930538K18Rik Eps8l3 Msln Dok2 6430548M08Rik Cdc42ep2 
Gramd1b Itgb6 Zfp709 Gsdmc3 Actbl2 Adprhl1 





K4me3 loss in Dnmt1-/- MEFs (difference < -0.5194664 (for Dnmt1-/- - Dnmt1+/+)) 
Tceal1 Gm1993 D330045A20Rik Zfp532 Stc1 4930519F16Rik 
Sv2a Flrt1 Zfhx4 Phyhd1 Cdo1 Itm2a 
Creld1 Efemp1 Zfp503 Slx Nr3c2 Sulf1 
Gdpd2 Dlx5 Lpar4 Col4a5 Nap1l2 Gria3 
Alx4 Pde9a Ddx3y Rxfp3 Gm5458 Cdh10 
Ntf3 Gm14347 Mir301b AW551984 Six2 Gm4297 
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